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Influenza is a major cause of death worldwide. In an attempt to decrease the morbidity 
and mortality associated with influenza, as well as its financial cost and burden to 
healthcare services, the influenza vaccine has been offered to children in England since 
2013. However, uptake is low. Fear of side-effects has been well-established as one of 
the major factors contributing to vaccination refusal. But not all side-effects perceived 
after vaccination can be attributed to the vaccine. Multiple psychological factors related 
to the ‘nocebo’ effect may influence parental perception of side-effects from 
vaccination. The role of cognitive biases and heuristics in vaccination has been well-
explored. However, there is no research investigating whether information processing 
biases are associated with vaccination behaviours. In this thesis, I aimed to identify 
psychological factors which were associated with uptake of the child influenza vaccine 
and parental perception of side-effects from vaccination.  
I conducted a nationally-representative online survey of parents of vaccine-eligible 
children in the 2015/16 influenza season (n=1001). Results suggested that believing that 
the vaccine caused adverse effects were associated with not vaccinating one’s child and 
perceiving side-effects from vaccination in those who did vaccinate. However, the 
cross-sectional nature of this study made it difficult to infer causality. To better 
investigate predictors of parental perception of side-effects from vaccination I 
conducted a prospective cohort study in the 2016/17 influenza season (n=270); the last 
follow-up was at the end of the 2017/18 influenza season (n=232). I found that multiple 
psychological factors were associated with parental perception of side-effects from 
vaccination. In particular, pre-vaccination expectations were strongly associated with 
perceiving side-effects from vaccination. I also investigated rates of re-vaccination for 
influenza in the 2017/18 season and factors associated with re-vaccination. Results 
indicated that over one in six children were not re-vaccinated for influenza in 2017/18. 
Perceived severity of side-effects from vaccination in 2016/17, and parental worry about 
side-effects perceived, were associated with not re-vaccinating one’s child in the 
2017/18 season. 
While many studies have identified that parental perception of side-effects plays a major 
role in vaccination refusal, few studies have investigated potential causes of parental 
perception of symptoms. My results indicate that managing parents’ expectations about 
the incidence and severity of vaccine side-effects may decrease parental perception of 
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side-effects from vaccination. Decreasing worry about side-effects perceived may 
increase vaccine uptake and re-vaccination rates. These are novel targets for vaccine 
communications and interventions.  
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Chapter 1. Influenza and the child 
influenza vaccine 
What are the deadliest diseases? When asked, many will point to infectious diseases 
currently attracting the greatest media attention, such as the Ebola and Zika viruses. 
Others might consider diseases that perpetually plague the developing world and result 
in periodic charity appeals in the West, for example cholera or malaria. People would 
rarely include common seasonal influenza on their list of the most troubling infectious 
diseases. Yet seasonal influenza causes up to 650,000 deaths a year (1); a great many 
more than diseases which often attract considerably more attention. For example, the 
Ebola outbreak in West Africa caused 11,310 deaths between December 2013 and June 
2016 (2). The latest figures indicate that there have been 303 deaths (of which 255 are 
confirmed and forty-eight are probable) in the Ebola outbreak declared on 1st August 
2018 (3). The Zika virus has been detected in 86 countries and has caused multiple 
outbreaks. One of the countries most affected by the Zika virus is Brazil, with over 
241,000 cases identified since 2016 (4, 5). However, Zika virus causes severe 
neurological complications in new-borns rather than death (6). Other diseases which 
attract a huge amount in charity donations also cause fewer deaths per year. For 
example, influenza causes almost seven times more deaths annually than cholera 
(estimated at 95,000) (7) and 50% more deaths annually than malaria (445,000 in 2015 
and 445,000 in 2016) (8). Annual estimates of deaths for influenza also surpass the 
number of deaths for one of the most common forms of cancer: breast cancer (627,000 
in 2018) (9). This stark fact has led to a raft of measures being introduced by 
governments around the world to combat influenza. One of them, child vaccination, has 
great potential. Improving the uptake of the child influenza vaccine, and saving lives, is 
the aim of this thesis. But before we consider how to do that, we must first understand 
the basics. What is influenza? How well does vaccination work? And, most importantly, 
why would people choose not to vaccinate their child? 
Influenza is a common viral illness which causes symptoms such as a high temperature, 
headache, coughing, aches and pains and a blocked or runny nose (10). There is no 
single ‘influenza virus.’ Rather, different strains of virus circulate at the same time, with 
some strains becoming more dominant and others less dominant over time. There are 
three modes of transmission for influenza; contact transmission (direct and indirect), 
droplet transmission and airborne transmission (11, 12). Contact transmission occurs 
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when a susceptible host touches an infected individual (direct) or an intermediate 
contaminated object (indirect). Droplet transmission occurs when an infected individual 
coughs, sneezes or speaks, releasing droplets from the respiratory tract into the air. 
These droplets then come into contact with the nasal or oral mucosa of a susceptible 
host. Airborne transmission occurs when droplet nuclei are suspended in the air by 
aerosolisation and inhaled by susceptible hosts. While for most people who contract 
influenza, symptoms will resolve within a week, for others in ‘at risk’ groups such as 
young children, the elderly and those with existing medical conditions, influenza can 
cause major complications (13). In the worst cases, influenza can kill.  
Estimates of the incidence of influenza and the number who die from it are difficult to 
provide because laboratory confirmation of influenza is not sought in routine general 
practice (14). Other illnesses also produce influenza-like symptoms; patients who 
display such symptoms in the absence of laboratory confirmation tend to be diagnosed 
with influenza-like illness (ILI). Annually, it is estimated that there are 779,000 general 
practice (GP) consultations, 19,000 hospital admissions and 10,500 deaths from 
influenza A and B in England and Wales alone (14). When including secondary 
bacterial infections and deaths from circulatory disease and other causes which are 
attributable to influenza, the number of estimated annual deaths rises to 24,800 (14). 
Evidence shows that 16,415 excess deaths (above the ‘baseline’ usually expected) were 
registered in the United Kingdom (UK) over the 2014/15 influenza season (15). While 
not the sole cause, a large number of these deaths were attributable to influenza (16). 
Worldwide, seasonal influenza epidemics may cause up to five million cases of severe 
illness and 650,000 deaths a year, with children being among those with the highest risk 
of complications (1). 
Influenza is a great burden to healthcare services in the winter months, having knock-on 
effects for other care provided by hospitals. For example, during the 2017/18 influenza 
season, National Health Service (NHS) trusts were told by NHS England to defer all 
non-urgent in-patient elective care from 21st December 2017 (17) to the 31st January 
2018 (18). This was in part due to the ‘sustained pressure over the Christmas period 
with high levels of respiratory illness’ (18). 
In addition to the morbidity and mortality associated with influenza and the burden to 
healthcare services, the financial cost can also be considerable. Whilst the economic 
cost of influenza is poorly researched in the UK, one study indicated that the cost of 
general practice visits and hospital admissions in low-risk patients who are not 
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vaccinated is approximately £111,529,226 more per year than in those who are 
vaccinated (19). This number is likely to be an underestimate, as it does not take into 
account the cost of influenza which may have been contracted in hospitals, nor does it 
include costs such as absence from work, loss of productivity, and the potential cost of 
childcare should a child or their parent be taken ill. In Western Europe, paediatric 
influenza caused children to be absent from day care or school for between 2.8 and 12 
days and their parents to be absent from work for between 1.3 to 6.3 days per influenza 
episode (20). Differing influenza severity and location of recruitment of the child (e.g. 
emergency department, physician’s office, or the community) caused the variation in 
estimates. Child vaccination is a cost saving intervention (21, 22). Vaccinating all 
children, rather than only ‘at risk’ children, is also cost-effective, with savings being 
more pronounced when vaccinating younger children (23). Further studies are needed to 
give a better understanding of the true financial cost of influenza and savings 
attributable to vaccination in the UK.  
The burden of influenza in children is significant. For example, estimates indicate that 
up to 9.8% of children aged zero to fourteen years present to their primary care practice 
with influenza in an average season (24). The burden of influenza seems to be greater in 
young children, with children aged five and under having more severe outcomes than 
older children and adults (25). The rate of general practice consultations for influenza-
like illness is higher in children aged four and under compared to those aged five to 
fourteen (24). Hospitalisation associated with influenza is also greater in younger 
children, ranging between 104 per 10,000 in children under six months and 4 per 10,000 
in children aged five to fourteen (26). Children are also good transmitters of influenza 
(27, 28), dubbed ‘super-spreaders’ (29) due to their less than optimal hand and 
respiratory hygiene, high number of people they are in contact with every day and their 
increased physical contact with others (30, 31). So seriously is the ability of children to 
spread influenza amongst themselves and their community taken, that school closures 
are commonly discussed as a key strategy for limiting the spread of influenza during a 
pandemic (32). 
Vaccination is one of the most effective ways of preventing influenza (33). In the UK, 
yearly influenza vaccination is offered to groups that are most vulnerable to 
complications from influenza, including pregnant women, older adults and people with 
underlying medical problems (34). In 2012, the British Joint Committee on Vaccination 
and Immunisation (JCVI) recommended that the influenza vaccination programme be 
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extended to include children aged two to sixteen, a process that began in September 
2013 (35). The child influenza vaccine was implemented in the UK, being offered for 
free, to limit the number of children who suffer from complications of influenza, 
prevent the spread of influenza and reduce morbidity and mortality among adults who 
may contract influenza from children.  
Other countries including the United States of America (USA) (36), Canada (37), 
Estonia, Poland, Austria, Finland, Latvia, Slovenia, Malta and Slovakia (38) also 
recommend annual child vaccination for influenza, although differences exist in the age 
groups and vaccines that are recommended. In the UK it is predicted that with 50% 
vaccine uptake in two to eighteen year olds and vaccine efficacy of 80%, up to 5.3 
million influenza infections per year could be averted; with 2.3 million infections 
prevented in children aged two to eighteen, and 3 million infections prevented through 
herd immunity in other age groups (39). Vaccination could also cause substantial 
reductions in clinical burden, potentially averting 700,000 general practice 
consultations, 19,200 hospitalisations and 14,740 deaths annually (39).  
Children between the age of two and sixteen in the UK are vaccinated using the Fluenz 
Tetra live attenuated influenza vaccine (LAIV); a nasal spray. This is a different vaccine 
from the inactivated injected vaccines commonly used in adults, and was chosen due to 
its increased efficacy in children (40). Fluenz Tetra is contraindicated for children who 
have an egg allergy. In addition, because the vaccine contains porcine gelatine there is 
some controversy in the Muslim community as to whether or not the vaccine should be 
accepted (41). In cases where LAIV cannot be given to children, the injected vaccine 
may be administered as an alternative (27). Although the patient information leaflet 
(PIL) for the vaccine states that each child should receive two doses of LAIV, the JCVI 
has recommended that children only receive one dose, due to the small additional 
protective value of the second dose (35). Vaccination for influenza is recommended 
yearly due to the constant mutation of the influenza virus and protects an individual for 
approximately six to eight months (42). 
Each year, influenza vaccines protect people from three or four different influenza 
strains (trivalent or quadrivalent vaccines respectively). Fluenz Tetra was trivalent in the 
2013/14 season but has been quadrivalent since the 2014/15 season (43). Strains to be 
included in influenza vaccinations are recommended by the World Health Organization 
(WHO) twice a year; once for vaccination in the Northern hemisphere and once for 
vaccination in the Southern hemisphere (44). Identification of strains is based on those 
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that have been circulating prominently in the opposite hemisphere in the previous 
winter period. For example, in the UK the winter period lasts from October to May (45), 
whereas in Australasia, most people contract influenza between May and September 
(46). This imprecise method of choosing vaccination strains can lead to a mismatch in 
the strains of influenza circulating and those included in vaccinations, decreasing a 
vaccine’s effectiveness.  
Vaccine effectiveness refers to the ‘real world’ proportion of cases that are avoided in 
those vaccinated compared to those not vaccinated, while vaccine efficacy refers to the 
proportion of cases avoided in tightly controlled conditions (47). It is estimated that the 
incidence of laboratory-confirmed influenza can be reduced by 8.2% to 5.9% with a 
well-matched vaccine, preventing 1.2 million cases of influenza in England; 73% of this 
protective effect is due to indirect protection or herd immunity (48). There is some 
evidence that influenza vaccines which have only 10% efficacy could still significantly 
reduce morbidity and mortality, even beyond those age groups which are vaccinated 
(49). For example, even if a vaccine is not well-matched, vaccination could still prevent 
up to 400,000 cases of influenza, 56% of which through indirect protection (48). 
 Uptake of the vaccine in England 
The child influenza vaccine programme is implemented differently across countries 
within the UK (50). In England, the vaccine was offered to all two to three year-olds 
through their general practice and piloted in primary-school age children in its first year 
(2013/14 influenza season) (51). Since then, the vaccine has been offered to 
increasingly older children each year (see Table 1) (52, 53). Routine vaccination in 
schools (school year one and two) started in the 2015/16 influenza season (54). In the 
2017/18 influenza season, children aged four started to be vaccinated through their 
school (school year reception) rather than at their general practice (55).  
To date, uptake in children aged two to four in England has consistently been around 
30% to 40% (15, 56-58), while uptake in primary school-aged children is slightly 
higher, at 53% to 58% (57, 58). Uptake in the 2017/18 influenza season was somewhat 
higher than previous years (59). A full breakdown of national uptake figures is shown in 
Table 1. There are no data available indicating the proportion of vaccinated children 
who are re-vaccinated for influenza the following year.  
24 
 
Table 1. Percentage of children vaccinated with the child influenza vaccine across ages 
and influenza seasons in England 
Age in 
years 
2 3 4 4 to 5 
(School 
Reception) 
5 to 6 
(School 
Year 1)  











42.6 39.5 N/A  N/A N/A N/A N/A 
2014/15 
(15) 
38.5 41.3 32.9  N/A N/A N/A N/A 
2015/16 
(57) 
35.4 37.7 30.0  54.4 52.9 N/A N/A 
2016/17 
(58) 
38.9 41.5 33.9  57.6 55.4 53.3 N/A 
2017/18 
(59) 
42.8 44.2 N/A 62.2 61.0 60.4 57.6 55.8 
 
Uptake of the influenza vaccine is notably worse than many other routine child 
vaccinations, for which uptake tends to be around 90-95% (60, 61). Uptake rates fell 
short of targets set by Public Health England (PHE) in the 2015/16 and 2016/17 
influenza seasons; targets which were themselves already modest (40% vaccination in 
those aged two to four) (50, 52). Among all groups for whom the influenza vaccine is 
recommended, children vaccinated at their primary care practice have the lowest uptake 
rate (62). 
Child influenza vaccination has become an increasing priority for Public Health 
England, NHS England and the Department of Health, with the ‘Stay Well This Winter’ 
campaign emphasising the child influenza vaccine (63). Statements highlighted that the 
‘children’s nasal spray flu vaccine plays an important role in protecting children, [one’s] 
families and others in the community from flu during the winter’ (64). Other messages 
mentioned the ‘quick, effective and painless’ nature of the vaccine (63), that ‘young 
children’s bodies can find it hard to cope with flu,’ and that the ‘vaccine helps to reduce 
the spread of flu to other more vulnerable family members’ (65). In September 2017, 
Public Health England and the NHS brought out an advert for the child influenza 
vaccine (66) which is shown on national television. 
Despite low uptake rates since its introduction to the vaccine schedule, the child 
influenza vaccine has been shown to limit the spread of, and decrease the cost 
associated with, seasonal influenza (67). Piloting of the child influenza vaccine in 
primary school children in the 2014/15 influenza season (in which uptake was 56.8%) 
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was shown to decrease general practice consultations for influenza-like illness by 94% 
and hospital admissions for influenza by 93% in children aged five to ten (68). The 
positive effects of vaccinating primary school children were also felt outside the 
vaccinated age group. In pilot areas, the number of general practice consultations for 
influenza-like illness decreased in over-seventeens (59% reduction) and under-fives 
(92%, p=.052) (68). 
Since its introduction to the vaccine schedule in the UK, the child influenza vaccine has 
had varying levels of effectiveness. In the 2015/16 influenza season, the vaccine was 
effective in reducing hospitalisation for laboratory-confirmed influenza, with a vaccine 
effectiveness of 54.5% (95% CI [31.5% to 68.4%]) in all children eligible for the 
vaccine (two to six year olds) (69). In the 2016/17 season, vaccine effectiveness was 
65.8% (95% CI [30.3% to 83.2%]) for influenza A and B in children aged two to 
seventeen (70, 71). Overall vaccine effectiveness in the 2017/18 influenza season was 
lower (26.9% (95% CI [-32.6% to 59.7%]), due to the poor effectiveness of the 
A(H3N2) strain included in the vaccine (72). 
 Side-effects 
As with all vaccines, the child influenza vaccine can cause side-effects. The frequency 
of side-effects as indicated by the patient information leaflet for Fluenz Tetra are shown 
in Table 2. Vaccine side-effects are mostly ‘mild in nature and short term’ (73). Data 
from post-licensure surveillance indicates that on average, side-effects occur on the day 
of vaccination (74). 
Table 2. Side-effects of Fluenz Tetra as described in the patient information leaflet 
Very common 
(may affect more 
than 1 in 10 people) 
Common (may 
affect up to 1 in 
10 people) 
Uncommon (may 
affect up to 1 in 100 
people) 
Very rare (may 
affect up to 1 in 
1,000,000 people) 
Runny or stuffy 
nose 
Fever Rash Severe allergic 
reaction 
Reduced appetite Muscle aches Nose bleed  
Weakness  Allergic reactions  
Headache    
 
Although large randomised-controlled trials are routinely conducted before licensing 
new medications, few trials use a placebo arm. The Declaration of Helsinki (75) states 
26 
 
that where an effective treatment is available for the condition, participants in trials 
should not be assigned a treatment which is less effective (76). Therefore, many clinical 
trials use the current best treatment as a control, rather than a placebo group. Where 
studies using a placebo group do exist, they are particularly informative about the true 
incidence of adverse effects that are attributable to a medication.  
Initial clinical trial data for the quadrivalent vaccine Fluenz Tetra compared it with the 
trivalent vaccine Fluenz/FluMist in children aged two to seventeen years using a 
randomised, double-blind study (77). These data indicated that 47.9% children given 
Fluenz Tetra experienced at least one symptom in the two weeks after vaccination, 
compared to 47.4% of those vaccinated with Fluenz/FluMist (77). More recently, a 
randomised, double-blind study in children aged seven to eighteen years compared 
Fluenz Tetra to placebo (78). In this trial, 41.7% of children vaccinated with Fluenz 
Tetra reported symptoms in the two weeks following vaccination, compared to 40.6% in 
the placebo arm (no significant difference); the most common symptoms in both groups 
were a runny or stuffy nose, cough and sore throat (78). This finding raises important 
questions about the true causes of the side-effects commonly attributed to the child 
influenza vaccination. I will return to these later in the thesis. For now, it is sufficient to 
note that, regardless of their cause, around 40 to 50% of children appear to experience 
symptoms following vaccination. 
Side-effects from vaccination are an important consideration in any discussion about 
vaccination and may affect child influenza vaccine uptake in two ways. First, fear of 
side-effects associated with vaccination is often cited by parents as a reason for not 
initially vaccinating their child. For example, during the 2009/10 influenza pandemic, 
50.6% of Dutch parents reported that they did not vaccinate their child for ‘fear of side-
effects/harmful consequences’ (79). Secondly, perceiving side-effects from vaccination 
might negatively affect parents’ decision to re-vaccinate their child for influenza in 
subsequent years. For example, in one study of parents who vaccinated their child aged 
six months to seven years for seasonal influenza, 63% of those who perceived side-
effects reported being uncertain about, or likely to refuse future influenza vaccinations 
for their child (80). 
Perceiving side-effects from the child influenza vaccine might also negatively influence 
parents’ perceptions about other vaccines and medications. For example, parents may 
consequently believe that their child is more sensitive to medicines. Parents’ 
perceptions about medicines in general, future treatment decisions for the child and 
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adherence to medications may also be negatively influenced. This is certainly the case 
in adults, with those who hold more negative beliefs about medicines showing 
decreased adherence to medications (81). 
 Conclusions 
The burden of influenza, in terms of morbidity, mortality, impact on healthcare services 
and financial cost, is considerable. Vaccination is one of the most effective ways to 
prevent the spread of influenza, but vaccination uptake remains low, especially in 
children. Side-effects from the child influenza vaccine are commonly perceived and 
may negatively affect parents’ future vaccination decisions, as well as altering beliefs 
about medicines and perceptions of how sensitive their child is to medicines. Although 
there is substantial scope to improve influenza vaccine uptake for children, 
understanding why uptake is low, and why side-effect perception by parents is high, is 
an essential first step in this process. To identify factors which might be important in 
influencing parental influenza vaccination behaviours I conducted two systematic 
reviews: one investigating psychological, social and contextual factors affecting vaccine 
uptake in young children, and the second investigating psychological and social factors 
affecting parental perception of symptoms in their children. These reviews are reported 
in Chapters 2 and 3.  
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Chapter 2. Systematic review of 
factors affecting vaccine uptake in 
young children 
In 2015 almost six million children died globally before the age of five (82). Over half 
died from preventable infectious diseases (83). Although vaccination is one of the best 
ways of preventing the spread of disease (84) and reducing morbidity and mortality 
(85), some parents choose not to vaccinate their child. While in developing countries, 
lack of access to vaccination and family characteristics such as low education, literacy 
and socio-economic status present some of the key reasons why children are not 
vaccinated (86), in developed countries parents often make conscious decisions not to 
use readily available vaccines. Understanding how to encourage uptake is an important 
public health aim.  
Many studies assessing parental decision making about vaccination are guided by an 
explicit theory of behaviour change (e.g. (87-89)), which identifies potential factors 
which may predict vaccination behaviour (90). Vaccine refusal has been associated 
with: perceived costs and lack of benefits of vaccination, such as believing that vaccines 
cause short- or long-term side-effects (91) or are ineffective (92); general beliefs, such 
as believing that children receive too many vaccinations and that vaccines overload the 
immune system (93); conflict with religious beliefs (94); distrust of healthcare systems 
and governments (91, 95); and emotional factors such as preferring to suffer the 
negative consequences of not vaccinating rather than those caused by vaccinating (92). 
Other commonly cited factors associated with vaccine refusal include forgetting and not 
knowing that the child needs the vaccine (91, 95). 
Parental personal characteristics, such as being unemployed and having a lower socio-
economic status (96) are also associated with child vaccine uptake, although the 
direction of associations in developed countries are unclear. For example, an association 
has been found between greater education and both vaccine uptake (97) and vaccine 
refusal (98); the role of age is also unclear (90). Yet while it is important to identify 
populations with low vaccine uptake to determine target audiences of public health 
messages or interventions, the identification of demographic factors associated with 
vaccination is less useful for informing the content of public health communications; 
here psychological, social and contextual factors become more important. 
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Moreover, while decisions will undoubtedly be made by parents based on information 
presented by the media, friends and family as well as factors discussed above, do 
individuals also have an underlying propensity which affects their vaccination decision? 
There is ample evidence that factors such as heuristics and cognitive biases affect 
peoples’ judgement when making decisions (99). Heuristics refers to the use of simple 
judgements rather than complex assessments of probabilities for an outcome to occur 
(99), while cognitive biases refers to the tendency to systematically choose a particular, 
often erroneous outcome, rather than the expected outcome, when presented with a 
certain type of evidence (100, 101). Heuristics and biases are known to exert a 
significant influence on vaccination behaviour (101, 102). In part, a decision not to 
vaccinate one’s child may reflect the influence of these cognitive processes.  
Past literature reviews on factors associated with vaccine uptake have focused on 
vaccines that have caused controversy in the media, such as combination vaccines 
including the measles, mumps and rubella vaccine (MMR) (93) and other relatively 
recently recommended vaccines, such as the human papillomavirus vaccine (HPV) 
(103). However, the highly charged media-driven debate over such vaccinations makes 
it difficult to generalise from them to other vaccinations. Identifying the wider barriers 
to vaccination is important as it allows public health messages to target those variables 
most consistently associated with non-vaccination. 
For this chapter, I conducted a systematic review to identify psychological, social and 
contextual factors affecting the uptake of routine childhood vaccination for healthy 
children aged five and under in high-income countries.  
 Method 
I carried out a review in accordance with PRISMA criteria (104). I searched Embase, 
Medline, PsycINFO, Maternity and Infant Care, Health Management Information 
Consortium and Social Policy and Practice through OvidSP, and Scopus. Databases 
were searched from inception to the 22nd November 2016. I used the following search 
terms: ((vaccine* OR innocul* OR immunis*) AND (child* OR newborn OR infant OR 
baby) AND (uptake OR adherence OR compliance OR decision* OR hesitanc* OR 
concern OR doubt)). Where possible, I limited the search to human studies. A MeSH 
terms search yielded 52,429 citations. Checking a random sample of 100 of these 
yielded no relevant papers. The MeSH search was therefore abandoned as impractical. 
References and forward citations of included articles were also searched. 
30 
 
2.1.1 Inclusion criteria 
Inclusion criteria were: 
Participants: Studies were included if children were aged five or under. Studies were 
excluded if children were recruited because of pre-existing ill health. 
Predictors/Exposures: Studies were included if they presented data on the association 
between possible psychological predictors and childhood vaccination or gave a 
quantitative account of parents’ self-reported reasons for or against vaccination. Studies 
presenting only demographic predictors, predictors related to the mode of delivery of 
information, or presence or frequency of vaccination appointment reminders were 
excluded. 
Outcomes: Studies were included if they presented data on uptake of a named vaccine 
and if the vaccine was part of the routine vaccination schedule in that region. 
Study reporting: Studies using quantitative methodology which were conducted in high-
income countries (as defined by the World Bank (64)) were included. For pragmatic 
reasons, I included only studies published in English. 
2.1.2 Data extraction 
For each study, I extracted details concerning country, study design, vaccine, 
psychological predictors of vaccine uptake and reasons for and against vaccination. 
2.1.3 Risk of bias 
Risk of bias was assessed using an adaptation of the Downs & Black (105) checklist, 
which is suitable for use in systematic reviews (106) and has been validated (107). 
Items relating to interventions were dropped as they were not relevant to any included 
study. Thus, the amended Downs & Black checklist included ten items assessing study 
reporting, two items assessing external validity, three items assessing internal validity 
(bias), three items assessing confounding (selection bias), and one item assessing 
whether there was a justification for the sample size used (power). Studies were 
classified as good quality if they scored sixteen or over out of a possible nineteen; poor 
quality studies scored ten or less. Moderate quality studies scored eleven to fifteen. 
Studies scored poorly for: reporting if they scored six or under out of a possible ten; 
internal validity (bias) and confounding (selection bias) if they scored one or under out 
of a possible three; external validity if they scored one or under out of a possible two; 
and if they did not include a justification for the sample size used. 
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2.1.4 Procedure  
The literature search, screening, data extraction and quality assessment were carried out 
by LS, with guidance from GJR and JY. Predictors were grouped according to 
categories identified by Bish and Michie in a review of factors associated with 
vaccination for pandemic influenza (90). I report results for discrete categories in the 
results section in order of strength of association. 
2.1.5 Registration 
I registered the protocol for this systematic review on PROSPERO (CRD42016037983) 
(108). 
 Results 
2.2.1 Study characteristics 
Following screening (Figure 1), sixty-eight citations were included in the review, 
describing sixty-four studies. Studies were conducted in twelve countries and 
investigated thirteen vaccines. Thirty-seven studies used cross-sectional designs, fifteen 




Figure 1. Flowchart depicting the selection of studies included in the systematic review 
of factors associated with vaccine uptake with reasons for exclusion
 










Number excluded after excluding 
duplicates (n=11,826) 
Number excluded after screening 
titles (n=7687) 
Number excluded after screening 
abstracts (n=1162) 
Full-text articles excluded (n=216). Reason for 
exclusions: 
- Does not report children’s age or includes 
children of the wrong age (n=63) 
- No psychological predictors of uptake (n=50) 
- Vaccine not named (n=18) 
- Reports health practitioners’ attitudes and 
intention to vaccinate (n=12) 
- No original data (n=11) 
- Child recruited due to ill health (n=10) 
- Qualitative study design (n=10) 
- Only intention to vaccinate data reported 
(n=9) 
- Foreign language (n=7) 
- Workshop paper/case 
study/reflection/conference abstract (n=7) 
- Report both actual and intended vaccination 
behaviour together (n=6) 
- Vaccine not in recommended schedule (n=5) 
- Studies carried out in low/middle-income 
countries (n=3) 
- Reasons against vaccination not quantitatively 
reported (n=2) 
- Unable to locate full text (n=2) 
- Unclear whether it fits inclusion criteria (n=1) 
Articles found in references and by 
other means (n=23) 
- Forward citation tracking 
(n=12) 





2.2.2 Risk of bias 
Scores on the amended Downs and Black checklist (105) ranged between two and 
eighteen out of a possible nineteen, with a median score of thirteen. In terms of common 
issues within the literature, it was notable that only ten studies reported a power 
calculation (109-118). Forty-nine studies scored poorly for external validity (79, 109, 
110, 112-115, 117-159); twenty-eight scored poorly for reporting (113, 115, 118-120, 
122-125, 127, 132, 134, 136, 138, 140-142, 149, 151, 152, 156, 157, 159-166); eight 
scored poorly for internal validity (bias) (119, 120, 122, 123, 132, 137, 140, 159, 161); 
and six scored poorly for confounding (selection bias) (79, 120, 128, 129, 133, 149). 
Scores for individual studies are shown in the Appendix 1. 
Figure 2. Chart indicating number of studies included in the systematic review of 
factors associated with vaccine uptake displaying different aspects of risk of bias 
 
 
2.2.3 Psychological, social and contextual factors associated with uptake  
Predictors and reasons given for or against vaccinating are summarised in Table 3 and 
Table 4 (for full tables see Appendix 1 and Appendix 2). Where relevant, only adjusted 
analyses are reported.
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Table 3. Psychological, social and contextual factors associated with not vaccinating one’s child 
Factor Psychological predictors of not giving child vaccinations / studies which investigated 
and did not find a significant association 
Number of studies finding a significant 
association/Number of studies investigating 
the factor 
Perception of adverse effects 
from vaccination 
Vaccine is unsafe (111, 112, 115-117, 120, 125, 143, 144, 149, 157, 167) / (109, 153, 
168) 
12/15 
Vaccine causes side-effects (112, 113, 115, 130, 143, 157, 158, 160, 168-170) / (116, 
139, 153) 
11/14 
Child unwell at time of vaccine appointment (129, 139) / 2/2 
Belief that the vaccine is more dangerous than the illness (143); injections are 
traumatic to the child (144) / 
2/2 
Can vaccinate child if they are ill (without fever)  (157) / (167); child is often too ill to 
receive vaccinations (139, 158) 
3/4 
Previous side-effects from vaccination (168) /(117, 126); negative previous vaccination 
experience (166) 
2/4 
Appraisal of the illness Low perceived susceptibility to illness (109, 111, 120, 133, 143, 148, 150, 160, 169) / 
(130, 153, 171) 
9/12 
Low perceived severity of illness (120, 121, 129, 143, 157) / (109-111, 126, 130, 137, 
153, 160, 170, 171) 
5/15 
Illness is dangerous (144) / 1/1 
General beliefs and attitudes Perception that it is not important for child to be vaccinated (112, 157, 160); 
vaccination is not useful (164); vaccines are not protective (170); no confidence in 
value of vaccines (149, 156) / 
7/7 
Religious objection to vaccination (133, 139) / 2/2 
Negative attitude towards vaccination (114); do not agree with vaccination (155) / 2/2 
Vaccine recommendations No vaccine recommendation by health professional (110, 113, 125, 130, 143, 157, 164, 
169) / (158) 
8/9 
No vaccine recommendation by friends or family (110, 143) / (126) 2/3 
Government advice to vaccinate / (127) 0/1 
Health professionals’ advice / (127) 0/1 
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Practicalities Logistical barriers (150, 172); inconvenient time or place of vaccination (139, 171) / 
(113, 158); perceived time pressure (155) 
5/7 
Expense of vaccine (113, 139) / (158) 2/3 
Vaccine course delivered in more doses (113) / 1/1 
Difficult to get the vaccine or appointment  (117) / (113) 1/1 
Knowledge Incorrect knowledge (130, 153, 158, 171); confusion about the vaccination schedule 
(139); difficulty remembering vaccine schedule / (129) 
5/6 
No knowledge about vaccination before appointment (109, 119) / 2/2 
Belief that the second dose of vaccine not essential (170) / (127); not important if a 
child misses a dose (172) 
2/3 
Social influences Normative beliefs (113); subjective norms (143, 148) / 3/3 
Lack of perceived social approval of vaccination (79, 121) / (173) 2/3 
Information about the vaccine Less satisfaction with information given (119, 157); information thought to be 
unhelpful (127) / 
3/3 
Information seeking behaviour (79) / 1/1 
Influence of information from the media (170) / 1/1 
No influence of information from the media (137) / 1/1 
Influence of research findings as important (127) / 1/1 
Influence of alternative/complementary medicine (157) / 1/1 
Faith in the media (126) / 1/1 
Less influence of healthcare provider (170) / (157) 1/2 
Perceived lack of information for vaccination decision (121) / (117) 1/2 
Adverse media publicity / (117) 0/1 
Trust in the healthcare 
profession 
Perception of a worse relationship with healthcare provider (149, 157) / 2/2 
No faith in the medical profession (112, 126) / (117, 156) 2/4 
Belief it is not right for health professionals to advise parents to vaccinate for the 
benefit of other children (121) / 
1/1 
Lack of perceived clinical support (114) / 1/1 
Lower parental satisfaction with care / (117, 146, 147) 0/2 
Perceived efficacy of 
vaccination 
Vaccine is not effective (111, 120, 148-150, 157, 160, 172) / (110, 115, 129, 130, 144, 
153, 170, 173) 
8/16 
Emotions Worry about the vaccine (137, 151) / 2/2 
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No fear that child will catch illness (143) / 1/1 
Anxiety about vaccination (143) / 1/1 
Inability to forgive oneself if child developed side-effects from vaccination (121); guilt 
about consequences / (126) 
1/2 
Maternal psychological distress / (155) 0/1 
Trust in the government No trust in the government (112, 133) / (117) 2/3 
Belief there is a conspiracy (170) / 1/1 
Perceive government pressure to vaccinate / (127) 0/1 
Multiple/combination vaccines  Appropriateness of separate vaccines over combination vaccines (112) / 1/1 
Combination vaccines are larger concern than single vaccines (121) / 1/1 
Combination vaccines are too much in one go (121) / 1/1 
Combination vaccines are harmful (170) / 1/1 
Children receive too many vaccines (157) / 1/1 
Not accepting multiple vaccines at once (117) / (113, 167) 1/3 
Multiple vaccines overwhelm the immune system (157) / (153, 172) 1/3 
Preference for natural 
immunity 
Belief that vaccination impairs body’s natural immunity (143) / 1/1 
Preference for the child to get immunity naturally, through having the illness (121) / 1/1 
Belief that infections are good for the immune system (170) / 1/1 
Vaccines are unhealthy (126) / 1/1 
Self-efficacy and perceived 
behavioural control 
Belief it is not the government’s responsibility to decide to vaccinate children (121) / 1/1 
Less perceived behavioural control (154); internal locus of control / (173) 1/2 
Self-efficacy / (172, 173) 0/2 




Table 4. Parental self-reported reasons for and against vaccinating child 
Factor Reasons given for not vaccinating N Reasons given for vaccinating  N 
Perception of adverse effects from 
vaccination 
Vaccine causes side-effects (79, 96, 110, 115, 116, 122-124, 130, 132, 
137, 141, 152, 168) 
14 Parents have been vaccinated without 
complication (119) 
1 
Child was unwell at time of vaccination (115, 120, 122, 130, 132, 136, 
141, 152, 162) 
9 Won’t harm the child even if vaccination does 
not benefit them (79) 
1 
Vaccine is unsafe (115, 119, 162, 163) 4 
Allergy to vaccine (79, 130, 132, 162) 4 
Vaccines are dangerous (96, 144) 2 
Previous side-effects: self (162); other person (165) 2 
Concern about vaccination (131) 1 
Appraisal of the illness Child has had the illness already (79, 120, 132, 136, 152) 5 Child is susceptible to illness (79, 165) 2 
Low perceived susceptibility to illness (110, 123, 124, 168) 4 Illness can be severe (79) 1 
Illness is not serious (116, 125, 168); illness is harmless (119) 4 To prevent complications of illness (119) 1 
Complications of illness not frequent enough (125) 1   
Parents have had the illness without harm (119) 1 
General beliefs and attitudes Parental choice, did not want vaccination (96, 120, 130, 136, 162) 5 Vaccine is important (151) 1 
Vaccination is unnecessary (119, 130); vaccination is not useful (113) 3 
Child is too young (130, 144, 162) 3 
Disagree with immunisation (131) 1 
Vaccine recommendations Advised against vaccination by health professional (120, 136, 141, 161) 4 Vaccine recommendation by health 
professional (79, 151) 
2 
No vaccine recommendation by health professional (130);weak 
vaccination recommendation by health professional (125)  
2 Vaccine recommendation by government (79) 1 
Negative influence of health visitor (137) 1 
Practicalities Practical barriers (79, 96, 131); inconvenient time or place of vaccination 
(120, 122, 136, 162) 
7   
Appointment not offered or missed appointment (115, 120, 131, 136, 
152, 162);  
6 
Expense of vaccine (113, 115, 125, 130) 4 
Lack of time (130, 141, 163) 3 
Vaccine out of stock (130, 141, 162) 3 
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Knowledge Inadequate knowledge about vaccine (130) 1   
Incorrect knowledge about the vaccination schedule (both parent and 
physician) (110, 124, 130, 131, 138, 152) 
6 
Lack of knowledge where to get vaccine (130) 1 
Lack of prior knowledge (141) 1 
Child was unwell (no fever or major illness) (115, 120, 122, 130, 132, 
136, 141, 152, 162) 
9 
Previous dose is still effective (130); one dose of vaccine is enough (137) 2 
Social influences Other parents don’t vaccinate child either (79) 1 Friends and family have accepted the vaccine 
(79) 
1 
Information about the vaccine Adverse media publicity (79, 96, 124, 161) 4   
Lack of information (163) 1 
Lack of scientific data (141) 1 
Heard problems with the vaccine (165) 1 
Trust in the healthcare profession Doctors vaccinate without differentiation (144) 1 Trust in healthcare provider (144, 165) 2 
Perceived efficacy of vaccination Vaccine is not effective (79, 115, 130, 152) 4 To protect child from illness (119, 144) 2 
Trust in effectiveness of vaccine (79) 1 
Emotions Fear about vaccination (96, 120, 136) 3 Anticipated regret if do not vaccinate (79) 1 
Concern about child becoming ill (165) 1 
Trust in the government No trust in the government (79) 1 Required by law (151) 1 
Child receives vaccines according to National 
Immunisation Program (79) 
1 
Multiple/combination vaccines Child receiving too many injections (116, 168); child receiving enough 
injections (124) 
3   
Did not want child to have vaccines all at once (162) 1 
Preference for natural immunity Preference for natural immunity (123, 152) 2 Vaccination will strengthen the child’s immune 
system (119) 
1 
Illness strengthens child’s immune system (119) 1 
Illness is beneficial for child (119) 1 
Prefer to use homeopathic alternative (79, 162) 2 
Intention Postpone vaccination to a later date, intend to vaccinate child later (110, 
122, 124, 152, 168) 




 Perception of adverse effects from vaccination 
There was strong evidence for an association between perception of adverse 
effects and vaccination. Self-reported reasons for not vaccinating included: 
believing the vaccine to cause side-effects (79, 96, 110, 115, 116, 122-124, 130, 
132, 137, 141, 152, 168) or to be unsafe (115, 119, 162, 163); believing one’s 
child to be allergic to the vaccine (79, 130, 132, 162); previous experience of the 
child or someone else experiencing side-effects (162, 165); believing that 
vaccines are dangerous or cause trauma (96, 144); and being concerned about the 
child becoming ill due to vaccination (165). Although recommendations state that 
children can be vaccinated if they are mildly ill (174), parents in nine studies 
reported not vaccinating their child because they were unwell (115, 120, 122, 
130, 132, 136, 141, 152, 162). Reasons for vaccination included that parents 
themselves had been vaccinated without complication (119) and that vaccination 
would not harm the child even if it did not benefit them (79). 
Twelve of fifteen studies found an association between perceiving vaccination to 
be unsafe and vaccine refusal (111, 112, 115-117, 120, 125, 143, 144, 149, 157, 
167). Four studies were good quality (111, 116, 117, 167); all those not finding 
an association were moderate quality (109, 153, 168). Eleven of fourteen studies 
found an association between perceiving a vaccine to cause side-effects and 
vaccine refusal (112, 113, 115, 130, 143, 157, 158, 160, 168-170). All fourteen 
were moderate or good quality. An association was found between vaccine 
refusal and the child being ill at the time of vaccination (129, 139) and the belief 
that the child was often too ill to receive vaccinations (139, 158). One study 
found that believing a child cannot be vaccinated if they are ill without a fever 
was associated with vaccination status (157), whereas another did not (167). 
These were moderate and good quality respectively. Another study found an 
association between vaccine refusal and believing that vaccination was more 
dangerous than the illness (143). 
 Appraisal of the illness 
There was strong evidence for an association between perceived susceptibility to 
an illness and child vaccination, however the link with perceived severity of the 
illness was tenuous. In terms of self-reported reasons against vaccination, studies 
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variously identified a belief that the child had already had the illness (79, 120, 
132, 136, 152); perceived low severity of the illness (116, 119, 125, 168); 
perceived low susceptibility to the illness (110, 123, 124, 168); belief that 
complications of the illness were not frequent enough (125); and belief that the 
parents had had the illness without harm (119).  Conversely, reasons for 
vaccinating included believing the child to be susceptible to the illness (79, 165); 
that the illness could be severe (79); and to prevent complications of the illness 
(119).  
Twelve studies investigated the association between perceived susceptibility to 
illness and vaccination, with nine finding a significant association (109, 111, 120, 
133, 143, 148, 150, 160, 169). Most studies were moderate quality, with one good 
quality study (111) and one poor quality study (120). Fifteen studies investigated 
the association between perceived severity of the illness and child vaccination, 
with five finding an association (120, 121, 129, 143, 157). Studies that found no 
association were generally better quality, with four good quality studies (110, 
111, 170, 171).  
 General beliefs and attitudes 
There was good evidence for an association between parental beliefs and attitudes 
and child vaccination. Self-reported reasons against vaccination included thinking 
that vaccination was not necessary or useful (113, 119, 130); and disagreeing with 
immunisation (131). Parental reasons for vaccinating included perceiving the 
vaccine to be important (151). 
Beliefs and attitudes positively associated with uptake included believing the 
vaccine to be important or useful; believing it to be protective; having confidence 
in the value of vaccines; holding a positive attitude towards immunisation; 
agreeing with vaccination; and not having religious objections to vaccination. All 
eleven studies investigating these beliefs and attitudes found a significant 
association with uptake (112, 114, 133, 139, 149, 155-157, 160, 164, 170). All 
were moderate quality, apart from two high quality (114, 170) and one poor 
quality (149) studies.  
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 Vaccine recommendations 
Across multiple studies, parents reported not vaccinating their child because: they 
were advised against vaccination (120, 136, 141, 161); did not receive a vaccine 
recommendation by a health professional (130); received a weak vaccination 
recommendation from a health professional (125); or because a health visitor had 
a negative influence (137). Two studies reported that parents vaccinated their 
child because they received a recommendation from a health professional or the 
government (79, 151). 
Of the ten studies investigating receiving vaccine recommendations from a health 
professional, friend or family member, eight found an association with uptake 
(110, 113, 125, 130, 143, 157, 164, 169). One study was good quality (110), 
while others were moderate quality. The two studies which did not find an 
association were both moderate quality (126, 158).  
 Practicalities 
Seven studies reported practical barriers, inconvenient timings or clinic locations 
as reasons against vaccination (79, 96, 120, 122, 131, 136, 162); six cited missing 
or not being offered an appointment (115, 120, 131, 136, 152, 162); four cited the 
expense of the vaccine (113, 115, 125, 130); and three each cited a lack of time 
(130, 141, 163) and the vaccine being out of stock (130, 141, 162). 
Perceiving logistical barriers towards vaccination; inconvenient appointment 
location or time; and time pressure were investigated as risk factors by seven 
studies, of which five found an association with refusal (139, 150, 155, 171, 172). 
Two were good quality (155, 171). Both studies which found no association were 
moderate quality (113, 158). Having to pay for the vaccine was associated with 
vaccine refusal in two studies (113, 139), while one (158) found no association; 
all were moderate quality. Perceiving it to be difficult to get the vaccine or a 
vaccination appointment was associated with not vaccinating in one of two 
studies (117); as was having a vaccine course delivered in multiple doses (113). 
 Knowledge 
Overall, there was good evidence for an association between increased 
knowledge about the vaccine and uptake. Six studies reported that parental 
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reasons against vaccination included incorrect knowledge of the vaccine schedule 
by the parent or physician (110, 124, 130, 131, 138, 152). Perceived inadequacy 
of knowledge about the vaccine or where to get it (130, 141) and believing that 
previous doses of the vaccine were still effective or that one dose was enough 
(130, 137) were also self-reported reasons for not vaccinating. 
Six studies found an association between vaccine refusal and incorrect 
knowledge, confusion or difficulty remembering the vaccination schedule (130, 
139, 153, 158, 171); or not knowing about the vaccination before the appointment 
(119). Of these, one study was good quality (171), one was low quality (119) and 
the rest were moderate quality. One moderate quality study found no association 
between difficulty remembering the vaccine schedule and vaccination (129). Not 
believing that it was important if a child missed a vaccination dose, or that the 
second dose was not essential was associated with uptake in two of three studies 
(170, 172). Studies finding an association were good (170) and moderate quality 
(172); the study not finding an association was also moderate quality (127).  
 Social influences 
There was mixed evidence for an association between social influences and 
vaccination. Parents’ self-reported reasons against vaccination included that other 
parents did not vaccinate their child (79), while reasons for vaccinating included 
that friends and family had vaccinated their child (79). 
Two moderate quality studies found an association between lack of perceived 
social approval of vaccination and vaccine refusal (79, 121), whereas one good 
quality study did not find an association (173). Subjective norms were associated 
with vaccine uptake (143, 148), as were normative beliefs (113).  
 Information about the vaccine 
There was some evidence for an association between information about the 
vaccine and vaccination, whereas there was mixed evidence for the direction of 
the association between the influence of the information source and vaccination. 
Studies indicated that parents reported not vaccinating their child because of 
adverse media publicity (79, 96, 124, 161); perceived lack of information (163); 




Three studies found an association between vaccine uptake and whether parents 
were satisfied with the information provided or thought it helpful (119, 127, 157). 
One of two studies investigating perceived lack of information and vaccine 
refusal found an association (121). Information seeking behaviour was associated 
with vaccine refusal (79). No association between vaccination and adverse media 
publicity was found in a good quality study (117).  
Increased influence of information disseminated by the media was associated 
with both vaccine uptake (137) and refusal (170). The study finding an 
association with vaccine refusal was better quality. Faith in the media (126), 
influence of a provider of alternative or complementary medicine (157), and 
perceiving research findings to be important (127) were associated with vaccine 
refusal. An association between influence of information from a healthcare 
provider and child vaccination was also found by one study (170), but was not 
replicated in another lower quality study (157).  
 Trust in the healthcare profession 
There was mixed support for an association between child vaccination and trust in 
the healthcare profession. One study reported that parents did not vaccinate their 
child because they believed that doctors vaccinate without differentiation (144). 
Parents in two studies gave trusting their healthcare provider as a reason for 
vaccination (144, 165). 
An association between uptake and faith in the medical profession was found by 
two of the four studies which investigated it (112, 126); both were moderate 
quality. One of the two studies which did not find an association was good quality 
(117). Two studies found an association between better perceived relationship 
with the healthcare provider and vaccination (149, 157); perceived clinical 
support was also associated with vaccination (114). Parental satisfaction with care 
was not associated with vaccination in either of two studies (117, 146, 147), one 
of which was good quality (117).  
 Perceived efficacy of vaccination 
Evidence for an association between perceived efficacy and child vaccination was 
mixed. Not believing that the vaccine was effective was reported by parents as a 
reason against vaccination in four studies (79, 115, 130, 152). Two studies found 
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that parents vaccinated their child to protect them from the illness (119, 144), and 
another cited trust in the effectiveness of the vaccine (79).  
Perceived efficacy was found by eight studies to be associated with child 
vaccination (111, 120, 148-150, 157, 160, 172). Of these, two were poor quality 
(120, 149) and one was good quality (111). Eight more studies found no 
significant association (110, 115, 129, 130, 144, 153, 170, 173), including three 
good quality studies (110, 170, 173). 
 Emotions 
There was good evidence for an association between parental emotions about the 
vaccine and uptake. Four studies cited fear of or concern about the vaccination as 
a self-reported reason against vaccination (96, 120, 131, 136). Reasons for 
vaccination included anticipated regret if parents refused vaccination and their 
child developed the illness (79),  
Studies investigating parental worry about vaccination (137, 151); fear of the 
illness (143); and anxiety about vaccination (143) all found an association with 
vaccine refusal. One study investigating maternal psychological distress did not 
find an association (155). Two studies investigated feelings of guilt or the 
inability to forgive oneself if the child developed side-effects from vaccination 
(121, 126). Only one found an association (121); both were similar quality. 
 Trust in the government 
Taken together, there was weak evidence for an association between trust in the 
government and child vaccination. Parents in one study reported not vaccinating 
their child because they did not trust the government (79). Parental self-reported 
reasons for vaccination included because it was required by law (151) and 
because the child received vaccines according to the national immunisation 
programme (79). 
An association was found by two of three studies that investigated trust in the 
government and child vaccination (112, 133). Both were moderate quality, 
however, the study not finding an association was good quality (117). Belief that 
there was a conspiracy was also associated with vaccine refusal (170), whereas 
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the perception that there was government pressure to vaccinate was not associated 
with vaccination (127).  
 Multiple/combination vaccines 
There was mixed evidence of an association between negative perceptions 
surrounding multiple vaccination and uptake of combination vaccines. Three 
studies reported that parents did not vaccinate their child because they felt that 
they received too many or enough injections (116, 124, 168); another reported 
that parents did not want the child to have multiple vaccines at once (162). 
One study found an association between vaccine refusal and the belief that 
children receive too many vaccines, and that multiple vaccinations overwhelm the 
immune system (157), whereas two studies found no association (153, 172). 
Similarly, only one of three studies found an association between not accepting 
multiple vaccines in a single appointment and vaccine refusal (117). Although 
this was a good quality study, one of the studies that did not find an association 
was also good quality (167), whereas the other was moderate quality (113). The 
perception that combination vaccines were a greater concern than single vaccines 
and were too much to give the child in one go (121); that combination vaccines 
were harmful (170); and that separate vaccines were more appropriate than 
combination vaccines (112) were also associated with vaccine refusal.  
 Preference for natural immunity 
There was some evidence for an association between parents’ preference for 
natural immunity and vaccine refusal. Parental reasons against vaccination 
included having a preference for natural immunity (123, 152) or a homeopathic 
alternative (79, 162); and believing that having the illness was beneficial for the 
child and strengthened their immune system (119). Parents’ reasons for 
vaccinating also included wanting to strengthen the child’s immune system (119). 
An association was found between vaccine refusal and parents’ preference for 
acquiring immunity through illness over vaccination (121); believing that 
infections are good for the immune system (170); believing that vaccination 
impairs natural immunity (143); and believing that vaccines were unhealthy 
(126). All studies were moderate quality bar one, which was good quality (170).  
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 Self-efficacy and perceived behavioural control 
Generally, there was weak evidence for an association between self-efficacy and 
perceived behavioural control and child vaccination. Perceived behavioural 
control was associated with vaccination in one moderate quality study (154), 
whereas locus of control was not associated with vaccination status in a good 
quality study (173). Two studies investigating the association between self-
efficacy and child vaccination found no association (172, 173).  
 Intention 
Parents of unvaccinated children reported intending to vaccinate their child in the 
future in five studies (110, 122, 124, 152, 168).  
One longitudinal study found that intention to vaccinate one’s child was 
associated with subsequent behaviour (113).  
 Combined effects 
Some studies investigated the combined effects of predictive factors on uptake of 
childhood vaccinations. In these cases, it was impossible to tease out how each 
factor affected uptake. An association between vaccination and immunisation-
related beliefs (114); attitude score (136, 154); vaccine efficacy and vaccination 
attitudes (143); lack of perceived vaccine harms (156); and lack of belief in 
disease susceptibility and severity, and vaccine effectiveness (117); knowledge 
and vaccine practice (118) was found. A lower score on the ‘parent attitudes 
about childhood vaccines’ survey, which identifies vaccine hesitancy through 
measuring perceived vaccine safety, efficacy and vaccination attitudes was also 
associated with vaccine uptake (135). Concern about the vaccine and potential 
adverse effects was associated with vaccine refusal (152), as was a lower number 
of cues to action (148).  
Some studies analysed multiple beliefs, attitudes and dimensions within the 
combined context of perceived barriers and benefits to vaccination. Among 
studies investigating perceived barriers to vaccination, one study of good quality 
which used eleven items to measure barriers to vaccination (173), two studies of 
moderate quality, which used five and six items respectively (134, 148, 173) and 
a low quality study using fourteen items (140, 159) found an association between 
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perceived barriers and vaccination refusal. One good quality study, measuring 
perceived barriers on a four-item scale did not find an association between 
perceived barriers and child vaccination (110). One moderate quality study, 
investigating the association between perceived benefits and vaccine uptake, 
found an association (156). This study used four items, investigating efficacy and 
safety of the vaccine as well as attitudes, to measure perceived benefits. However, 
a good quality study, which used ‘one or two items’ did not find this association 
(171). 
 Other 
Parents’ self-reported reasons for not vaccinating their child included not wanting 
the vaccine (96, 120, 130, 136, 162); not knowing about or refusing the vaccine 
(115); deciding against the vaccine after having had one or more doses (138); not 
knowing whether to vaccinate and not having thought about vaccination (130); 
vaccination no longer being mandatory (152); the child never getting ill (79); or 
rarely going out (130); or perceiving the vaccine to be an adjuvant (enhancing the 
body’s natural immune response) (123). Parents did not vaccinate their child 
because they should have been vaccinated in school, but there was no record of 
the vaccination and parents did not recall whether their child had been vaccinated 
or not (131) and because the mother had been vaccinated for the illness (144). 
Reasons given by parents for vaccination included doing so because their child 
had a chronic disease (79, 119); there was a vulnerable person in household (79); 
and it was required by the day care the child attended (151).  
Perceiving the child to be too young (130, 144, 162); having a previous negative 
vaccination experience (166) or having previously refused a vaccine for reasons 
other than ill-health (168); having fewer general problems during immunisation 
(114); and having difficulty remembering the vaccination appointment (158) were 
associated with vaccine refusal. No feelings of doubt, but more negative feelings 
experienced following the vaccination decision were associated with vaccine 
uptake (79). 
Some studies yielded contradictory results. Parental acculturation to the host 
country was found to be associated with both vaccine uptake (142) and vaccine 
refusal (145). Uptake was also associated with the belief that it was easier to be 
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told whether or not to vaccinate your child (121) and that parents had the right to 
determine the treatment given to their child (144). Both were moderate quality 
studies. 
 Discussion 
This is the first comprehensive review describing psychological, social and 
contextual factors associated with vaccination in young children. In line with 
findings from previous reviews of child vaccination (91, 93) and wider reviews of 
medication adherence (175), perceiving vaccination to cause adverse effects was 
consistently associated with vaccine refusal. Many high-quality papers (111, 116, 
117, 167) found this association and it was the most common self-reported reason 
against vaccination. While there was strong evidence for an association between 
low perceived susceptibility to an illness and vaccine refusal, evidence for a role 
of perceived illness severity was weak. This may be because parents first consider 
whether their child is susceptible to an illness before considering how severe the 
illness may be.  
Few studies have investigated information about vaccination or the influence of 
different sources of information, with inconsistent results. Although parental 
satisfaction with information was associated with vaccine uptake (119, 157), 
information seeking behaviour was associated with vaccine refusal (79). One 
possible explanation is that parents’ distrust of information causes them to seek 
information from multiple sources, including the internet and social media (176). 
Unfortunately, many websites perpetuate vaccine ‘myths’ (177). Likewise, 
influence of information disseminated by the media (in newspapers, magazines 
and on the television) was associated with vaccine uptake (137) and refusal (126, 
170). No studies included in the review investigated the influence of social media 
on vaccine uptake, even though it likely affects vaccination behaviour in certain 
countries. This is perhaps due the fact that social media is a relatively new 
phenomenon. More research is needed on the influence of information to improve 
the content and dissemination of public health messages.  
I found no experimental studies which investigated whether interventions to alter 
parental beliefs and attitudes affected vaccine uptake in children aged five and 
under. This is a logical next step for child vaccine uptake research. Although 
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research on interventions to change parental beliefs about and attitudes towards 
vaccination have been conducted (178), outcomes are usually measured as a 
change in attitudes or vaccination intentions (179). Some intervention studies 
have investigated the impact of additional vaccine reminders through new modes 
of communication, such as text message reminders (180, 181), but very few have 
investigated the effectiveness of different messages in increasing vaccination 
(179). My review highlights factors which could be targeted by such messages. 
Since having conducted the review, a systematic review of factors associated with 
influenza vaccine hesitancy in all age groups has been published (182). This 
review identified 470 studies which investigated influenza vaccine hesitancy, of 
which eighteen investigated vaccination in children under the age of five. Vaccine 
hesitancy was defined by the study as low vaccination intention or vaccination 
refusal. This review identified similar barriers to child seasonal and pandemic 
vaccination as I found in my review, including: higher perceived risk of side-
effects from vaccination; worry about the safety of the vaccine; perceived low 
severity of influenza; perceived low susceptibility to influenza; belief that the 
vaccine is ineffective; low perceived behavioural control; lack of general 
knowledge about influenza; past vaccination behaviour; perceiving vaccination to 
be inconvenient; fewer interactions with the healthcare system; and no direct 
recommendation from a healthcare professional.  
As we have seen, there is a wealth of research investigating vaccine uptake in 
various disciplines, including public health, psychology and sociology, but little 
research integrating different disciplines (179). Interdisciplinary research may 
help shed light on mechanisms underlying vaccination behaviours. For example, 
biases and heuristics are known to exert a significant influence on vaccination 
behaviour (101, 102). Common biases affecting vaccination identified in the 
literature include: the omission bias, in which the negative consequences of action 
are considered worse than the negative consequences of inaction (101, 102, 183-
186) and the availability bias, whereby judgements about the probability of an 
incident occurring are based on the availability with which examples of that 
incident come to mind (101, 102, 184, 185). In the vaccine literature, the term 
‘cognitive bias’ tends to refer to these processes of thinking and reasoning which 
are associated with vaccination behaviour. However, ‘cognitive biases’ is also 
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used to refer to biases in information processes such as attention, interpretation 
and recall, and can be defined as ‘the tendency to attend to a certain type of 
stimulus or consistently interpret emotionally ambiguous information in one 
direction’ (187) (p. 516). 
One of the key differences between ‘cognitive biases’ as used in the vaccine 
literature and cognitive biases of information processing is the influence of 
emotional valence in the latter. Cognitive biases of information processing 
manifest as systematic patterns of attention, interpretation and recall in response 
to emotionally valenced stimuli. These biases have been heavily implicated in 
vulnerability to emotional disorders, such as depression and anxiety (188, 189). 
Biases can influence behaviour by promoting selective attention to, and 
interpretation and recall of, specific emotional material associated with the 
behaviour. Cognitive biases can be modified, often resulting in changes to 
attitudes and behaviour. This makes cognitive biases an important option to 
explore with regard to child vaccination behaviour. Unless otherwise stated, use 
of the term ‘cognitive biases’ in the remainder of this thesis refers to cognitive 
biases of information processing. 
Cognitive psychology indicates that one specific subset of the cognitive bias 
phenomena may be particularly relevant in parental vaccination behaviour, 
namely interpretation bias. The term ‘interpretation’ has a very precise meaning 
within cognitive psychology and has been defined as ‘the process through which 
one meaning is extracted from ambiguous information in order to construct a 
mental representation’ (190) (p.562). This is distinguished from the related, but 
cognitively distinct, processes of judgement, reasoning and decision making. 
Interpretation bias is defined as ‘a consistent tendency to interpret emotionally 
ambiguous stimuli, situations, or events in a negative (or positive) manner’ (191) 
(p. 26). Interpretation bias has the potential to promote the selective processing of 
material which is likely to trigger or maintain the behaviour (192). A systematic 
bias in interpretation that acts specifically upon vaccination-relevant information 
could either promote or inhibit behaviours related to vaccination uptake. Thus, 
cognitive biases could act as a mechanism underlying vaccination behaviour. 
However, no studies investigating the association between vaccination and 
information processing biases were included in the systematic review. 
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One characteristic of information processing biases is that they act specifically on 
information that matches the core concerns of the sample under study, a 
phenomenon known as content-specificity (193). Vaccination is an emotionally 
ambiguous health intervention which can be interpreted as a positive, protective 
intervention, or as posing a significant health threat through potential adverse 
effects (102). When considering potential associations between cognitive biases 
and child vaccination behaviour, it is likely that biases about the type of health 
threats associated with child vaccination will show the strongest association with 
vaccination behaviours. 
Two domains might be particularly relevant in child vaccination. First, when 
deciding whether to vaccinate their child, parents must weigh up the relative 
threats posed by the ‘unnatural’ man-made vaccine and the naturally-occurring 
illness (102). Two factors identified in the systematic review are relevant here. 
Parents’ belief that the vaccine could cause adverse effects would be included in 
their interpretation of man-made health threats, while parents’ appraisal of the 
illness would be included in their interpretation of naturally-occurring health 
threats. Man-made threats tend to elicit higher levels of concern than naturally-
occurring threats (194). This is a common finding in the risk perception literature, 
with the degree to which the threat ‘interferes with nature’ or is perceived as 
being ‘unnatural,’ greatly impacting on risk perception (195, 196). Some parents 
may perceive natural interventions as preferable to artificial, man-made 
interventions. Evidence shows that endorsement of natural interventions is 
associated with vaccination refusal (102, 197). Thus, parents may have different 
interpretation biases based on the source of the health threat. It is likely that 
parents will have more negative interpretation biases for man-made health threats, 
such as the influenza vaccine, than for naturally-occurring health threats, such as 
influenza itself. 
Second, child vaccination is potentially unusual as a public health behaviour in 
that it represents a threat to someone other than oneself (one’s child). While 
cognitive biases are generally investigated in oneself, research indicates that 
parental negative biases carry over into ambiguous situations involving one’s 
child (198-200), although results are weaker than in situations involving the self 
(198, 199). Therefore, parents may have different interpretation biases based on 
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the subject of the health threat. It is likely that parents will have more negative 
interpretation biases for threats to their own health, than for threats to their child’s 
health.  
While the influence of cognitive biases is well-researched in emotional disorders 
such as anxiety and depression (188, 201), there is little research investigating the 
influence of cognitive biases on the adoption of public health behaviours. These 
studies investigate interpretation bias and attention bias – the systematic tendency 
to attend to emotionally valenced stimuli over neutral stimuli (202). Content-
specific interpretation biases have been associated with problem drinking (203, 
204), while content-specific attention biases have been associated with lapses in a 
smoking cessation attempt (205) and with being overweight (206). However, the 
role of attention biases in consummatory behaviours (such as excessive eating 
and drug or alcohol misuse) is mixed, with evidence indicating that biases are not 
consistently associated with body weight, food consumption or substance use 
(207). One study, investigating the association between attention bias and 
medication adherence may shed light on how cognitive biases could influence 
child vaccination. This study found that both those low and high in asthma 
medication adherence showed increased attention bias for asthma-symptom 
words (208). This pattern of results is in line with evidence suggesting that the 
emotional valence of stimuli is associated with biased processing (188), but 
suggests that the impact of biases on public health behaviours can be beneficial or 
maladaptive based on individual differences (208). In the case of child influenza 
vaccination, underlying cognitive biases may influence parents’ vaccination 
decision, with biases being most evident in those who strongly agree or disagree 
with vaccination. 
2.3.1 Limitations of the literature  
First, studies included in the systematic review varied in quality and reported 
different details of methods used. For example, some studies defined ‘vaccinated’ 
by specifying a number of vaccine doses, a time frame and how it was ascertained 
that the child was vaccinated, while others simply stated that children ‘were 
vaccinated.’  
Second, papers also differed in factors adjusted for in their analyses. 
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Third, most included studies were cross-sectional, therefore causal inferences 
between psychological predictors and vaccine uptake can only be made with 
caution. However, twelve cohort studies were included in the review. More 
prospective longitudinal or intervention studies are now needed. 
2.3.2 Limitations of the review 
First, demographic predictors of vaccination and qualitative research were 
excluded from the review for pragmatic reasons, meaning some potential 
predictors of vaccination may have been overlooked. However, reviews of 
qualitative literature investigating child vaccination yield similar results to those 
found in this review (91).  
Second, results were not split by vaccine. Differing strengths of association 
between factors and particular vaccines may exist. 
Third, some studies investigated differences between parents who did not 
vaccinate their child on time and those who did not vaccinate their child at all 
(e.g. (115, 209)). I did not differentiate between these outcomes. It may be that 
important differences exist between hesitancy and refusal that could be studied by 
future research.  
Fourth, literature not published in English was excluded due to time and cost 
constraints. Grey literature was not searched for the same reasons. This increases 
the risk that I did not identify some studies that reported largely non-significant 
findings. 
Finally, as one person carried out the review, data extraction and risk of bias 
assessment, I cannot rule out human error or experimenter bias.  
2.3.3 Conclusions 
This is the first systematic review identifying psychological predictors of uptake 
of routine child vaccinations. My results indicate that the factor most consistently 
associated with vaccine refusal is concern about potential adverse effects of the 
vaccine. The child’s susceptibility to the illness and the belief that the vaccine is 
effective are also likely to be relevant predictors of uptake. Increasing parents’ 
knowledge of the vaccine schedule and ensuring all healthcare providers 
recommend vaccination may also be associated with uptake. More research on the 
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influence of different sources of information is needed to determine the best way 
to disseminate information about vaccines to parents. Underlying parental 
cognitive biases may also influence the parental vaccination decision, however as 
no research exists, the extent of the association remains unclear.  
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Chapter 3. Systematic review of 
factors affecting parental perception 
of symptoms 
In Chapter 2, I found strong evidence that parents who believe that vaccines cause 
side-effects are less likely to vaccinate their child. This is a particular problem for 
the child influenza vaccine as children must be vaccinated each year and clinical 
trial data indicate that 40% to 50% will report at least one side-effect (77, 78). 
Although acute symptoms are common following many vaccinations, their cause 
is not always straightforward. As noted in Chapter 1, a recent clinical trial 
comparing Fluenz Tetra to placebo found that 41.7% of participants who received 
the drug reported side-effects, as did 40.6% in the placebo arm; there was no 
statistical difference in side-effect reporting between the two groups (78). It 
therefore cannot be concluded that the pharmacological properties of Fluenz Tetra 
are the source of symptoms perceived following vaccination.  
The finding that there is no difference between the proportion of people reporting 
side-effects in the active and sham arms of the Fluenz Tetra clinical trial is not an 
isolated occurrence in the literature. Many clinical trials of medications used for a 
range of conditions have found no difference between rates of adverse effects 
reported in the placebo and active arm, despite a common perception that the drug 
in question causes side-effects. For example, a meta-analysis comparing adverse 
events in the intervention and placebo arms of statin trials indicated that 
symptoms commonly perceived as side-effects from statin were perceived just as 
frequently in the placebo arm as in the intervention arm (placebo: 0.1%-17.7%, 
active drug: 0.1%-18.1% depending on the specific symptom) (210). Similarly, in 
a meta-analysis of fifty-three trials for migraine medication in adults, the 
incidence of adverse events in the active drug arm was similar to placebo for four 
of the twelve drug-dosage combinations investigated (211). Less research has 
been conducted in children, but where it has, results are analogous. For example, 
a systematic review of ten trials for migraine medication in children found that 
for four of five drugs prescribed (acetaminophen, ibuprofen, rizatriptan, 
dihydroergotamine; not sumatriptan), adverse events were seen just as frequently 
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in the placebo and active drug arm of the study (placebo: 1.6%-8.3%, active drug: 
1.2%-16.7% depending on the medication and the specific symptom) (212).  
Not only are side-effect rates often similar in the active and sham arms of 
randomised-controlled trials for a given drug, but the side-effect profiles 
experienced by participants in placebo-controlled trials are similar to those 
experienced by those in the active drug arm. A recent meta-analysis of 231 
randomised, placebo-controlled trials investigating a variety of disorders in those 
aged sixteen and over found that reporting of adverse events in the placebo and 
active drug arm was highly correlated for most symptoms (213). This pattern has 
also been found in other reviews of clinical trials for specific disorders. For 
example, a systematic review of seventy-three placebo-controlled trials for 
migraine medication found that participants in the placebo condition experienced 
a symptom profile similar to that of the class of drug they thought they were 
taking (non-steroid anti-inflammatory drugs (NSAIDs), triptans and 
anticonvulsants) (214). Likewise, in a systematic review of 143 trials for 
antidepressant medications, the symptom profile experienced in the placebo arm 
of trials for tricyclic (TCA) medications was different to that experienced in the 
placebo arm of selective-serotonin reuptake inhibitor (SSRI) medications; 
symptoms experienced in the placebo arm matched the side-effect profile in the 
active drug arm for the respective class of antidepressant (215, 216). A similar 
pattern of adverse events in the placebo and active drug arms has also been found 
in a meta-analysis of treatments for fibromyalgia (217) and, though no statistical 
comparison was made, analogous results are presumed for Parkinson’s disease 
treatment trials (218). 
If side-effects attributed by patients to a particular medication are equally likely 
to be triggered by a sham medication, it is clear that the symptoms are not 
necessarily caused by the pharmacological action of the drug. What, then, is their 
cause? One possibility is the nocebo effect, a phenomenon whereby the 
expectation that symptoms will develop following exposure to an inert substance 
becomes self-fulfilling (214, 218, 219). A recent systematic review of 89 studies 
found that three factors were particularly influential in triggering a nocebo 
response, namely: having seen or heard suggestions that an exposure causes 
symptoms; having higher expectations of symptoms; and increased dose of 
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exposure (220). As such, adverse effects seen in the placebo arms of trials may 
arise from participant expectations about side-effects that they might experience, 
including patients’ prior experience with similar medications (214, 215). 
The literature on medically unexplained symptoms may also provide some insight 
into the origin of symptoms that are attributed to medications. Definitions of 
medically unexplained symptoms vary, but they are generally understood as the 
presence of symptoms which cannot be linked to a medically diagnosed cause 
(221, 222). Some symptoms are commonly experienced together and have come 
to be referred to as ‘functional syndromes,’ for example chronic fatigue 
syndrome, fibromyalgia and irritable bowel syndrome (223). Medically 
unexplained symptoms are common, with estimates indicating that 19% (224) to 
66% (225) of symptoms in primary care are unexplained. The wide range in 
prevalence estimates is likely due to differing definitions of what counts as 
‘unexplained.’ Medically unexplained symptoms persist into secondary and 
tertiary care, with as many as 52% of new patients referred by their primary 
clinician to outpatient clinics in hospital being thought to have at least one 
medically unexplained symptom (222). Unexplained symptoms are likely to recur 
or be chronic in at least one in five patients (223), with a longitudinal study 
indicating that symptoms in over one-third of patients presenting to a primary 
care clinic remained medically unexplained after five years (226). In some cases, 
medically unexplained symptoms may be the physical manifestation of 
psychological disorders (222). As with the nocebo effect, the literature on 
medically unexplained symptoms has focussed on how psychological processes 
can result in patients identifying symptoms in themselves and how these 
symptoms are then interpreted and maintained.  
Limited research has been conducted on the psychological or contextual factors 
that affect perception of symptoms in one’s child. However, literature relating to 
the nocebo effect and medically unexplained symptoms in oneself may cast light 
on possible mechanisms that may be involved when a parent comes to perceive 
side-effects in their child following vaccination. A number of models have been 
put forward which attempt to explain symptom perception in oneself. In the 
following sections I review existing models of symptom perception and factors 
underlying subjective symptom perception with the aim of identifying factors that 
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may influence parental perception of side-effects in one’s child following 
vaccination. I then describe a formal systematic review of the factors associated 
with parental perception of symptoms in one’s child. 
  Models of symptom perception  
Physical symptoms were initially thought to occur following certain biological 
processes, assuming a correspondence between the pathology and the symptom, 
as well as between the severity of the pathology and the severity of the symptom 
(227). However, symptom perception is now thought to be a more complex 
process, with convincing evidence that psychological factors, such as the wider 
context, behaviour of others, and beliefs and attitudes held, are important (227). 
The perception of pain, for example, is not linearly related to the activation of 
primary sensory neurons, with multiple factors such as genetics, cognitions and 
emotions affecting neural signals (228). In addition, a range of cognitive 
processes, such as attention to bodily sensations and interpretation of sensations 
as benign or malignant, play an integral part in symptom perception (229). 
Attention and interpretation have been implicated in the perpetuation of 
symptoms as well as initial symptom perception (230). 
The influence of cognitive processes on symptom perception was first highlighted 
by Pennebaker (229) and has given rise to a number of models, such as the 
cognitive-perceptual model (227) and the symptom perception model (231) which 
attempt to describe mechanisms underlying symptom perception in oneself. 
Models of symptom perception have also been put forward for medically 
unexplained symptoms (232-234), somatisation disorder (235) and asthma (236).  
While models differ in the components included and associations suggested, the 
majority of models implicate attention and interpretation as part of symptom 
perception (see Van den Bergh et al. (233) for summary). A simple portrayal of 
the basic structure of these models is the modal model of symptom perception, 
seen in Figure 3 (237). Typically, there is an initial peripheral somatic input; 
these bodily sensations can arise from pathology, arousal, or stress. The next 
stage suggested by the model is cognitive processing, in which bodily sensations 
are attended to and interpreted, resulting in experience of a symptom. Symptom 
experience can in turn influence somatic input and further cognitive processing. 
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Psychological factors such as trait negativity, health anxiety, and learning may 
moderate the association between bodily sensations and cognitive processing, and 
between cognitive processing and symptom experience. For example, those with 
increased neuroticism, negative affect and anxiety attend more to bodily 
sensations and are more likely to interpret a sensation as threatening or malign 
(231, 238-240).  
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Figure 3. Modal model of symptom perception. Reproduced from “Symptoms and the body: Taking the inferential leap,” by O Van den Bergh et 
al., 2017, Neuroscience and Biobehavioural Reviews, 74 (Pt A), p. 187. Copyright 2017 by Elsevier. Reprinted with permission. 
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 Factors affecting symptom perception in oneself 
The modal model suggests that psychological and cognitive processes play a key 
role in subjective symptom perception. A wealth of evidence supports this and 
suggests avenues for investigation with regard to parental perception of 
symptoms. In the sections below, I review the main evidence for psychological 
factors underpinning subjective symptom perception. 
3.2.1 Misattribution of existing symptoms 
Subjective health complaints, including non-specific symptoms such as headache, 
pain and tiredness are commonly experienced in everyday life. Studies indicate 
that at least 75% of people aged fifteen and over reported experiencing symptoms 
in the last thirty days in Denmark, Sweden, Norway and Finland (241-243). This 
phenomenon has been long documented, with one study published in 1969 
finding that 81% of a cohort of hospital staff and university students had 
experienced common symptoms; however, the time frame over which symptoms 
were perceived was not specified (244). While some might argue that the finding 
that symptoms are experienced in everyday life is just a function of modernity, 
this is not the case, with another study finding that all participants belonging to 
indigenous groups living in a remote area of the Philippines had experienced 
symptoms in the last thirty days (245). This pattern of findings is not exclusive to 
adults. One study, using parental-report of symptoms, indicated that 56% children 
aged three to five years experienced at least one symptom in the last fourteen 
days (246). 
There is evidence that misattribution of commonly occurring symptoms may 
underlie many of the symptoms that are attributed to certain exposures. A recent 
comprehensive systematic review investigating the nocebo effect found that 
symptom misattribution was a key factor underlying the nocebo response (220). 
Misattribution of symptoms can occur after exposure to both active and inert 
substances. For example, in Auckland, a number of residential and industrial 
areas were sprayed using a biological insecticide to eradicate a moth which posed 
a threat to local flora and fauna (247, 248). People who lived in the spray zone 
completed questionnaires ten weeks before aerial spraying of the insecticide 
began which included the number of symptoms experienced in the past four 
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weeks. After the area had been sprayed three times, participants completed a 
follow-up questionnaire. The number of symptoms that people reported following 
the insecticide spray was strongly associated with the number of symptoms 
reported before spraying. However, this result should be taken with caution as 
when using a Bonferroni correction to account for multiple comparisons, this 
association was no longer significant. Participants were also asked whether their 
symptoms could be attributed to the insecticide spray; an association between the 
number of symptoms attributed to the spray and baseline symptom reporting was 
found (248).  
Another study investigated the number of symptoms experienced by adults 
receiving a travel vaccination (249). Prior to receiving the travel vaccination, 
participants were asked whether they had experienced any symptoms in the past 
four weeks. Twenty minutes and one week after vaccination, participants were 
asked to indicate if they had experienced any symptoms ‘since [their] 
vaccination’ and whether they attributed the symptoms to the vaccine. 
Participants who were symptomatic before vaccination reported more symptoms 
twenty minutes after vaccination and attributed more symptoms to the vaccine 
than those who were not symptomatic. There was no association between pre-
vaccination symptoms and post-vaccination symptom experience or symptom 
attribution one week after vaccination. Taken together, evidence suggests that the 
symptoms commonly experienced in everyday life are sometimes mistakenly 
attributed to a new exposure. This effect may be particularly prevalent in 
measures of symptoms immediately following exposure. 
3.2.2 Expectation 
There are two key lines of evidence which support the role of expectations in the 
perception of symptoms. First, it has been demonstrated numerous times that 
expectations influence perception of symptoms in different clinical populations. 
For example, expectations of nausea before chemotherapy have also been 
strongly associated with experiencing nausea during chemotherapy (250), even 
when controlling for other pharmacological and physiological predictors of 
nausea (251), and most recent experience with chemotherapy (252). Asthma 
patients who expect to experience more symptoms of asthma are also more likely 
to perceive symptoms (236). A systematic review of psychological predictors of 
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neck and back pain in adults has also found that expectation of pain was 
associated with later perception of pain (253).  
Second, laboratory studies with healthy volunteers have shown that 
experimentally induced expectations drive symptom perception. One recent 
systematic review of factors associated with the nocebo effect identified seventy 
experimental studies and nineteen prospective studies (220). Results indicated 
that baseline expectation, verbal suggestions of symptoms, learning from 
previous experience and seeing another person experiencing symptoms following 
exposure were key predictors of the nocebo response (220). Expectation was also 
identified as a key component in the perception of non-specific side-effects from 
medication in another systematic review (219). Overall, the evidence for the 
importance of expectations is robust. 
 Verbal suggestion of symptoms 
Expectations do not simply appear. Several triggers for expectations have been 
explored. Perhaps the most researched of these is the verbal suggestion of 
symptoms. The effect of a verbal suggestion of symptoms can be strong, 
overriding the true pharmacological action of a drug. For example, one study 
manipulated instructions about the effect of a drug, with participants receiving no 
information about the drug, being given information that the drug was a relaxant, 
or being told that the drug was a stimulant (254). In the active drug group, 
participants received carisoprodol, a muscular relaxant drug which causes 
drowsiness, while in the sham group participants received lactose pills. 
Regardless of whether they were given the active drug or the sham pill, 
participants who received information that the drug was a stimulant showed 
increased feelings of tension. 
Expectations related to the intensity of symptoms can also influence their 
perceived severity. One study, investigating perceived pain and cortical activation 
in response to an infrared laser, gave participants a valid or invalid auditory cue 
about the pain intensity of upcoming laser stimuli (255). Participants’ pain 
perception was influenced by the auditory cue rather than the intensity of the 
stimulus, with more intense stimuli which were preceded by low intensity pain 
cues being rated as less painful, and less intense stimuli preceded by high 
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intensity pain cues being rated as more painful. Neuroimaging techniques 
indicated that invalid cues might modulate pain experience through amplification 
of the nociceptive response in early cortical processes. However, results should 
be taken with caution as only six participants were included in the study.  
Other evidence for the influence of symptom expectation on later symptom 
perception comes from clinical trials showing similar rates of adverse effects in 
the placebo and active drug arms. As noted earlier (Chapter 3, paragraph 2 and 3), 
similar prevalence and patterns of side-effects in the placebo and active drug arms 
are reported in clinical trials for anti-migraine medications (214), anti-depressants 
(215), statins (210) as well as the child influenza vaccine (78). Expectations are 
likely to arise from the information about the medications given to participants 
prior to the blinded portion of the study (214, 215). Researchers’ framing of the 
medication will influence participants’ expectations of the incidence of adverse 
effects. Thus, both participant and researcher expectations may influence later 
symptom perception. 
Health professionals are not the only source of information which may influence 
expectations about symptoms. Information about individual symptoms and 
symptom likelihood from different sources, such as friends or family, the media 
and other official sources may also influence expectations (236). In New Zealand, 
in the month following news coverage of the reformulation of tablets for thyroid 
hormone replacement treatment, there was an increase in side-effect reporting 
even though there was no change to the active ingredient in the tablet (256). In 
particular, reports of symptoms explicitly mentioned in individual news stories 
increased significantly. Also in New Zealand, a retrospective longitudinal study 
investigating adverse event reporting for the HPV vaccination in relation to 
Google searches and news coverage found that the number of Google searches in 
the current month was associated with adverse event reporting (257). Negative 
media coverage in the previous month was associated with the number of adverse 
events reported. Furthermore, the effect of news coverage in the previous month 




People may judge information from individual sources based on their trust in that 
source. For example, in a nationally representative survey of American adults, 
physicians were rated the most trusted source of health information, followed by 
the internet, television, family or friends, magazines, newspapers and radio (258). 
However, peoples’ trust in a source does not necessarily mean that they would 
consult that source for health advice in the first instance. Although 49.5% of 
people indicated that they would go to their physician first for advice, 48.6% 
people consulted the internet as their first source of information, with only 10.9% 
consulting their physician first. Similarly, another study asking parents of 
children aged less than one year about their trust in sources of information about 
the MMR vaccine and outbreak found that while information from government 
sources and healthcare practitioners was the most trusted, online and television 
news and social media were the most used sources of information (259). It is 
likely that ease of access to information plays an important part in influencing 
one’s choice of source of information to consult. Thus, peoples’ expectations of 
symptoms may be influenced by multiple sources. 
 Observation of symptoms in others 
Fewer studies have investigated the social modelling of symptoms, in other 
words, the effect of seeing others undergo an exposure which brings about 
symptoms. Where studies do exist, they investigate the effect of social modelling 
on the nocebo response to inert exposures only, presumably due to ethical 
considerations. The effects of social modelling can be strong, with some studies 
indicating that social modelling of symptoms can bring about changes in 
physiological outcomes. One study exposed participants to a female confederate 
who stated that she either felt ‘calmer and more relaxed, and like [her] heart rate 
[had] gone down’ (social modelling condition) or that she ‘[didn’t] feel any 
different’ (control condition) after having supposedly taken a fast-acting beta-
blocker (260). After having taken an inert pill, participants in the social modelling 
condition had decreased heart rate, blood pressure and anxiety; these effects were 
not seen in participants in the control condition. 
While social modelling of symptoms has been identified as one of the strongest 
predictors of the nocebo effect in a recent systematic review of eighty-nine 
studies (220), there is some evidence that this effect may be more prominent in 
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females than in males (261, 262). Faasse and colleagues have conducted two 
studies in which participants were randomised to view either a study confederate 
modelling the adverse effects of a pill (social modelling condition) or ‘not feeling 
any different’ (control condition) (261, 262). The first study used a female 
confederate to model the adverse effects of the pill (261). Social modelling 
influenced the physiological marker of blood pressure, with participants in the 
control condition showing larger decreases in blood pressure after taking the inert 
pill compared to those in the social modelling condition; there was no effect on 
heart rate. While the positive and desired effects of the inert pill were experienced 
by male and female participants, social modelling of adverse effects by the 
female confederate only increased female participants’ reports of side-effects. 
The second study used both female and male confederates to model the adverse 
effects of the pill, finding that participants (both male and female) who witnessed 
the confederate experiencing adverse symptoms perceived more specific adverse 
symptoms of the medication during the experimental session; female participants 
reported more general symptoms during the session than male participants 
regardless of the modelling condition (262). At a 24-hour follow-up, as well as 
specific adverse symptoms, participants who had seen the confederate modelling 
symptoms reported more general symptoms and misattributed more symptoms to 
the inert pill.  
 Prior learning 
Another mechanism which may influence expectations is learning from previous 
experiences. Learning that symptoms are associated with an exposure may lead to 
the conditioned experience of symptoms when later presented with that same 
exposure. While some theories suggest that expectancy and conditioning are 
separate mechanisms which cause symptoms as part of the nocebo response 
(263), it is likely that learning feeds into expectations. As well as being associated 
with the nocebo response (220), prior learning that an exposure causes symptoms 
has also been implicated in the perception of medically unexplained symptoms 
(234) and non-specific symptoms attributed to medication (219). Prior learning 
may also underlie some of the adverse events experienced by participants in the 
placebo arm of randomised-controlled trials (215). The effect of learning that a 
medication causes side-effects has been investigated in a group of participants 
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taking the antidepressant amitriptyline (264). Participants were randomised to 
either the active medication group (amitriptyline), or the placebo group, in which 
participants received placebo pills which appeared identical to the active drug. 
Participants were instructed to take the pills each night alongside a neutral 
stimulus, a lychee flavoured drink. Participants randomised to the active 
medication group took amitriptyline for four nights, followed by a three-day 
washout period. After the four-night acquisition phase, participants taking 
amitriptyline reported more anti-depressant specific symptoms than those taking 
the placebo pill; there was no difference between groups for non-specific side-
effects. On the eighth day, all participants were given a placebo pill alongside the 
lychee flavoured drink. Participants assigned to the active medication group 
reported more anti-depressant specific symptoms than those taking the placebo 
pill.  
3.2.3 Beliefs and attitudes about medicines and other technologies 
There are subtle differences between beliefs and attitudes. Beliefs have been 
defined as ‘the probability dimension of a concept’ (265) (p. 35), while attitudes 
are the ‘evaluative dimension of the concept’ (265) (p. 35). Thus, beliefs 
encompass the likelihood of something happening, whereas attitudes encompass 
the tendency to consistently evaluate a particular entity in a negative or positive 
manner (266). Beliefs and attitudes have also been implicated in the nocebo 
response, and are thought to manifest through expectation or changes in 
attribution of symptoms (220). In the case of the child influenza vaccine, parents’ 
beliefs about medicines, perceptions of how sensitive their child is to 
medications, modern health worries and general attitudes may be important.  
 Beliefs about medicines 
Beliefs about medicines, in particular beliefs about their necessity and concerns 
associated with their use, have been consistently associated with medication 
adherence in a range of conditions including asthma, chronic pain from dialysis, 
diabetes, HIV, back problems and other chronic illnesses (267). While the 
association between beliefs and symptom perception is less well documented, 
negative medication beliefs are associated with perception of side-effects from 
medication in patients with rheumatoid arthritis (268) and asthma (269).  
68 
 
Beliefs about medicines have also been investigated more generally, focussing on 
the notions that medicines cause harm and are overused. Vaccination refusal has 
been associated with the notion that vaccines cause harm through adverse effects 
(91, 95, 270) as well as that vaccines are overused, playing into perceptions that 
vaccination will overburden the child’s immune system (93). While these beliefs 
have been consistently linked to vaccination uptake, less research exists 
investigating their impact on perception of symptoms. Where evidence does exist, 
it is mixed. Among heart failure patients, the perception that medicines were 
overused was associated with perceiving at least one side-effect from medication 
for heart failure in the past four weeks; no association was found between 
perceived harm and perception of side-effects (271). Although not investigating 
symptom perception itself, in a nationally representative sample of English adults, 
those who believed that medicines were more harmful and were overused had 
higher expectations of side-effects from a hypothetical medication for dizziness 
and kidney failure (272).  
A further two studies have investigated the role of beliefs about medicines with 
relation to a hypothetical new asthma drug ‘molair’ (273, 274). In these studies, 
participants were given variants of an information leaflet to read, in which 
headache was not mentioned as a side-effect of ‘molair.’ Participants were asked 
to imagine they had been taking the new drug daily for the last two weeks with no 
symptoms, but had begun to develop a headache at the beginning of the third 
week. Participants were then asked whether the headache had been a symptom of 
‘molair.’ Symptom misattribution to ‘molair’ was associated with general and 
specific negative medication beliefs (273, 274). However, when specific 
medication beliefs about the necessity of ‘molair’ and concern surrounding it 
were controlled for, the association between general beliefs about medicines and 
symptom misattribution was no longer significant (273). Participants were later 
presented with a list of side-effects, some of which were listed in the patient 
information leaflet for ‘molair’ (274). Participants who thought medicines were 
more harmful in general were less able to correctly identify whether individual 
side-effects had been listed in the leaflet and recalled fewer side-effects correctly. 
69 
 
 Perceived sensitivity to medicines 
Perceived sensitivity to medicines is associated with symptom perception in 
everyday life. In a nationally representative sample of the New Zealand adult 
population, perceived sensitivity to medicines was associated with the number of 
symptoms experienced over the last week (275). When split into groups with low, 
moderate and high perceived sensitivity to medicines, post-hoc analyses indicated 
that there was no difference in symptom reporting in those with low and moderate 
perceived sensitivity to medicines, while those with high perceived sensitivity to 
medicines perceived more symptoms in the last seven days than both low and 
moderate groups. However, these analyses were not adjusted for demographic 
characteristics despite associations being found between higher perceived 
sensitivity to medicines and being female, unemployed and older. 
Perceived sensitivity to medicines may also influence perception of symptoms 
after taking medication. Perceived sensitivity to medicines was associated with 
the number of symptoms reported and symptom attribution to a travel vaccine, 
twenty minutes after vaccination (249, 276). One week after vaccination, only the 
number of symptoms reported was associated with perceived sensitivity. In 
people starting antiretroviral therapy, perceived sensitivity to medicines was 
associated with perception of side-effects after one month of treatment (277). 
Reactions to hypothetical medications for dizziness and kidney failure were also 
investigated with relation to perceived sensitivity to medicines, with those who 
thought they were more sensitive to medicines having higher expectations of 
side-effects (272). In response to a fictitious asthma medication however, no 
association was found between perceived sensitivity to medicines and 
misattribution of headache to ‘molair’ when controlling for demographic 
characteristics and beliefs about medicines (273).  
 Modern Health Worries 
Concerns about aspects of modern life, such as potential toxic interventions 
(including vaccination programmes), environmental pollution, tainted food and 
radiation, and their impact on health are associated with increased symptom 
reporting in everyday life. This association has been found in a cohort of New 
Zealand students (278), North American students (279), young adults in Hungary 
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(280), and the general population aged fourteen and above in Germany (281). 
There may be some specificity in associations between the different aspects of 
modern health worries and symptom reporting. For example, those with higher 
concerns about tainted foods had increased gastrointestinal symptoms, while 
those who were more worried about toxic interventions (including vaccines) 
reported more musculoskeletal pain (278). 
Modern health worries are also associated with symptom perception following 
exposure to potential health threats. For example, participants who scored more 
highly for modern health worries attributed more symptoms to a recent aerial 
spraying of crops with pesticide (247, 248).  
Other potential modern health worries such as hazardous waste sites, high voltage 
transmission lines and emissions from industry have also been investigated. For 
example, although there was no direct association between perceiving odours 
from a biofuel facility and symptom perception, there was an indirect association 
mediated by perceived pollution and health threats (282). Participants who 
thought a hazardous disposal waste site was having an effect on their environment 
were more likely to perceive symptoms than those who did not (283), as were 
participants who exhibited more environmental worry (284). Industry-related 
worries was also associated with symptom in people living close to heavy 
industry such as coking works and steel and petrochemical complexes (285). 
Worry about transmission lines was associated with reporting more health 
problems in participants who lived close to high voltage transmission lines in the 
USA (286).  
 General beliefs and attitudes 
General beliefs and attitudes about illness and recommended illness prevention 
methods may also influence subjective perception of symptoms. One recent study 
asked whether students had ‘ever had adverse reactions after being vaccinated’ 
(287). Students who reported moderate or severe vaccine side-effects, compared 
to those who had not experienced side-effects or in whom side-effects were mild, 
were more likely to have a fear of side-effects and associate the term 
‘vaccination’ with needles and syringes. Beliefs about symptoms and illness may 
lead to the perception of symptoms. For example, patients with medically 
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unexplained symptoms and those with hypochondriasis tend to hold the 
inaccurate belief that all bodily sensations and symptoms are a sign of illness 
(288, 289). 
3.2.4 Psychological traits 
Traits can be defined as ‘dimensions of individual differences in tendencies to 
show consistent patterns of thoughts, feelings, and actions’ (290) (p. 25). 
Psychological traits, such as positive and negative affect, pessimism and 
neuroticism have been implicated in the nocebo response (220). Several 
convergent lines of evidence support the notion that psychological traits influence 
symptom perception. Anxiety and negative affect cause heightened attention 
towards bodily sensations and lower the threshold at which sensations are 
detected (231, 238) and it is likely that other psychological traits may influence 
symptom perception through similar mechanisms. Negative affect and 
neuroticism are also thought to bring about symptom reporting through increased 
scanning for, perception of, reaction to and complaints about, physical sensations 
(239, 240). 
There is much overlap between psychological traits (291, 292), with similarities 
being identified between dispositional optimism, pessimism, neuroticism and 
negative affect (293, 294). However, despite substantial overlap between 
psychological traits, there is evidence that separate traits measure distinct 
dimensions (295). The role of anxiety, positive and negative affect, neuroticism, 
and optimism and pessimism in symptom perception is explored. 
 Anxiety 
Although anxiety has long been associated with the nocebo effect (219), a recent 
comprehensive review found weak evidence for an association with state and trait 
anxiety (220). A study investigating symptom misattribution in response to a 
hypothetical new asthma drug also found no association between state or trait 
anxiety and symptom misattribution (273).  
The role of anxiety seems to be stronger in functional syndromes, with a meta-
analysis finding that patients with three of four functional syndromes (irritable 
bowel syndrome, nonulcer dyspepsia and chronic fatigue syndrome; not 
fibromyalgia) were more anxious than healthy controls (238). There was also 
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some evidence that those who were more anxious experienced a higher number of 
medically unexplained symptoms (238). However, it is difficult to uncover the 
direction of this relationship. The association between anxiety and symptom 
perception in somatisation persists across cultures, with one study finding that 
after adjusting for the effects of age and sex, those identified as somatic by the 
Somatic Symptom Index, were more likely to have concurrent generalised 
anxiety disorder, as diagnosed by ICD-10, in twelve sites across eleven countries 
(296). Associations between generalised anxiety disorder and the more restrictive 
ICD-10 diagnosis of somatisation disorder were not investigated. There is also 
evidence for an association between anxiety and symptom perception in general 
healthcare, with anxiety being a strong predictor of symptom reporting in patients 
in primary care in the USA (297).  
Worry about symptoms may also play an instrumental part in symptom 
perception. For example, patients with somatisation display increased illness 
worries (234). In patients with chronic fatigue syndrome and multiple sclerosis, 
worry was associated with making somatic attributions for symptoms (298). In a 
six-day diary study of secondary school Dutch teachers, worry frequency and 
duration were associated with number of symptoms experienced, when 
controlling for number of symptoms experienced the previous day (299). When 
investigating worry intensity, only worry intensity remained associated with the 
number of symptoms reported; worry frequency and duration were no longer 
associated. 
 Negative Affect 
Trait negative affect is consistently correlated with symptom report (240). A diary 
study in which participants were asked to complete a questionnaire every six 
hours while they were awake, found that participants with higher levels of 
negative affect were more likely to report somatic symptoms (300). The study 
also investigated variations of affect within-participants, finding that both 
increased negative affect and decreased positive affect were associated with 
reporting more somatic symptoms. Increased negative affect has also been 
associated with symptom reporting following an exposure, such as receiving a 
travel vaccination. For example, participants with increased negative affect 
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reported more symptoms one week after the vaccination and attributed more 
symptoms to the vaccination (249). 
Among participants presenting to primary care practices, those with increased 
negative affect and decreased positive affect reported a higher number of 
medically unexplained symptoms (301). Patients in primary care with medically 
unexplained symptoms who had high positive affect were more likely to report a 
decrease in the number of symptoms experienced at a six-month follow-up (302).  
 Neuroticism 
Less research exists investigating the role of neuroticism on symptom reporting. 
In a nationally representative sample of American twenty-four to seventy-four 
year olds without self-reported medical problems, neuroticism was associated 
with perceived poor health (303). 
There is mixed evidence for an association between neuroticism and medically 
unexplained symptoms, with one study finding that patients with medically 
unexplained symptoms show elevated neuroticism (304). Another study found no 
association between neuroticism and medically unexplained symptoms in adults 
presenting to primary care when controlling for positive and negative affect (301, 
302). 
 Optimism and pessimism 
Very few studies have investigated the role of optimism and pessimism in 
subjective symptom perception. Where evidence exists, it yields mixed results. 
Patients with the functional syndrome ‘temporo-mandibular dysfunction’ who 
were less optimistic showed a lower pain tolerance than more optimistic patients 
and healthy controls (305). 
Pessimism was associated with symptom perception in undergraduates who were 
told they were taking an over-the-counter pill which caused unpleasant symptoms 
(306). However, there was no association in a group who were unsure whether 
they were taking an inert placebo pill or the active medication or in the control 
group who were told they would be taking an inert pill (306).  
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 Other personality traits 
Depression has been investigated in relation to symptom perception in many 
studies. A systematic review identified that depressed mood increased the risk of 
neck and back pain in adults (253). Another systematic review of psychological 
factors associated with chronicity of back pain also identified distress and 
depressive mood as contributors, however these results should be taken with 
caution as few studies were included in the review (307). Associations between 
clinical depression and somatisation disorder have been found across different 
cultures, with one study finding an association in fourteen sites across thirteen 
countries (296). Depression was also a strong predictor of symptom reporting in 
patients in primary care in the USA (297). An experimental study manipulating 
mood found that college students with influenza or the common cold who 
underwent mood induction to a sad mood state reported more aches and pains 
than those inducted to a happy mood state (308). However, not all studies 
investigating symptom perception and depression have found an association. 
Depressive symptoms in adolescents were not associated with self-reported 
everyday symptom perception two years later (309). 
Other studies have investigated the grouped effect of multiple psychological traits 
on symptom perception. A systematic review reported that of eleven studies 
included which investigated stress, distress or anxiety, all found an association 
with neck and back pain (253). One study, investigating patients who presented at 
primary care services with medically unexplained symptoms, grouped negative 
affect, anxiety and depression scores to give a composite measure of ‘negative 
affect,’ which was associated with consistently reporting high levels of medically 
unexplained symptoms (302).  
3.2.5 Cognitive processes 
Attention and interpretation play a central role in many models of symptom 
perception (233). However, they tend to be discussed in terms of the attention one 
pays to bodily sensations, and the interpretation of the cause of symptoms, also 
known as symptom attribution. While the role of biases in information processing 
has been researched less, cognitive biases of attention and interpretation may also 




Although attention to one’s own bodily sensations allows identification of 
injuries, increased attention to bodily sensations is associated with increased 
symptom reports (234). For example, increased body consciousness in healthy 
participants was associated with making somatic attributions for a bodily 
sensation (310) and with increased symptom reporting in everyday life (311). 
Patients with somatisation syndrome and those with hypochondriasis also show 
increased body scanning (288). Further evidence that symptom report may be 
associated with increased attention to subjective bodily sensations comes from 
research finding that when distracted by a mental arithmetic task, patients with 
psychosomatic diseases showed decreased pain intensity and pain unpleasantness 
(312).  
It could be hypothesised that people who pay more attention to their bodily 
sensations are more able to detect physiological sensations, however this is not 
the case. Patients with hypochondriasis often consider themselves to be more 
sensitive to harmless bodily sensations, however, they show no increase 
compared to healthy controls in their ability to detect tactile stimuli (313). 
Despite evidence indicating that patients with functional syndromes display 
increased attention to bodily sensations, evidence for the role of attention bias in 
perception of medically unexplained symptoms is inconclusive (234). Meta-
analytic results indicate that although chronic pain patients display attention 
biases towards pain-related stimuli, they do so no more than healthy controls 
(314). Chronic fatigue patients display attention biases only when using particular 
tasks (315-318). One explanation for this pattern of results may be that chronic 
fatigue patients are only biased in the elaborative phase of attention, in which 
patients relate a word to their personal concerns, rather than the orientation phase 
of attention, in which participants direct their attention (318). Similarly, in 
somatoform patients, bias for physical threat words was found at the supraliminal 
but not subliminal level, suggesting that somatoform disorders may be associated 
with maladaptive biases in later stages of processing, such as interpretation (319). 
Results for irritable bowel syndrome patients are mixed. One study found that 
compared to controls, who oriented more quickly to neutral words than pain 
words, irritable bowel syndrome patients showed no difference in their 
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orientation to pain and neutral words (320). Another study found that differences 
in attention bias between irritable bowel syndrome patients and healthy controls 
existed for socially threatening words (321). Taken together, it seems that while 
patients with functional syndromes may display attention biases, these biases are 
displayed only in the more conscious, rather than unconscious, phases of 
information processing. 
Content-specific attention biases have been found in patient populations with 
physical illnesses such as asthma (208), a history of cancer (322), a family history 
of cancer (though who have never had the disease themselves) (323) and 
pathological health anxiety (324). Those who have experienced a minor health-
related problem in the last month, but who are otherwise generally healthy, and 
those with poorer self-assessed health also systematically attend to health-related 
and illness-related words compared to non-illness or neutral words (325, 326). 
Although studies are cross-sectional and causation cannot be inferred, studies 
seem to indicate that a history of symptoms is associated with greater attention to 
symptom-related stimuli. Thus, symptom experience may influence bias, rather 
than bias influencing symptom experience.  
 Interpretation 
Less research exists investigating the interpretation of bodily sensations as 
symptoms. Interpretations are likely to be made in line with schema already held 
by the individual, with people selectively searching for confirmatory sensory 
information and forming interpretations which agree with their hypotheses (327). 
For example, one study found that groups with diagnoses for different 
psychological disorders held different interpretations of the cause of their 
symptoms, in line with relevant schema (328). In this study, participants with 
anxiety disorders tended to believe that bodily sensations were a result of their 
anxiety, giving more psychological interpretations of symptoms, whereas those 
with hypochondriasis tended to hold more somatic interpretations of bodily 
sensations, interpreting bodily sensations as symptoms of illness (328). 
Increased health anxiety can impact symptom interpretation even in non-clinical 
populations. Healthy participants with increased health anxiety tended to interpret 
diagnostic information about whether they were at risk for experiencing problems 
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during painful medical tests more negatively than those with lower anxiety (329). 
More anxious individuals also tended to catastrophise more about the meaning 
and implications of bodily sensations experienced (329). 
Although these studies show that those with specific disorders tend to interpret 
the cause of symptoms according to their own schema, they do not measure 
whether systematic interpretation biases differ in those who perceive more 
physical symptoms. While few studies have investigated the associations between 
interpretation bias and symptom perception in functional syndromes, results 
indicate evidence for an association. A systematic review and meta-analysis of 
the role of interpretation bias in chronic pain found that when presented with 
ambiguous words, participants with chronic pain tended to choose the pain-
related or illness-related interpretation (330). A recent systematic review found 
that chronic fatigue patients showed negative interpretation biases on tasks where 
they had time to generate their responses, but not when having to make more 
automatic, spontaneous responses (318). Again, this points to the notion that 
biases in chronic fatigue patients may only manifest in the elaborative phase of 
information processing, when patients have the time to draw upon existing illness 
schemas. While causation cannot be inferred, evidence suggests that negative 
interpretation biases underlie perception of symptoms in functional syndromes. 
3.2.6 Personal characteristics 
Higher rates of symptoms are consistently perceived by females than males in 
health surveys, clinical registration of health complaints by physicians, and 
studies investigating symptom reporting (331). In the primary care setting, female 
sex was associated with increased symptom reporting (297) and reporting high 
levels of medically unexplained symptoms (302). Female sex was also associated 
with number of self-reported physical symptoms in a population of adolescents 
attending school (309). Higher side-effect reporting in females than males has 
also been found for corticosteroid drugs for asthma (269). Gender effects in the 
nocebo phenomenon are less clear. Though most research points to an association 
between female sex and symptom perception, a meta-analysis identifying factors 
associated with the nocebo response in placebo-controlled clinical trials for 
neuropathic pain (pain which arises as the result of a lesion or disease affecting 
the somatosensory system) found an association between male sex and the 
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nocebo response (332). More recently, a comprehensive systematic review of 
factors associated with the nocebo response found no significant gender effects 
(220).  
Sex differences in symptom perception, in particular perception of pain, have 
been investigated using neuroimaging techniques, finding differences in patterns 
of neural activation in response to pain (333). Females show increased activation 
in areas of the brain associated with affective and motivational components of 
pain, including emotion-arousal, compared to males (334, 335). It is therefore 
possible that differences in pain reporting are due to females placing more 
emotional importance on pain than men, rather than there being differences in 
sensory impulses in the central nervous system (334).  
The direction of association between symptom perception and other personal 
characteristics is less clear. For example, age has been investigated by multiple 
studies with varying results. While not associated with full somatisation disorder, 
when using a less rigorous classification, participants aged forty-five and over 
were more likely to fall into the somatisation category than younger participants 
(296). In contrast, another study using primary care data indicated that younger 
participants reported more symptoms (297). Younger participants were also more 
likely to misattribute symptoms to the fictitious drug ‘molair’ (273). Education 
and socio-economic status were also investigated with relation to symptom 
reporting in primary care, finding that patients with lower education and socio-
economic status reported more physical symptoms (297). 
3.2.7 Clinical characteristics 
Clinical characteristics may also impact subjective symptom perception. The 
number of medical comorbidities was associated with increased symptom 
reporting in primary care patients in the USA (297). This is logical, with those 
who have more comorbidities, likely experiencing more symptoms. 
Other studies have investigated self-reported symptom perception in children of 
parents with chronic illnesses. A recent meta-analysis investigating chronic pain 
found that children of parents with chronic pain were more likely to report 
chronic pain themselves (336). A longitudinal study following a birth cohort until 
adulthood found that children who experienced recurrent abdominal pain were 
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more likely to have parents who reported illness in their own childhood (337). In 
these cases, child-reported symptom perception could be due to biological factors, 
such as the child being more likely to inherit illness from their parents, or 
psychological factors, with children adopting similar coping strategies to their 
parents. 
3.2.8 Interaction between factors 
So far, factors associated with subjective symptom perception have been 
discussed individually. However, as proposed by models of symptom perception, 
it is likely that these factors interact with each other. Studies have focused on the 
potential mediating and moderating effects of psychological traits on symptom 
perception. For example, there is evidence that the relationship between 
neuroticism and symptom perception may be mediated by negative affect. This 
was the case in patients with medically unexplained symptoms (301) and Type 2 
diabetes (239). Low positive affect also mediated the relationship between 
neuroticism and symptom perception in patients with medically unexplained 
symptoms (301). Negative affect has also been proposed to mediate the 
perception of asthma symptoms, as it explains more of the variance in asthma 
symptoms than does pulmonary function (338). 
Neuroticism moderated the relationship between negative affect and symptom 
reporting in patients with Type 2 diabetes, with those who were low in 
neuroticism showing a stronger relationship between negative affect and 
symptom reporting (239). Neuroticism also moderated the relationship between 
positive affect and symptom reporting, with patients with high, but not low, 
neuroticism, displaying an association between positive affect and symptom 
reporting (239). 
Beliefs, attitudes and personal characteristics may also interact with subjective 
symptom perception. For example, one study found that worry intensity mediated 
the relationship between stressful events and symptom reporting in Dutch 
teachers (299). Another study found that the relationship between modern health 
worries and somatic symptoms in adolescents was mediated by health anxiety and 
somatosensory amplification (280). 
80 
 
 Parental perception of symptoms 
There is strong evidence for the influence of psychological factors in subjective 
symptom perception in oneself, as well as numerous models which attempt to 
explain symptom perception both generally and across a range of medical 
conditions (233). There is much less research, and no models explaining how 
psychological and social factors may affect the perception of symptoms in 
someone other than oneself.  
The ability to accurately identify symptoms in others is particularly important for 
parents. If parents are unable to accurately perceive symptoms in their child, they 
might incorrectly detect or miss signs of illness, symptoms of allergy or 
intolerance, or side-effects of medications, and make inappropriate decisions for 
their child regarding medical care, lifestyle, or medication adherence as a result. 
Perceived food intolerance is one example of this. Parents who perceive 
symptoms after their child eats a certain food may conclude that their child is 
intolerant. Approximately one-third of parents believe their child has a food 
sensitivity (339). However, the majority of these children do not undergo any 
formal testing of food allergy such as skin prick tests or oral food challenges. 
When formal testing does occur, the actual prevalence of food hypersensitivity is 
much lower (339, 340), suggesting that many parents are unnecessarily restricting 
their child’s diet as a result of this misperception (341). 
Parental perception of symptoms in children is common. Although formal data 
are scarce, one study based on parental report estimated that 56% of children aged 
three to five had experienced symptoms such as headache, stomach ache, 
tiredness and dizziness in the last fourteen days (246), a broadly similar rate to 
that seen in adults (241-243). While rates are similar, it is likely that different 
factors come into play when identifying symptoms in others and oneself. While 
perception of symptoms in oneself is driven by detection of internal cues and 
bodily sensation, parental perceptions of symptoms in a child relies on external 
cues, such as observations of the child’s behaviour, or listening to and assessing 
self-report from the child. Parents of young or severely disabled children, who are 
unable to verbalise their bodily sensations, may have to rely solely on observation 
of the child’s behaviour. 
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To collate the available evidence regarding factors affecting parental perception 
of symptoms, I conducted a systematic review to identify psychological and 
social factors pertaining to the parent and child which are associated with parent-
report of physical symptoms in one’s child. 
 Methods 
I conducted a systematic review in accordance with PRISMA criteria (104), to 
identify factors associated with parental perception of symptoms in children. I 
searched Embase, Ovid and PsycINFO through OvidSP; and Scopus. The final 
search used the terms (Parent* ADJ3 (perception OR perceive)) AND (side effect 
OR symptom* OR pain* OR asthma*). Asthma was included in the search terms 
as it is a condition experienced commonly in childhood, which was prevalent in 
my preliminary searches. MeSH terms were also searched where possible. 
Databases were searched from inception to 12th July 2018. References and 
forward citations of included articles were also searched. 
3.4.1 Inclusion criteria 
I applied the following inclusion criteria: 
Participants: Studies were included if they investigated parents of children aged 
zero to eighteen years. Studies were excluded if parents discussed symptom 
report outcome measures with their child or if it was unclear whether the parent 
or the child completed outcome measures. 
Predictors/Exposures: Studies were included if they investigated the association 
between psychological or social factors and parental perception of symptoms. 
Outcomes: Studies were included if the outcome was parental report of symptoms 
in the child, including pain, asthmatic symptoms, side-effects from medication, or 
perceived allergy or food intolerance. Outcomes relating to parental contact with 
health professionals following symptom perception were excluded. Outcomes 
based on parental report of a diagnosis by a healthcare practitioner for the child 
were also excluded. 
Study reporting: Only studies published in English were included. 
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3.4.2 Data extraction 
I extracted information about study design, inclusion criteria, number of 
participants, child age, symptom type, symptom measure used, and predictors of 
symptom perception. 
3.4.3 Risk of bias 
I measured risk of bias using an amended version of the Downs & Black checklist 
(105), as in Chapter 2. This version did not include items referring to 
interventions as they were not relevant for any included study. The Downs & 
Black checklist has been validated (107) and is suitable for use in systematic 
reviews (106). The amended Downs & Black checklist included ten items 
assessing study reporting, two items assessing external validity, three items 
assessing internal validity (bias), three items assessing confounding (selection 
bias), and one item assessing whether there was a justification for the sample size 
used (power). I rated studies as good quality if they scored sixteen or over, 
moderate quality if they scored eleven to fifteen, and poor quality if they scored 
ten or less. I rated studies as scoring poorly if they: scored six or under out of a 
possible ten for study reporting; scored one or under out of a possible three for 
internal validity (bias) and confounding (selection bias); scored one or under out 
of a possible two for external validity; and if they did not include a justification 
for the sample size used. 
3.4.4 Procedure 
I developed the search terms, carried out the search, screened papers, extracted 
data and completed risk of bias assessment with guidance from GJR.  
 Results 
3.5.1 Study characteristics 
3765 citations were found by the original search. After removing duplicates, 3232 
citations remained. After title, abstract and full-text screening, seven citations 
remained. This number included the paper that resulted from the cross-sectional 
study reported in Chapter 5. This study has been left in the search flowchart, but 
the study itself has been excluded from the results section of this review. Instead, 
its methods, results and contribution to the literature are reported in detail in 
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Chapter 5. Reference searching and forward citation tracking identified a further 
twenty-nine citations which met the inclusion criteria. Forward citation tracking 
identified the paper that resulted from the prospective cohort study in Chapter 6; 
this study has also been excluded from the current review, for the same reasons 
outlined above. This study is not included in the search flowchart. Thus, a total of 
thirty-four citations (six from the search and twenty-eight from reference 
searching and forward-citation tracking) reporting on thirty-two studies were 
included in this review (see Figure 4). Twenty-two studies used a cross-sectional 
design, seven used a cohort design and three used case-control design (see 
Appendix 3). Nine studies investigated somatic symptoms in general, with a 
further nine investigating solely headache, three investigating abdominal pain or 
stomach ache, and two investigating both headache and stomach ache; one 
investigated recurrent symptoms. Six studies investigated pain. One study 
investigated perceived food allergy and one investigated infectious diseases. 
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Figure 4. Flowchart depicting the selection of studies included in the systematic 
review of parental perception of symptoms with reasons for exclusion 
 










Number excluded after excluding 
duplicates (n=533) 
Number excluded after 
screening titles (n=2933) 
Number excluded after screening 
abstracts (n=248) 
Full-text articles excluded (n=45). Reason for 
exclusions: 
- No psychosocial predictors of symptom 
perception identified (n=15) 
- Symptom perception not outcome 
measured (n=10) 
- Not parental perception of symptoms 
(n=9) 
- Conference abstract (n=3) 
- Unable to locate full text (n=3) 
- Foreign language (n=2) 
- Age range too broad/not child population 
(n=1) 
- Child and parent completed outcome 
measure together (n=1) 
- Reported in later chapter of thesis (n=1) 
Articles found in references and by 
other means (n=28) 
- Forward citation tracking 
(n=14) 
- Reference tracking (n=9) 






3.5.2 Risk of bias 
Scores ranged between three and sixteen out of a possible nineteen, with a median 
score of nine (see Appendix 3). There was only one good quality study (342). The 
majority of studies were poor quality (n=19), with twelve moderate quality 
studies. Only two studies gave a justification for the sample size used (343, 344) 
(see Figure 5). With respect to internal validity, ten studies scored poorly for 
confounding (selection bias) (345-354) and thirteen scored poorly for bias (246, 
345, 346, 348-351, 353-358). External validity was poor in twenty-nine studies 
(246, 343-356, 358-373), while reporting was poor in twenty-four studies (246, 
343, 345-349, 351-365, 369, 374).  
Figure 5. Chart indicating number of studies included in the systematic review of 
factors associated with parental perception of symptoms displaying different 
aspects of risk of bias 
 
3.5.3 Predictors of parental symptom perception 
Parental and child psychosocial factors associated with parental perception of 
symptoms are reported in Table 5 (for full results tables see Appendix 4). Where 
studies used adjusted analyses only these are reported. Many studies used the 
Strengths and Difficulties Questionnaire (375), which is made up of five 
components: emotional problems, conduct problems, hyperactivity-inattention, 
peer problems and prosocial behaviour. Where possible I have reported results for 
each component separately. 
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 Parent psychosocial characteristics 
There was good evidence for an association between parent anxiety and parental 
symptom perception. One moderate quality study found an association between 
parent anxiety and report of somatic symptoms (373). Four studies found mixed 
evidence of an association with increased symptom presence, frequency and 
severity: two studies were moderate quality (367, 370-372) and two were poor 
quality (352, 353).  
There was mixed evidence for an association between parent depression and 
parental symptom perception. Maternal depression was associated with 
perception of recurrent symptoms in one poor quality study (358), while a 
moderate quality study found mixed evidence (370-372). Three further studies, 
two moderate quality (364, 373) and one poor quality (354), found no association 
between increased presence and frequency of parent-reported symptoms. 
There was mixed evidence for an association between parent distress or stress and 
parental symptom perception. Distress was associated with perception and 
frequency of parent-reported symptoms in a moderate quality study (374) and a 
poor quality study (246). Three moderate quality studies investigated the 
association between parental stress and perception and frequency of parent-
reported symptoms. One found an association (373), one found mixed evidence 
for an association (366), and one found no association (361). 
There was little evidence for an association between perceived emotional and 
social support and parental symptom perception. A moderate quality study found 
that paternal, but not maternal, low emotional support was associated with 
perception of recurrent stomach aches in the child (366). A poor quality study 
found an association between maternal relationship dissatisfaction and perception 
of a number of parent-reported symptoms (365). Conversely, a poor quality study 
found an association between high perceived emotional support and increased 
perception of concurrent headaches and stomach aches in the child (356). Two 
poor quality studies found no association with parental perception of recurrent 
headaches and stomach aches (354, 358).  
There was little evidence for an association between parenting style and parental 
symptom perception. A poor quality study found an association between maternal 
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involvement and parent-reported somatisation (349). Conversely, a moderate 
quality study found an association between punitive behaviours and less frequent 
perception of headaches in the child (368). No association was found between 
parenting style and pain sensitivity in another poor quality study (348). 
Only one poor quality study investigated the effect of believing the symptom was 
common with respect to parental symptom perception, finding that parental 
perception that food allergy was common was associated with parental perception 
of food allergy in one’s child (357). 
Table 5. Parent and child psychosocial characteristics associated with parental 
perception of symptoms 
 Parent characteristic Child characteristic 
Category Studies finding an 













Anxiety (373) / (352, 353, 
367, 370-372) 
 (246, 347, 350, 
359, 368) / (346) 
 
Depression (358) / (370-372) (354, 364, 
373) 
(350, 362) / (346, 359, 
368) 
Attention deficit and 
hyperactivity 






(369)  (246) / (346) (368) 
Emotional problems   (342, 368) / (356, 
370-372) 
 
Stress (373) / (366) (361)   
Mental distress (246, 374) /   (347) 
Stressful/adverse 
life event 
 / (365)  (246, 347) / (344, 361, 
366) 
Behavioural or 
conduct problems or 
disorder 
  (355, 356, 370-




Total strengths and 
difficulties 
  (342, 343, 368, 
370-372, 374) / 
 





  (342) / (346, 368, 
370-372) 
Perceived lack of 
emotional or social 
support 




perception). / (366) 
(354, 358)   




 Child psychosocial characteristics 
There was good evidence for an association between child anxiety and parental 
symptom perception. Child anxiety was associated with increased presence, 
frequency and severity of parent-reported symptoms in two moderate quality 
studies (359, 368) and three poor quality studies (246, 347, 350). Another poor 
quality study found mixed evidence of an association with parent-reported 
somatic symptoms (346). All studies investigated parent-reported child anxiety, 
aside from two (350, 368), which investigated child-reported anxiety. One poor 
quality study found mixed evidence for an association between parental report 
that the child was ‘fearful or anxious’ and perception of recurrent symptoms 
(360). 
There was little evidence for an association between child depression and parental 
symptom perception. An association was found between child depression and 
presence and severity of parent-reported symptoms in two poor quality studies 
(350, 362). Two moderate quality studies (359, 368) and one poor quality study 
(346) found no association between child depression and presence, frequency and 
severity of parent-reported symptoms. All studies investigated parental reports of 
depression, aside from two (350, 368), which investigated child-reported 
depression. Three studies investigated the effect of child anxiety and depression 
together, with one poor quality study finding an association between child-
reported depression and anxiety and parent-reported child somatisation (350). 
Parent-reported anxiety and depression was not associated with parental 
perception of recurrent headache in one moderate quality (344) and one poor 
quality study (363).  
There was good evidence for an association between child emotional problems 
and parental perception of symptoms. Associations were found with parent-
reported frequent or severe headaches in one good quality (342) and one 
moderate quality study (368). There was mixed evidence for an association with 
presence and frequency of parent-reported symptoms in one moderate quality 
(370-372) and one poor quality study (356). 
There was mixed evidence for an association between child attention-deficit 
hyperactivity disorder (ADHD) and parental symptom perception. Two studies 
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found an association between ADHD and presence, frequency and severity of 
parent-reported symptoms: one study was good quality (342) and one was poor 
quality (246). One moderate quality study found mixed evidence for an 
association with recurrent stomach ache (370-372). Three studies found no 
evidence for an association between ADHD and presence and frequency of 
parent-reported symptoms: one study was moderate quality (368) and two were 
poor quality (346, 363). 
There was mixed evidence for associations between other child psychological 
disorders and parental symptom perception. Adjustment disorder was associated 
with perception of parent-reported physical symptoms in a poor quality study 
(246). There was mixed evidence for an association between social phobia and 
separation anxiety and parental perception of physical symptoms in a poor quality 
study, however when investigated as a predictor of frequent somatisation an 
association was found (346). Neither social phobia nor separation anxiety were 
associated with parent-reported frequent headache in a moderate quality study 
(368). There was no evidence for an association between oppositional defiant 
disorder and parent-reported presence or frequency of symptoms in a moderate 
quality (368) and poor quality study (346). Parent-reported somatic symptoms 
were not associated with dysthymia and alexithymia (345, 346), or severe mood 
dysregulation (346).  
There was mixed evidence for an association between child conduct disorder and 
behavioural problems and parental perception of symptoms. Conduct problems 
were associated with parent-reported perception and frequency of symptoms in 
one moderate quality study (370-372); a good quality study found mixed 
evidence (342). Two studies found no association: one moderate quality (368) 
and one poor quality (346). Behavioural problems were associated with parental 
perception of headache and stomach ache in two poor quality studies (355, 356); 
there was mixed evidence in two poor quality studies (354, 358). One poor 
quality study found no association between parent-reported recurrent headache 
and aggressive behaviour (363).  
There was good evidence for an association between total high difficulties on the 
Strengths and Difficulties questionnaire and parental symptom perception. Total 
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high difficulties was associated with parental perception of frequent child 
headaches in one good quality study (342) and two moderate quality studies (343, 
368) and with parent-reported recurrent stomach aches and frequent pain in two 
moderate quality studies (370-372, 374). 
There was some evidence for an association between child temperament and 
parental perception of symptoms, however studies varied in the aspects of 
temperament measured. One moderate quality study found that increased activity 
and lack of rhythmicity of eating were associated with parent-reported recurrent 
stomach ache (370-372). One moderate quality study found associations with 
parent-reported somatisation only for certain aspects of temperament (373). One 
poor quality study did not distinguish between aspects of temperament, finding 
that child temperament was associated with parent-reported pain, but only in 
children with a birth weight over 801 grams (348). Another poor quality study 
found an association between emotionality (but not shyness, sociability or 
activity) and parent-reported somatisation in full-term children; there was no 
association between any aspect of temperament in extremely-low birth weight 
children (349).  
There was little evidence for an association between adverse or stressful life 
events and parent-reported physical symptoms, with two poor quality studies 
finding an association (246, 347). Three moderate quality studies investigating 
presence and frequency of parent-reported symptoms found no association (344, 
361, 366). 
There was little evidence for an association between problematic relationships 
with peers and parental perception of symptoms. One good quality study found an 
association between peer problems and parent-reported frequent or severe 
headaches (342). However, three studies investigating presence and frequency of 
parent-reported studies, two moderate quality (368, 370-372) and one poor 
quality (346), found no association. 
 Discussion 
While mechanisms underlying symptom perception in oneself are more clearly 
understood, less research has explored factors associated with parental perception 
of symptoms in children. Studies included in my review were heterogeneous, 
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investigating parents of children of different ages and with different medical 
conditions, and were generally of poor quality. Evidence for factors was 
sometimes mixed and difficult to interpret. In addition, as diary methodologies 
were not used, parental report of symptoms may have been affected by factors 
such as recall bias and therefore may not have mapped exactly on to symptom 
perception. Above all, my review highlights the need for better quality research in 
this important and seemingly overlooked area. 
This point notwithstanding, some factors appear to be associated with parental 
perception of symptoms. These can be grouped into two broad categories 
previously identified by others (376): psychological traits and behavioural 
difficulties. Looking first at psychological traits, there was good evidence for an 
association between child anxiety and parental symptom perception, but less 
evidence for a role of child depression, ADHD and emotional problems. This 
mirrors findings for parent psychological traits. This pattern of findings is perhaps 
unsurprising. One of the conditions necessary for the diagnosis of anxiety 
disorders in adults is the presence of physical symptoms (377). In children, 
presence of recurrent somatic symptoms is also one of the diagnostic criteria for 
generalised anxiety disorder (378). However, the presence of physical symptoms 
is not included in the diagnosis of other disorders such as ADHD (379) or 
depressive disorder, aside from disturbed sleep and diminished appetite (380).  
How child behavioural difficulties, such as having problems with peers, may 
affect parental symptom perception is poorly understood. While all studies 
investigating child temperament in the review found an association with parent-
reported symptoms, no rationale was given for investigating these factors. Studies 
were heterogeneous in the aspects of behaviour and temperament measured, 
making interpretation difficult. Physical symptoms are not implicated in conduct 
disorder (381), with the exception of measures of rhythmicity of sleeping and 
eating which are sometimes included in temperament (e.g. the Carey Infant 
Temperament Scale Revised (382)). The effects of temperament and behaviour 
on parental symptom perception likely manifest differently in different parent-
child dyads. Children perceived as ‘difficult’ may verbally report more 
symptoms, leading to increased parental symptom perception. Children may also 
behave differently in the presence of their parents, leading to increased possibility 
92 
 
of symptom detection by parents. For example, children display more pain in the 
presence of a parent than a stranger (383). Better quality research is necessary to 
clarify the nature of, and reasons underlying, associations between temperament 
and parental symptom perception. 
One important question to consider is whether parent and child psychosocial 
factors are associated with increased symptoms experienced by the child, or 
increased parental detection of symptoms, irrespective of the child’s subjective 
experience. This distinction has already been identified as a concern in the 
literature (373) and it is likely that both mechanisms are relevant. Theories 
attempting to explain how parental anxiety may increase child symptom 
experience include that parents model illness behaviour which is then replicated 
by the child; that parents reinforce symptomatic behaviour; that the child may be 
genetically predisposed to respond to environmental stress through somatisation; 
and that perceiving anxiety or physical symptoms in the adult may cause the child 
to experience anxiety or stress, which in turn may manifest as physical symptoms 
in the child (367, 371-373). Anxious parents may also pay more attention to the 
child, leading them to detect more symptoms (367, 371-373). 
The effect of some psychosocial factors on parental symptom perception were 
conspicuous by their absence from my review. In particular, no studies 
investigated the effect of expectation on parental symptom perception. Given the 
importance of expectation in the nocebo effect (220) and the wealth of evidence 
suggesting that expectation influences symptom perception in oneself (219, 220, 
234, 255, 260-262, 384), it is surprising that no studies have investigated the 
influence of parental expectation on parent-reported symptoms. One possible 
explanation for this dearth of research is that studies have so far focused on 
finding factors associated with increases in symptoms experienced by the child, 
rather parental reporting of symptoms. However, regardless of a child’s 
subjective experience, parental perception and recall of symptoms will influence 
their decision-making about medical treatments or potential lifestyle adjustments. 
Therefore, it is important to identify factors which may influence parental 
perception of symptoms.  
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Although no studies were included in the systematic review, it may be the case 
that parental cognitive biases are associated with perception of symptoms. There 
is very little evidence in this field, with research into cognitive biases typically 
focussing on oneself. However, parental interpretation biases have been 
implicated in symptom perception, with mothers of children with chronic 
abdominal pain tending to interpret ambiguous emotional facial expressions as 
pain (385). While causation cannot be inferred, it seems plausible that consistent 
negative interpretation of ambiguous illness-stimuli may lead parents to perceive 
symptoms in their child. For example, in the case of the child influenza 
vaccination, if the child sneezed in the hours following vaccination, parents with 
negative biases for man-made health threats may interpret this as a side-effect of 
vaccination, rather than as a sign that the child is currently cold. 
There is some evidence that parental attention biases are associated with 
symptom perception, with studies finding that caregivers of chronic pain patients 
have biased attention towards painful faces (386, 387). Caregiver attention bias 
for pain-related stimuli was also associated with increased reporting of pain in the 
child (387). Attention biases may be more influential in parental perception of 
symptoms in the child than in perception of symptoms in oneself, due to the 
reliance on external cues to identify symptoms in the child. However, as with the 
association between attention bias and symptom perception in oneself, it is likely 
that parents of children with chronic pain attend more to behavioural pain cues as 
a result of their child’s pain experience. There are no studies investigating 
whether parental attention or interpretation biases are associated with perception 
of side-effects following vaccination. 
3.6.1 Limitations of studies included in the review 
Most studies included in my review were poor quality. In particular, studies fell 
short on reporting and external validity. Studies were also heterogeneous with 
regard to their populations and statistical analyses, used inappropriate statistical 
tests or did not report the statistical tests used (354, 358), or had small samples 
(354, 358). Symptom perception was also defined differently by different studies, 
with some studies using higher thresholds for symptom perception than others. 
Studies included in the review used many different scales to measure the same 
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construct; this was particularly notable for temperament and behaviour (307) and 
made it difficult to compare results between studies. 
3.6.2 Limitations of the review 
Several limitations of my review should be considered. First, symptoms perceived 
by parents in this review were wide ranging, including pain, allergy and non-
specific symptoms such as headache and stomach ache. I was unable to 
investigate whether predictive factors differed in relation to different symptoms.  
Second, few studies investigated the same factors, meaning that my conclusions 
for some risk factors are based on limited results and should be treated with 
caution.  
Third, it was notable that only seven citations were identified through my search 
strategy, with most citations being found through forward citation and reference 
tracking. As parental perception of child symptoms is rarely studied as a topic in 
its own right and has no specific, easily-searchable terminology, relevant data 
were difficult to find. I also did not search grey literature. It is likely that other 
studies investigating relevant risk factors exist, but I was unable to locate them.  
Fourth, I restricted my search to psychosocial predictors of parental symptom 
perception. Other studies exist investigating personal and clinical factors such as 
breastfeeding (388-390), smoke exposure (391-395), exposure to indoor 
dampness and mould (396, 397), attending day care (398), and number of siblings 
(399) on parental symptom perception, particularly with relation to child asthma 
and allergic symptoms. A full model of parental symptom perception may need to 
account for these factors. 
3.6.3 Conclusions 
Despite poor quality and heterogeneous research, some factors stand out as being 
associated with parental perception of symptoms. In particular, parent and child 
anxiety are likely to be associated with parental symptom perception, as are child 
behavioural difficulties. However, mechanisms underlying the latter are unclear. 
Parent and child psychosocial factors may impact symptom perception through 
increasing child symptom experience, or parental detection of symptoms 
irrespective of child symptom experience. Increases in parental symptom 
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perception are likely brought about by a combination of these aspects. Some 
factors which are likely to influence parental perception of symptoms have not 
yet been investigated. First, the effect of expectation in parental symptom 
perception has not been researched, despite strong evidence indicating its key role 
in the nocebo phenomenon. Second, potential underlying associations between 
parental cognitive biases and symptom perception should be investigated. Better 
quality research is needed to more fully understand the impact of, and 




Chapter 4. Summary, research 
aims and hypotheses 
Influenza is a serious illness which causes complications in many and presents a 
significant financial and clinical burden. Fortunately, vaccination can reduce 
these burdens. In my literature review, I found evidence that the factor most 
consistently associated with vaccination refusal was parental perception that the 
vaccine caused side-effects (Chapter 2). While there is ample evidence that 
parents choose not to vaccinate their child for fear of side-effects (91, 93, 95, 
182), the root cause of parental perception of side-effects from vaccination is 
unclear. Although some side-effects may occur as a result of the pharmacological 
action of the vaccine, others may reflect pre-existing or coincidental symptoms 
that are misattributed to the vaccine, and still others may arise as a result of 
psychological factors such as parental expectations, or other psychological 
mechanisms such as information processing biases. Little research into why 
parents perceive symptoms in their children exists. Where it does, research is 
heterogeneous and poor quality, making it difficult to state conclusively how 
factors are associated with parental symptom perception (Chapter 3). In 
particular, the expectation of side-effects, which may arise from previous 
experience of side-effects or seeing side-effects in other children, may play a key 
role in parental perception of side-effects from vaccination. Parental anxiety, 
general beliefs and attitudes about vaccinations, and biases of information 
processing may also influence perception of side-effects following vaccination. 
Diminishing parental perception of side-effects from vaccination, by influencing 
factors associated with side-effect perception, could be a novel target for 
interventions aiming to increase vaccine uptake. Furthermore, diminishing 
parental perception of side-effects from vaccination could positively impact 
parental medication beliefs and future medication adherence. 
While many biases of information processing exist, for my thesis I have chosen to 
investigate the influence of interpretation bias on vaccination behaviour for the 
following reasons. First, while parental perception of symptoms is likely 
impacted more by attention biases than perception of symptoms in oneself, 
evidence for the role of attention biases in symptom perception was mixed. I 
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found stronger evidence for a potential causal role of interpretation bias (Chapter 
3). Second, bias modification shows more consistent, stronger effects for 
interpretation than attention (400). Bias modification is the logical next step for 
research if an association between interpretation bias and vaccination behaviour is 
identified. Third, knowing how people interpret information related to child 
vaccination could help inform the phrasing of official vaccine communications. 
The content-specific nature of biases suggests that information processing biases 
will be strongest in those areas most closely related to vaccination behaviour. I 
have identified two facets of vaccination behaviour which might be particularly 
important here: the source of the health threat (man-made or naturally-occurring) 
and the subject of the health threat (self- or child-relevant). 
The literature reviews presented in Chapters 2 and 3 resulted in a series of 
research aims and hypotheses that I investigated using a cross-sectional survey of 
parents whose child was eligible to receive the influenza vaccine in England 
during the 2015/16 influenza season (Chapter 5) and a prospective cohort study of 
parents vaccinating their child for influenza in primary care surgeries in South 
London during the 2016/17 influenza season, who were followed up in the 
2017/18 influenza season (Chapter 6). 
 Hypotheses relating to vaccine uptake 
I investigated whether psychological factors were associated with uptake of the 
child influenza vaccine and vaccination intention for the following season. 
Specifically, I hypothesised that parents a) who refused the vaccine and b) did not 
intend to vaccinate their child the following year would be more likely to: 
1. believe that influenza was benign;  
2. have negative beliefs and attitudes about vaccinations in general and the 
child influenza vaccine in particular; 
3. Have different patterns of interpretation biases, specifically: 
a. have more negative interpretation biases for man-made health 




b. have similar negative biases for self-relevant and child-relevant 
health threats (subject of health threat); 
4. have no history of child influenza vaccination. 
All hypotheses were investigated in the cross-sectional study (Chapter 5). 
As exploratory analyses, I also used the cross-sectional study to investigate 
potential associations between parent and child personal and clinical 
characteristics and vaccine uptake and vaccination intention.  
 Hypotheses relating to re-vaccination  
I investigated whether psychological factors were associated with child influenza 
re-vaccination intention and actual re-vaccination behaviour in the next influenza 
season among parents who had already vaccinated their child once. Specifically, I 
hypothesised that parents who did not re-vaccinate their child and who did not 
intend to re-vaccinate their child the following year would be more likely to: 
1. have perceived side-effects from vaccination;  
2. have perceived more severe side-effects; 
3. be more worried about the side-effects that were perceived; 
4. have heard from a healthcare worker in the vaccination appointment that 
the vaccine caused side-effects; 
5. think their child was more sensitive to medicines after they had been 
vaccinated for influenza; 
6. have less trust in healthcare workers after their child had been vaccinated 
for influenza; 
7. have different patterns of interpretation bias, specifically: 
a. have more negative interpretation biases for man-made health 
threats as opposed to naturally-occurring health threats; 




8. In addition, I hypothesised that parents who did not intend to re-vaccinate 
their child the following year would be less likely to re-vaccinate their 
child. 
All hypotheses were investigated in the prospective cohort study (Chapter 6). 
As exploratory analyses, I also used the prospective cohort study to investigate 
potential associations between parent and child personal and clinical 
characteristics and actual and intended re-vaccination for influenza in children 
who had already been vaccinated. 
 Hypotheses relating to parental side-effect perception 
I investigated whether psychological factors were associated with parental 
perception of side-effects following one’s child’s influenza vaccination. 
Specifically, I hypothesised that parents who reported side-effects from the child 
influenza vaccine would be more likely to: 
1. report symptoms in the child before vaccination; 
2. expect their child to develop side-effects from vaccination; 
3. have negative beliefs about medicines; 
4. think their child was more sensitive to medicines; 
5. have increased modern health worries; 
6. believe that influenza was benign; 
7. have negative beliefs and attitudes about vaccinations in general and the 
child influenza vaccine in particular; 
8. have increased trait anxiety; 
9. have increased negative affect; 
10.  have increased neuroticism; 
11. have increased pessimism; 
12. have decreased positive affect; 
13. have decreased optimism; 
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14. have different patterns of interpretation bias, specifically: 
a. have more negative interpretation biases for man-made health 
threats as opposed to naturally-occurring health threats; 
b.  have similar negative biases for self-relevant and child-relevant 
health threats. 
15. I also hypothesised that parental expectations might mediate the 
relationship between psychological predictors and parental perception of 
side-effects. 
Hypothesis six, seven and fourteen were investigated in the cross-sectional study 
(Chapter 5). All hypotheses were investigated in the prospective cohort study 
(Chapter 6). 
As exploratory analyses, I also used the cross-sectional and prospective cohort 
studies to investigate potential associations between parent and child personal and 
clinical characteristics and parental perception of side-effects from vaccination.  
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Chapter 5. Cross-sectional study 
As we have seen, many psychological, social and contextual factors are 
associated with not vaccinating, with the most consistent reason given for 
refusing vaccination being the fear of side-effects (Chapter 2). Biases and 
heuristics have long been implicated in vaccine uptake (101, 102), but the 
influence of information processing biases has not yet been investigated. In 
Chapter 4, I hypothesised that more benign beliefs about influenza and more 
negative beliefs and attitudes about the vaccine; negative interpretation biases; 
and parent and child personal and clinical characteristics would be associated 
with child influenza vaccine uptake in 2015/16 and vaccination intention in 
2016/17 (Hypothesis 4.1.1, Hypothesis 4.1.3). 
While symptoms are commonly reported following vaccinations, their causes are 
not always straightforward. Although some may be directly attributable to the 
vaccine, pre-existing or coincidental symptoms may be misattributed to the 
vaccine, while still others may occur due to a ‘nocebo’ effect. There is good 
evidence that psychosocial factors influence subjective symptom perception. 
However, there is less research investigating the influence of psychosocial factors 
on parental perception of symptoms in one’s child. Where it does exist, research 
is highly heterogeneous and mostly poor quality (Chapter 3). Information 
processing biases may also play a role in parental symptom perception (385). 
However, to the best of my knowledge there is no research investigating whether 
cognitive biases are associated with parental perception of vaccination side-
effects. In Chapter 4, I hypothesised that more benign beliefs about influenza and 
more negative beliefs and attitudes about the vaccine; negative interpretation 
biases; and parent and child personal and clinical characteristics would be 
associated with parental perception of side-effects from the child influenza 
vaccination in those who were vaccinated in 2015/16 (Hypothesis 4.3.6, 
Hypothesis 4.3.14). I also hypothesised that those who perceived side-effects 
from vaccination, in particular those who perceived more severe side-effects and 
who were more worried about side-effects perceived, would be less likely to 
intend to re-vaccinate their child in 2016/17. 
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Research into terms used to describe the incidence of side-effects shows that 
using verbal descriptors of risk, such as those used in current communications 
(73, 401), often leads to heightened estimations of incidence (272, 402, 403). 
Other vaccine-specific terms often used in current communications, such as 
‘effectiveness’ are also likely to be poorly understood. Thus, I used the same 
study to test whether terms currently used to describe the incidence of side-effects 
and the effectiveness of the child influenza vaccine were understood by parents. 
For this chapter, I conducted a nationally-representative cross-sectional study of 
parents of children eligible for the influenza vaccine in the 2015/16 influenza 
season. I investigated whether psychological factors were associated with child 
influenza vaccine uptake in 2015/16; parental perception of side-effects from 
vaccination in those who were vaccinated; and vaccination intention for 2016/17.  
 Method 
5.1.1 Design 
I commissioned the market research company Ipsos MORI to conduct an online 
survey of parents or guardians of children aged between two and seven years on 
31st August 2015 living in England. Data collection took place between 16th and 
30th March 2016, after the end of England’s child influenza vaccination campaign 
for that year (404). 
5.1.2 Participants and recruitment 
Ipsos MORI recruited participants from an existing panel of people willing to 
take part in internet surveys (n=160,000 in England). Invitations to take part were 
sent to those who had previously indicated that they were a parent or legal 
guardian of a child born between 1st September 2008 and 31st August 2013 living 
in England. Quotas based on parent age and gender (combined), region, working 
status, gender of child and age of child were set to reflect the known demographic 
profile of parents of children in England (405). Participants spoke fluent English 
and were aged eighteen or over. Panel participants typically receive points for 




 Selection of index child 
Where participants had two or more eligible children, the survey software chose 
one child for them to think about when answering questions, based on the need to 
fill quotas for child age. If parents had two children of the same age, they were 
asked to choose one to think about for the duration of the survey.  
5.1.3 Materials 
Full study materials can be found in Appendix 5. 
 Vaccine uptake in 2015/16 
Participants were asked whether their child ‘had received the influenza vaccine 
this winter (2015/16),’ answering either ‘yes,’ ‘no’ or ‘don’t know.’ Parents were 
also asked to state their main reasons for vaccinating or not vaccinating their 
child.  
 Side-effect perception 
Participants whose child had been vaccinated were asked whether the child had 
experienced any out of a list of 23 symptoms ‘because of the child flu vaccine.’ I 
included symptoms listed as potential vaccine side-effects in the patient 
information leaflet by the manufacturer (73), common symptoms taken from the 
Patient Health Questionnaire (PHQ-15) (406), other symptoms suggested by the 
literature (dizziness) (246), and a more general non-specific symptom (the child 
being ‘not themselves’) that was recommended when the materials were piloted 
with eleven parents. Participants who reported symptoms were asked how severe, 
overall, the symptoms had been and how worried they had been about them. 
 Vaccination intention for 2016/17 
Participants were asked whether they agreed or disagreed with the statements ‘I 
want [child] to be vaccinated for flu next year’ and ‘I intend [child] to be 
vaccinated for flu next year.’ Answers were given on a five-point Likert scale 
from ‘strongly disagree’ to ‘strongly agree.’ This approach was taken from 
Payaprom et al. (407). 
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 Beliefs and attitudes about influenza and the child influenza vaccine 
Participants’ beliefs and attitudes about influenza and the child influenza vaccine 
were measured using nineteen items adapted from previous work (408); these 
statements were rated on a five-point Likert scale from ‘strongly agree’ to 
‘strongly disagree.’ Statements referred to parents’ beliefs about the vaccine, 
including whether they thought it to be safe; effective; to cause long- or short-
term side-effects; possible interactions with other medication taken by the child; 
and whether it suited religious or cultural beliefs. Statements also referred to 
possible vaccine recommendations made by health professionals and friends or 
family and whether the vaccine campaign was ‘just about making money for the 
manufacturers.’ Beliefs about influenza were measured by asking whether parents 
thought influenza would be a serious illness for themselves, the child, or someone 
else in the child’s household as well as the child’s perceived vulnerability to 
influenza. Higher scores to belief and attitude statements indicated a more 
positive belief or attitude. 
 Terminology used in vaccine communications 
Understanding of current communications regarding the effectiveness of the 
vaccine was assessed by one item asking participants to imagine that the child 
influenza vaccine was ‘50% effective.’ Participants endorsed one of five options 
for what this means, including the correct answer ‘if a child had a 50% chance of 
catching flu before being vaccinated, they now have half that chance (i.e. 25%).’ 
I included four items to assess understanding of terms used to communicate the 
incidence of acute side-effects. The four items described side-effects that were 
‘very common’ (runny or stuffy nose), ‘common’ (fever), ‘uncommon’ (rash) and 
‘very rare’ (severe allergic reaction) as indicated by the patient information leaflet 
for Fluenz Tetra (73). These terms are recommended for use in patient 
information leaflets by European Commission guidelines and are intended to 
reflect side-effects that affect more than one in ten patients (very common), up to 
one in ten (common), up to one in 100 (uncommon) and up to one in 10,000 (very 
rare) (409). Items stated, for example, that ‘the patient information leaflet 
mentions that fever is a common side-effect’ and asked participants to estimate 
how many out of 10,000 vaccinated children would develop the specified 
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symptom. The patient information leaflet for Fluenz Tetra does not describe any 
‘rare’ side-effects, so participants’ understanding of this term was not assessed. 
 Interpretation bias 
Interpretation bias can be measured using a wide range of tasks in which 
participants are asked to interpret ambiguous stimuli. If participants consistently 
interpret items negatively, they are said to have a negative interpretation bias. 
Many different variations of interpretation bias tasks exist, in which participants 
are required to unscramble sentences, or interpret ambiguous words, images or 
scenarios (see Schoth et al. (410) for a review of tasks). Generally, participants 
are presented with several ambiguous stimuli which can be interpreted either 
positively or negatively. While it depends on the individual tasks, negative 
interpretation bias tends to be calculated as the proportion of ambiguous stimuli 
interpreted in a negative manner. Positive interpretation biases can also be 
measured, by calculating the proportion of ambiguous stimuli interpreted 
positively.  
I used the scrambled sentences task (411) to measure interpretation biases in this 
study due to its sensitivity to individual differences (191, 412) and good 
reliability (413). Items consisted of six words presented in a fixed-random order 
which had to be unscrambled to create a meaningful five-word statement. Each 
word string could be resolved into either a positive or a negative statement. For 
example, the words ‘illness   a   flu   serious   is   minor’ could produce either ‘flu 
is a serious illness’ or ‘flu is a minor illness.’ Participants were given two minutes 
to complete ten items. Items were presented in a random order. 
Given the theoretical differences between domains that might be most associated 
with child influenza vaccination, I developed materials to test interpretation 
biases specific to a) the source of a health threat (two levels: man-made or 
naturally-occurring) and b) the subject of a health threat (two levels: self-relevant 
or child-relevant). For the source of the health threat items, man-made health 
threats (five items) included vaccination, medicines, side-effects, new inventions 
and mobile phones, while naturally-occurring health threats (five items) included 
influenza, illness, bacteria, germs and getting a sun-tan. For the subject of a 
health threat items, self-relevant health threats (five items) included physical 
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health, feeling tired and suffering aches and pains, and child-relevant health 
threats (five items) included physical health, development and illness. Items were 
pilot tested with four parents of children aged two to seven years for validity and 
were revised as necessary. The final twenty items are provided in Appendix 6. 
Participants completed the scrambled sentence task under cognitive load, as this 
has previously been shown to prevent strategic inhibition of biases and increase 
the sensitivity of the measure to interpretation bias (411). Before unscrambling 
the sentences, participants memorized a six-digit number. Participants were 
instructed not to use memory aides (such as writing the number down). At the end 
of the task, participants were asked to recall the number. Participants were also 
asked to report any strategy they used to help them recall the number.   
Negative interpretation bias scores were calculated by dividing the number of 
negative statements produced by the total number of items attempted. Higher bias 
scores indicated higher negative interpretation bias. 
 Personal and clinical characteristics 
Participants were asked for their age, gender, employment status, highest level of 
education, total household income, ethnicity and whether they had a chronic 
illness. The child’s age, gender, and whether they were first-born or had a chronic 
illness were also recorded. 
5.1.4 Piloting materials 
Questionnaire materials were piloted with eleven parents of children aged two to 
seven years for understanding; items were amended according to problems 
identified. Interpretation bias items were piloted on four parents of children aged 
two to seven years for validity and revised if parents had difficulty unscrambling 
them. 
5.1.5 Ethical approval 
The study was approved by the King’s College London Psychiatry, Nursing and 




Ipsos MORI sent an email to their panel members identified as parents inviting 
them to complete the study materials online. Panel members taking part were 
presented with an online information sheet and provided electronic consent 
through the use of a tick box.  
Participants then completed a questionnaire (approximately ten minutes long) 
which asked about child influenza vaccine uptake, parental perception of side-
effects, parental beliefs and attitudes about influenza and the vaccine, and 
personal and clinical characteristics. 
Participants then completed interpretation bias materials (scrambled sentence 
task, ten items) pertaining to either the source of the health threat or the subject of 
the threat. Each participant was allocated by the survey software to either the 
source or subject items based on which version had the fewest number of 
respondents at that point. 
5.1.7 Power 
I intended to recruit 1,000 participants to provide me with a sample error of 
approximately plus or minus 3%.  
Only a subset of survey participants completed interpretation bias materials to a 
satisfactory level and were included in the analyses presented here. I used 
G*Power (414) to run post-hoc power analyses for each of the interpretation bias 
analyses. For the vaccine uptake in 2015/16 analyses, I based power analyses on 
the use of a repeated measures ANOVA. Using a-priori parameters of two groups 
and two measures, with the correlation between measures being 0.5 and an alpha 
of .05 I had over 99.9% power to detect a medium effect size (f=0.25) for a 
within-between interaction in analyses pertaining to the source of the health threat 
(n=153) and the subject of the health threat (n=159). 
For the side-effect perception analyses, I based power analyses on the use of a 
repeated measures ANOVA. Using a-priori parameters of two groups and two 
measures, with the correlation between measures being 0.5 and an alpha of .05, I 
had 99.7% power to detect a medium effect size between groups (f=0.25) for a 
within-between interaction in analyses pertaining to the source of the health threat 
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(n=79) and 99.2% power in analyses pertaining to the subject of the health threat 
(n=159). 
For the vaccination intention in 2016/17 analyses, I based power analyses on the 
use of a fixed effects multiple linear regression. Using a-priori parameters of 
three tested predictors and five total predictors, with an alpha of .05, I had 98.6% 
power to detect a medium effect size (f2=0.15) in analyses pertaining to the 
source of the health threat (n=153) and 98.9% power in analyses pertaining to the 
subject of the health threat (n=159). 
5.1.8 Analysis 
Where relevant, I excluded data from participants who did not know or could not 
remember if their child had been vaccinated or had experienced side-effects. 
Scores for the two items assessing intention to vaccinate in 2016/17 were 
combined to produce an intention score from two to ten (407), with a higher score 
indicating a stronger intention. If participants had answered ‘don’t know’ to one 
or both intention questions they were excluded from the intention analyses. I 
defined a score of six or lower as indicating a low intention to vaccinate again in 
2016/17, and a score of seven or more as high intention. 
I recoded beliefs and attitudes about influenza and the vaccine as ‘agree’ or 
‘disagree’. Responses of ‘don’t know’ and ‘neither agree nor disagree’ were 
treated as missing data. 
Because rates of reported vaccine uptake, perceived side-effects, and intention to 
vaccinate the child did not change by more than 1% when using data weighted by 
age, gender, region and working status, I used unweighted data for my analyses. 
I used binary logistic regressions to identify whether influenza vaccine uptake in 
2015/16 and side-effect perception were associated with: beliefs and attitudes 
about influenza and the child influenza vaccine; and personal and clinical 
characteristics. Multivariate logistic regressions were used to calculate the same 
associations adjusting for personal characteristics. I used linear regressions to 
identify whether vaccination intention was associated with: beliefs and attitudes 
about influenza and the child influenza vaccine; perception of side-effects from 
vaccination in 2015/16, perceived severity of side-effects and worry about side-
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effects; and personal and clinical characteristics. A second set of linear 
regressions adjusted for personal characteristics. Only results of multivariate 
analyses are reported narratively; results of univariate analyses are shown in the 
tables. Where analyses relied on under ten participants in one cell, these are not 
reported narratively unless they have a material impact on results. 
 Interpretation bias 
Participants were excluded from the analyses if they did not complete 
interpretation bias task materials adequately, defined as 40% missing data from 
any domain (man-made or naturally-occurring health threats; self-relevant or 
child-relevant health threats), or if participants reported using a strategy to 
remember the number. Data for interpretation bias tasks pertaining to the source 
and the subject of the health threat were analysed separately. 
To investigate whether there was an association between child influenza vaccine 
uptake and interpretation bias, I ran two mixed-model, repeated measures 
ANOVAs on bias scores with vaccination status as a between-participant factor 
(uptake, or no uptake). In one ANOVA, the within participant factor was the 
source of the health threat (two levels: man-made and naturally-occurring), 
whereas in the other it was the subject of the health threat (two levels: self-
relevant and child-relevant).  
To investigate whether there was an association between parental perception of 
side-effects from vaccination and interpretation bias, I ran two mixed-model, 
repeated measures ANOVAs with side-effect perception as a between-participant 
factor (side-effects perceived, or no side-effects perceived). In one ANOVA, the 
within participant factor was the source of the health threat (two levels: man-
made and naturally-occurring), whereas in the other it was the subject of the 
health threat (two levels: self-relevant and child-relevant). 
To investigate the association between vaccination intention and interpretation 
bias, I ran two hierarchical linear regressions with bias score as the dependent 
variable. Vaccination intention, health threat (source of health threat: man-made 
and naturally-occurring; subject of health threat: self-relevant and child-relevant) 




For all interpretation bias analyses, personal and clinical characteristics (parent 
gender, parent age, parent employment, total household income, parent education, 
parent ethnicity, parent chronic illness, child gender, first-born child, child age 
and child chronic illness) were investigated to see whether there was a univariate 
association (p≤.05) with outcome variables. Where personal and clinical 
characteristics were associated with outcome variables, they were entered into the 
analyses as covariates. In regression analyses, covariates were entered into the 
regression model as the first block; predictor variables were entered into the 
model as the second block. Controlling for all personal and clinical characteristics 
was considered too conservative in interpretation bias analyses due to the smaller 
sample sizes and innovative nature of the research (e.g. (415)). 
5.1.9 Statistical software 
I analysed data using SPSS 22 (416). 
 Results 
5.2.1 Participants 
Of 11,563 people emailed the link to the survey, 1,310 began it. After removing 
those who did not complete the survey (n=268), who completed suspiciously 
quickly or who provided identical answers to multiple consecutive questions 
(‘speeding’ or ‘straightlining;’ n=34), or who experienced a technical malfunction 
during the survey (n=7), 1001 parents or guardians completed the study (response 
rate = 8.7%).  
Personal characteristics of participants and their children are shown in Table 6. 
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Table 6. Parent and child personal and clinical characteristics and associations with influenza vaccine uptake in 2015/16 and vaccination 
intention for 2016/17 
Participant 
characteristics 








Odds ratio (95% 
CI) 
Adjusted odds 
ratio (95% CI)a 
Total=950. N, M, SD B (95% CI) Adjusted B (95% 
CI)a 
Parent gender Female 317 (55.9) 247 (44.1) 1.16 (0.89 to 1.50)  1.13 (0.79 to 1.64) N=548, M=7.66, SD=2.59 0.06 (-0.26 to 
0.38) 
-0.06 (-0.39 to 0.27) 
Male 212 (52.6) 191 (47.4) Reference  Reference N=402, M=7.59, SD=2.35 Reference Reference 
Parent age 45+ 53 (42.1) 73 (57.9) 0.47 (0.31 to 0.71)* 0.84 (0.47 to 1.50) N=119, M=7.10, SD=2.59 -0.74 (-1.25 to -
0.23)* 
-0.35 (-0.88 to 0.17) 
35-44 238 (53.0) 211(47.0) 0.73 (0.56 to 0.96)* 0.88 (0.60 to 1.28) N=440, M=7.58, SD=2.48 -0.26 (0-.60 to 
0.08) 
-0.05 (-0.38 to 0.29) 





403 (55.0) 330 (45.0) 1.05 (0.78 to 1.41) 0.98 (0.63 to 1.52) N=726, M=7.62, SD=2.40 -0.04 (-0.41 to 
0.34) 
-0.15 (-0.55 to 0.25) 
Not working 126 (53.8) 108 (46.2) Reference  Reference N=224, M=7.66, SD=2.78 Reference Reference 
Total household 
income before 
tax and other 
deductions 
≥£30,000 311 (54.3) 262 (46.7) 0.91 (0.69 to 1.19)  0.88 (0.60 to 1.29) N=565, M=7.63, SD=2.39 -0.10 (-0.44 to 
0.23) 
-0.07 (-0.41 to 0.28) 





Degree or higher 
(Bachelors, Masters, 
PhD) 
289 (55.5) 232 (44.5) 1.06 (0.82 to 1.37) 1.18 (0.82 to 1.71) N=513, M=7.66, SD=2.35 0.03 (-0.29 to 
0.35) 




230 (54.1) 195 (45.9) Reference Reference N=415, M=7.62, SD=2.63 Reference Reference 
Parent ethnicity Black and Minority  66 (48.9) 69 (51.1) 0.75 (0.52 to 1.08)   0.69 (0.42 to 1.12) N=133, M=7.49, SD=2.50 -0.20 (-0.65 to 
0.26) 
-0.16 (-0.61 to 0.28) 
White 456 (56.0) 358 (44.0) Reference  Reference N=798, M=7.68, SD=2.48 Reference Reference 
Parent chronic 
illness 
Present  183 (59.6) 124 (40.4) 1.34 (1.02 to 1.77)* 1.06 (0.71 to 1.57) N=308, M=7.84, SD=2.34 0.32 (-0.19 to 
0.66) 
0.12 (-0.23 to 0.47) 
None 343 (52.4) 312 (47.6) Reference  Reference N=639, M=7.52, SD=2.56 Reference Reference 
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Child gender Female 270 (55.0) 221 (45.0) 1.02 (0.80 to 1.32)  1.23 (0.87 to 1.73) N=484, M=7.63, SD=2.53 0.01 (-0.31 to 
0.33) 
0.15 (-0.16 to 0.46) 
Male 259 (54.4) 217 (45.6) Reference  Reference N=466, M=7.62, SD=2.46 Reference Reference 
First-born child Yes 319 (61.2) 202 (38.8) 1.78 (1.37 to 2.29)* 1.35 (0.95 to 1.93) N=517, M=7.78, SD=2.35 0.34 (0.02 to 
0.66)* 
-0.05 (-0.37 to 0.27) 
No 210 (47.1) 236 (53.9) Reference Reference N=433, M=7.45, SD=2.64 Reference Reference 






0.92 (0.85 to 0.99)* 0.96 (0.87 to 1.06) N=950, M=7.63, SD=2.49 -0.09 (-0.18 to 
0.01) 
-0.04 (-0.13 to 0.05) 
Child chronic 
illness 
Present  103 (66.9) 51 (33.1) 1.84 (1.28 to 2.64)* 1.36 (0.82 to 2.26) N=158, M=8.04, SD=2.15 0.51 (0.08 to 
0.93)* 
0.02 (-0.42 to 0.46) 




Yes 434 (81.0) 102 (19.0) 17.13 (12.35 to 
23.76)* 
15.54 (11.00 to 
21.96)* 
N=537, M=8.61, SD=1.72 2.37 (2.08 to 
2.67)* 
2.25 (1.94 to 2.57)* 
No 79 (19.9) 318 (80.1)  Reference Reference N=369, M=6.24, SD=2.78 Reference Reference 
*p≤.05 
a Adjusting for all other personal characteristics (both parent and child) 
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5.2.2 Vaccine uptake in 2015/16 
529 participants (52.8%) reported that their child had been vaccinated for 
influenza in the 2015/16 influenza season, 438 (43.8%) reported that their child 
had not been vaccinated and 34 (3.4%) did not know. Participants’ reasons for 
vaccinating or not vaccinating their child are reported in Appendix 7. The most 
common reason for vaccinating was to protect the child from influenza, cited by 
61.2% of participants who vaccinated their child. The most commonly reported 
reason for not vaccinating was because participants thought that the child was 
generally healthy and they were not overly worried about them catching influenza 
(43.2%), followed by the perception that the vaccine causes side-effects (21.7%). 
Associations between personal and clinical characteristics, beliefs and attitudes 
about influenza and the vaccine and vaccination uptake in the 2015/16 season are 
reported in Table 6 and Table 7. When controlling for personal and clinical 
characteristics, participants whose child had a previous influenza vaccination; 
who believed the influenza vaccine to be effective; who perceived the child to be 
susceptible to influenza; who had a health professional recommend that the child 
should be vaccinated; and who perceived influenza to be a serious illness for the 
child had increased odds of vaccine uptake. Factors associated with lower 
likelihood of uptake included: participants feeling that they did not know enough 
about the vaccine; perceiving the vaccine to be unsafe; believing the vaccination 
campaign to be only about making money for the manufacturers; believing that 
the vaccine caused short-term side-effects and long-term health problems; 
believing that yearly vaccination would overload the child’s immune system; not 
liking vaccines in general; and believing yearly influenza vaccinations to be too 
much of an ongoing time commitment.
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Table 7. Parental beliefs and attitudes about influenza and the child vaccine and associations between vaccine uptake in 2015/16 and vaccination 
intention for 2016/17 
Statement Level Influenza vaccine uptake in 2015/16 Vaccination intention for 2016/17 
Vaccinated 
n=529, n (%) 
Not vaccinated 






Total=950. N, M, SD B (95% CI) Adjusted B (95% 
CI)a 
The child flu vaccine has not 
been tested enough for me to 
feel it is safe 
Agree 89 (34.9) 166 (65.1) 0.15 (0.11 
to 0.22)* 
0.16 (0.10 to 
0.26)* 
N=251, M=6.48, SD=2.80 -2.34 (-2.68 to -
2.00)* 
-1.78 (-2.12 to -1.44)* 
Disagree 315 (77.8) 90 (22.2) Reference Reference N=410, M=8.82, SD=1.64 Reference Reference 
The child flu vaccine can 
cause unpleasant short-term 
side-effects 
Agree 206 (47.5) 228 (52.5) 0.23 (0.16 
to 0.35)* 
0.26 (0.16 to 
0.43)* 
N=423, M=7.13, SD=2.73 -1.76 (-2.18 to -
1.35)* 
-1.37 (-1.77 to -0.96)* 
Disagree 151 (79.5) 39 (20.5) Reference Reference N=192, M=8.89, SD=1.55 Reference Reference 
The child flu vaccine can 
cause long-term health 
problems 
Agree 86 (45.5) 103 (54.5) 0.31 (0.22 
to 0.45)* 
0.26 (0.15 to 
0.42)* 
N=188, M=6.64, SD=2.92 -2.05 (-2.43 to -
1.67)* 
-1.83 (-2.22 to -1.45)* 
Disagree 293 (72.9) 109 (27.1) Reference Reference N=402, M=8.69, SD=1.72 Reference Reference 
The flu vaccine would 
interact with other 
medications that [child] is 
currently taking 
Agree 71 (64.5) 39 (35.5) 1.49 (0.98 
to 2.26) 
0.74 (0.41 to 
1.32) 
N=109, M=8.21, SD=1.96 0.55 (0.04 to 
1.06)* 
0.05 (-0.46 to 0.55) 
Disagree 370 (55.1) 302 (44.9) Reference Reference N=653, M=7.66, SD=2.59 Reference Reference 
Vaccinating [child] against 
flu each year will overload 
his/her immune system 
Agree 90 (45.0) 110 (55.0) 0.37 (0.27 
to 0.52)* 
0.27 (0.16 to 
0.44)* 
N=193, M=6.92, SD=2.67 -1.62 (-2.00 to -
1.25)* 
-1.43 (-1.80 to -1.05)* 
Disagree 316 (68.7) 144 (31.3) Reference Reference N=464, M=8.54, SD=2.03 Reference Reference 
Another child I know had 
side-effects from the vaccine 
Agree 113 (58.9) 79 (41.1) 1.10 (0.79 
to 1.54) 
0.647 (0.41 to 
1.02) 
N=193, M=7.49, SD=2.58 -0.48 (-0.88 to -
0.73)* 
-0.83 (-1.21 to -0.44)* 
Disagree 312 (56.5) 240 (43.5) Reference Reference N=536, M=7.96, SD=2.41 Reference Reference 
A health professional has 
recommended that [child] 
should be vaccinated 
Agree 284 (76.3) 88 (23.7) 6.08 (4.37 
to 8.47)* 
3.61 (2.36 to 
5.50)* 
N=375, M=8.61, SD=1.98 1.95 (1.59 to 
2.30)* 
1.11 (0.72 to 1.49)* 
Disagree 112 (33.6) 211 (66.4) Reference Reference N=300, M=6.66, SD=2.75 Reference Reference 
A health professional has 
recommended that [child] 
shouldn’t be vaccinated 
Agree 84 (62.7) 50 (37.3) 1.24 (0.84 
to 1.81) 
0.853 (0.51 to 
1.44) 
N=131, M=7.95, SD=2.28 0.16 (-0.30 to 
0.63) 
-0.13 (0.58 to 0.32) 
Disagree 381 (57.6) 280 (42.4) Reference Reference N=648, M=7.79, SD=2.50 Reference Reference 
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A friend/relative has 
recommended that [child] 
shouldn’t be vaccinated 
Agree 90 (60.0) 60 (40.0) 1.14 (0.79 
to 1.64) 
0.73 (0.45 to 
1.18) 
N=146, M=7.77, SD=2.33 -0.07 (-0.51 to 
0.38) 
-0.41 (-0.85 to 0.02) 
Disagree 363 (56.8) 276 (43.2) Reference Reference N=627, M=7.84, SD=2.51 Reference Reference 
If I don’t vaccinate [child], 
then [child] will get flu 
Agree 225 (74.8) 76 (25.2) 8.79 (6.00 
to 12.87)* 
4.46 (2.66 to 
7.48)* 
N=310, M=8.85, SD=1.62 3.42 (3.06 to 
3.78)* 
2.90 (2.48 to 3.31)* 
Disagree 66 (25.2) 196 (74.8) Reference Reference N=249, M=5.43, SD=2.67 Reference Reference 
Flu would be a serious 
illness for [child] 
Agree 370 (62.2) 225 (37.8) 2.60 (1.84 
to 3.67)* 
1.66 (1.03 to 
2.66)* 
N=583, M=8.26, SD=2.09 2.01 (1.61 to 
2.41)* 
1.40 (0.99 to 1.81)* 
Disagree 69 (38.8) 109 (61.2) Reference Reference N=170, M=6.25, SD=3.04 Reference Reference 
Flu would be a serious 
illness for me 
Agree 287 (62.0) 176 (38.0) 2.14 (1.57 
to 2.91)* 
1.40 (0.92 to 
2.13) 
N=255, M=8.26, SD=2.07 1.61 (1.24 to 
1.98)* 
0.97 (0.60 to 1.35)* 
Disagree 113 (43.3) 148 (56.7) Reference Reference N=452, M=6.65, SD=2.93 Reference Reference 
Flu would be a serious 
illness for someone living in 
[child]’s household 
Agree 301 (61.6) 188 (38.4) 1.94 (1.41 
to 2.69)* 
1.36 (0.87 to 
2.12) 
N=480, M=8.24, SD=2.19 1.78 (1.38 to 
2.17)* 
1.27 (0.88 to 1.66)* 
Disagree 98 (45.2) 119 (54.8) Reference Reference N=207, M=6.47, SD=2.96 Reference Reference 
Having the child flu vaccine 
is an effective way of 
preventing [child] from 
catching flu 
Agree 427 (71.6) 169 (28.4) 8.28 (5.27 
to 13.01)* 
4.56 (2.58 to 
8.08)* 
N=599, M=8.75, SD=1.63 4.14 (3.77 to 
4.51)* 
3.43 (3.03 to 3.82)* 
Disagree 29 (23.4) 95 (76.6) Reference Reference N=118, M=4.62, SD=2.77 Reference Reference 
I don’t like [child] having 
vaccinations in general 
Agree 103 (47.2) 115 (52.8) 0.53 (0.38 
to 0.73)* 
0.53 (0.34 to 
0.82)* 
N=209, M=6.71, SD=2.95 -1.55 (-1.96 to -
1.15)* 
-1.34 (-1.73 to -0.95)* 
Disagree 308 (63.0) 181 (37.0) Reference Reference N=482, M=8.26, SD=2.23 Reference Reference 
I don’t know enough about 
the child flu vaccine 
Agree 124 (32.8) 254 (67.2) 0.14 (0.10 
to 0.20)* 
0.16 (0.10 to 
0.25)* 
N=362, M=6.80, SD=2.61 -1.69 (-2.06 to -
1.32)* 
-1.08 (-1.45 to -0.70)* 
Disagree 242 (77.3) 71 (22.7) Reference Reference N=319, M=8.49, SD=2.23 Reference Reference 
Vaccinating [child] against 
flu each year is too much of 
an ongoing time 
commitment 
Agree 82 (60.3) 54 (39.7) 1.00 (0.68 
to 1.46) 
0.59 (0.35 to 
1.00)* 
N=137, M=7.74, SD=2.26 -0.22 (-0.67 to 
0.23) 
-0.48 (-0.94 to -0.03)* 
Disagree 381 (60.3) 251 (39.7) Reference Reference N=619, M=7.96, SD=2.47 Reference Reference 
The child flu vaccine does 
not suit my religious or 
cultural beliefs/values 
Agree 74 (62.2) 45 (37.8) 1.24 (0.83 
to 1.86) 
0.93 (0.54 to 
1.61) 
N=118, M=7.57, SD=2.60 -.33 (-0.81 to 
0.14) 
-0.55 (-1.02 to -0.09)* 
Disagree 385 (57.0) 291 (43.0) Reference Reference N=660, M=7.90, SD=2.38 Reference Reference 
The vaccination campaign is 
just about making money for 
the manufacturers 
Agree 77 (39.9) 116 (60.1) 0.28 (0.20 
to 0.40)* 
0.23 (0.14 to 
0.38)* 
N=192, M=6.20, SD=3.04 -2.39 (-2.77 to -
2.00)* 
-2.14 (-2.53 to -1.75)* 
Disagree 314 (70.4) 132 (29.4) Reference Reference N=442, M=8.59, SD=1.86 Reference Reference 
Perception of side-effects Yes     N=212, M=8.62, SD=1.61 -0.54 (-0.78 to -
0.31)* 
-0.53 (-0.79 to -0.26)* 
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No - - - - N=301, M=9.17 (1.13) Reference Reference 
Severity of side-effects Severe     N=5, M=7.20, SD=1.92 -2.09 (-3.49 to -
0.69)* 
-2.02 (-3.46 (-0.58)* 
Moderate     N=38, M=7.82, SD=1.98 -1.47 (-2.11 to -
0.83)* 
-1.59 (-2.27 to -0.91)* 
Mild     N=116, M=8.68, SD=1.28 -0.61 (-1.11 to -
0.11)* 
-0.63 (-1.18 to -0.08)* 
Very mild - - - - N=52, M=9.29, SD=1.60 Reference Reference 
Worry about side-effects Very 
worried 
    N=20, M=8.25, SD=2.63 -0.88 (-1.72 to -
0.04)* 
-0.72 (-1.60 to 0.16) 
Fairly 
worried 
    N=68, M=8.49, SD=1.25 -0.65 (-1.25 to -
0.04)* 
-0.53 (-1.19 to 0.13) 
Not very 
worried 
    N=79, M=8.53, SD=1.56 -0.60 (-1.18 to -
0.02)* 
-0.44 (-1.07 to 0.19) 
Not at all 
worried 
- - - - N=46, M=9.13, SD=1.54 Reference Reference 
*p≤.05 
a Adjusting for all personal characteristics (both parent and child) 
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5.2.3 Side-effect perception 
Of participants who reported that their child had been vaccinated, 215 (41.0%) 
indicated that their child had experienced at least one side-effect. The most 
common side-effect reported was runny or stuffy nose (n=84, 16.0%). ‘Flu’ was 
reported as a side-effect by 33 participants (6.3%; see Appendix 8 for full 
results).  
Side-effects were described as ‘very mild’ by 52 participants (24.3%), ‘mild’ by 
118 (55.1%), ‘moderate’ by 39 (18.2%) and ‘severe’ by five (2.3%). No-one 
reported ‘very severe’ side-effects. Forty-seven (21.8%) participants indicated 
that they were ‘not at all worried’ about their child’s side-effects, 80 (37.0%) 
stated that they were ‘not very worried,’ 68 (31.5%) were ‘fairly worried’ and 21 
(9.7%) were ‘very worried.’  
Associations between personal and clinical characteristics, beliefs and attitudes 
about influenza and the vaccine, and perception of side-effects are reported in 
Table 8 and Table 9. When controlling for all other personal and clinical 
characteristics, participants were more likely to report side-effects if the child had 
a chronic illness or was first-born. Participants had increased odds of perceiving 
side-effects if they: knew another child who had experienced side-effects from 
the influenza vaccine; thought that the influenza vaccine would interact with 
other medications that the child was taking; believed that yearly influenza 
vaccination was too much of an ongoing time commitment; believed that yearly 
vaccination would overload the immune system; believed the influenza vaccine 
could cause short-term side-effects or long-term health problems; believed the 
vaccine went against one’s religious or cultural beliefs; believed that the 
vaccination campaign was just about making money for the manufacturers; had a 
health professional, friend or relative recommend that the child should not be 
vaccinated; believed the vaccine to be unsafe; did not like vaccines for the child 
in general; believed influenza to be a serious illness for the child, oneself or 
someone in the child’s household; or felt they did not know enough about the 





Table 8. Parent and child personal and clinical characteristics and associations 
with perception of side-effects from vaccination 
Parent 
characteristics 


















Parent gender Female 118 (37.6) 196 (62.4) 0.71 (0.50 
to 1.01) 
0.65 (0.42 to 
0.99)* 
Male 97 (46.0) 114 (54.0) Reference Reference 
Parent age 45+ 14 (26.9) 38 (73.1) 0.38 (0.20 
to 0.73)* 
0.45 (0.21 to 
0.96)* 
35-44 84 (35.6) 152 (64.4) 0.57 (0.29 
to 0.82)* 
0.58 (0.38 to 
0.88)* 
18-34 117 (47.6) 129 (52.4) Reference Reference 
Parent 
employment 
Working 171 (42.8) 229 (57.3) 1.38 (0.91 
to 2.09) 
0.96 (0.57 to 
1.60) 




tax and other 
deductions 
≥£30,000 132 (42.9) 176 (57.1) 1.15 (0.80 
to 1.66) 
0.93 (0.60 to 
1.45) 





Degree or higher 
(Bachelors, Masters, 
PhD) 
137 (47.7) 150 (52.3) 1.86 (1.30 
to 2.67)* 





75 (32.9) 153 (67.1) Reference Reference 
Parent 
ethnicity 
Black and Minority  35 (54.7) 29 (45.3) 1.87 (1.11 
to 3.17) 
1.55 (0.85 to 
2.80) 
White 178 (39.2) 276 (60.8) Reference Reference 
Parent chronic 
illness 
Present  75 (41.7) 105 (58.3) 1.04 (0.72 
to 1.51) 
1.05 (0.68 to 
1.63) 
None 139 (40.6) 203 (59.4) Reference Reference 
Child gender Female 97 (36.3) 170 (63.7) 0.68 (0.48 
to 0.96)* 
0.74 (0.50 to 
1.09) 
Male 118 (45.7) 140 (54.3) Reference Reference 
First-born child Yes 151 (47.5) 167 (52.5) 2.02 (1.40 
to 2.92)* 
1.61 (1.06 to 
2.43)* 
No 64 (30.9) 143 (69.1) Reference Reference 












Present  54 (52.4) 49 (47.6) 1.79 (1.16 
to 2.76)* 
1.67 (1.01 to 
2.78)* 
None 159 (38.1) 258 (61.9) Reference Reference 
                                                 
1 When asked why they had not vaccinated their child, three people indicated that they had answered the vaccination 
question incorrectly and that they had indeed vaccinated their child; these participants’ results were recoded, but because 
of the scripting of the questionnaire, they were not asked side-effect perception questions. One participant stated that their 
child had been vaccinated could not remember whether they had experienced any side-effects, therefore side-effect 







Yes 189 (43.8) 243 (56.3) 1.65 (0.99 
to 2.75) 
1.43 (0.80 to 
2.53) 
No 25 (32.1) 53 (67.9) Reference Reference 
*p≤.05 




Table 9. Parental beliefs and attitudes about influenza and the child vaccine and 
associations with perception of side-effects from vaccination 















The child flu 
vaccine has not 
been tested enough 
for me to feel it is 
safe 
Agree 59 (66.3) 30 (33.7) 3.99 (2.42 to 
6.57)* 
3.31 (1.87 to 
5.88)* 
Disagree 103 (33.0) 209 (67.0) Reference Reference 
The child flu 
vaccine can cause 
unpleasant short-
term side-effects 
Agree 131 (63.9) 74 (36.1) 5.45 (3.42 to 
8.71)* 
6.11 (3.61 to 
10.35)* 
Disagree 37 (24.5) 114 (75.5) Reference Reference 
The child flu 
vaccine can cause 
long-term health 
problems 
Agree 63 (73.3) 23 (26.7) 6.32 (3.69 to 
10.83)* 
5.16 (2.70 to 
9.85)* 
Disagree 88 (30.2) 203 (69.8) Reference Reference 




[child] is currently 
taking 
Agree 56 (78.9) 15 (21.1) 8.05 (4.37 to 
14.82)* 
7.18 (3.42 to 
15.04)* 
Disagree 116 (31.7) 250 (68.3) Reference Reference 
Vaccinating 
[child] against flu 
each year will 
overload his/her 
immune system 
Agree 68 (75.6) 22 (24.4) 6.68 (3.91 to 
11.43)* 
5.65 (2.96 to 
10.80)* 
Disagree 99 (31.6) 214 (68.4) Reference Reference 
Another child I 
know had side-
effects from the 
vaccine 
Agree 83 (74.1) 29 (25.9) 8.33 (5.08 to 
13.66)* 
7.27 (4.11 to 
12.83)* 




[child] should be 
vaccinated 
Agree 136 (48.4) 145 (51.6) 1.95 (1.23 to 
3.10)* 
1.66 (0.98 to 
2.82) 






Agree 61 (73.5) 22 (26.5) 5.29 (3.11 to 
9.00)* 
4.17 (2.25 to 
7.72)* 






Agree 59 (65.6) 31 (34.4) 3.89 (2.39 to 
6.33)* 
3.46 (1.94 to 
6.15)* 
Disagree 118 (32.9) 241 (67.1) Reference Reference 
If I don’t vaccinate 
[child], then 
[child] will get flu 
Agree 112 (50.2) 111 (49.8) 1.42 (0.81 to 
2.48) 
1.11 (0.57 to 
2.18) 
Disagree 27 (41.5) 38 (58.5) Reference Reference 
Flu would be a 
serious illness for 
[child] 
Agree 164 (44.6) 204 (55.4) 3.40 (1.80 to 
6.44)* 
2.43 (1.19 to 
4.98)* 
Disagree 13 (19.1) 55 (80.9) Reference Reference 
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Flu would be a 
serious illness for 
me 
Agree 139 (48.4) 148 (51.6) 2.42 (1.51 to 
3.90)* 
2.45 (1.41 to 
4.24)* 
Disagree 31 (27.9) 80 (72.1) Reference Reference 
Flu would be a 
serious illness for 
someone living in 
[child]’s 
household 
Agree 131 (43.8) 168 (56.2) 1.92 (1.17 to 
3.15)* 
1.84 (1.04 to 
3.25)* 
Disagree 28 (28.9) 69 (71.1) Reference Reference 
Having the child 
flu vaccine is an 
effective way of 
preventing [child] 
from catching flu 
Agree 169 (39.8) 256 (60.2) 0.572 (0.27 to 
1.23) 
0.54 (0.22 to 
1.28) 
Disagree 15 (53.6) 13 (46.4) Reference Reference 




Agree 65 (63.1) 38 (36.9) 3.60 (2.25 to 
5.74)* 
2.91 (1.71 to 
4.94)* 
Disagree 98 (32.2) 206 (67.8) Reference Reference 
I don’t know 
enough about the 
child flu vaccine 
Agree 64 (52.0) 59 (48.0) 2.09 (1.34 to 
3.26)* 
2.09 (1.26 to 
3.46)* 
Disagree 82 (34.2) 158 (65.8) Reference Reference 
Vaccinating 
[child] against flu 
each year is too 
much of an 
ongoing time 
commitment 
Agree 63 (76.8) 19 (23.2) 7.37 (4.22 to 
12.87)* 
6.16 (3.17 to 
11.98)* 
Disagree 117 (31.0) 260 (69.0) Reference Reference 
The child flu 
vaccine does not 
suit my religious 
or cultural 
beliefs/values 
Agree 56 (75.7) 18 (24.3) 6.45 (3.64 to 
11.43)* 
4.94 (2.55 to 
9.57)* 
Disagree 124 (32.5) 257 (67.5) Reference Reference 
The vaccination 
campaign is just 
about making 
money for the 
manufacturers 
Agree 56 (72.7) 21 (27.3) 5.23 (3.01 to 
9.10)* 
4.49 (2.33 to 
8.66)* 
Disagree 105 (33.8) 206 (66.2) Reference Reference 
*p≤.05 
a Adjusting for all personal characteristics (both parent and child) 
 
5.2.4 Vaccination intention for 2016/17 
Six-hundred and sixty-eight (70.3%) participants had a high intention to vaccinate 
their child in the 2016/17 influenza season. Associations between personal 
characteristics, beliefs and attitudes about influenza and the child vaccine, and 
intention to vaccinate in the 2016/17 season are reported in Table 6 and Table 7. 
The pattern of results for vaccination intention was broadly similar to that for 
reported uptake. Participants who perceived side-effects following vaccination in 
the 2015/16 influenza season were less likely to intend to vaccinate their child the 
following year, as were those who knew another child who had experienced side-
effects from the vaccine. In those participants who stated that their child had 
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experienced a side-effect as a result of the influenza vaccine, perceived severity 
of the side-effect was associated with decreased intention to vaccinate one’s 
child. 
5.2.5 Terminology used in vaccine communications 
The correct interpretation of ‘50% vaccine effectiveness’ was selected by 195 
participants (19.5%; see Table 10). The most commonly endorsed option was that 
‘50% of children who have the vaccine will be immune to flu’ (28.8%, n=288).  
Table 10. Table of participants’ understanding of the phrase ‘50% vaccine 
effectiveness’ 
Statement Number of 
parents (%) 
50% of children who have the vaccine will be immune to flu 288 (28.8) 
A vaccinated child will have a 50% chance of catching flu 265 (26.5) 
If a child had a 50% chance of catching flu before being 
vaccinated, they now have half that chance (i.e. 25%) [Correct 
option] 
195 (19.5) 
Can’t tell the difference between the options above 102 (10.2) 
Don’t know 151 (15.1) 
 
Estimates of the incidence of acute side-effects with different verbal descriptors 
of risk are reported in Table 11. The median estimate for a ‘very common’ side-
effect was 5,000 in every 10,000 children (1 in 2), 2,000 for ‘common side-
effects’ (1 in 5), 199 for ‘uncommon’ side-effects (1 in 50) and 50 for ‘very rare’ 




Table 11. Table of predicted incidence of side-effects by verbal descriptor of risk 
out of 10,000 vaccinated children (n = 1001) 






Very rare, n 
(%) 
0-100 493 (49.3) 219 (21.9) 157 (15.7) 735 (73.4) 
101-500 174 (17.4) 76 (7.6) 58 (5.8) 101 (10.1) 
501-1000 173 (17.3) 15.7 (15.7) 141 (14.1) 77 (7.7) 
1001-2500 68 (6.8) 76 (7.6) 57 (5.7) 28 (2.8) 
2501-5000 67 (6.7) 233 (2.3) 203 (20.3) 40 (4.0) 
5001-7500 10 (1.0) 100 (10.0) 112 (11.2) 11 (1.1) 
7501-10000 16 (1.6) 140 (14.0) 273 (27.3) 9 (0.9) 
Median 5000 2000 199 50 









5.2.6 Interpretation bias 
 Participants 
Of the 1001 participants who completed the survey, 500 completed interpretation 
bias items pertaining to the source of the health threat and 501 completed 
interpretation bias items pertaining to the subject of the health threat. Many 
participants did not complete interpretation bias items to levels required for 
inclusion in the analyses, thus analyses presented are for those who completed the 
interpretation bias task to an adequate standard (source of health threat, n=158; 
subject of health threat, n=163). Participant characteristics are shown in Table 12. 
Child age differed between those who were assigned to complete items pertaining 
to the source and subject of the health threat (t(999)=0.25, p=.02), with those who 
completed items pertaining to the source of the health threat having older children 
(M=4.62, SD=1.63) than those who completed items pertaining to the subject of 
the health threat (M=4.39, SD=1.73; see Appendix 9 for full results). There were 
no other differences in parent or child personal or clinical characteristics (parent 
gender, parent age, region, working status, household income, parent education, 
parent ethnicity, parent chronic illness, first-born child, child age and child 
chronic illness) between those who were assigned to complete items pertaining to 
the source and subject of the health threat. 
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In those who completed bias items pertaining to the source of the health threat, 
household income differed between those who were and were not included in 
analyses, with those with a household income of £30,000 or over being more 
likely to be included in the analyses (χ2(1, n=476)=3.96, p=.05). Ethnicity also 
varied, with white participants being more likely to be included in analyses than 
black and minority ethnic groups (χ2(1, n=491)=11.04, p=.001). No other parent 
or child personal or clinical characteristics differed between those who were and 
were not included in the analyses for bias pertaining to the source of the health 
threat. 
In those who completed bias items pertaining to the subject of the health threat, 
ethnicity differed between those who were and were not included in analyses, 
with white participants being more likely to be included in analyses than black 
and minority ethnic groups (χ2(1, n=490)=4.75, p=.03). No other parent or child 
personal or clinical characteristics differed between those who were and were not 
included in the analyses for bias pertaining to the subject of the health threat.
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Table 12. Parent and child personal and clinical characteristics for those included in interpretation bias analyses and associations with vaccine 
uptake in 2015/16 and perception of side-effects from vaccination  
Participant 
characteristics 
 Influenza vaccine uptake in 2015/16 Side-effects perceived 
 Source of health threat 
 (n = 153) 
Subject of health threat  
(n = 159) 
Source of health threat  
(n = 91) 
Subject of health threat  




































Parent gender Female 55 (61.1) 35 (38.9) .78 52 (56.5) 40 (43.5) .07 16 (29.1) 39 (70.9) .67 16 (31.4) 35 (68.6) .69 
Male 37 (58.7) 26 (41.3)  28 (41.8) 39 (58.2)  12 (33.3) 24 (66.7)  10 (35.7) 18 (64.3)  
Parent age 35+ 47 (55.3) 38 (44.7) .17 44 (47.8) 48 (52.2) .46 9 (19.6) 37 (80.4) .02* 13 (30.2) 30 (69.8) .58 
18-34 45 (66.2) 23 (33.8)  36 (53.7) 31 (46.3)  19 (42.2) 26 (57.8)  13 (36.1) 23 (63.9)  
Parent 
employment 
Working 66 (59.5) 45 (40.5) .78 62 (48.4) 66 (51.6) .34 22 (33.8) 43 (66.2) .32 22 (36.1) 39 (63.9) .39 
Not working 26 (61.9) 16 (38.1)  18 (58.1) 13 (41.9)  6 (23.1) 20 (76.9)  4 (22.2) 14 (77.8)  
Total household 
income before 
tax and other 
deductions 
≥£30,000 54 (53.5) 47 (46.5) .01* 47 (53.4) 41 (46.6) .41 16 (30.2) 37 (69.8) .9 17 (36.2) 30 (63.8) .72 





Degree or higher 
(Bachelors, Masters, 
PhD) 




42 (62.7) 25 (37.3)  37 (49.3) 38 (50.7)  10 (23.8) 32 (76.2)  10 (27.8) 26 (72.2)  
Parent ethnicity Black and Minority 5 (41.7) 7 (58.3) .22 9 (69.2) 4 (30.8) .25 3 (75.0) 1 (25.0) .09 3 (33.3) 6 (66.7) 1.00 
White 87 (62.6) 52 (37.4)  69 (48.3) 74 (51.7)  25 (28.7) 62 (71.3)  23 (33.8) 45 (66.2)  
Parent chronic 
illness 
Present 35 (64.8) 19 (35.2) .38 26 (57.8) 19 (42.2) .22 11 (32.4) 23 (67.6) .80 11 (44.0) 14 (56.0) .17 
None 57 (57.6) 42 (42.4)  53 (46.9) 60 (53.1)  17 (29.8) 40 (70.2)  15 (28.3) 38 (71.7)  
Child gender Female 52 (62.7) 31 (37.3) .49 37 (51.4) 35 (48.6) .81 12 (23.5) 39 (76.5) .09 10 (27.0) 27 (73.0) .30 
Male 40 (57.1) 30 (42.9)  43 (49.4) 44 (50.6)  16 (40.0) 24 (60.0)  16 (38.1) 26 (61.9)  
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First-born child Yes  50 (63.3) 29 (36.7) .41 48 (55.2) 39 (44.8) .18 18 (36.0) 32 (54.0) .23 18 (37.5) 30 (62.5) .28 
No 42 (56.8) 32 (43.2)  32 (44.4) 40 (55.6)  10 (24.4) 31 (75.6)  8 (25.8) 23 (74.2)  



























Present 18 (66.7) 9 (33.3) .47 14 (51.9) 13 (48.1) .83 6 (33.3) 12 (66.7) .79 8 (57.1) 6 (42.9) .04* 




 Vaccine uptake in 2015/16 
5.2.6.2.1 Source of the health threat 
Of parents who completed items pertaining to the source of health threat, 92 had 
vaccinated their child for influenza in the 2015/16 influenza season and 61 had 
not. Mean bias scores are shown in Table 13.  
There was a group difference between those who did and did not vaccinate their 
child for household income (see Table 12). Therefore, household income was 
entered into the model as a covariate. There was a significant main effect of 
source of health threat (F(1,144)=16.46, p<.001, ηp²=.10) reflecting higher 
negative bias for naturally-occurring (M=0.45, SD=0.26) than man-made threats 
(M=0.22, SD=0.23). This was qualified by a significant interaction between 
vaccination status and source of health threat (F(1,144)=5.22, p=.02, ηp²=.04; see 
Figure 6). Within-group contrasts revealed that there was a significantly bigger 
difference between bias for naturally-occurring health threats and man-made 
health threats in parents who had vaccinated (mean difference=-.28, 95% CI [-.34 
to -.22], t(91)=-9.09, p<.001, d=-0.95) than in parents who had not vaccinated 
(mean difference=-.15, 95% CI [-.24 to -.06], t(60)=-3.44, p=.001, d=-.44). There 





Table 13. Mean negative interpretation bias scores (95% CI) for source of the 
health risk and subject of the health risk by vaccine uptake and side-effect 
perception 
 
Figure 6. Mean negative interpretation bias scores with 95% CI error bars by 
source of health threat and vaccine uptake 
  













mean (95% CI) 
No side-effects 
perceived n=63, 





0.27 (0.21 to 
0.34) 
0.19 (0.11 to 
0.27) 







0.42 (0.36 to 
0.49) 
0.44 (0.33 to 
0.54) 












mean (95% CI) 
No side-effects 
perceived n=53, 
mean (95% CI) 
Child-relevant 
health threat  
0.04 (0.02 
to 0.07) 
0.03 (0.01 to 
0.05) 
0.03 (0.00 to 
0.07) 
0.05 (0.01 to 
0.09) 
Self-relevant 
health threat  
0.18 (0.14 
to 0.21) 
0.18 (0.13 to 
0.22) 
0.14 (0.08 to 
0.20) 





5.2.6.2.2 Subject of the health threat 
Of parents who completed items pertaining to the subject of health threat, 80 had 
vaccinated their child for influenza in the 2015/16 influenza season and 79 had 
not. Mean bias scores are shown in Table 13. 
Participants who did and did not vaccinate their child did not differ in any 
personal or clinical characteristics (see Table 12). There was a main effect of 
subject of health threat (F(1,157)=79.21, p<.001, ηp²=.34) indicating a higher 
negative bias for self-relevant (M=0.18, SD=0.19) than child-relevant (M=0.04, 
SD=0.12) health threats. There was no main effect of vaccine uptake 
(F(1,157)=0.15, p=.70, ηp²=.001), nor was there an interaction effect 
(F(1,157)=0.15, p=.70, ηp²=.001). 
 Side-effect perception 
5.2.6.3.1 Source of the health threat 
Of those who completed bias items pertaining to the source of the health threat 
and had vaccinated their child, 28 perceived side-effects while 63 did not. Mean 
bias scores are shown in Table 13. 
Group differences were found only for parent age (see Table 12). When including 
parent age as a covariate, there was a main effect of source of health threat 
(F(1,88)=4.05, p=.047, p²=.04). As previously, this reflected a higher negative 
bias for naturally-occurring (M=0.46, SD=0.26) than man-made (M=0.19, 
SD=0.22) health threats. There was no main effect of side-effect perception 
(F(1,88)=0.10, p=.76, p²=.001), nor was there a significant interaction effect 
(F(1,88)=0.16, p=.69, p²=.002).  
5.2.6.3.2 Subject of the health threat 
Of those who completed bias items pertaining to the subject of the health threat 
and had vaccinated their child, 26 participants perceived side-effects in their child 
while 53 did not. Mean bias scores are shown in Table 13. 
There were group differences in the presence of a chronic illness in the child (see 
Table 12), which was included as a covariate. There was a main effect of subject 
of health threat (F(1,75)=44.54, p<.001, p²=.37) with higher negative biases for 
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self-relevant (M=0.18, SD=0.18) than child-relevant health threats (M=0.05, 
SD=0.13). There was no main effect of side-effect perception (F(1,75)=0.83, 
p=.37, p²=.01), nor was there a significant interaction effect (F(1,75)=0.17, 
p=.90, p²<.001). 
 Vaccination intention for 2016/17 
Associations between participant personal and clinical characteristics and 
negative interpretation bias are shown in Table 14. 
5.2.6.4.1 Source of the health threat 
There were group differences in bias for man-made health threats in parent 
gender, and in employment status for naturally-occurring health threats (see Table 
14). When including parent gender and employment status as a covariate, the 
regression model explained 24% of the variance in bias (R2=.239, 
F(5,300)=18.80, p<.001). Bias scores were significantly associated with 
vaccination intention (β=-.60, p<.001). Bias scores were also associated with the 
intention and source of health threat interaction term (β=.90, p<.001). To interpret 
the interaction, I examined the relationship between vaccination intention and 
negative bias for naturally-occurring and man-made health threats separately. The 
higher participants’ intention to vaccinate, the less negatively they interpreted 
man-made health threats (β=-.25, p=.002) and the more negatively they 
interpreted naturally-occurring health threats (β=.17, p=.04; see Figure 7). There 
was no association between source of health threat and intention (β=-.24, p=.19).   
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 Source of health threat (n=158) Subject of health threat (n=163) 
Level Man-made health threat Naturally-occurring health threat Child-relevant health threat Self-relevant health threat 
N, M, SD p N, M, SD p N, M, SD p N, M, SD p 
Parent gender Female N=90, M=0.26, SD=0.24 .03* N=90, M=0.47, SD=0.25 .34 N=95, M=0.05, SD=0.12 .54 N=95, M=0.18, SD=0.18 .54 
Male N=68, M=0.18, SD=0.23  N=68, M=0.43, SD=0.26  N=68, M=0.03, SD=0.13  N=68, M=0.16, SD=0.19  
Parent age 35+ N=89, M=0.23, SD=0.26 .89 N=89, M=0.46, SD=0.25 .81 N=94, M=0.04, SD=0.13 .88 N=94, M=0.17, SD=0.18 .72 
18-34 N=69, M=0.22, SD=0.21  N=69, M=0.44, SD=0.26  N=69, M=0.04, SD=0.11  N=69, M=0.18, SD=0.20  
Parent 
employment 
Working N=116, M=0.21, SD=0.22 .18 N=116, M=0.42, SD=0.26 .03* N=131, M=0.04, SD=0.12 .85 N=131, M=0.16, SD=0.18 .03* 
Not working N=42, M=0.27, SD=0.28  N=42, M=0.52, SD=0.24  N=32, M=0.04, SD=0.15  N=32, M=0.24, SD=0.21  
Total household 
income before 
tax and other 
deductions 
≥£30,000 N=104, M=0.20, SD=0.23 .20 N=104, M=0.44, SD=0.26 .40 N=90, M=0.06, SD=0.14 .23 N=90, M=0.17, SD=0.18 .61 














N=67, M=0.25, SD=0.24  N=67, M=0.48, SD=0.25  N=76, M=0.03, SD=0.12  N=76, M=0.17, SD=0.19  
Parent ethnicity Black and 
Minority 
N=12, M=0.28, SD=0.26 .36 N=12, M=0.47, SD=0.32 .84 N=13, M=0.08, SD=0.16 .29 N=13, M=0.24, SD=0.21 .16 
White N=144, M=0.21, SD=0.23  N=144, M=0.45, SD=0.25  N=147, M=0.04, SD=0.12  N=147, M=0.17, SD=0.19  
Parent chronic 
illness 
Present N=57, M=0.21, 0.23 .55 N=57, M=0.49, SD=0.27 .18 N=46, M=0.05, SD=0.13 .51 N=46, M=0.21, SD=0.22 .11 
None N=101, M=0.23, SD=0.24  N=101, M=0.43, SD=0.25  N=116, M=0.04, SD=0.12  N=116, M=0.16, SD=0.17  
Child gender Female N=86, M=0.20, SD=0.22 .17 N=86, M=0.46, SD=0.24 .60 N=75, M=0.05, SD=0.15 .35 N=75, M=0.18, SD=0.20 .70 
Male N=72, M=0.25, SD=0.25  N=72, M=0.44, SD=0.27  N=88, M=0.03, SD=0.10  N=88, M=0.17, SD=0.18  
First-born child Yes N=81, M=0.23, SD=0.24 .92 N=81, M=0.42, SD=0.25 .08 N=89, M=0.04, SD=0.11 .63 N=89, M=0.17, SD=0.18 .65 
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No N=77, M=0.22, SD=0.23  N=77, M=0.49, SD=0.26  N=74, M=0.05, SD=0.14  N=74, M=0.18, SD=0.19  
Child age Range 2 to 7 
years 
N=158, M=0.22, SD=0.24 .20 N=158, M=0.45, SD=0.25 .54 N=163, M=0.04, SD=0.12 .76 N=163, M=0.17, SD=0.19 .79 
Child chronic 
illness 
Present N=28, M=0.24, SD=0.25 .63 N=28, M=0.44, SD=0.25 .77 N=28, M=0.11, SD=0.20 .06 N=28, M=0.16, SD=0.23 .73 




Figure 7. Association between negative interpretation bias and vaccination 
intention for 2016/17 by source of health threat 
 
5.2.6.4.2 Subject of the health threat 
There were no group differences in demographics in bias for child-relevant health 
threats, while for self-relevant health threats there were group differences only for 
employment status (see Table 14). When including employment status as a 
covariate, the regression model explained 16% of the variance in bias (R2=.155, 
F(4,297)=13.42, p<.001).  There was an association between subject of the health 
threat and bias score (β=-.40, p=.013), reflecting a higher negative bias for self-
relevant (M=0.17, SD=0.19) than child-relevant content (M=0.04, SD=0.12). 
There was no association between bias score and vaccination intention (β=.05, 
p=.75), nor was there an association between the between bias score and the 
intention and subject of health threat interaction term (β=.03, p=.91). 
 Discussion 
In this study, I observed similar child influenza vaccine uptake rates (52.8%) as 
national estimates (52). However, over 70% of participants reported intending to 
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vaccinate their child in the 2016/17 influenza season. Rather than reflecting a 
sudden increase in uptake between the two influenza seasons, this difference 
probably reflects the gap between intentions and behaviours that is commonly 
observed across many health behaviours (417). 
The largest effect exerted by any factor on uptake was that of having previously 
vaccinated the child for influenza, a common finding in the literature (93, 130, 
408). Parental beliefs and attitudes were also strongly associated with uptake in 
2015/16 and vaccination intention for 2016/17. Perceptions about the risk 
associated with influenza, including severity of influenza and the child’s 
vulnerability, and believing the vaccine to be an effective way of reducing the 
risk of influenza were associated with vaccine uptake in 2015/16. This is in line 
with theories of uptake of health protective behaviours (87-89, 418) and other 
findings in the wider literature (91, 93). Factors relating to possible future adverse 
events caused by the vaccine, such as it causing short-term side-effects, long-term 
health problems and overloading the child’s immune system, were associated 
with a decrease in the odds of vaccination, as was perceiving the vaccine to be 
unsafe. This is in line with results from my systematic review of factors 
associated with vaccine uptake in young children (Chapter 2) and other research 
investigating the effect of parental attitudes on vaccine uptake (135, 419). These 
factors were also strongly associated with intention to vaccinate the child in 
2016/17. 
Since conducting the cross-sectional study in Chapter 5, two other studies 
investigating parental beliefs and attitudes about vaccination and child influenza 
vaccine uptake in England have been published. The first of these investigated 
factors associated with parental hesitancy to vaccinate one’s child for influenza in 
the 2014/15 season in England (420). This study found that concern about side-
effects of the vaccine, the effectiveness of the vaccine, suspicions about others 
making money from vaccination and mistrust of healthcare services were among 
the most frequently cited reasons for vaccine refusal, in line with my results. The 
second study investigated the association between parental beliefs and attitudes 
towards vaccination using the ‘vaccine attitudes examination’ scale and uptake of 
the child influenza vaccine in the UK ‘in the past year’ (dates not specified) 
(421). Consistent with my findings, this study found that parents of children who 
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had not been vaccinated for influenza in the last twelve months had more 
negative attitudes than parents who did vaccinate their child; in particular parents 
were more worried about the unforeseen future effects of vaccination. 
Of parents who vaccinated their child, 41% perceived acute side-effects, in line 
with clinical trial data (77, 78). Beliefs and perceptions relating to possible 
adverse effects from the vaccine were associated with increased odds of parental 
perception of side-effects. Social influences, including knowing another child 
who had experienced side-effects from the influenza vaccine and having friends, 
relatives or a health professional recommend against vaccination, were also 
associated with perception of side-effects. These factors may contribute to 
parents’ expectations that their child will experience side-effects following 
vaccination, with this expectation becoming self-fulfilling (219, 249). Personal 
characteristics that may link to perceptions of a child’s general vulnerability, 
including whether the child had a chronic illness or was first-born were also 
associated with parental perception of side-effects. 
Observing side-effects following vaccination was associated with reduced re-
vaccination intention for the 2016/17 influenza season; a result also seen in other 
studies (80). Interestingly, perceived severity of side-effects, but not worry about 
side-effects, was associated with decreased re-vaccination intention. This differs 
from evidence indicating that adherence to asthma medication is lower in children 
whose parents are more concerned about adverse effects from the medication 
(422). 
Implementing an effective communication strategy targeting variables associated 
with vaccine uptake and intention presents a number of challenges. Terminology 
used in past communications about the influenza vaccine discusses the 
‘effectiveness’ of vaccines (423, 424), however, this terminology was 
incompletely understood by participants. Given the association between 
perceived efficacy and uptake, research on how best to communicate about 
efficacy should now be a priority. Terminology surrounding the incidence of side-
effects from vaccination used in past communications (73, 425) also gave rise to 
elevated estimates of incidence. In my study, median estimates of side-effects 
were higher than those described in the patient information leaflet for three out of 
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four verbal descriptors of risk (‘common,’ ‘uncommon,’ and ‘very rare;’ not 
‘very common’) (73). Previous research has shown that verbal descriptors of risk 
often result in elevated estimates of incidence (402, 403). Additional research on 
how best to communicate this information is required.  
My interpretation bias analyses indicated that parents tended to interpret health 
threats associated with natural causes, such as germs and bacteria, more 
negatively than health threats that were man-made, such as vaccines and other 
medicines. This is surprising considering the wealth of research indicating that 
fears about modern health are prevalent in the general population (278-281) and 
that unnatural, man-made health risks are perceived more negatively than 
naturally-occurring health risks (195, 196). The more benign interpretation of 
man-made health threats in my study may be due to the items used in the study. 
Man-made health threat items referred to medicines, vaccines, and mobile 
phones. Had items referenced other man-made health threats, such as radiation or 
nuclear waste, interpretations would likely have been more negative. My results 
indicate that it is important to remember that naturally-occurring health threats 
are also appraised negatively. 
I observed no overall differences in interpretation bias between those who did and 
did not vaccinate their child, however there was a significant interaction effect 
between vaccine uptake and source of the health threat. Parents who vaccinated 
their child in 2015/16 interpreted naturally-occurring health threats, such as 
influenza, more negatively, and man-made health threats, such as vaccination, 
less negatively than parents who did not vaccinate their child. There was also a 
significant interaction between source of the health threat and vaccination 
intention, with those who interpreted man-made health threats more positively 
and naturally-occurring health threats more negatively being more likely to intend 
to vaccinate their child in 2016/17. These results appear logical: a greater 
tendency to consider man-made vaccination as less threatening and the naturally-
occurring influenza virus as more threatening should translate into a greater 
willingness to use the vaccination. As no other studies have investigated the 
association between cognitive biases and child vaccination, I cannot state whether 
my findings are in line with the results of others, however the convergent nature 
of findings from these two outcome measures lends confidence to my results. 
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Results from the most closely related study I have found, investigating attention 
biases in asthma medication adherence, lend support to the notion that 
information processing biases are associated with uptake of medication (208). 
Relating these findings to the wider vaccination literature, underlying differences 
in cognitive biases may affect child vaccination uptake through the higher-level, 
conscious appraisal of health threats. For example, associations between vaccine 
uptake and intention and interpretation bias pertaining to the source of the health 
threat map on to factors associated with vaccine refusal in my systematic review 
(Chapter 2). Specifically, a more negative interpretation of man-made health 
threats potentially may be reflected in the belief that the vaccine can cause 
adverse effects, while less negative interpretations of naturally-occurring health 
threats may be reflected in a more benign appraisal of influenza. The health belief 
model, the theory of planned behaviour, the protection motivation theory and the 
health action process approach all postulate that perceived risks of a behaviour 
influence the uptake of health behaviours (87-89, 418). My results indicate threat 
appraisal may be biased at a more basic level: information processing. 
Parents also consistently interpreted threats to their own health more negatively 
than threats to their child’s health. Interpreting threats to oneself more negatively 
than threats to others is a common finding in the interpretation bias literature (e.g. 
(426)), with previous research indicating that parental interpretation biases for 
physical threats are stronger in self-relevant situations than child-relevant 
situations (198, 199). This is in spite of the fact that when asked, parents tend to 
claim that the risk of their child becoming ill is more important than the risk of 
themselves becoming ill (92). The use of strict task parameters such as a time 
limit in which to complete task materials and being under cognitive load, may 
have reduced parents’ ability to complete task materials in a socially desirable 
manner (410). I found no evidence for associations between parental 
interpretation biases pertaining to the subject of the health threat and child 
influenza vaccination in 2015/16 or vaccination intention for 2016/17. 
With relation to perception of side-effects from the child influenza vaccination, I 
found no evidence for an association with interpretation bias pertaining to either 
the source or the subject of the health threat. These findings differ from results of 
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another study in which mothers of children with chronic abdominal pain tended to 
interpret ambiguous facial stimuli as being painful (385). The use of ambiguous 
scenarios in my study, as opposed to ambiguous images, might explain this 
difference in findings. Pictorial stimuli are more aversive than verbal stimuli 
(427) and thus potentially invoke a stronger emotional response, causing more 
biased processing. In addition, only those who had vaccinated their child were 
included in the side-effect perception analyses. This subset of parents may have 
had more similar patterns of interpretation biases, meaning that differences 
between parents who did and did not perceive side-effects were more difficult to 
detect. 
5.3.1 Limitations 
Although the study included a large, demographically representative cross-section 
of parents, several limitations need to be considered. One limitation is its cross-
sectional design, making causal inferences difficult to draw for some of the 
associations observed. This is particularly problematic with respect to the 
association between beliefs and attitudes and side-effect reporting. While it is 
possible that negative beliefs and attitudes towards the vaccine lead to an 
increased likelihood of side-effects being observed, it is also possible that 
observing side-effects leads to negative beliefs and attitudes. Similarly, I was 
unable to demonstrate causality between interpretation biases and vaccination 
behaviour. To disentangle the direction of causality, a longitudinal study should 
be conducted. 
A second limitation relates to selection bias. Whether members of market 
research panels are psychologically representative of the general population in 
terms of beliefs and attitudes to vaccination is unknown (428). While it is 
possible that parents who had vaccinated their child were more likely to be 
generally ‘compliant’ or publicly spirited and hence complete the study, rates of 
reported uptake were in line with national figures (52). Although quotas were 
used to ensure a nationally representative sample, it should be noted that parent 
gender was not split equally in the study; this is likely due to the uneven split in 
parent gender in those registered in the National Readership Survey which 
formed the basis for my quotas (405). In interpretation bias analyses, as 
participants assigned to receive bias items pertaining to the source and the subject 
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of the health threat and those included and excluded from analyses differed in 
their personal and clinical characteristics, those included in the analyses were no 
longer representative of the general population of parents of vaccine-eligible 
children in the UK. 
Third, the response rate for this study was low. However, such response rates are 
common in market research (e.g. (272, 429)) and evidence indicates that resulting 
estimates of health-related outcome variables are accurate (429). 
Fourth, group sizes differed for analyses pertaining to vaccine uptake, side-effect 
perception and vaccination intention. In interpretation bias analyses, personal and 
clinical characteristics controlled for also differed. However, due to the 
innovative nature of the interpretation bias research and smaller sample sizes 
included in analyses, controlling for all personal and clinical characteristics was 
considered too conservative.  
Fifth, while the scrambled sentence task is usually completed in person under the 
supervision of the researcher, participants in this study completed the task 
remotely. Although this enabled many participants to complete materials in a 
short space of time, only approximately one-third of participants completed the 
task to the standard necessary for inclusion in the analysis. While sample sizes 
were still large and I was well powered to detect medium effect sizes in 
interpretation bias analyses, it is possible that I failed to detect small, yet relevant 
effects. 
Sixth, while the scrambled sentences task measures interpretation bias, no task 
can measure only one single information processing system. Consequently, there 
is a chance that participants’ attention biases could have affected scrambled 
sentence task results, with negatively biased participants attending more to the 
negative, rather than positive, words which made up items. In spite of this, the 
scrambled sentence task remains a widely-used and valid measure of 
interpretation bias. 





This study was the first to investigate parental beliefs and attitudes towards the 
newly introduced child influenza vaccine in the UK and the first to investigate the 
association between beliefs and attitudes and side-effect perception following 
immunisation. Although a causal link cannot definitively be established, the data 
are consistent with the theory that past behaviour, beliefs, attitudes and social 
influences affect both uptake and side-effect perception. This was the also the 
first study to investigate whether information processing biases were associated 
with child vaccination, finding evidence for an association between interpretation 
biases pertaining to the source of the health threat and vaccine uptake and 
vaccination intention. Specifically, actual and intended vaccination was 
associated with a tendency to interpret man-made health threats less negatively 
and naturally-occurring health threats more negatively. To determine whether 
psychological factors play a causal role in vaccine uptake, vaccination intention 
and parental side-effect perception, longitudinal research is required.  
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Chapter 6. Prospective cohort 
study 
In my cross-sectional study (Chapter 5), I found good evidence that parental 
beliefs and attitudes about influenza and the child influenza vaccine were 
associated with child influenza vaccination and perception of side-effects from 
vaccination. Parental interpretation biases pertaining to the source of the health 
threat were also associated with vaccination. Parents who perceived side-effects 
from vaccination were less likely to intend to re-vaccinate their child the 
following year than those who did not perceive vaccine side-effects. However, 
the cross-sectional nature of the study limited my interpretation of the results. 
First, I was unable to make causal inferences about the nature of associations 
between beliefs and attitudes, interpretation biases and vaccination behaviour. For 
example, it is entirely plausible that having perceived side-effects following 
vaccination might alter parental beliefs and attitudes towards vaccination. 
Second, I was unable to measure vaccination rates in the 2016/17 influenza 
season to identify whether parental vaccination intention for 2016/17 was 
associated with actual vaccination in 2016/17. Third, I was unable to measure 
some variables of interest. Most notably, I was not able to assess expectations, 
which play a central role in the nocebo phenomenon (214, 218, 219). In Chapter 
4, I hypothesised that parental perception of side-effects from the child influenza 
vaccine would be associated with: pre-existing symptoms in the child; parental 
expectation that the child would develop side-effects; negative beliefs about 
medications; parental perception that the child was sensitive to medicines; 
modern health worries; more benign beliefs about influenza and more negative 
beliefs and attitudes about the vaccine; negative psychological traits; negative 
interpretation biases; and parent and child personal and clinical characteristics 
(Hypothesis 4.3.1 to Hypothesis 4.3.6). 
While side-effects from the child influenza vaccine tend to occur on the day of 
vaccination (74) and are mostly ‘mild in nature and short term’ (73), parents 
decide whether to re-vaccinate their child for influenza one year after their initial 
vaccination. Parents who remember that their child experienced side-effects from 
the vaccine in the previous year might be less likely to re-vaccinate their child. 
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However, symptom recall is often inaccurate, and is influenced by environmental 
factors, symptom expectation, previous symptom experiences from the exposure 
and symptom severity (234). Thus, it is important to identify psychological 
factors associated with both side-effect perception and side-effect recall. I 
measured parental perception of side-effect three days and one month after their 
child’s vaccination. 
Parental perception of side-effects may also affect how sensitive parents believe 
their child to be to medicines and how much parents trust healthcare workers such 
as those delivering vaccination. Therefore, I also used this study to investigate 
whether parental perception of side-effects negatively affected parents’ 
perception of their child’s sensitivity to medicines and parental trust in healthcare 
workers. 
While there is much research investigating why parents initially choose to accept 
or refuse vaccination for their child, there are no publicly available data on re-
vaccination rates for the child influenza vaccine or analyses investigating why 
parents who vaccinate their child for influenza in one year, choose not to do so in 
a subsequent year. In addition to perception of side-effects from the initial 
vaccination and associated worry, other factors which may change between a 
parent’s initial vaccination decision and their decision to re-vaccinate one year 
later may also affect re-vaccination. For example, following initial vaccination, 
increases in how sensitive parents believe their child to be to medicines, or 
decreases in their trust in healthcare workers, may be associated with later 
vaccine refusal (430, 431). Negative information received from healthcare 
workers during the initial vaccination appointment, and the interaction between 
information received and how much trust the parent has in the healthcare worker 
may also influence a parent’s decision to re-vaccinate. In Chapter 4, I 
hypothesised that a lack of intention to re-vaccinate in 2017/18 and re-vaccination 
refusal in 2017/18 would be associated with: perception of side-effects from the 
vaccine in 2016/17; a suggestion from the healthcare worker in the 2016/17 
vaccination appointment that the vaccine caused side-effects; perceiving the child 
to be more sensitive to medicines after vaccination in 2016/17; decreased trust in 
healthcare workers after vaccination in 2017/18; negative interpretation biases; 
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and parent and child personal and clinical characteristics (Hypothesis 4.2.1 to 
Hypothesis 4.2.5). 
Results from my cross-sectional study indicated that interpretation biases 
pertaining to the subject of the health threat (self- and child-referent) were not 
associated with vaccination behaviour (Chapter 5). Therefore, in this study, I 
chose to investigate only parental interpretation biases pertaining to the source of 
the health threat (man-made and naturally-occurring).  
For this chapter, I conducted a prospective cohort study of parents vaccinating 
their child for influenza in primary care practices in South London during the 
2016/17 influenza season. I investigated whether psychological factors were 
associated with parental perception of side-effects from the influenza vaccine and 
re-vaccination intention for the 2017/18 influenza season. I also investigated re-




Participants in this prospective cohort study completed questionnaires before their 
child received the influenza vaccine for the 2016/17 influenza season (T1), three 
days after their child’s vaccination (T2) and one month after their child’s 
vaccination (T3). Re-vaccination was assessed at the end of the 2017/18 influenza 
season (T4).  
6.1.2 Participants and recruitment 
Participants were eligible for the study if they: had a child aged two to four on 
31st August 2016; were eighteen years or over; and spoke fluent English. 
Potential participants were identified by eleven primary care practices in South 
London and were sent letters informing them about the study. Parents were then 
approached upon arrival at the practice for their child’s influenza vaccination by 





Full study materials can be found in Appendix 10 (T1 questionnaire), Appendix 
11 (T2 questionnaire), Appendix 12 (T3 questionnaire), Appendix 6 (scrambled 
sentence task) and Appendix 13 (similarity ratings task).  
 Outcome measures 
I asked parents at T2 and T3 if they thought their child had ‘experienced any of 
the following side-effects because of their latest child flu vaccine.’ For my list of 
side-effects, I used an adapted parent-report form of the Patient Health 
Questionnaire (PHQ-15) (406), to which I added potential side-effects of the 
vaccine listed in the patient information leaflet (77), and symptoms suggested by 
the literature (246), or by parents during previous piloting. The symptom list was 
the same as that used in the cross-sectional study described in Chapter 5.  
As in my cross-sectional study, re-vaccination intention for the 2017/18 influenza 
season was measured at T2 and T3 by two items adapted from Payaprom et al. 
(407) (‘I want [child] to be vaccinated for flu next year’ and ‘I intend [child] to 
be vaccinated for flu next year’) which were rated on a five-point Likert scale 
from ‘strongly disagree’ to ‘strongly agree.’  
Re-vaccination in the 2017/18 influenza season was ascertained where possible 
by accessing vaccination records from the primary care practice. If this was not 
possible, parents were contacted directly and asked if their child had been 
‘vaccinated in the 2017/18 flu season.’ Possible answers were ‘yes,’ ‘no,’ and 
‘don’t know.’  
 Symptoms prior to vaccination 
A child’s existing symptoms at the time of vaccination were measured by asking 
parents if their child had ‘shown signs of any of the following symptoms in the 
last 24 hours.’ The list of symptoms provided was the same as that used in my 
outcome measure for reporting side-effects perceived.  
 Expectation 
A single direct measure of expectation asked parents how likely it was that their 
child would ‘get short term side-effects from the flu vaccine’ on a five-point 
Likert scale of ‘very unlikely’ to ‘very likely.’ Parents were also asked how likely 
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five different sources (friends and family, official websites and departments, the 
media, the NHS influenza vaccination leaflet, and the healthcare worker) had said 
side-effects were from the vaccine on a four-point Likert scale from ‘very likely’ 
to ‘very unlikely.’ Parents were asked to what extent they agreed that these 
sources of information could be trusted on a five-point Likert scale from ‘strongly 
agree’ to ‘strongly disagree.’ Parents were also asked whether they knew ‘any 
children who have experienced side-effects from the flu vaccine,’ with possible 
answers of ‘yes, several other children,’ ‘yes, one other child,’ and ‘no, I don’t 
know any children who had side-effects from the flu vaccine.’ All expectation 
questions were asked at T1 apart from those relating to the suggestion of side-
effects from the heath care worker as these could not be asked until after the 
vaccination appointment had taken place, at T2. 
 Symptoms following previous vaccinations 
At T1, parents were asked if the child had ‘ever had side-effects’ from previous 
influenza vaccinations and other routine vaccinations. Parents who indicated their 
child had experienced side-effects from previous influenza vaccinations were 
asked how severe the side-effects were on a five-point Likert scale of ‘very mild’ 
to ‘very severe’ and how worried they had been about the side-effects on a four-
point Likert scale from ‘not at all worried’ to ‘very worried.’ Parents who 
indicated their child had experienced side-effects from other routine childhood 
vaccinations were asked how worried they had been.  
 Psychological traits 
Participants completed four personality measures at T2. Trait anxiety was 
measured by the short form of the State-Trait Anxiety Inventory (STAI-T) (432). 
Trait affect was measured using the short form Positive and Negative Affect 
Schedule (PANAS) (433). Neuroticism was measured using the neuroticism items 
from an abbreviated form of the Eysenck Personality Questionnaire – Revised 
(EPQR-A) (434). Optimism and pessimism were measured using the revised Life 
Orientation Test (LOT-R) (294).  
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 Beliefs about medicines and other technologies 
Participants’ perception of their child’s sensitivity to medicines was measured at 
both T1 and T3 using an adapted parental report version of the Perceived 
Sensitivity to Medicines questionnaire (PSM) (275).  
The Modern Health Worries Questionnaire (MHW) (278) and the Beliefs about 
Medicines Questionnaire, general section (BMQ-G) (435) were both completed at 
T2. 
 Beliefs and attitudes about influenza and the child influenza vaccine 
Beliefs and attitudes towards influenza and the child influenza vaccine were 
measured by a series of fifteen statements. Belief and attitude statements were the 
same as those used in the cross-sectional study in Chapter 5; only those that 
significantly associated with vaccination uptake or perception of side-effects in 
the cross-sectional study were selected for use in the current study. Parents 
indicated how much they agreed with belief and attitude statements on a five-
point Likert scale from ‘strongly agree’ to ‘strongly disagree.’ Beliefs and 
attitudes were measured at T1, apart from statements relating to how serious 
parents thought influenza would be for the child, themselves and other people in 
the child’s household, which were measured at T2. At T2, parents were also 
asked how much it would impact their daily life if their child were to catch 
influenza on a four-point Likert scale from ‘not at all’ to ‘a great extent.’ 
 Trust in healthcare workers 
Participants’ trust in healthcare workers was measured at both T1 and T3 using an 
adapted form of the Meyer Credibility Scale (MCS) (436). 
 Interpretation bias 
As I found no evidence for associations between vaccination behaviour and 
parental interpretation biases pertaining to the subject of the health threat (self- 
and child-referent) (Chapter 5), I only investigated parental interpretation biases 
pertaining to the source of the health threat (man-made and naturally-occurring) 
in this study. 
Two tasks were used to measure interpretation bias; the scrambled sentence task 
(411) and the similarity ratings task.  
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6.1.3.9.1 Scrambled sentence task 
The scrambled sentence task consisted of ten items. Items were the same as those 
used in the cross-sectional study for the source of the health threat (Chapter 5), 
except for four items which yielded multiple responses which were similarly 
endorsed and thus were replaced (see Appendix 6 for full item list). Man-made 
health threats included vaccines, household cleaning products, medicines, side-
effects and mobile phones (five items), while naturally-occurring health threats 
included influenza, illnesses, bacteria, wild plants and getting a sun-tan (five 
items). Items consisted of six words presented in a fixed-random order which 
could be unscrambled to create a meaningful five-word statement which was 
either positive or negative. Items were presented in a fixed-random order. Bias 
scores were calculated by dividing the number of negative statements produced 
by a participant by the total number of items attempted. Higher bias scores 
indicate higher negative interpretation bias. 
Participants completed the scrambled sentence task under cognitive load, which 
increases the sensitivity of the task by stopping strategic inhibition of biases 
(411). Before unscrambling the sentences, participants were asked to learn a six-
digit number. After unscrambling the sentences, participants were asked to recall 
the number and indicated whether they used any memory aides, such as writing 
the number down, to help them recall the number. The task was also completed 
under timed conditions, with participants having two minutes in which to 
complete the ten items. 
6.1.3.9.2 Similarity ratings task 
Participants also completed a similarity ratings task, however due to the small 
number of parents who completed the similarity ratings task and resulting lack of 
power, I was unable to draw any conclusions from these results. For 
completeness, I have reported the methods and results of the similarity ratings 
task in Appendix 14. 
 Personal and clinical characteristics  
Participants were asked for their age and gender. Personal characteristics relating 
to the index child included age, gender and whether they were the parent’s first 
child. I also asked about clinical characteristics, such as whether the parent or 
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child had a long-term health condition and whether there were any people ‘at 
risk’ for influenza in the child’s household. Participants were asked whether the 
child was up-to-date for other routine vaccines. 
6.1.4 Piloting  
Questionnaire materials were piloted with three parents of children aged two to 
four years for understanding; items were reworded if necessary, except where 
items came from a published scale. 
6.1.5 Procedure 
Ethical approval for the study was granted by the NHS Research Ethics 
Committee (Reference: IRAS ID: 192325, REC reference: 16/LO/1003). 
Participants were recruited into the study between 1st October 2016 and 16th 
December 2016. Prior to completing T1 materials, consent was obtained from all 
parents following standard practice from my research ethics committee.  
A summary of measures included at each time point of the study is shown in 
Table 15. Parents completed T1 materials in the waiting room at the primary care 
practice immediately prior to their child’s vaccination appointment, or online 
before their child’s vaccination appointment. One item in T1, asking whether the 
child had experienced any symptoms in the past 24 hours, was excluded from the 
online version; participants were contacted on the day of their child’s vaccination 
appointment to answer this.  
Three days after the vaccination appointment, parents were contacted via email 
with a link to the T2 materials, which were available online. If participants did 
not have access to email, T2 materials were completed by telephone. The 
scrambled sentence task was included as part of T2 materials. All interpretation 
bias materials were completed online; those completing T2 task materials by 
telephone did not complete the scrambled sentence task. At the end of the T2 
questionnaire I asked parents for consent to access their child’s vaccination 
records for the 2017/18 season through the primary care practice. 
One month after the vaccination appointment, parents were emailed a link to T3 
task materials. If participants did not have access to email, T3 materials were 
completed by telephone.  
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Re-vaccination status was collected at the end of the 2017/18 influenza season 
(T4). After the end of vaccination at each primary care practice, vaccination 
records were accessed for children of parents who had given consent. For those 
who had not consented to me accessing the child’s vaccination records, or whose 
records were unable to be accessed, I contacted parents via email or telephone. 




Table 15. Summary of measures included at each time point of the prospective cohort study 




Expectation (direct measure) Likelihood of child getting ‘short-term side-effects from the flu vaccine’ Waiting room of 
primary care 
practice/online 
Expectation (source of suggestion of 
symptoms) 
Trust in sources of information (friends/family/relatives; official websites; media; 
NHS influenza vaccination leaflet); suggestion of side-effects from sources of 
information (friends/family/relatives; official websites; media; NHS influenza 
vaccination leaflet) 
Expectation (social observation) Knowing another child who had side-effects from the child influenza vaccine; 
severity of side-effects 
Beliefs about medicines and other 
technologies 
Adapted parental report form of perceived sensitivity to medicines scale 
Trust in healthcare workers Meyer Credibility Scale 
Beliefs and attitudes about influenza and 
the child influenza vaccine 
Beliefs and attitudes about influenza and the child influenza vaccine 
Symptoms following previous 
vaccinations (influenza vaccine) 
Previous side-effects from the child influenza vaccine; severity of side-effects; 
and worry about side-effects perceived 
Symptoms following previous 
vaccinations (other routine vaccines) 
Previous side-effects from other routine vaccines; and worry about side-effects 
perceived 
Symptoms prior to vaccination Pre-existing symptoms in the child* 
Personal and clinical characteristics Child gender; child age; relationship to child; previous child influenza vaccination 
T2 (three days after 
vaccination)† 
Outcome measure (side-effect 
perception) 
Side-effect perception; severity of side-effects perceived; and worry about side-
effects 
Online/telephone 
Outcome measure (re-vaccination 
intention) 
Re-vaccination intention 
Expectation (source of suggestion of 
symptoms) 
Trust in healthcare worker as a source of information; suggestion of side-effects 
from healthcare worker in vaccination appointment 
Beliefs and attitudes about influenza and 
the child influenza vaccine 
Influenza would be a serious illness for child/oneself/someone in child’s 
household; impact on daily life if child were to catch influenza 
Beliefs about medicines and other 
technologies 
Beliefs about medicines questionnaire – general section; modern health worries 
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Psychological traits State-Trait Anxiety Inventory (STAI-T); abbreviated form of the Eysenck 
Personality Questionnaire – Revised (EPQR-A); Positive and Negative Affect 
Schedule (PANAS); revised Life Orientation Test (LOT-R) 
Interpretation bias Scrambled sentence task‡ 
Personal and clinical characteristics Other ‘at risk’ people in household; first child; parent chronic illness; child 
chronic illness; child up-to-date on other routine vaccines; parent age; parent 
gender 
T3 (one month after 
vaccination)† 
Outcome measure (side-effect 
perception) 
Side-effect perception; severity of side-effects perceived; and worry about side-
effects 
Online/telephone 
Outcome measure (re-vaccination 
intention) 
Re-vaccination intention 
Beliefs about medicines and other 
technologies 
Adapted parental report form of perceived sensitivity to medicines scale 
Trust in healthcare workers Meyer Credibility Scale 
T4 (end of the 
2017/18 influenza 
season) 
Re-vaccination Re-vaccination in 2017/18 influenza season Vaccine records/ 
email/telephone 
* Participants who completed T1 materials online were not asked this question as part of T1 as materials could be completed at any time before 
vaccination. Instead, they were contacted on the day of their child’s vaccination to answer this item. 
† For those completing T2 and T3 materials online, after completing T2 and T3, participants were asked if they wanted to complete an additional 
task: the similarity ratings task. 
‡ Participants who completed T2 materials by telephone did not complete the scrambled sentence task; only participants completing T2 online 




I used G*Power (414) to run a sample size calculation based on the ability to 
detect a small odds ratio of 1.6 (437) for symptom perception between parents 
with high and low expectation of symptoms. Clinical trial data suggested that 
47.9% of children who received the Fluenz tetra vaccine experienced side-effects 
(77). Survey data suggested that I could assume equal sample sizes between those 
who did and did not expect symptoms (408). To detect this difference as 
significant at the 5% level with 85% power required a total sample size of 180. I 
therefore aimed to recruit 300 people at T1, to allow for a 40% attrition rate. 
Only a subset of survey participants completed interpretation bias materials to a 
satisfactory level and were included in the analyses presented here. I ran post-hoc 
power analyses for each of the interpretation bias analyses. For the cross-sectional 
tests (side-effect perception at T2 and re-vaccination intention for 2017/18), I 
based power analyses on the use of a repeated measures ANOVA. Using a-priori 
parameters of two groups and two measures, with the correlation between 
measures being 0.5 and an alpha of .05 I had 98.9% power to detect medium 
effect size (f=0.25) for a within-between interaction in the side-effect perception 
analyses (n=74) and 99.0% power for the re-vaccination intention analyses 
(n=75). 
For the longitudinal tests (side-effect perception at T3 and actual re-vaccination 
in 2017/18), I based power analyses on the use of logistic regression analyses. 
Using a-priori parameters of a two-tailed test, I had 77.6% power to detect 
medium size effects (OR=2.5) in the side-effect perception analyses (n=66) and 
81.5% power in the re-vaccination for 2017/18 analyses (n=72). 
6.1.7 Protocol registration 





 Predictors of side-effect report 
I recoded report of a symptom at T2, T3 or in the 24 hours prior to vaccination 
into three binary variables (reported at least one symptom at the relevant time 
point versus no symptoms reported).  
I recoded data where parents indicated that they had not received information 
from a particular source as missing. A composite measure of symptom suggestion 
from each information source was created by multiplying the suggestion of side-
effects from that source by the participant’s trust in that source. I treated knowing 
another child who had experienced side-effects following vaccination for 
influenza as a binary variable (yes or no). General beliefs and attitude questions 
were recoded to binary variables (agree or disagree); as in the cross-sectional 
study, I treated ‘neither agree nor disagree’ as missing data (Chapter 5). 
I used separate binary logistic regressions to determine whether perception of 
side-effects at T2 and T3 were associated with: pre-existing symptoms; 
expectation for the child to develop side-effects; previous experience of side-
effects; personality traits; beliefs about medicines and other technologies; beliefs 
and attitudes about influenza and the child vaccine; and personal and clinical 
characteristics. Multivariate logistic regressions were used to calculate the same 
associations adjusting for personal characteristics. For predictors of side-effect 
report, re-vaccination intention for 2017/18 and re-vaccination in 2017/18, only 
results of multivariate analyses are reported narratively; results of univariate 
analyses are shown in the tables. In addition, where analyses relied on under ten 
participants in one cell, these are not reported narratively unless they have a 
material impact on results. 
 Expectations as a mediating variable 
I ran zero-order correlations to identify factors that were correlated with direct 
expectations of the child developing side-effects and side-effect report at T2 and 
T3. Factors that were correlated with both direct expectations and side-effect 
report at either T2 or T3 were entered into mediation analyses using the method 
described by Mackinnon (438). I ran mediation using standardised coefficients to 
see whether the report of side-effects was mediated by expectation. I computed 
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bias-corrected 95% confidence intervals using bootstrapping (2000 repetitions). I 
entered personal and clinical characteristics into the model as covariates. 
 Predictors of re-vaccination intention for 2017/18 
I dichotomised answers to re-vaccination intention questions, with participants 
coded as ‘definitely intending’ to re-vaccinate their child (answered ‘agree’ or 
‘strongly agree’ to both questions) or ‘not definitely intending’ to re-vaccinate 
(answered ‘neither agree nor disagree,’ ‘disagree’ or ‘strongly disagree’ to one or 
both questions). I then used intention at both T2 and T3 to create a single overall 
intention score. Where participants only completed one follow-up questionnaire I 
used the data available to me to classify their response as either ‘definitely intend’ 
or ‘do not definitely intend’ to re-vaccinate. Where participants completed both 
T2 and T3 and had concordant intentions, I classified them as either ‘definitely 
intend’ or ‘do not definitely intend’ as appropriate. If conflicting intentions were 
given at T2 and T3 I classified participants as ‘do not definitely intend.’  
I computed the difference between perceived sensitivity to medicines at T3 and 
T1 by subtracting T1 scores from T3. I computed the difference between trust in 
healthcare workers at T3 and T1 by subtracting scores from T1 from T3. 
I used binary logistic regression analyses to identify whether re-vaccination 
intention for 2017/18 was associated with: report of a side-effect at T2 or T3; 
perceived severity and worry about side-effects; suggestion that the child would 
experience side-effects by a healthcare worker; the combined score for suggestion 
that the child would experience side-effects and trust in the healthcare worker; 
changes in the parents’ perception of how sensitive the child was to medicines 
following vaccination in 2016/17; changes in trust in healthcare workers 
following vaccination in 2016/17; and personal and clinical characteristics. 
Multivariate logistic regressions were used to calculate the same associations 
adjusting for personal characteristics. Re-vaccination intention was coded 
positively, with an odds ratio greater than one indicating increased odds of 
definitely intending to re-vaccinate. 
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 Predictors of re-vaccination in 2017/18 
I coded re-vaccination status in the 2017/18 influenza season into a binary 
variable (re-vaccinated or not re-vaccinated). I coded data where parents 
indicated they were not sure if their child had been re-vaccinated as missing data. 
I used binary logistic regression analyses to identify whether not re-vaccinating 
one’s child in the 2017/18 influenza season was associated with: report of a side-
effect at T2 or T3; perceived severity of and worry about side-effects; suggestion 
that the child would experience side-effects by a healthcare worker; the combined 
score for suggestion that the child would experience side-effects and trust in the 
healthcare worker; changes in the parents’ perception of how sensitive the child 
was to medicines following vaccination in 2016/17; changes in trust in healthcare 
workers following vaccination in 2016/17; and personal and clinical 
characteristics. Multivariate logistic regressions were used to calculate the same 
associations adjusting for personal characteristics. Re-vaccination was inversely 
coded, with an odds ratio greater than one indicating increased odds of re-
vaccination refusal. 
 Predictors of change in perceived sensitivity  
I used a paired samples t-test to see if parents’ perception of their child’s 
sensitivity to medicines had changed from T1 to T3. I used linear regression 
analyses to identify whether reporting side-effects at T2 or T3 was associated 
with an increase in perceived sensitivity to medicines. For these analyses, I 
controlled for perceived sensitivity to medicines at T1 (439).  
 Predictors of change in trust in healthcare workers 
I used a paired samples t-test to see if parents’ trust in healthcare workers had 
changed from T1 to T3. I used linear regression analyses to identify whether 
reporting side-effects at T2 or T3 was associated with a decrease in trust in 
healthcare workers. For these analyses, I controlled for trust in healthcare workers 
at T1 (439).  
 Sensitivity analyses 
I ran sensitivity analyses to identify whether clustering by primary care practice 
affected the significance of any of the results. Primary care practice was used as a 
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proxy for socio-economic factors. I used mixed models, including primary care 
practice as a random effect in the regressions. For mediation analyses, I followed 
the same approach to see if clustering affected pathways. 
Analyses controlled for all personal and clinical characteristics apart from 
whether the child was up-to-date with other routine vaccinations. 
 Interpretation bias 
I excluded participants from the interpretation bias analyses if they had more than 
40% missing data for either man-made health threat items or naturally-occurring 
health threat items. I also excluded participants if they reported using a strategy to 
remember the number and therefore were not under cognitive load. 
As the scrambled sentence task was included in T2 task materials, analyses with 
the outcomes of side-effect perception at T2 and re-vaccination intention for 
2017/18 were cross-sectional, while analyses with the outcomes of side-effect 
perception at T3 and re-vaccination in 2017/18 were longitudinal. 
To investigate whether there was an association between interpretation bias and 
cross-sectional outcomes (side-effect perception at T2 and re-vaccination 
intention for 2017/18) I ran two mixed-model, repeated measures ANOVAs. In 
the first, the between-participant factor was side-effect perception at T2 (side-
effects perceived; no side-effects perceived), while in the second it was re-
vaccination intention (intend to re-vaccinate; do not definitely intend to re-
vaccinate). The within-participant factor for both ANOVAs was the source of the 
health threat (man-made or naturally-occurring). 
To investigate whether there was an association between interpretation bias and 
longitudinal outcomes (side-effect perception at T3 and re-vaccination in 
2017/18), I ran two hierarchical logistic regressions. In the first, the dependent 
variable was side-effect perception at T3 (side-effects perceived; no side-effects 
perceived), while in the second it was, re-vaccination in the 2017/18 influenza 
season (re-vaccinated; not re-vaccinated). Bias score, source of health threat 
(man-made or naturally-occurring) and a bias score*source of health threat 




For all interpretation bias analyses, personal and clinical characteristics (parent 
age, parent gender, parent chronic illness, other ‘at risk’ person in household, 
child gender, child age, first-born child and child chronic illness) were 
investigated to see whether there was a univariate association (p≤.05) with 
outcome variables. As in chapter 5, where personal and clinical characteristics 
were associated with outcome variables, they were entered into the analyses as 
covariates. In regression analyses, covariates were entered into the regression 
model as the first block; predictor variables were entered into the model as the 
second block. 
6.1.9 Statistical software 
All analyses were run in SPSS version 22 (416), apart from mediation analyses 
which were run in Stata 12 (440). The binary_mediation macro was used, which 
allows for dichotomous outcomes as well as taking covariates into account.  
 Results 
6.2.1 Participants 
270 participants were recruited from fourteen primary care practices. 233 
participants initiated T2 follow-up, with 202 (74.8%; 185 mothers) participants 
completing all items. 200 participants initiated T3 follow-up, with 195 (72.2%; 
164 mothers) completing all items. 232 (85.9%; 190 mothers) participants 
completed T4 follow-up. 177 participants (65.6%) initiated all three follow-ups 
with 145 participants (53.7%) completing them all.  Participants’ personal 
characteristics can be found in Table 16.  
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Table 16. Parent and child personal and clinical characteristics and associations with perception of side-effects from vaccination 
Participant 
characteristics 




















ratio (95% CI)a 
Parent gender Female 81 (43.8) 104 (56.2) 1.15 (0.58 to 
2.26) 
1.23 (0.47 to 
3.24) 
57 (34.8) 107 (65.2) 0.75 (0.36 to 
1.56) 
0.78 (0.28 to 
2.15) 
Male 17 (40.5) 25 (59.5) Reference Reference 15 (41.7) 21 (58.3) Reference Reference 
Parent age 45+ 8 (50.0) 8 (50.0) 1.55 (0.50 to 
4.80) 
1.44 (0.43 to 
4.88) 
4 (30.8) 9 (69.2) 0.86 (0.23 to 
3.26) 
0.77 (0.19 to 
3.07) 
35-44 41 (40.2) 61 (59.8) 1.04 (0.52 to 
2.07) 
1.01 (0.46 to 
2.20) 
34 (36.6) 59 (63.4) 1.11 (0.53 to 
2.37) 
1.07 (0.46 to 
2.50) 
18-34 20 (39.2) 31 (60.8) Reference Reference 15 (34.1) 29 (65.9) Reference Reference 
Parent chronic 
illness 
Present  18 (36.7) 31 (63.3) 0.74 (0.38 to 
1.43) 
0.57 (0.23 to 
1.42) 
15 (34.1) 29 (65.9) 0.95 (0.46 to 
1.94) 
1.00 (0.39 to 
2.56) 
None 72 (43.9) 92 (56.1) Reference  Reference 47 (35.3) 86 (64.7) Reference Reference 
Other ‘at risk’ 
people in child’s 
household 
Yes 33 (40.7) 48 (59.3) 0.85 (0.48 to 
1.52) 
0.99 (0.47 to 
2.06) 
23 (34.3) 44 (65.7) 0.95 (0.49 to 
1.84) 
0.87 (0.39 to 
1.92) 
No 50 (44.6) 62 (55.4) Reference Reference 33 (35.5) 60 (64.5) Reference Reference 
Child gender Female 42 (35.9) 75 (64.1) 0.53 (0.31 to 
0.90)* 
0.45 (0.23 to 
0.88)* 
34 (34.3) 65 (65.7) 0.85 (0.48 to 
1.52) 
0.85 (0.41 to 
1.75) 
Male 56 (51.4) 53 (48.6)  Reference 38 (38.0) 62 (62.0)  Reference 
First-born child Yes 53 (40.2) 79 (59.8) 0.78 (0.45 to 
1.36) 
0.78 (0.39 to 
1.60) 
35 (30.7) 79 (69.3) 0.73 (0.32 to 
1.15) 
0.91 (0.42 to 
2.00) 
No 38 (46.3) 44 (53.7) Reference Reference 27 (42.2) 37 (57.8) Reference Reference 
Child age Range 1 





0.90 (0.68 to 
1.21) 






1.09 (0.80 to 
1.48) 




Present 9 (50.0) 9 (50.0) 1.39 (0.53 to 
3.66) 
2.25 (0.64 to 
7.97) 
6 (33.3) 12 (66.7) 0.93 (0.33 to 
2.61) 
0.97 (0.26 to 
3.57) 






5 (50.0) 5 (50.0) 1.35 (0.38 to 
4.81) 
1.16 (0.24 to 
5.68) 
3 (50.0) 3 (50.0) 1.90 (0.37 to 
9.70) 
1.42 (0.21 to 
9.72) 




a Adjusting for all other personal characteristics (both parent and child, apart from child up-to-date vaccine status for other routine vaccines) 
Abbreviations. UTD = up-to-date 
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6.2.2 Side-effect reporting 
At T2, 98 people out of 227 who completed the question (43.2%, 95% CI [36.7, 
49.7]) reported at least one side-effect. At T3, 72 people out of 200 who 
completed the question (36.0%, 95% CI [29.3, 42.7]) recalled at least one side-
effect. Associations between personal characteristics, predictor variables and 
side-effect report can be found in Table 16, Table 17 and Table 18. 
Three days after their child’s vaccination, parents were more likely to report side-
effects in boys; if they had expected their child to experience side-effects; and if 
they had perceived a suggestion of side-effects from the media, NHS vaccination 
leaflet, or healthcare worker during their vaccination appointment. When taking 
into account trust in the source of information on the suggestion of side-effects, 
only trust and suggestions from healthcare workers increased the odds of 
reporting side-effects. 
One month after their child’s vaccination, parents were more likely to recall that 
their child had experienced side-effects if they had expected side-effects; 
perceived a suggestion of side-effects from the NHS vaccination leaflet; had high 
trait anxiety; high pessimism; and if they perceived their child to be sensitive to 
medicines. Perceiving oneself not to know enough about the vaccine was also 




Table 17. Psychological predictors and associations with perception of side-effects from vaccination 




















































Expectation for child to get side-effects  5-point Likert 
(1=‘very unlikely’ 











































































Suggestion of side-effects by the media 4-point Likert 
(1=‘very unlikely’ 














































Suggestion of side-effects by the HCW 
in the vaccine appointment 
4-point Likert 
(1=‘very unlikely’ 





















Suggestion of side-effects by 
friends/family/relatives, by trust 






















Suggestion of side-effects by official 
websites/helplines/departments/agencies, 
by trust 
























Suggestion of side-effects by the media, 
by trust 






















Suggestion of side-effects by the NHS 
vaccination leaflet, by trust  






















Suggestion of side-effects by the HCW 
in the vaccine appointment, by trust 

































No 82 (42.5) 111 (57.5) Reference Reference 61 (35.3) 112 (64.7) Reference Reference 
Severity of side-effects observed in other 
children 
5-point Likert 


























[Child] having side-effects from 
influenza vaccine previously 








No 27 (43.5) 35 (56.5) Reference Reference 18 (29.0) 44 (71.0) Reference Reference 
Worry about [child]’s previous side-
effects 
4-point Likert 
(1=‘not at all’ to 


















Severity of [child]’s previous side-
effects 
5-point Likert 























[Child] side-effect from other routine 
vaccines 









No 37 (34.9) 69 (65.1) Reference Reference 27 (28.4) 68 (71.6) Reference Reference 
Worry about side-effect from other 
routine vaccine 
4-point Likert 






































































































































































































Beliefs about Medicines Questionnaire-
general, harm subscale 




















Beliefs about Medicines Questionnaire-
general, overuse subscale 





















a Adjusting for all personal characteristics (both parent and child, apart from child up-to-date vaccine status for other routine vaccines) 
† Adjusted calculations unable to be run due to lack of cases in some groups. 
Abbreviations. NHS = National Health Service, HCW = healthcare worker
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Table 18. Beliefs and attitudes about influenza and the child vaccine and associations with perception of side-effects from vaccination 
Statement Level Side-effects reported at T2 Side-effects reported at T3 
Side-effects 
perceived 












n=72, n (%) 
No side-effects 
perceived 






The child flu vaccine has 
not been tested enough for 
me to feel it is safe 
Agree 9 (60.0) 6 (40.0) 2.25 (0.76 to 
6.66) 
1.19 (0.25 to 
5.69) 
8 (66.7) 4 (33.3) 4.62 (1.32 
to 16.18)* 
6.47 (1.08 to 
38.59)* 
Disagree 58 (40.0) 87 (60.0) Reference Reference 42 (30.2) 97 (69.8) Reference Reference 
The child flu vaccine can 
cause unpleasant short-term 
side-effects 
Agree 23 (57.5) 17 (42.5) 2.07 (0.97 to 
4.40) 
1.55 (0.57 to 
4.24) 
11 (36.7) 19 (63.3) 1.45 (0.61 
to 3.46) 
1.35 (0.44 to 
4.18) 
Disagree 36 (39.6) 55 (60.4) Reference Reference 26 (28.6) 65 (71.4) Reference Reference 
The child flu vaccine can 
cause long-term health 
problems 
Agree 1 (50.0) 1 (50.0) 1.33 (0.08 to 
21.68) 
0.00 (†) 2 (66.7) 1 (33.3) 4.378 (0.39 
to 49.43) 
† 
Disagree 72 (42.9) 96 (57.1) Reference Reference 48 (31.4) 105 (68.6) Reference Reference 
The child flu vaccine does 
not suit my religious or 
cultural beliefs/values 
Agree 6 (85.7) 1 (14.3) 8.21 (0.97 to 
69.62) 
4.81 (0.46 to 
49.86) 
3 (75.0) 1 (25.0) 6.28 (0.64 
to 61.84) 
2.04 (0.12 to 
36.17) 
Disagree 76 (42.2) 104 (57.8) Reference Reference 53 (32.3) 111 (67.7) Reference Reference 
I don’t like [child] having 
vaccinations in general 
Agree 6 (75.0) 2 (25.0) 3.74 (0.74 to 
19.03) 
2.93 (0.39 to 
21.76) 
3 (60.0) 2 (40.0) 2.48 (0.40 
to 15.29) 
4.23 (0.32 to 
55.81) 
Disagree 81 (44.5) 101 (55.5) Reference Reference 61 (37.7) 101 (62.3) Reference Reference 
I don’t know enough about 
the child flu vaccine 
Agree 24 (49.0) 25 (51.0) 1.18 (0.60 to 
2.32) 
1.41 (0.56 to 
3.61) 
20 (50.0) 20 (50.0) 1.83 (0.87 
to 3.85) 
3.01 (1.03 to 
8.80)* 
Disagree 48 (44.9) 59 (55.1) Reference Reference 36 (35.3) 66 (64.7) Reference Reference 
The vaccination campaign is 
just about making money 
for the manufacturers 
Agree 3 (42.9) 4 (57.1) 0.99 (0.21 to 
4.54) 
0.28 (0.01 to 
5.23) 
4 (66.7) 2 (33.3) 4.08 (0.72 
to 22.99) 
4.94 (0.37 to 
66.52) 
Disagree 73 (43.2) 96 (56.8) Reference Reference 52 (32.9) 106 (67.1) Reference Reference 
The flu vaccine would 
interact with other 
medications that [child] is 
currently taking 
Agree 0  0 † † 1 (100.0) 0 (0.0) † † 
Disagree 129 (59.2) 89 (40.8) Reference Reference 52 (34.4) 99 (65.6) Reference Reference 
Vaccinating [child] against 
flu each year will overload 
his/her immune system 
Agree 9 (69.2) 4 (30.8) 3.13 (0.93 to 
10.54) 
1.38 (0.27 to 
7.10) 
5 (50.0) 5 (50.0) 1.96 (0.54 
to 7.08) 
2.36 (0.42 to 
13.39) 
Disagree 72 (41.9) 100 (58.1) Reference Reference 53 (33.8) 104 (66.2) Reference Reference 
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Vaccinating [child] against 
flu each year is too much of 
an ongoing time 
commitment 
Agree 3 (33.3) 6 (66.7) 0.67 (0.16 to 
2.76) 
1.16 (0.15 to 
9.22) 
2 (28.6) 5 (71.4) 0.68 (0.13 
to 3.61) 
1.10 (0.09 to 
13.71) 
Disagree 82 (42.7) 110 (57.3) Reference Reference 64 (37.0) 109 (63.0) Reference Reference 
Having the child flu vaccine 
is an effective way of 
preventing [child] from 
catching flu 
Agree 81 (43.3) 106 (56.7) 0.87 (0.30 to 
2.51) 
0.67 (0.17 to 
2.61) 
63 (37.0) 107 (63.0) 1.96 (0.52 
to 7.40) 
2.46 (0.48 to 
12.53) 
Disagree 7 (46.6) 8 (53.3) Reference Reference 3 (23.1) 10 (76.9) Reference Reference 
If I don’t vaccinate [child], 
then [child] is likely to catch 
flu 
Agree 28 (52.8) 25 (47.2) 1.36 (0.67 to 
2.76) 
1.20 (0.48 to 
3.01) 
23 (44.2) 29 (55.8) 1.85 (0.85 
to 4.03) 
1.86 (0.69 to 
5.02) 
Disagree 33 (45.2) 40 (54.8) Reference Reference 18 (30.0) 42 (70.0) Reference Reference 
Flu would be a serious 
illness for child 
Agree 55 (40.4) 81 (59.6) 0.97 (0.45 to 
2.08) 
0.71 (0.25 to 
1.95) 
41 (33.9) 80 (66.1) 1.09 (0.434 
to 2.735) 
0.90 (0.30 to 
2.65) 
Disagree 14 (41.2) 20 (58.8) Reference Reference 8 (32.0) 17 (68.0) Reference Reference 
Flu would be a serious 
illness for self 
Agree 42 (41.2) 60 (58.8) 0.96 (0.50 to 
1.86) 
0.82 (0.35 to 
1.94) 
32 (36.4) 56 (63.6) 1.407 
(0.647 to 
3.060) 
1.38 (0.54 to 
3.53) 
Disagree 24 (42.1) 33 (57.9) Reference Reference 12 (27.3) 32 (72.7) Reference Reference 
Flu would be a serious 
illness for someone in 
child’s household 
Agree 54 (44.3) 68 (55.7) 1.28 (0.64 to 
2.55) 
1.09 (0.46 to 
2.62) 
38 (36.2) 67 (63.8) 1.237 
(0.547 to 
2.802) 
1.11 (0.43 to 
2.88) 
Disagree 18 (38.3) 29 (61.7) Reference Reference 11 (31.4) 24 (68.6) Reference Reference 
If [child] were to catch flu, 
how much, if at all, would it 
impact your daily life? 
4-point Likert 









0.99 (0.64 to 
1.53) 










0.81 (0.44 to 
1.50) 
*p≤.05 
a Adjusting for all personal characteristics (both parent and child, apart from child up-to-date vaccine status for other routine vaccines) 
† Adjusted calculations unable to be run due to lack of cases in some groups 
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6.2.3 Expectation as a mediator 
The results of mediation analyses are shown in Table 19. Mediation models with 
estimates for paths a, b, c and c’ are illustrated in Figure 8.  
When controlling for personal and clinical characteristics, the total effect of 
suggestion of side-effects from the media on side-effects reported three days after 
vaccination neared significance, indicating that increased suggestion of side-
effects was associated with increased likelihood of side-effect perception (b=.59, 
p=.06). When taking into account the influence of expectation, there was no 
direct effect of suggestion of side-effects from the media on side-effects reported 
three days after vaccination (b=.39, p=.23). 39.5% of the effect of media 
suggestion of side-effects on side-effects reported three days after vaccination 
was mediated by expectation.  
When controlling for personal and clinical characteristics, there was a total effect 
of suggestion of side-effects from the NHS vaccination leaflet on side-effects 
reported three days after vaccination, with increased suggestion of side-effects 
being associated with increased likelihood of side-effect perception (b=.56, 
p=.05). The direct effect of suggestion of side-effects from the NHS vaccination 
leaflet on side-effects reported three days after vaccination was not significant 
(b=.21, p=.52). 64.1% of the effect of NHS vaccination leaflet suggestion of side-
effects on side-effects reported three days after vaccination was mediated by 
expectation.  
When controlling for personal and clinical characteristics, there was a total effect 
of parents’ perception of their child’s sensitivity to medicines before vaccination 
on side-effects reported one month after vaccination, with increased sensitivity 
being associated with increased likelihood of side-effect perception (b=.14, 
p=.02). The direct effect of parents’ perception of their child’s sensitivity to 
medicines before vaccination on side-effects reported one month after vaccination 
was not significant (b=.10, p=.10). 36.6% of the effect of parents’ perception of 
their child’s sensitivity to medicines before vaccination on side-effects reported 
one month after vaccination was mediated by expectation.  
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There was no evidence that the suggestion of side-effects from the NHS 
vaccination leaflet or pessimism on side-effect perception one month after 
vaccination were mediated by expectation. 
Table 19. Mediation analyses for standardised effects of direct expectation as a 














































































































a Adjusting for all personal characteristics (both parent and child), apart from 
child up-to-date vaccine status for other routine vaccines  
*p≤.05 
Abbreviations. NHS = National Health Service 
 




recalled at T2 
Suggestion of side-





c= .59, p=.06 
(c’=.39, p=.23) 
a. Mediation model showing the effect of media suggestion on side-effects reported 








Abbreviations. NHS = National Health Service 
 
6.2.4 Re-vaccination intention for 2017/18 
204 (83.6%, 95% CI [78.9, 88.3]) parents indicated that they definitely intended 
to re-vaccinate their child in the next influenza season (2017/18), while 40 
(16.4%, 95% CI [11.7, 21.1]) indicated that they did not definitely intend to re-
Expectation 
Side-effects 
recalled at T2 
Suggestion of side-






c= .56, p=.05* 
(c’=.21, p=.52) 
b. Mediation model showing the effect of NHS vaccination leaflet suggestion on 
side-effects reported at T2, mediated by expectation  
Expectation 
Side-effects 
recalled at T3 
Suggestion of side-






c= .75, p=.02* 
(c’=.53, p=.13) 
c. Mediation model showing the effect of NHS vaccination leaflet suggestion on 
side-effects reported at T3, mediated by expectation  
Expectation 
Side-effects 
recalled at T3 
Perceived 
sensitivity to 







d. Mediation model showing the effect of perceived sensitivity to medicines at T1 
on side-effects reported at T3, mediated by expectation  
Expectation 
Side-effects 





c= .20, p=.03* 
(c’=.19, p=.05*) 
e. Mediation model showing the effect of pessimism on side-effects reported at T3, 
mediated by expectation  
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vaccinate their child. Associations between personal characteristics, predictor 
variables and definitely intending to re-vaccinate can be found in Table 20 and 
Table 21. 
Re-vaccination intention was associated with parent age, with parents aged thirty-
five to forty-four being more likely to intend to re-vaccinate their child than those 
aged eighteen to thirty-four. 
Decreased re-vaccination intention was associated with higher parental worry 
about side-effects three days after vaccination; increased perceived severity of 
side-effects three days after vaccination; parental recall of side-effects one month 
after vaccination; and higher worry about side-effects one month after 
vaccination. 
6.2.5 Re-vaccination in 2017/18  
Vaccination status in 2017/18 was ascertained for 232 participants (response rate 
85.9%), of whom 190 were mothers. 
Forty-one children (17.7%, 95% CI [12.7, 22.6]) had not been re-vaccinated; 188 
children (81.0%, 95% CI [76.0, 86.1]) had been re-vaccinated; and three parents 
(1.3%) indicated they did not know if their child had been re-vaccinated. 
Associations between personal characteristics, predictor variables and re-
vaccination refusal can be found in Table 20 and Table 21. 
Parents who were aged thirty-five to forty-four were less likely to re-vaccinate 
their child compared to those aged eighteen to thirty-four, however these analyses 
relied on a cell count of fewer than ten participants and so should be taken with 
caution. No other personal or clinical characteristics were associated with re-
vaccination status.  
Parents who reported that their child experienced more severe side-effects three 
days after vaccination were more likely not to re-vaccinate their child in 2017/18. 
Parents who reported being more worried about their child’s side-effects one 
month after vaccination were also more likely not to re-vaccinate their child in 
2017/18. No other variables showed an association with re-vaccination status. 
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Table 20. Parent and child personal and clinical characteristics and associations with re-vaccination intention for 2017/18 and re-vaccination 
status in 2017/18 
Participant 
characteristics 
Level Re-vaccination intention for 2017/18 Re-vaccination in 2017/18 influenza season 









ratio (95% CI)a 
Not re-
vaccinated 
n=41, n (%) 
Re-vaccinated 




ratio (95% CI)a 
Parent gender Female 38 (19.0) 162 (81.0) 0.20 (0.05 to 
0.88)* 
0.40 (0.08 to 
2.00) 
34 (17.9) 156 (82.1) 1.00 (0.41 to 
2.45) 
0.50 (0.15 to 
1.74) 
Male 2 (4.5) 42 (95.5) Reference Reference 7 (17.9) 32 (82.1) Reference Reference 
Parent age 45+ 1 (6.3) 15 (93.8) 4.50 (0.54 to 
37.66) 
5.28 (0.59 to 
47.47) 
2 (12.5) 14 (87.5) 0.43 (0.09 to 
2.16) 
0.46 (0.08 to 
2.66) 
35-44 17 (16.5) 86 (83.5) 1.52 (0.66 to 
3.48) 
2.93 (1.05 to 
8.20)* 
9 (8.9) 92 (91.1) 0.29 (0.11 to 
0.76)* 
0.30 (0.09 to 
0.96)* 
18-34 12 (23.1) 40 (76.9) Reference Reference 12 (25.0) 36 (75.0) Reference Reference 
Parent chronic 
illness 
Present  7 (14.0) 43 (86.0) 1.37 (0.56 to 
3.33) 
2.29 (0.56 to 
9.33) 
6 (13.3) 39 (86.7) 0.83 (0.32 to 
2.17) 
1.21 (0.33 to 
4.41) 
None 30 (18.2) 135 (81.8) Reference Reference 24 (15.7) 129 (84.3) Reference Reference 
Other ‘at risk’ 
people in child’s 
household 
Yes 14 (17.3) 67 (82.7) 0.73 (0.33 to 
1.60) 
0.56 (0.22 to 
1.62) 
9 (12.0) 66 (88.0) 0.74 (0.31 to 
1.78) 
0.35 (0.10 to 
1.20) 
No 15 (13.2) 99 (86.8) Reference Reference 16 (15.5) 87. (84.5) Reference Reference 
Child gender Female 21 (16.4) 107 (83.6) 0.95 (0.48 to 
1.88) 
1.71 (0.67 to 
4.42) 
24 (19.5) 99 (80.5) 1.26 (0.63 to 
2.49) 
1.66 (0.58 to 
4.77) 
Male 18 (15.7) 97 (84.3) Reference Reference 17 (16.2) 88 (83.8) Reference Reference 
First-born child Yes 23 (17.3) 110 (82.7) 0.97 (0.47 to 
2.01) 
0.78 (0.28 to 
2.16) 
19 (15.6) 103 (84.4) 1.09 (0.49 to 
2.44) 
0.60 (0.20 to 
1.86) 
No 14 (16.9) 69 (83.1) Reference Reference 11 (14.5) 65 (85.5) Reference Reference 
Child age Range 1 





0.83 (0.57 to 
1.21) 






0.91 (0.63 to 
1.33) 




Present 2 (11.1) 16 (88.9) 1.72 (0.38 to 
7.81) 
2.39 (0.24 to 
23.67) 
3 (16.7) 15 (83.3) 1.13 (0.31 to 
4.18) 
1.92 (0.35 to 
10.57) 






1 (10.0) 9 (90.0) 0.52 (0.06 to 
4.22) 
1.42 (0.15 to 
13.59) 
0 (0.0) 9 (100.0) † † 




a Adjusting for all other personal characteristics (both parent and child, apart from child up-to-date vaccine status for other routine vaccines) 
† Calculations unable to be run due to lack of cases in some groups 
Abbreviations: UTD = up-to-date
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Table 21. Psychological predictors and associations with re-vaccination intention for 2017/18 and re-vaccination status in 2017/18 
Category Psychological 
predictor 
Level Re-vaccination intention for 2017/18 Re-vaccination in 2017/18 influenza season 
Do not intend 
to re-
vaccinate 


























effects as recalled at 
T2 
Yes 21 (21.4) 77 (78.6) 0.56 (0.28 
to 1.12) 
0.63 (0.24 to 
1.62) 
13 (15.7) 70 (84.3) 1.18 (0.54 
to 2.62) 
2.21 (0.72 to 
6.82) 
No 17 (13.2) 112 (86.8) Reference Reference 16 (13.6) 102 (86.4) Reference Reference 
Worry about side-
effects as recalled at 
T2 
4-point Likert 





















1.35 (0.44 to 
4.18) 
Severity of side-

























2.83 (1.05 to 
7.63)* 
Presence of side-
effects as recalled at 
T3 
Yes 16 (22.2) 56 (77.8) 0.40 (0.18 
to 0.88)* 
0.27 (0.09 to 
0.83)* 
11 (16.7) 55 (83.3) 0.89 (0.40 
to 1.97) 
1.45 (0.50 to 
4.49) 
No 13 (10.2) 115 (89.8) Reference Reference 22 (18.3) 98 (81.7) Reference Reference 
Worry about side-
effects as recalled at 
T3 
4-point Likert 





















4.57 (1.01 to 
20.58)* 
Severity of side-































Yes - - - - 31 (17.4) 147 (82.6) 1.31 (0.47 
to 3.63) 
0.49 (0.13 to 
1.90) 









effects by the HCW 




























effects by the HCW 
in the vaccine 
appointment, by trust 
by Trust 




















1.02 (0.83 to 
1.25) 
Change in perceived 
sensitivity to 
medicines 

















1.03 (0.89 to 
1.20) 
Change in trust in 
healthcare workers 



















1.07 (0.89 to 
1.27) 
*p≤.05 
a Adjusting for all personal characteristics (both parent and child, apart from child up-to-date vaccine status for other routine vaccines) 
Abbreviations: HCW = healthcare worker 
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6.2.6 Change in perceived sensitivity to medicines 
At T1, the overall mean perceived sensitivity to medicines score was 10.03 
(SD=3.34, n=270), while at T3 it was 9.40 (SD=3.36, n=194). There was no 
difference in parents’ perceptions of how sensitive their child was to medicines 
after their child’s influenza vaccination in 2016/17 (t(193)=1.26, p=.21). 
There was no association between reporting side-effects three days after the 
child’s vaccination and change in perceived sensitivity to medicines score 
(overall model, R2=.35, F(10,129)=6.30, p<.001). However, an association 
between side-effect perception one month after the child’s vaccination and 
change in perceived sensitivity to medicines score was found (overall model, 
R2=.39, F(10,131)=7.81, p<.001; see Table 22). Parents who recalled that their 
child experienced side-effects had increased perceptions of their child’s 
sensitivity to medicines compared to those who did not recall side-effects (β=.20, 
p=.01). 
Table 22. Associations between side-effect reporting and parents’ perceptions of 
their child’s sensitivity to medicines and trust in healthcare workers 
Side-effect 
reporting 
Level Perceived sensitivity to 
medicinesa 
Trust in healthcare 
workersb 
n β p n β p 
Side-effects 
recalled at T2 
Side-effects 
perceived 
73 .06 .43 97 -.09 .32 
No side-effects 
perceived 
104 Reference  127 Reference  
Side-effects 
recalled at T3 
Side-effects 
perceived 
71 .20 .01* 72 -.03 .73 
No side-effects 
perceived 
123 Reference  103 Reference  
*p≤.05 
a Adjusting for all personal characteristics (both parent and child, apart from child 
up-to-date vaccine status for other routine vaccines) and perceived sensitivity to 
medicines at T1 
b Adjusting for all personal characteristics (both parent and child, apart from child 
up-to-date vaccine status for other routine vaccines) and trust in healthcare 
workers at T1 
 
6.2.7 Change in trust in healthcare workers 
At T1, the overall mean score on the Meyer Credibility Scale was 21.68 
(SD=3.43, n=264), while at T3 it was 21.20 (SD=4.19, n=192). There was no 
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difference in parents’ trust in healthcare workers after their child’s influenza 
vaccination in 2016/17 (t(188)=1.72, p=.09). 
There was no association between change in trust in healthcare workers and 
reporting side-effects three days (overall model, R2=.15, F(10,125)=1.98, p=.04), 
or one month (overall model, R2=.138, F(10,127)=1.87, p=.06) after the child’s 
vaccination (see Table 22). 
6.2.8 Sensitivity analyses 
Sensitivity analyses indicated that there were no substantial differences to the 
results when taking into account the effect of clustering by primary care practice. 
Only four results were changed: worry about side-effects at T3 was no longer 
significantly associated with re-vaccination intention; side-effects recalled at T3 
were no longer significantly associated with change in parental perceived 
sensitivity to medicines; perceived severity of side-effects at T2 was no longer 
significantly associated with re-vaccination in 2017/18; and worry about side-
effects at T3 was no longer significantly associated with re-vaccination in 
2017/18. 
For the mediation analyses, there was no difference to the strength or the 
significance of any of the main pathway effects. Thus, clustering should not 
change the results of the binary_mediation analysis macro. 
6.2.9 Interpretation bias 
 Participants 
196 parents initiated the scrambled sentences task of whom 75 fulfilled inclusion 
criteria. Participant personal and clinical characteristics for those included in 
interpretation bias analyses and how they differ by side-effect perception, re-
vaccination intention and actual re-vaccination are shown in Table 23. 
Female parents were more likely to be excluded from the analyses (χ2(1, 
n=196)=4.28, p=.04). There were no other differences in parent or child personal 
or clinical characteristics (parent age, parent chronic illness, other ‘at risk’ people 
in child’s household, child gender, first-born child, child age or child chronic 




Table 23. Parent and child personal and clinical characteristics for those included in interpretation bias analyses and associations with perception 
of side-effects from vaccination, re-vaccination intention for 2017/18 and re-vaccination status in 2017/18 
Participant 
characteristics 
 Side-effects reported at T2 Side-effects reported at T3 Re-vaccination intention for 
2017/18 season 
Re-vaccination in 2017/18 
influenza season 
 Level Side-effects 
perceived 




n=45, n (%) 
p Side-effects 
perceived 




n=49, n (%) 
p Do not 
intend to re-
vaccinate 
n=16, n (%) 
Intend to 
re-vaccinate 
n=59, n (%) 
p Not re-
vaccinated 
n=11, n (%) 
Re-
vaccinated 
n=61, n (%) 
p 
Parent gender Female 25 (43.9) 32 (56.1) .16 13 (26.0) 37 (74.0) 1.00 14 (24.1) 44 (75.9) .34 8 (14.5) 47 (85.5) .71 
Male 4 (76.5) 13 (23.5) 4 (25.0) 12 (75.0) 2 (11.8) 15 (88.2) 3 (17.6) 14 (82.4) 
Parent age 35+ 19 (39.6 29 (60.4) .93 32 (72.7) 12 (27.3) .77 11 (22.9) 37 (77.1) .77 5 (10.4) 43 (89.6) .16 
18-34 10 (38.5) 16 (61.5) 17 (77.3) 5 (22.7) 5 (18.5) 22 (81.5) 6 (25.0) 18 (75.0) 
Parent chronic 
illness 
Present 6 (31.6) 13 (68.4) .43 4 (22.2) 14 (77.8) .76 4 (20.0) 16 (80.0) 1.00 2 (10.5) 17 (89.5) .72 
None 23 (41.8) 32 (58.2) 13 (27.1) 35 (72.9) 12 (21.8) 43 (78.2) 9 (17.0) 44 (83.0) 
Other ‘at risk’ 
people in child’s 
household 
Yes 12 (41.4) 17 (58.6) .88 8 (30.8) 18 (69.2) .40 7 (24.1) 22 (75.9) .23 
 
2 (7.1) 26 (92.9) .17 
No 15 (39.5) 23 (60.5) 7 (21.2) 26 (78.8) 5 (12.8) 34 (87.2) 8 (21.6) 29 (78.4) 
Child gender Female 14 (35.9) 25 (64.1) .47 9 (27.3) 24 (72.7) .84 8 (20.0) 32 (80.0) .95 6 (16.2) 31 (83.8) 1.00 
Male 15 (44.1) 19 (55.9) 8 (25.0) 24 (75.0) 7 (20.6) 27 (79.4) 5 (14.7) 29 (85.3) 
First-born child Yes 18 (38.3) 29 (61.7) .84 7 (15.9) 37 (84.1) .01* 11 (22.9) 37 (77.1) .77 10 (21.3) 37 (78.7) .08 
No 11 (40.7) 16 (59.3) 10 (45.5) 12 (54.5) 5 (18.5) 22 (81.5) 1 (4.0) 24 (96.0) 






























Present 4 (66.7) 2 (33.3) .20 0 (0.0) 6 (100.0) .33 1 (16.7) 5 (83.3) 1.00 2 (33.3) 4 (66.7) .23 
None 25 (36.8) 43 (63.2) 17 (28.3) 43 (71.7) 15 (21.7) 54 (78.3) 9 (13.6) 57 (86.4) 
Child up-to-date 






0 (0.0) 2 (100.0) .52 1 (50.0) 1 (50.0) .45 0 (100.0) 2 (100.0) 1.00 0 (0.0) 2 (100.0) 1.00 
UTD 29 (40.3) 43 (59.7) 16 (25.0) 48 (75.0) 16 (21.9) 57 (78.1) 11 (15.7) 59 (84.3) 
* p≤.05 
Abbreviations: UTD = up-to-date 
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 Side-effect perception at T2 
Of parents included in interpretation bias analyses, twenty-nine perceived side-
effects in their child three days after vaccination, while 45 did not. Mean bias 
scores are shown in Table 24. 
No personal or clinical characteristics differed by side-effect perception three 
days after the child’s influenza vaccination (see Table 23). There was a main 
effect of source of health threat (F(1,72)=16.96, p<.001, ηp²=.19) on bias with 
higher negative bias for naturally-occurring health threats (M=0.36, SD=0.25) 
than man-made health threats (M=0.20, SD=0.24). There was no main effect of 
side-effect perception (F(1,72)=0.17, p=.68, ηp²=.002), nor was there an 
interaction effect (F(1,72)=2.30, p=.13, ηp²=.03). 
Table 24. Mean negative interpretation bias scores (95% CI) by perception of 
side-effects from vaccination, re-vaccination intention for 2017/18 and re-
vaccination status in 2017/18 
 
 Side-effect perception at T3 
Of parents included in interpretation bias analyses, seventeen parents perceived 
side-effects in their child one month after vaccination, while 49 did not. Mean 
bias scores are shown in Table 24. 
 Side-effects 
reported at T2 
Side-effects 























































































































There was a group difference between those who did and did not perceive side-
effects one month after vaccination for first-child status (χ2(1, n=66)=6.67, p=.01, 
see Table 23). Therefore, first-child status was entered into the regression model 
as the first block. Negative bias was associated with perception of side-effects 
one month after vaccination (aOR=20.59, 95% CI [1.76 to 236.09]). There was a 
significant interaction effect between negative bias and source of health threat 
(aOR=0.02, 95% CI [0.001 to 0.66]; see Figure 9). Within group contrasts 
indicated that there was a significant difference in bias for man-made and 
naturally-occurring health threats in those who did not perceive side-effects 
(mean difference=-.22, 95% CI [-.30 to -.15], t(48)=-5.91, p<.001, d=-1.01), but 
no difference in those who did perceive side-effects (mean difference=.02, 95% 
CI [-.17 to .20], t(16)=.21, p=.84, d=0.06). There was no association between 
source of health threat and perception of side-effects one month after vaccination 
(aOR=2.58, 95% CI [0.70 to 9.53]). 






 Re-vaccination intention for 2017/18 
Of parents included in interpretation bias analyses, 59 indicated that they 
definitely intended to re-vaccinate their child, while sixteen did not definitely 
intend to re-vaccinate. Mean bias scores are shown in Table 24. 
No personal or clinical characteristics differed by re-vaccination intention (see 
Table 23). There was a main effect of source of health threat (F(1,73)=11.11, 
p<.001, ηp²=.13) on bias with higher negative bias for naturally-occurring health 
threats (M=0.37, SD=0.25) than man-made health threats (M=0.20, SD=0.24). 
There was no main effect of re-vaccination intention (F(1,73)=0.46, p=.50, 
ηp²=.01), nor was there an interaction effect (F(1,73)=0.63, p=.43, ηp²=.01). 
 Re-vaccination in 2017/18 
Of parents included in interpretation bias analyses, 61 re-vaccinated their child in 
the 2017/18 influenza season while eleven did not. Mean bias scores are shown in 
Table 24. 
Group differences were found for child age and re-vaccination (t(-25.66)=-2.85, 
p=.01, see Table 23). Therefore, child age was entered into the regression model 
as the first block. There was no association between re-vaccination in 2017/18 
and negative bias (aOR=0.47, 95% CI [0.03 to 6.70]) or source of health threat 
(aOR=2.03, 95% CI [0.35 to 11.75]), nor was there an interaction effect 
(aOR=0.23, 95% CI [0.004 to 14.28]). 
 Discussion 
Concern about side-effects is a frequently cited reason for declining vaccination 
(91, 95, 270). This is a potential problem for the child influenza vaccine as side-
effects are common and yearly vaccination is recommended. However, factors 
affecting parental perception of symptoms have been poorly researched (Chapter 
3). The primary aim of this study was to investigate psychological factors 
associated with parental perception of side-effects.  
Pre-vaccination expectations were strongly associated with side-effect reporting 
both three days and one month after vaccination, indicating the stability of 
expectations as a predictive factor over time. These results confirm previous 
findings from cross-sectional research in which parents who thought that their 
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child would experience a reaction that would need medical treatment from their 
latest vaccination were more likely to have ever reported their child’s side-effects 
to a health professional or surveillance system (441). Results are also in line with 
a substantial body of work suggesting that expectations make symptom 
perception in oneself more likely (220), at least partly because of the increased 
monitoring for symptoms that can occur as a result of increased expectation. To 
my knowledge, this is the first time the role of expectation has been demonstrated 
for the perception of symptoms in someone other than oneself, presumably as a 
result of a similar monitoring-related mechanism. 
Parents who thought that the NHS vaccination leaflet, healthcare worker or the 
media had suggested that the vaccine caused side-effects were also more likely to 
report side-effects three days after vaccination. Although I had expected parental 
trust in a source of information to strengthen the relationship between suggestion 
of side-effects and later perception of side-effects, when taking into account 
parental trust, only suggestion from the healthcare worker was associated with 
side-effect perception. Results indicate that parents’ immediate perception of 
side-effects may be influenced by the number and nature of suggestions of side-
effects received, in line with the availability heuristic (442). Only suggestion of 
side-effects from the NHS vaccination leaflet was associated with side-effect 
reporting one month after vaccination, implying that while suggestions are 
important for immediate perception of symptoms, they may be less important in 
the longer-term recall of those symptoms. The effect of suggestion from the 
media and the NHS vaccination leaflet were both mediated by direct expectation, 
indicating that suggestion of side-effects from these sources increases 
expectations about the incidence of side-effects.  
Interestingly, although learning and social observation are associated with the 
nocebo response (220), I found no effect of having seen other children experience 
side-effects from the vaccine or having previously perceived side-effects from 
vaccination in one’s own child, on reporting of side-effects. However, analyses 
investigating previous perception of side-effects from the child influenza vaccine 
in one’s child were underpowered due to small cell counts. Therefore, I may have 
failed to detect small, but important effects. Another possible explanation for this 
pattern of results  may be that symptom perception is not happening in oneself, as 
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in previous research, but in one’s child. In these situations, parents are unable to 
access bodily cues and sensations and must attend to and interpret their child’s 
behaviour (443). It is possible that social observation specifically affects bodily 
sensations.  
I also found a gender difference in perception of side-effects, with parents being 
more likely to report side-effects in boys than girls three days after vaccination. 
The reasons for this are unclear. Contrary to my results, another study has found 
that a higher proportion of mothers contacted healthcare workers about side-
effects experienced by their female, rather than male child, three days after their 
child’s diphtheria, pertussis and tetanus vaccination (444). However, these results 
may not be directly comparable, as they relate to parental behaviour in response 
to side-effects, rather than perception of side-effects per se (445). 
Exclusively associated with recall of side-effects one month after vaccination was 
the feeling that one did not know enough about the vaccine, as well as personality 
traits such as anxiety and pessimism. The effect of beliefs and personality traits 
should be treated with caution as confidence intervals for the effect of the former 
were wide, and the effect sizes of the latter were small. However, these results 
suggest that different factors are more influential for the medium-term recall of 
side-effects compared to the immediate perception of side-effects, and are 
consistent with findings that general negative affect is associated with negative 
memory bias (446). 
The perception that one’s child is particularly sensitive to medicines was also 
associated with recall of side-effects one month after vaccination. This effect was 
mediated by parents’ expectations of how likely their child was to experience 
side-effects from the vaccine. Again, this is consistent with evidence suggesting 
that such perceptions can prompt people to monitor for evidence that is in line 
with their expectations (275). I also found evidence that a feedback loop might be 
in operation – parents who recalled symptoms one month after vaccination also 
tended to have elevated perceptions of their child’s sensitivity to medicines. 
However, these results should be taken with caution as there was no longer an 
association when taking into account clustering by primary care practice. 
Whether this effect persists in the long term is unknown. 
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As might be expected in a cohort of parents who have already vaccinated their 
child once (270), most of my participants intended to vaccinate their child again 
the following year. However, one in six parents were less than certain in their 
intentions. Factors that strongly predicted being uncertain about re-vaccination 
intention were perceived severity and worry about side-effects three days after 
vaccination and recalling one month later that the child had experienced side-
effects. However, worry about side-effects was no longer associated with re-
vaccination intention when taking into account the effect of clustering by primary 
care practice. These results are in line with evidence indicating that fear of side-
effects is associated with vaccine hesitancy (447). 
This was the first study to investigate re-vaccination rates for the child influenza 
vaccine in England, with results indicating that 18% of children who were 
vaccinated in the 2016/17 influenza season were not re-vaccinated in the 2017/18 
season. Although previous vaccination has been repeatedly suggested as one of 
the strongest predictors of future vaccine uptake (93, 130, 408), my study 
suggests that we cannot rely on this trend to maintain vaccination rates over time, 
with over one in six children who initially received the influenza vaccine being 
lost to the vaccination programme in the subsequent year. This disappointingly 
high proportion of children not re-vaccinated for influenza highlights the need to 
identify factors associated with re-vaccination refusal and to incorporate these 
into communications with parents whose children have just been vaccinated. 
While parental perception of side-effects was not associated with re-vaccination, 
parental worry about, and perceived severity of, side-effects were associated with 
not re-vaccinating one’s child. This is in line with the wealth of evidence 
indicating that parents do not vaccinate their child for fear of side-effects (91, 95, 
270) and highlights the importance of parental perception of side-effects in the 
child influenza vaccination decision. Worry about, and perceived severity of side-
effects may impact vaccine uptake through the omission bias, with parents 
judging the potential adverse effects of vaccinating as worse than adverse effects 
associated with the child contracting influenza (183). However, these findings 
should be taken with caution as there was no longer an association when taking 
into account clustering by primary care practice. 
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Interestingly, my data also suggest that re-vaccination intention was not 
associated with later re-vaccination. However, caution should be taken when 
interpreting this result as analyses may have been underpowered due small cell 
counts for those who did not intend to re-vaccinate their child. While this may be 
a manifestation of the intention-behaviour gap commonly found in studies of 
health behaviours (417), this pattern of results is different to other research which 
has found parental intention to be associated with later vaccine uptake (113, 448). 
One factor which might have reduced the importance of intention in this study is 
the year-long delay between completion of the two measures. It is possible that 
novel information about the vaccine may have changed parents’ re-vaccination 
intention and subsequent behaviour in this time. Practical considerations, such as 
the child being ill on the day of vaccination, or vaccine shortages (179) may also 
be particularly influential in child influenza vaccination, limiting the potential 
impact of psychological factors. 
In relation to my interpretation bias analyses, I found evidence that people 
consistently interpret health threats from naturally-occurring sources (e.g. bacteria 
and germs) more negatively than health threats from man-made sources (e.g. 
medications and mobile phones). This is in line with results from my cross-
sectional study (Chapter 5), with findings reflecting the relatively benign nature 
of the man-made health threats included in study materials. 
Parental interpretation biases were associated with perceiving side-effects from 
the child influenza vaccine, with evidence for a significant interaction effect 
between bias and perception of side-effects at T3. Parents who perceived side-
effects from vaccination made similarly negative interpretations of man-made and 
naturally-occurring health threats. However, those who did not perceive side-
effects had more positive interpretations of man-made health threats than 
naturally-occurring health threats. These results suggest that increasingly negative 
interpretations of man-made health threats may influence parental perception of 
side-effects. This is mirrored in the wider literature, with evidence indicating that 
worry about modern, man-made health threats is associated with increased 
symptom perception in oneself (278-281) and the belief that one’s child’s health 
was affected by an environmental exposure (248). Similarly, another study also 
found that those who had a negative interpretation of the word ‘vaccination,’ 
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associating it with needles and syringes, were more likely to have ever perceived 
side-effects from vaccination (287). Though no associations were found between 
side-effect perception and interpretation biases in the cross-sectional study 
(Chapter 5), the results from this prospective cohort study are consistent with the 
notion that parental interpretation biases play a causal role in parental perception 
of vaccine side-effects. 
Interpretation bias may influence perception of side-effects through worry. 
Interpretation bias is thought to play a causal and maintaining role in worry (449), 
and associations between interpretation bias and worry and rumination have been 
found in healthy individuals (450), as well as those with generalised anxiety 
disorder (451, 452) and depression (452). Interpretation biases about man-made 
and naturally-occurring health threats may underlie worry about adverse effects 
and worry about the severity of the illness, respectively. Worry is associated with 
increased symptom perception in everyday life (247, 248, 278-281). In this case, 
interpretation bias may have caused worry about vaccine side-effects, which in 
turn affected parental perception of side-effects from vaccination.  
I found no evidence for an association between parental interpretation biases and 
intended or actual re-vaccination behaviour. This is a difference to findings from 
my cross-sectional study, in which biases were associated with vaccine uptake 
and vaccination intention (Chapter 5). Cognitive biases have also been associated 
with the uptake of other public health behaviours, such as alcohol consumption 
(203, 204), smoking behaviour (205, 453, 454) and healthy eating (206, 455). 
Multiple differences between these studies and my study could explain why I did 
not find an association. First, studies into smoking cessation and unhealthy eating 
relate to habitual behaviours completed every day; parents must make the 
decision to vaccinate their child for influenza once a year. Second, studies 
investigating smoking and healthy eating looked at associations with attention 
bias, while I investigated interpretation bias. Third, parental interpretation biases 
were measured one year before child re-vaccination. Other external pressures 
could have come into play in this time, such as having encountered novel 
negative information about the child influenza vaccine. Side-effect perception 
may be less influenced by external pressures and circumstantial factors than re-
vaccination, explaining why an association between interpretation bias and side-
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effect perception was found. Fourth, circumstantial factors may have influenced 
re-vaccination, such as lack of the vaccine at the child’s general practice (179), 
the influence of one’s partner in the vaccination decision and other practicalities 
associated with taking the child to be vaccinated (see Chapter 2). Fifth, although 
power analyses indicated that I was well powered to detect medium effect sizes, 
there was an imbalance in numbers between those who did and did not re-
vaccinate their child (n=61 and n=11 respectively). It is also possible that parental 
interpretation bias exerted a small effect on re-vaccination behaviour, which I was 
unable to detect. 
6.3.1 Limitations 
Several limitations should be considered for this study. First, my sample may not 
be fully representative of the wider population of vaccinating parents. However, 
rates of side-effect perception identified in this study (43.2%) are close to those 
found in clinical trial data (47.9%) (77) and in the demographically representative 
survey presented in Chapter 5 (41.0%), suggesting that no major systematic bias 
exists with regards to my main outcome.  
Second, my sample was mostly made up of mothers and I cannot say whether 
these findings would hold in a population of fathers. 
Third, interpretation bias analyses were run on a subsection of the overall sample: 
those who completed the scrambled sentence task to levels which satisfied 
inclusion criteria. Female parents were more likely to be excluded from the 
analyses than male parents. Interpretation biases of parents completing the study, 
and those included in analyses, may not have been representative of interpretation 
biases held by the wider population. 
Fourth, not all potential predictors were measured at T1 due to time constraints as 
parents completed materials before their child’s vaccination appointment. 
However, only variables which should not change between time points, such as 
demographics and personality traits, were measured at T2. 
Fifth, it is possible that a child may have been vaccinated privately even if their 
vaccination record from the primary care clinic indicated that they had not been 
vaccinated in the 2017/18 influenza season. This seems unlikely, given that the 
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vaccination was available without cost through the primary care practice and at 
school. Nonetheless, to combat this risk, parents of all children who were eligible 
to receive the vaccine at school were contacted to ascertain their child’s vaccine 
status. 
Sixth, the study was powered to find medium effect sizes in ANOVA and logistic 
regression analyses, but it is possible that I failed to detect small size effects. In 
particular, interpretation bias analyses were underpowered. Few parents indicated 
that they did not definitely intend to re-vaccinate their child in 2017/18, or that 
they did not re-vaccinate their child in 2017/18, leading to an imbalance in group 
numbers and a resulting lack of power. Thus, the interpretation of some results 
should be taken with caution due to resulting wide confidence intervals.  
Finally, results should be interpreted with caution due to the large number of 
analyses run, which increases the likelihood of type 1 errors. 
6.3.2 Conclusions 
This study suggests that to decrease side-effect perception and recall, parental 
expectations of side-effects following vaccination should be minimised. By 
managing parents’ expectations about the incidence and severity of side-effects 
and by decreasing parental concern about side-effects, more parents may decide 
to re-vaccinate their child. There is some evidence that a tendency to interpret 
man-made health threats more negatively may also underlie parental perception 
of side-effects from vaccination. My results indicate that over one in six children 
were not re-vaccinated for influenza in the 2017/18 season, despite being 
vaccinated in 2016/17. While there was no evidence for a role of other 
psychological factors in child influenza re-vaccination, perhaps due to the year-
long gap between measurements, the effect of parental perception of severe side-
effects from vaccination and worry about side-effects persisted, negatively 
influencing re-vaccination. These results highlight the need to focus on 
minimising parental perception of, and worry about, vaccination side-effects to 
maintain vaccine uptake rates.   
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Chapter 7. General discussion 
Since its introduction to the UK vaccine schedule, low uptake of the child 
influenza vaccine means that the burden of influenza on healthcare services is still 
considerable. During the 2017/18 influenza season, 2.8% of all general practice 
consultations and 1.3% of all calls to NHS 111 in England were attributed to cold 
or influenza (59). In the UK, there were 372 deaths from laboratory-confirmed 
influenza in 2017/18, of which sixteen were children (59). Influenza vaccine 
history was available for six of these children; none had been vaccinated that year 
(59). The 2018/19 season has brought further initiatives to increase child 
influenza vaccine uptake. Parents of one child for whom influenza was fatal have 
started the social media campaign #ThumbsUpForCoby, which is supported by 
the Devon NHS Clinical Commissioning Group (456). Whether efforts are 
successful in increasing uptake remains to be seen. 
My thesis aimed to identify psychological factors associated with child influenza 
vaccination in England and with parental perception of side-effects from the 
vaccine. I was also interested in how the perception of side-effects and other 
psychological factors influenced re-vaccination rates in those vaccinated for 
influenza the previous year. In this chapter, I will summarise my hypotheses and 
whether they are supported, what we have learned and discuss my findings in the 
context of the wider literature. I will then consider the practical implications my 
findings have for public health and future research. 
 Overview of hypotheses and empirical support 
In Chapter 4, I outlined a number of hypotheses for factors associated with child 
influenza vaccine uptake, re-vaccination, and parental perception of side-effects. 
Table 25 summarises these hypotheses and outlines whether hypotheses were 
supported by studies in the thesis.  
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Table 25. Summary of and support for hypotheses 
Outcome Section Factor hypothesised to be related to 









4.1.1 Believe influenza was benign 
 
Supported 
4.1.2 Have negative beliefs and attitudes about 
vaccinations in general and the child 
influenza vaccine in particular 
Supported 
4.1.3 Interpretation bias. a. Source of health 
threat b. Subject of health threat 
a. Supported 
b. Not supported 










4.2.1 Perceived side-effects from vaccination T2 not supported. T3 
partially supported. 
4.2.2 Perceived more severe side-effects T2 partially 
supported. T3 not 
supported. 
4.2.3 Higher worry about side-effects perceived T2 partially 
supported. T3 
partially supported. 
4.2.4 Heard from healthcare worker in the 
vaccination appointment that the vaccine 
caused side-effects 
Not supported 
4.2.5 Thought the child was more sensitive to 
medicines after they had been vaccinated 
for influenza 
Not supported 
4.2.6 Had less trust in the healthcare worker 
after their child had been vaccinated for 
influenza 
Not supported 
4.2.7 Interpretation bias. a. Source of health 
threat b. Subject of health threat 
a. Not supported 
b. Not tested 
4.2.8 Parents who did not intend to re-vaccinate 
their child would be less likely to re-





4.3.1 Report symptoms in the child before 
vaccination 
Not supported 
4.3.2 Expect their child to develop side-effects 
from vaccination 
Supported 
4.3.3 Have negative beliefs about medicines Not supported 
4.3.4 Think their child was more sensitive to 
medicines 
T3 not supported. T3 
supported. 
4.3.5 Have increased modern health worries Not supported 
4.3.6 Believe influenza was benign  Not supported 
4.3.7 Have negative beliefs and attitudes about 
vaccinations in general and the child 
influenza vaccine in particular 
Not supported 
4.3.8 Have increased trait anxiety 
 
T2 not supported. T3 
supported. 
4.3.9 Have increased negative affect Not supported 
4.3.10 Have increased neuroticism Not supported 
4.3.11 Have increased pessimism T2 not supported. T3 
supported. 
4.3.12 Have decreased positive affect Not supported 
4.3.13 Have decreased optimism Not supported 
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4.3.14 Interpretation bias. a. Source of health 
threat b. Subject of health threat 
a. Partially supported  
b. Not supported 
4.3.15 Parental expectations might mediate the 
relationship between psychological 
predictors and parental perception of side-
effects 
T2 supported. T3 
partially supported. 
 
 Factors associated with child influenza vaccine uptake 
Factors associated with vaccine uptake have been well-researched (91, 93, 95, 
182, 270). However, my study was the first to investigate psychological factors 
associated with uptake of the child influenza vaccine since its introduction to the 
vaccine schedule in England. I investigated factors associated with vaccine 
uptake in the 2015/16 influenza season using a cross-sectional study. In my study 
52.8% of children were vaccinated (Chapter 5); similar to official national uptake 
rates for that year (57).  
Many theories of behaviour such as the health belief model, the theory of planned 
behaviour, the protection motivation theory and the health action process 
approach postulate that attitudes about perceived risks and benefits play a key 
role in uptake of health behaviours (87-89, 418). In line with my hypotheses 
(Hypothesis 4.1.1, Hypothesis 4.1.2), I found good evidence for a role of parental 
beliefs and attitudes in child influenza vaccination. In line with results from my 
systematic review of vaccine uptake (Chapter 2), I found that acceptance of the 
child influenza vaccine in 2015/16 was associated with believing that the vaccine 
was effective, that vaccination had been recommended by a health professional 
and that influenza was a serious illness in my cross-sectional study (Chapter 5). 
Vaccine refusal was associated with the belief that the vaccine could cause 
adverse effects, that the vaccination campaign was about making money for the 
manufacturers, and uncertainty-related beliefs such as feeling that you did not 
know enough about the vaccine (Chapter 5). Other surveys investigating beliefs 
about vaccine safety and efficacy, attitudes about vaccine mandates and 
exemptions, trust, mistrust of vaccine benefit, worries about unforeseen future 
effects, concerns about commercial profiteering, and preference for natural 
immunity (419, 457) have also found associations with child vaccination (135, 
419). My results are also in keeping with findings from other studies investigating 
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parental attitudes and child influenza vaccine uptake in the UK that have been 
published since I conducted the cross-sectional study (420, 421). 
My cross-sectional study was also the first to investigate the relationship between 
parental interpretation biases and child vaccination (Hypothesis 4.1.3). Parents 
who vaccinated their child in the 2015/16 influenza season tended to interpret 
naturally-occurring health threats more negatively and man-made health threats 
less negatively than those who did not vaccinate their child; this pattern was also 
seen for those who intended to vaccinate their child in 2016/17 (Chapter 5). These 
results are the first to indicate that there is an association between parental 
interpretation biases and vaccination behaviour, in line with research indicating 
that information processing biases are associated with the uptake of other public 
health behaviours (203-206, 208). Interpretation biases mirror factors consistently 
associated with vaccination refusal, namely the perception that the vaccine causes 
adverse effects and the benign appraisal of the illness (Chapter 2). Biases in threat 
appraisal may therefore exist at the information processing level, acting as an 
underlying mechanism influencing child vaccination.  
I also investigated parental interpretation biases pertaining to the subject of the 
health threat (self- or child-relevant) in relation to vaccine uptake, finding no 
evidence for an association (Hypothesis 4.1.3). Although there was a slight 
tendency for parents who had vaccinated their child for influenza in 2015/16 and 
who intended to vaccinate their child in 2016/17 to interpret threats to their 
child’s health more negatively than those who did not, this difference was not 
statistically significant. My study was the first to investigate the association 
between parental interpretation biases for health threats in the child’s 
environment and uptake of a health behaviour. Previous research aimed to 
investigate whether parents showed biased interpretation in ambiguous situations 
involving their child, rather than themselves (198-200). 
There was good evidence for my hypothesis that previous influenza vaccination 
would be associated with child influenza vaccine uptake in 2015/16 (Hypothesis 
4.1.4, Chapter 5). Previous vaccination has been identified as a strong predictor of 
current vaccination in the literature (93, 182, 270).  
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I also used the cross-sectional study to explore whether parent or child personal 
or clinical characteristics were associated with child influenza vaccine uptake in 
2015/16. I found no evidence for associations between vaccine uptake and parent 
or child personal or clinical characteristics. Since having conducted the cross-
sectional study, another study has investigated personal characteristics associated 
with child influenza vaccine uptake in England and Wales (458). This study 
investigated factors associated with vaccine uptake in the 2014/15 season, finding 
that children were more likely to be vaccinated if they were: aged two compared 
to those aged four; and in a clinical risk group compared to those not in a clinical 
risk group. This study had a larger sample size than mine (n=57,545) and would 
have had greater power to detect small effects than I did. 
 Factors associated with re-vaccination in those who had 
already received the child influenza vaccine 
My prospective cohort study sample was made up of parents who had already 
chosen to vaccinate their child for influenza in the 2016/17 influenza season; as 
such I was unable to investigate vaccine uptake rates. Instead, I used this study to 
investigate rates of intended re-vaccination for 2017/18 and actual re-vaccination 
in 2017/18. In this sample, 16.4% of parents indicated that they did not definitely 
intend to re-vaccinate their child in 2017/18, with 17.7% actually not re-
vaccinating their child. These are the first estimates of re-vaccination rates for the 
child influenza vaccine in England. This is surprising in itself. While a focus on 
getting parents to engage with the vaccination programme in the first place is 
clearly important, understanding why some subsequently fail to re-vaccinate their 
child as requested is also important. My finding that over one in six children are 
not re-vaccinated makes this especially true. 
Despite the central role that intention plays in many theories of behaviour (88, 89, 
418), I found no evidence that re-vaccination intention for 2017/18 was 
associated with re-vaccination in 2017/18 (Hypothesis 4.2.8, Chapter 6). One 
possible explanation for this is that few participants who indicated that they did 
not definitely intend to re-vaccinate their child also indicated that they had not re-
vaccinated their child, leading to a small cell count. Consequently, this analysis 
lacked power, meaning that I was unable to detect anything other than relatively 
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large effects. While this remains the most likely reason for not finding an 
association between re-vaccination intention and re-vaccination behaviour, other 
factors may also have played a role. For example, practical considerations, such 
as the child being ill on the day of vaccination, or vaccine shortages (179) may 
have been influential in child influenza re-vaccination, limiting the potential 
impact of psychological factors. In my study, there was a tendency for children 
originally vaccinated at their general practice surgery in 2016/17 to be re-
vaccinated at school in 2017/18. This was partly as a result of children reaching 
school age between the two time points and partly because of changes to official 
recommendations in the 2017/18 influenza season, stating that children aged four 
be vaccinated at school rather than at their primary care practice (55, 459). This 
may also have reduced the impact of intention in my study.  
The perceived risk of potential adverse effects from vaccination is one of the 
factors most consistently associated with vaccination refusal (91, 93, 95, 270). 
But do parents still decide to have their child vaccinated for influenza after 
having perceived side-effects from previous influenza vaccinations (Hypothesis 
4.2.1)? I found evidence that having perceived side-effects from the influenza 
vaccine lowers parents’ intentions to re-vaccinate their child in the following 
season, but does not affect actual re-vaccination rates. In my cross-sectional 
study, parents who had vaccinated their child in the 2015/16 influenza season 
were asked whether they had perceived side-effects from vaccination or not. 
Those who had perceived side-effects showed decreased re-vaccination intention 
for the 2016/17 season compared to those who had not perceived side-effects 
(Chapter 5). Longitudinal evidence from my prospective cohort study indicated 
that reporting side-effects one month, but not three days, after vaccination in 
2016/17 was associated with not definitely intending to re-vaccinate in 2017/18 
(Chapter 6). I found no evidence for an association between parental perception 
of side-effects either three days or one month after vaccination and actual re-
vaccination in 2017/18 (Chapter 6).  
While side-effect perception alone may not have impacted re-vaccination 
behaviour, I found evidence that emotion-related variables such as worry about 
side-effects and perceived severity of side-effects were associated with not 
intending to re-vaccinate and re-vaccination refusal (Hypothesis 4.2.2, 
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Hypothesis 4.2.3, Chapter 5, Chapter 6). Perceived severity of side-effects may 
impact vaccine uptake through worry, with those who perceive more severe side-
effects being more worried about them. My findings are in line with research 
indicating that vaccine uptake may be more strongly associated with emotion-
related variables, such as perceived responsibility and anticipated regret, than 
variables which are associated with beliefs about the probability of benefits and 
risks of vaccination (460, 461). However, results should be taken with caution as 
perceived severity of side-effects three days after vaccination, and worry about 
side-effects one month after vaccination were no longer significantly associated 
with re-vaccination in 2017/18 when taking into account the effect of clustering 
by primary care practice. 
I hypothesised that a suggestion from the healthcare worker in the vaccination 
appointment that the vaccine caused side-effects would be associated with 
reduced intention to re-vaccinate and re-vaccination refusal (Hypothesis 4.2.4). I 
found no evidence to support this hypothesis. Contrary to my hypothesis, I found 
that when taking into account parental trust in the healthcare worker, suggestion 
of side-effects was associated with increased re-vaccination intention for 2017/18 
(Chapter 6). One speculative explanation for this is that parents who trusted 
healthcare workers may have felt more fully informed about the potential adverse 
effects of vaccination and were therefore more inclined to intend to re-vaccinate 
their child.  
As perceived sensitivity to medicines and trust in healthcare workers have been 
associated with medication adherence (430, 431), I investigated whether changes 
in parents’ perceptions of their child’s sensitivity to medicines and trust in 
healthcare workers following vaccination in the 2016/17 season were associated 
with re-vaccination in 2017/18 (Hypothesis 4.2.5, Hypothesis 4.2.6). I found no 
evidence for either of these hypotheses. One important difference between 
medication adherence studies and my prospective cohort study may explain this. 
Medication adherence is usually investigated in populations which take a certain 
medication daily for a chronic condition, for example diabetes, whereas child 
influenza vaccination is a single behaviour completed once a year. Perceived 
sensitivity to medicines and trust in healthcare workers may affect habitual 
medication uptake more strongly than one-off vaccination behaviours. 
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In contrast to my finding that vaccination was associated with parental 
interpretation biases pertaining to the source of the health threat in the cross-
sectional study (Chapter 5), I found no evidence that interpretation bias was 
associated with intended or actual re-vaccination in my prospective cohort study 
(Hypothesis 4.2.7, Chapter 6). Multiple reasons might explain this finding. First, 
the year-long gap between measuring interpretation bias and re-vaccination might 
mean that parental interpretation biases and resulting behaviour had changed in 
this time. Second, practical aspects affecting re-vaccination behaviour may have 
masked the effect of interpretation biases on re-vaccination. Third, my 
prospective cohort study had a restricted sample compared to my cross-sectional 
study, being made up of parents who had already vaccinated their child in the 
2016/17 influenza season. Fourth, parental interpretation biases only exerted a 
small effect on vaccination in my cross-sectional study (Chapter 5). My cohort 
study had weaker power to detect effects than my cross-sectional study (Chapter 
5, Chapter 6). Thus, it is possible that I failed to detect small effects exerted by 
parental interpretation biases on re-vaccination in my prospective cohort study. 
I did not investigate interpretation biases pertaining to the subject of the health 
threat (self- or child-relevant) in my prospective cohort study. This was due to the 
smaller number of participants included in the study compared to the cross-
sectional study. Investigating the influence of biases pertaining to both the source 
and subject of the health threat would have resulted in fewer participants in each 
group and further decreased power to detect associations. The lack of evidence 
for associations between bias pertaining to the source of the health threat and any 
outcome measure in my cross-sectional study (Chapter 5) suggests that it would 
be unlikely that I would have found any significant associations had I investigated 
bias pertaining to the subject of the health threat in the prospective cohort study.  
I found little evidence that parent or child personal and clinical characteristics 
were associated with re-vaccination. Only parent age was associated with re-
vaccination intention and behaviour, with parents aged thirty-five to forty-four 
years being more likely to re-vaccinate their child compared to those aged 
eighteen to thirty-four years. However, these results should be taken with caution 
as analyses were likely to lack power due to small cell counts. Child personal and 
clinical characteristics have been investigated with relation to child influenza 
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vaccine uptake in the UK, however, parental factors have not been investigated 
(62, 458). This is surprising given that parents make the decision as to whether to 
vaccinate their child and would ultimately be the target of vaccine 
communications or interventions to increase vaccine uptake. 
 Factors associated with parental perception of side-effects 
from the child influenza vaccine 
Although symptoms were once thought to be linearly related to pathology, there 
is now good evidence for the role of psychological factors in subjective symptom 
perception (227, 228). However, the influence of psychosocial factors on parental 
perception of symptoms in one’s child have been poorly investigated (Chapter 3). 
Research into the provenance of parental perception of side-effects from 
vaccination may provide a novel approach for communications and interventions 
aiming to increase vaccination uptake. 
Clinical trial data indicate that approximately 40% to 50% of children vaccinated 
with Fluenz Tetra will report side-effects (77, 78). I observed similar rates of 
side-effect perception in my studies, with 52.8% parents reporting side-effects in 
my cross-sectional study (Chapter 5) and 43.2% reporting side-effects three days 
after vaccination in my cohort study (Chapter 6). Recall of side-effects 
diminished over time, with 36.0% parents reporting that their child experienced 
side-effects when asked one month after vaccination (Chapter 6).  
I used a cross-sectional study (Chapter 5) and a prospective cohort study (Chapter 
6) to investigate factors associated with parental perception of side-effects from 
the child influenza vaccine. A limitation of the cross-sectional study is that I was 
unable to determine the causal direction of the associations between 
psychological factors and parental perception of side-effects. The strength of 
prospective longitudinal evidence over retrospective cross-sectional evidence has 
been considered when discussing psychological factors associated with parental 
side-effect perception. 
The strongest predictor of parental perception of side-effects in my prospective 
cohort study, both three days and one month after vaccination, was the pre-
vaccination expectation that the child would develop side-effects (Chapter 6, 
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Hypothesis 4.3.2). The role of expectation has been well-researched in subjective 
symptom perception, and there is good evidence that heightened expectations can 
cause symptoms through the nocebo response (219, 220). Symptom expectation 
has also been associated with perception of side-effects from medication (236, 
250-252). However, to the best of my knowledge, no other studies have 
investigated the effect of expectation in perception of symptoms in someone other 
than oneself. While it is unlikely that parental expectations influence child side-
effect experience, heightened pre-vaccination expectations may increase the 
likelihood of parents detecting and reporting side-effects. As symptom 
expectations are thought to arise in part from prior symptom experience (237, 
264, 462), the potential for a vicious cycle exists here. The expectation that the 
vaccine causes side-effects may heighten perception of side-effects, which in turn 
may further strengthen the expectation that the vaccine causes side-effects.  
Not only was parental expectation associated with side-effect perception, it also 
mediated the relationship between certain other psychological factors and 
parental perception of side-effects (Hypothesis 4.3.15). The effect of verbal 
suggestions of side-effects from the media and the NHS vaccination leaflet on 
side-effect perception three days after vaccination was mediated by expectation, 
as was the effect of parents’ perceptions of their child’s sensitivity to medicines 
before vaccination and side-effect perception one month after vaccination 
(Chapter 6). These results imply that a suggestion of symptoms, and heightened 
perceived vulnerability to symptoms, influence symptom expectations. Previous 
research has established that verbal suggestions of symptoms and increased 
perceived sensitivity to medicines are associated with increased subjective 
symptom perception (249, 254, 275, 276, 384), most likely as a result of the 
nocebo effect. However, my research is the first to indicate that the nocebo-like 
phenomenon can occur in someone other than oneself, with expectation 
influencing symptoms perceived in others.   
Another factor implicated in parental perception of side-effects is parental anxiety 
(Chapter 3). Although other studies have found an association between parental 
anxiety and perception of symptoms in the child, these studies investigated 
parental perception of somatic complaints (373) and pain (352, 353, 367, 370-
372) in the child. My prospective cohort study was the first to investigate the 
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effect of parental psychological traits on perception of vaccination side-effects in 
the child. I found evidence for an association between parental anxiety and side-
effect perception at one month, but not three days, after vaccination (Chapter 6, 
Hypothesis 4.3.8). There is some evidence that anxious individuals are less likely 
to endorse the belief that vaccination is safe (463). This may bring about parental 
perception of side-effects by increasing expectations that the vaccine causes side-
effects. As well as increasing parental detection and reporting of symptoms, 
parental anxiety may also have increased child symptom experience as a result of 
parental modelling and reinforcement of symptomatic behaviour and child 
predisposition to manifest symptoms in the presence of stressors, as well as 
increased (367, 371-373). 
There was little evidence for a role of other parental psychological traits in side-
effect perception (Hypothesis 4.3.9, Hypothesis 4.3.10, Hypothesis 4.3.12, 
Hypothesis 4.3.13, Chapter 6). This mirrors findings from my systematic review 
of psychological factors associated with parental symptom perception (Chapter 
3). The only exception was the association between pessimism and increased 
side-effect perception one month, but not three days, after vaccination 
(Hypothesis 4.3.11, Chapter 6). This finding is in line with research indicating 
that pessimism is associated with the nocebo response (306) and that pessimism 
is more strongly associated with symptom recall than immediate symptom 
perception (464). 
Parental interpretation biases may also be implicated in the perception of side-
effects, with biases pertaining to the source of the health threat (man-made or 
naturally-occurring) being particularly influential (Hypothesis 4.3.14). I found 
some evidence for an association between parental interpretation biases and side-
effect perception in my prospective cohort study (Chapter 6). While parents who 
did not report side-effects one month after vaccination interpreted man-made 
health threats more positively than naturally-occurring health threats, parents who 
did report side-effects interpreted man-made and naturally-occurring health 
threats as equally negative (Chapter 6). These results suggest that a tendency to 
interpret man-made health threats negatively is associated with parental 
perception of side-effects. There was no association between bias and side-effect 
perception three days after vaccination (Chapter 6). Therefore, negative biases for 
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man-made health threats may be particularly influential in parental recall of side-
effects from vaccination. It was notable that the results of the larger cross-
sectional study did not support an association between interpretation biases and 
side-effect perception (Chapter 5). 
Interpretation biases pertaining to the source of the health threat, in particular 
man-made health threats, are consistent with factors in the wider literature which 
have been found to be associated with symptom perception. Interpretation biases 
are thought to cause and maintain worry (449) and there is good evidence that 
worry about man-made health threats is associated with symptom perception in 
oneself (278-281) and one’s child (248). This lends support to the notion that 
threat appraisal may be influenced by underlying information processing biases, 
acting as a mechanism underlying parental side-effect perception. However, 
further research is needed to substantiate this theory.  
General beliefs and attitudes may also play a role in parental side-effect 
perception (Hypothesis 4.3.6, Hypothesis 4.3.7). To the best of my knowledge, no 
other studies have investigated the association between parental beliefs and 
attitudes and symptom perception in the child (Chapter 3). I found evidence in my 
cross-sectional study that uncertainty-related beliefs, such as believing the 
vaccine had not been tested enough and feeling that you did not know enough 
about the vaccine, were associated with parental side-effect perception (Chapter 
5). I also found evidence in my prospective cohort study that feeling that you did 
not know enough about the vaccine was associated with recalling side-effects 
from the child influenza vaccine one month after vaccination (Chapter 6). While I 
investigated associations between other beliefs and attitudes and parental side-
effect perception in my prospective cohort study, data were skewed, leading to 
small cell counts. Thus, results should be interpreted with caution. My research 
did not directly test how uncertainty-related beliefs may lead to increased 
symptom reporting. However, it is possible that in uncertain or ambiguous 
situations, there is more scope for parents’ pre-existing biases to come into play. 
Given the tendency for parents to view man-made health threats negatively, and 
the association between negative interpretation bias and parental perception of 
side-effects (Chapter 5, Chapter 6), this may lead to increased detection of 
vaccine side-effects. Other beliefs and attitudes were also associated with side-
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effect perception in my cross-sectional study (Chapter 5) but not my prospective 
cohort study (Chapter 6). Thus, evidence for their role in parental side-effect 
perception is weaker and I have not discussed them in detail here. 
I also investigated whether beliefs about medicines, perceived sensitivity to 
medicines and worries about aspects of modern life and their impact on health 
were associated with parental symptom perception (Hypothesis 4.3.3, Hypothesis 
4.3.4, Hypothesis 4.3.5). In line with findings that increased perceived sensitivity 
to medicines was associated with subjective symptom perception following 
vaccination (249, 276), parents who thought their child was more sensitive to 
medicines were more likely to report perceiving side-effects one month after 
vaccination (Chapter 6). I found no evidence for a role of general negative beliefs 
about the harm and overuse of medicines in parental side-effect perception, 
despite other research finding an association with increased side-effect 
expectations from a hypothetical medication (272). I also found no evidence for 
an association between modern health worries and parental side-effect perception 
(Chapter 6), despite research suggesting that modern health worries are associated 
with subjective symptom reporting in everyday life (278-281) and following an 
exposure (247, 248). This pattern of results suggests that vaccine-specific beliefs 
and attitudes are more influential in parental perception of side-effects from 
vaccination than general medication beliefs. 
The misattribution of existing symptoms has been associated with experiencing 
symptoms from a sham medication (220) and perceiving side-effects in oneself 
immediately following a travel vaccination (249). However, I found no evidence 
that parents who reported symptoms in their child immediately before vaccination 
were more likely to perceive side-effects from the child influenza vaccine 
(Chapter 6, Hypothesis 4.3.1). One recent randomised-controlled trial also found 
no evidence for an association between pre-existing symptoms and attribution of 
symptoms to a sham medication after controlling for medication beliefs and 
perceived sensitivity to medicines (465). Therefore, vaccine-specific beliefs and 
attitudes may play a more important role in parental perception of side-effects 
from vaccination than misattribution of existing symptoms. 
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I also used the prospective cohort study to investigate whether parents’ 
perceptions of how sensitive their child was to medicines and their trust in 
healthcare workers changed after vaccinating their child for influenza. In 
particular, parents who perceived side-effects from vaccination might have 
thought their child was more sensitive to medicines and had less trust in 
healthcare workers. While parents’ perceptions of how sensitive their child was to 
medicines did increase after perceiving side-effects from vaccination, there was 
no effect on parental trust in healthcare workers (Chapter 6). However, results 
should be taken with caution as this association was no longer significant when 
taking into account the effect of clustering by primary care. If associated, the 
potential for a vicious circle could exist here, with parents who believe their child 
is more sensitive to medicines, perceiving more side-effects in their child, which 
further heightens their perception of how sensitive their child is to medicines. 
Although not a central aim of this thesis, I also investigated whether parent or 
child personal and clinical characteristics were associated with parental 
perception of side-effects from vaccination. Contrary to previous research which 
indicates that females are more likely to perceive symptoms in themselves than 
males (269, 297, 302, 331), I found that female parents were less likely to report 
side-effects in their child than males in my cross-sectional study (Chapter 5). A 
comprehensive systematic review of factors associated with the nocebo effect 
found ‘very little’ evidence for the role of gender in the nocebo effect (220), and 
research published since has suggested that males may be more likely to perceive 
symptoms from sham medications (465). I found no evidence for an association 
between parent gender and parental side-effect perception in my prospective 
cohort study (Chapter 6). To the best of my knowledge only one other study has 
investigated the effect of parent gender on parental side-effect perception from 
vaccination, also finding no association (466, 467).  
I also found evidence in my prospective cohort study that parents were more 
likely to perceive side-effects in their male child, rather than female child, one 
month after vaccination (Chapter 6). It is not clear why this was. There was no 
evidence for an association between child gender and parental perception of side-
effects three days after vaccination (Chapter 6) or in my cross-sectional study 
(Chapter 5). Whether these findings are replicable remains to be seen. 
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Previous studies indicate that parents who have a history of, or who are currently 
experiencing, similar symptoms to those being investigated in their child report 
increased perception of symptoms in their child (344, 355, 373, 468-470). 
Likewise, parents who think their child has previously experienced symptoms are 
also more likely to perceive symptoms in their child (344, 350, 351, 355, 370-
372). I found evidence for an association between child chronic illness and 
parental side-effect perception in my cross-sectional study (Chapter 5), but not 
my prospective cohort study (Chapter 6). The lack of evidence for an association 
in my study could be due to the mild and transitory nature of side-effects from the 
child influenza vaccine (73), compared to the more chronic nature of the 
symptoms investigated in the previous literature. Increased parental perception of 
side-effects in children with chronic illnesses may be due to the parental 
perception that the child is vulnerable. In line with this notion, I also found 
evidence that parents of first-born children were more likely to perceive side-
effects from the child influenza vaccine (Chapter 5). However, I found no 
evidence for this association in my prospective cohort study (Chapter 6).  
I also found evidence in my cross-sectional study that older parents were less 
likely to perceive side-effects in their child (Chapter 5); I found no evidence for 
this association in my prospective cohort study (Chapter 6). Older parents may be 
more likely to have had other, older children and so may have been less likely to 
perceive side-effects from vaccination in the index child. Other studies have also 
found no association between parent age and symptom perception (355, 357, 358, 
361).  
7.4.1 A model of parental perception of symptoms 
There is good evidence that psychological factors influence parental perception of 
side-effects from vaccination. While multiple models exist which attempt to 
describe subjective symptom perception (233), there are no models describing 
symptom perception in others. This is probably due to the dearth of research and 
lack of comprehensive reviews investigating factors associated with symptom 
perception in someone other than oneself. However, the ability to perceive 
symptoms in others has important consequences, particularly for parents who are 
in charge of treatment decisions for their child. With this in mind, I have 
proposed a model of parental symptom perception based on research investigating 
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symptom perception in one’s child and oneself (see Figure 10). Factors that I did 
not investigate in my theses are outlined using dotted lines. 
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Figure 10. Model of parental symptom perception 
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For parents to perceive symptoms in their child, they must attend to their child’s 
behaviour and interpret behavioural cues as the child experiencing a symptom. 
This can occur in the presence or absence of an exposure such as vaccination. If 
and how a child expresses that they are experiencing a physical symptom may 
depend on the child’s psychosocial characteristics, such as their temperament. A 
child’s ability to verbalise their bodily sensations will also depend on their age 
and health status. 
Expectation is likely to play a key role in parental perception of symptoms, 
directly influencing parental symptom perception as well as parental cognitive 
processes. Expectation could arise from receiving verbal suggestions that 
symptoms are likely, seeing others experiencing symptoms in the same or similar 
situations, or having previously experienced symptoms in the same or similar 
situations.  
While trait negativity has been implicated in models of subjective symptom 
perception (233), my research found that parental anxiety played a stronger role 
in symptom perception in one’s child than trait negativity (Chapter 3, Chapter 6). 
Anxiety is associated with increased attention to negative stimuli (471) and 
negative interpretations of information (472). It is therefore likely that parental 
anxiety is associated with parental cognitive processing of the child’s behaviour. 
Parents’ reactions to a symptom, for example seeking help from a medical 
practitioner, are likely to be modified by a range of factors which influence 
behaviour change, such as capability, opportunity and motivation described by 
the behaviour change wheel (473). For example, a parent may be less likely to 
seek help if they are ill themselves and so lack the ability to take their child to 
visit a health professional (capability); if they do not have access to a mode of 
transport to take their child to visit a health professional (opportunity); or if they 
do not foresee any positive impact of taking their child to visit a health 
professional (motivation). Increased worry may also influence help-seeking 
behaviour. Parental behaviour, such as giving the child medication or seeking 
medical attention, may bring about further changes in the child’s behaviour and 
self-report of symptoms.  
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Parent and child personal and clinical characteristics may affect parental 
symptom perception at all stages of the process. For example, parents may feel 
that their young child or first child is more vulnerable to illness, causing parents 
to selectively attend to their child’s behaviour and interpret cues as indicative of 
physical symptoms. Clinical characteristics, such as a history of symptoms in the 
parent (344, 373, 468) or child (344, 370-372) are also associated with increased 
symptom perception. Parent or child history of a symptom may increase parental 
symptom expectation, increasing attention to indicators of that symptom and 
causing parents to interpret cues as the presence of that symptom.  
To the best of my knowledge, this is the first model describing parental symptom 
perception. It could also be extended to symptom perception in others more 
generally. One key difference to models of subjective symptom perception is that 
in oneself, a bodily sensation interpreted as a symptom may cause anxiety or 
stress, which may cause further bodily sensations such as an increased heart rate 
or sweaty palms. These sensations would then be interpreted as further signs of 
illness (235). In parental symptom perception, this physiological feedback cannot 
exist as information about child symptoms comes from external cues. 
 Implications and recommendations 
As we have seen, psychological factors are associated with child vaccine uptake 
and parental perception of side-effects from vaccination. But what are the 
ramifications of these findings? Based on the results of my thesis and the wider 
literature I have made several recommendations for vaccine communications and 
future research.  
The recommendations I have made are specific to the child influenza vaccine, but 
many could generalise for use in communications and research about other 
vaccines. However, care needs to be taken when extrapolating guidance to other 
vaccines, to ensure that nuances relevant to individual vaccinations are taken into 
account. For example, whether the media furore over MMR in recent years (474, 
475) or the peculiarities of the HPV vaccination, with parental concerns 
influenced by complex underlying attitudes towards sex (476), require a 
qualitatively different approach is unclear.  
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7.5.1 Perception of adverse effects from vaccination 
Public health communications and interventions aim to increase vaccine uptake. 
To be maximally effective, messages to parents should target perceptions that are 
both amenable to change and strongly associated with vaccine uptake. Evidence 
from my systematic review of factors affecting vaccine uptake in young children 
(Chapter 2) and cross-sectional study (Chapter 5) indicated that parental 
perception that a vaccine causes adverse effects and parental fear or concern 
about potential adverse effects was strongly associated with vaccination uptake. 
My results highlight the importance that parents place on perceiving side-effects 
from vaccination and demonstrate that the perception of side-effects is susceptible 
to influence from psychological factors. By reducing parental perception of side-
effects from vaccination, vaccination intention and initial uptake may increase. 
This is a novel target for public health communications and vaccine intervention 
research.  
I investigated associations between psychological factors and parental perception 
of side-effects in my cross-sectional (Chapter 5) and prospective cohort study 
(Chapter 6). Parents’ pre-vaccination expectations that the vaccine would cause 
side-effects were strongly associated with later perception of side-effects in my 
prospective cohort study (Chapter 6); I did not investigate this factor in my cross-
sectional study. My results suggest that parental perception of side-effects could 
be reduced by decreasing parental expectations that the vaccine causes side-
effects (Chapter 6). Mediation analyses indicated that suggestion of side-effects 
from the media and the NHS vaccination leaflet affected parental perception of 
side-effects through expectations (Chapter 6). Therefore, parents’ side-effect 
expectations could be minimised by decreasing the suggestion that the vaccine 
causes side-effects in information disseminated by influential sources, such as the 
NHS vaccination leaflet. Despite their obligation to inform patients about adverse 
effects of medication, these sources should aim to minimise their suggestion of 
the incidence of side-effects as much as possible. Although the ethical 
implications of decreasing parental expectations of side-effects need to be 
considered, so too do the implications of causing parents to consistently 
overestimate the likelihood of side-effects from vaccination.  
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I investigated how current phrasing used in vaccine communications was 
understood by a nationally-representative sample of 1001 parents of children 
eligible for the child influenza vaccine (Chapter 5). In line with other research 
(272), I found that current phrasing describing the incidence of side-effects from 
vaccination was associated with substantial overestimation of the likelihood of 
side-effects (Chapter 5). Overestimation of the incidence of side-effects likely 
impacts treatment decisions and medicine adherence (402, 403) as well as causing 
unnecessary symptoms through the nocebo phenomenon (220). Changing how 
side-effect information from influential sources, such as the NHS vaccination 
leaflet, is presented might bring parental expectations in line with more accurate 
estimates of the incidence of side-effects.  
While there is good evidence that worry about side-effects is associated with 
initial vaccine uptake (91, 93)(Chapter, 2, Chapter 5), I also investigated the 
implications of parental perception of side-effects from the child influenza 
vaccine on intended and actual re-vaccination in my cross-sectional study 
(Chapter 5; only intention investigated) and prospective cohort study (Chapter 6; 
intention and uptake investigated). There was some evidence that parental 
perception of side-effects, increasing severity of side-effects perceived and worry 
about side-effects was negatively associated with re-vaccination intention 
(Chapter 5, Chapter 6) and actual re-vaccination behaviour (Chapter 6). 
Therefore, providing reassurance to parents about the typically transitory and 
non-harmful nature of side-effects (73) may be a useful strategy in increasing 
initial vaccine uptake, as well as potentially reducing long-term attrition among 
parents who have previously vaccinated their child. However, results should be 
taken with caution as there was no longer a significant association with actual re-
vaccination when accounting for clustering by primary care practice (Chapter 6). 
In spite of this, due to the wide-scale nature of the child influenza vaccine 
programme, if a factor exerts even a small positive effect on vaccination intention 
or uptake, this could have greater consequences on a nationwide scale.  
One way to reduce side-effect expectations could be to make subtle changes to 
the wording of side-effect information in patient information leaflets for 
vaccinations and other official vaccine communications. Positive framing of side-
effect information has been shown to successfully decrease side-effect 
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expectations and experience. For example, one study aiming to increase influenza 
vaccine uptake in ‘at risk’ adults who had never previously been vaccinated, 
investigated the effect of framing side-effect information positively, as the 
percentage of people who did not experience side-effects from vaccination and 
remained influenza free, or negatively, as the percentage of people who did 
experience side-effects from vaccination and who went on to experience 
influenza (477). Although there was no difference in rates of uptake, those in the 
positive framing condition had more realistic, lower expectations of vaccine side-
effects and experienced fewer side-effects (477). Another recent randomised-
controlled trial also found that fewer participants attributed side-effects to a sham 
medication when side-effect information was framed positively in the patient 
information leaflet (478). There was no scope to investigate the effect of positive 
framing on uptake of the child influenza vaccine in the studies included in the 
thesis. Using results from the thesis, this could be a next step for research aiming 
to increase uptake of the child influenza vaccine.  
One issue worth noting is that adding more information about vaccine side-effects 
to vaccine communications may raise parents’ expectations that the vaccine 
causes side-effects. However, if the addition is short and does not talk about the 
incidence of side-effects, or replaces redundant text currently being used, it 
should not raise parental expectations. The ‘protecting your child against flu’ 
vaccine leaflet currently states that ‘children may develop a runny or blocked 
nose, headache, general tiredness and some loss of appetite. However, these are 
much less serious than developing flu or complications associated with flu’ (479). 
This does not give parents an indication of how long side-effects may last, nor 
does it tell parents that vaccine side-effects are usually harmless. Information 
published online by the NHS states that the side-effects ‘linked with the flu nasal 
spray vaccine are almost always mild and short-lived’ (401). This sentence could 
be added to the ‘protecting your child against flu’ leaflet, while the sentence 
comparing the severity of symptoms from influenza and the vaccine could be 
removed. 
Altering how side-effects are framed in the patient information leaflet and 
communications by Public Health England and the NHS could be an easy, 
effective and far-reaching way of reducing parental expectations about side-
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effects from vaccination and later perception of side-effects from vaccination. 
There would be no cost implications of altering side-effect information (478) and 
this intervention would be in line with recent legislation stating that all potential 
risks from medications should be disclosed to patients (480). Research also 
indicates that leaflets which employ positive framing of side-effects are as 
credible as those which are negatively framed (478).  
7.5.2 General beliefs and attitudes 
Very little research has focused on comparing the efficacy of messages to 
determine which are most beneficial in increasing vaccine uptake (179). Where 
studies do exist, outcomes are often proxy measures such as vaccination intention 
or attitudes, rather than vaccine uptake (179, 481). A recent review of the 
literature on vaccine interventions found that interventions which induced more 
positive vaccine beliefs; influenced social norms associated with vaccination; and 
reduced barriers to motivation and facilitated actions through reminders and 
prompts, increased vaccine uptake (179). These map on to theoretical constructs 
of attitudes, subjective norms and perceived behavioural control which are 
thought to underpin health behaviours (87, 88, 418). Multiple negative vaccine 
beliefs and attitudes were associated with vaccine uptake in my cross-sectional 
study (Chapter 5), suggesting them as possible targets for future vaccine 
communications and intervention research. As this study was conducted on a 
sample of nationally-representative parents of children eligible for the child 
influenza vaccine, the strength of the evidence is good. However, due to the 
cross-sectional and retrospective nature of the study, I am unable to conclude 
whether there is a causal influence of parental beliefs and attitudes on vaccine 
uptake. 
Beliefs which exerted strong effects on vaccine uptake included feeling that the 
vaccine was safe and effective (Chapter 5); communications could promote these 
beliefs. This may be easier said than done, however. The term ‘vaccine 
effectiveness’ is poorly understood, with only 19% of parents correctly 
interpreting the meaning of the hypothetical statement that the ‘child flu vaccine 
is 50% effective’ (Chapter 5). Vaccine effectiveness should be more clearly 
described in communications. Communications should explain that the 
effectiveness of the vaccine is related to their child’s risk of catching influenza. 
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For example, communications could state that ‘everyone’s individual risk of 
catching flu varies depending on many different factors. The effectiveness of the 
vaccine relates to how much the risk of your child catching flu is reduced after 
they are vaccinated.’ Pictograms could be used to help illustrate this case further 
(482). 
One finding from my systematic review of factors associated with vaccine uptake 
was that vaccination was more often associated with parents’ perception of how 
susceptible their child was to the illness (nine of twelve studies found), than with 
how severe parents thought the illness would be for the child (five of fifteen 
studies found; Chapter 2). This indicates that future communications should focus 
on children’s susceptibility to the illness over illness severity. In my cross-
sectional study, I also found evidence that parents who believed that their child 
was susceptible to influenza or that influenza would be a serious illness for their 
child were more likely to have vaccinated their child in 2015/16 and to intend to 
vaccinate their child in the 2016/17 influenza season (Chapter 5). The current 
2018/19 ‘protecting your child against flu’ leaflet does not mention that children 
are susceptible to influenza (479). Instead it states that ‘having the vaccine will 
help protect your child from what can be a very nasty illness in children. Children 
under the age of five have the highest rate of hospital admissions due to flu’ 
(479). Based on my work, adding a sentence that states that ‘children have a high 
risk of catching flu as they come into contact with lots of people each day and 
have poor hand hygiene’ may be warranted. 
Efforts must be made to ensure that interventions are easily accessible to the 
general population, for example using simple language. Easily implementable 
interventions, such as changing the wording of existing information and 
communications about vaccination, are likely to be particularly attractive options. 
Recently, there has been a rise in interventions delivered through mobile phones 
(mHealth) and the internet (eHealth). These are likely to be particularly good 
targets for vaccine interventions as they are accessible to most, with 85% adults 
in the UK owning a smartphone (483). Electronic interventions also have the 
added benefit of being able to tailor messages based on parents’ specific concerns 
about vaccination. Systematic review evidence indicates that media such as 
mobile phone applications have great potential for improving vaccination uptake 
 211 
 
(484). While not it was not in the scope of this thesis to investigate the influence 
of interventions, electronic or otherwise, on vaccine uptake and parental side-
effect perception, this could be a direction for future research. 
Social media might also be a particularly important target for novel interventions. 
One recent study compared the use of a website with vaccine information, a 
website with vaccine information plus additional interactive social media 
components and usual care on parental attitudes about vaccination and vaccine 
uptake for a number of routine child vaccinations, not including influenza (485, 
486). Parents who were vaccine hesitant during pregnancy and who were 
assigned to either website condition showed a significant amelioration of vaccine 
attitudes compared to usual care (485). Children of parents assigned to use the 
website with the additional interactive social media component were more likely 
to be vaccinated on time and to be up-to-date on their vaccines at age 200 days 
compared to usual care; there was no evidence for an effect in children of parents 
who used the vaccine website with no additional social media component (486). 
Interventions which make use of social media may work by influencing parents’ 
social norms: a factor implicated in theories of behaviour (88) and which has 
been identified by a recent review of vaccine interventions as being particularly 
effective at increasing vaccine uptake (179). 
When deciding whether to vaccinate their child, parents often consult multiple 
sources for advice, such as their friends and family, healthcare providers and 
information published online by official and non-official sources (487). Given 
that we know that people will be exposed to multiple messages about the vaccine 
from different sources, an important question to ask is how do we make sure that 
parents treat official communications as true? Inoculation theory posits that 
attitudes can be inoculated against persuasion (488) and suggests that two 
components bring about resistance to other attitudes: the recognition that one is 
vulnerable to threat, and raising and discrediting counterarguments (489). 
Phrasing official vaccine communications in this way may make induced positive 
vaccine beliefs and attitudes more resistant to change; this could be investigated 
by future research. 
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There is also much evidence indicating that people prefer messages that are in 
line with their own beliefs, often discounting information which is incongruous as 
being unimportant or not relevant to oneself (490). This is also known as 
defensive processing or bias and is thought to happen when the message threatens 
one’s sense of self (491, 492). In the context of child vaccination, this might 
mean that parents who are not in favour of child vaccination could refute 
information in which vaccines are presented positively without engaging with it. 
So how could we increase the receptivity of these parents to health messages 
about the benefits of vaccination and the dangers of vaccine-preventable 
diseases? One option could be self-affirmation, in which people reflect on values, 
attributes, and past behaviours important to themselves, reinforcing one’s sense of 
self-integrity and adequacy (493). Reaffirming self-worth is thought to protect 
self-integrity, reducing defensive bias and allowing threating information to be 
processed (494). In line with this theory, self-affirmation is associated with 
acceptance of messages about health threats, and positive behaviour intention and 
behaviour change (495, 496). Many different methods have been used to 
manipulate self-affirmation. However, they often involve burdensome tasks such 
as writing about why a particular value is important; these tasks would be 
difficult to include in widespread vaccine communications (497). Nevertheless, 
some studies have successfully induced self-affirmation using less intensive 
manipulations (e.g. (498, 499)). To the best of my knowledge, there is only one 
study investigating the manipulation of self-affirmation on child vaccine uptake. 
In this study, parents who self-affirmed had lower vaccination intentions and 
were more likely to believe that the MMR vaccine caused side-effects (500). 
Therefore, the use of self-affirmation to increase vaccination should be 
approached with caution. However, better quality research is needed to see 
whether these results are replicated with other types of manipulations of self-
affirmation which would be more suited to inclusion in national vaccination 
campaigns, such as including a phrase stating that ‘we know that you are doing 
your best for your child,’ and different vaccines. 
7.5.3 Knowledge 
Vaccine interventions often aim to increase parents’ knowledge about vaccines. I 
investigated whether feeling that parents’ perception that they did not know 
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enough about the vaccine was associated with child influenza vaccine refusal in 
my cross-sectional study (Chapter 5). Parents who felt that they did not know 
enough were less likely to vaccinate their child in 2015/16 and less likely to 
intend to vaccinate their child in 2016/17. These results suggest that increasing 
parental knowledge about influenza and the child vaccine might increase uptake. 
In my cross-sectional study, approximately 5% and 15-25% of participants 
answered belief and attitude items as ‘don’t know’ and ‘neither agree nor 
disagree’ respectively (Chapter 5). This suggests that a substantial proportion of 
the public are willing to admit their lack of knowledge about influenza and the 
child vaccine and may be open to new information. 
While outside the scope of this thesis, other research investigating the effect of 
increasing parental knowledge about vaccines and vaccine-preventable illnesses 
gives mixed results. For example, a recent comprehensive systematic review of 
randomised-controlled trials found low- to moderate-certainty evidence that face-
to-face educational interventions increase vaccine uptake (501). Similarly, a 
recent summary of interventions to tackle vaccine hesitancy indicated that 
educational interventions yield mixed results: some studies found a positive 
influence of increased knowledge on vaccine intentions, attitudes and uptake, 
while others found no change or a worsening of intentions (481). One reason why 
interventions increasing parental knowledge may not be successful in increasing 
vaccine uptake is that vaccination is a complex behaviour which depends on 
many factors. One influential theory of behaviour change, the behaviour change 
wheel, has identified nine intervention functions, including persuasion, 
incentivisation, enablement and modelling, which should be targeted to bring 
about behaviour change (473). Interventions which target multiple behaviour 
change techniques may be more successful in increasing vaccine uptake.  
In addition to identifying messages which could be targeted by vaccine 
communications and vaccine interventions, my research also identified other 
issues which might hinder uptake of the child influenza vaccine in England. One 
example is poor vaccine-eligibility knowledge by both parents and healthcare 
practitioners. Almost one-third of parents of vaccine-eligible children in my 
cross-sectional study did not know their child was eligible for the child influenza 
vaccine in 2015/16, or incorrectly thought that their child was not eligible 
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(Chapter 5). In my systematic review of vaccine uptake, there was good evidence 
that incorrect knowledge, confusion, or difficulty remembering the vaccine 
schedule was associated with not vaccinating the child (six of seven studies 
found; Chapter 2). In healthcare practitioners, incorrect vaccine-eligibility 
knowledge may mean that vaccine-eligible children are denied vaccination. In the 
2016/17 influenza season, children aged two, three and four years on 31st August 
2016 (i.e. birth dates between 1st September 2011 and 31st August 2014) were 
eligible for vaccination through their primary care practice (502). As the 
influenza season progressed, some of these children turned five but were eligible 
for the vaccine, while other children born on or after 1st September 2014 turned 
two but were not eligible for vaccination. During recruitment for my prospective 
cohort study, I informally observed the misinterpretation of vaccine-eligibility 
guidelines. Some primary care practices interpreted guidelines to mean that 
children should be aged two, three or four years on the day of vaccination. Thus, I 
saw some children who were aged five and were eligible for the vaccine, being 
refused vaccination. Better communication to practitioners, as well as parents, 
may be required. 
7.5.4 Anxiety 
While not investigated with relation to vaccine uptake in this thesis, one factor 
which is unlikely to be changed by vaccine communications, but which may be 
important to keep in mind when thinking about child vaccine uptake, is parental 
trait anxiety. Anxiety is characterised by excessive worry (377). Worry, in 
particular about possible adverse effects of the vaccine, is strongly associated 
with child vaccination refusal (91, 95, 270) and increased subjective symptom 
perception (247, 248, 278-281). I investigated the association between parental 
trait anxiety and parental perception of side-effects in my prospective cohort 
study, finding evidence of an association with parental recall of side-effects from 
the child influenza vaccine one month after vaccination (Chapter 6). This 
evidence suggests that minimising parental concern about potential adverse 
effects of vaccination and fostering the belief that vaccination is safe may reduce 
the number of parents recalling side-effects from the child influenza vaccination. 
However, further research is needed to characterise the role of worry and anxiety 
in vaccine uptake and side-effect perception. 
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7.5.5 Vaccine recommendations from a healthcare provider 
In my systematic review of vaccine uptake in young children I found good 
evidence that receiving a vaccine recommendation from a healthcare professional 
was associated with uptake of child vaccinations (eight of nine studies found an 
association; Chapter 2). Another narrative review has also identified that 
receiving a recommendation from a healthcare provider that one’s child should be 
vaccinated is strongly associated with vaccine uptake (179). Despite being unable 
to infer causality due to its cross-sectional nature, I also found that receiving a 
vaccine recommendation from a healthcare provider was associated with uptake 
of the child influenza vaccine in my cross-sectional study (Chapter 5). While all 
healthcare providers are encouraged to provide strong vaccine recommendations 
(503, 504), data indicated that almost half of participants disagreed that a health 
professional had recommended vaccination (Chapter 5). In conducting my 
prospective cohort study, I also informally found that multiple primary care 
practices did not send vaccine invitations to parents of vaccine-eligible children. 
This is in spite of guidance stating that primary care practices should ‘ensure that 
they are making every effort to identify and contact eligible patients’ (503). New 
best practice guidance for primary care practices states that personalised 
invitations should be sent to parents of vaccine-eligible children and that multiple 
contact should be made ‘until the child is immunised or an active refusal is 
received’ (504). However, whether primary care practices follow guidance is not 
regulated. 
7.5.6 Practicalities 
Other factors which may hinder uptake of the child influenza vaccine relate to 
practicalities associated with child vaccination. In my systematic review of 
factors associated with uptake of child vaccinations, I found good evidence that 
practicalities such as perceived logistical barriers and inconvenient appointment 
locations or times, were associated with not vaccinating the child (five of seven 
studies found; Chapter 2). One such practicality which affects child influenza 
vaccination and which has influenced recent vaccination recommendations is the 
location of delivery of the vaccine. National uptake rates indicate that vaccination 
is consistently higher in children who are vaccinated in school (approximately 
52% to 61% vaccinated), compared to those vaccinated at their primary care 
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practice (approximately 30% to 44% vaccinated) (15, 56-59). This is likely due to 
the relative ease for parents of school vaccination. As such, recommendations 
were updated for the 2017/18 influenza season, with children in school year 
reception being offered vaccination in school (503). For parents of young children 
offered vaccination in the primary care practice, making vaccination as easy as 
possible, for example by holding evening and weekend vaccination clinics, will 
likely help increase vaccination rates (505). 
7.5.7 Interpretation bias 
Although information processing biases can be modified, it is unlikely that short 
vaccine communications will alter parents’ interpretation biases. I investigated 
whether parental negative interpretation biases were associated with vaccine 
uptake, intention and side-effect perception in my cross-sectional (Chapter 5) and 
prospective cohort study (Chapter 6). Results were mixed. I found evidence for an 
association between parental negative biases pertaining to the source of the health 
threat (naturally-occurring or man-made) for vaccine uptake in 2015/16 and 
vaccination intention for 2016/17 in my cross-sectional study; there was no 
association between bias and parental perception of side-effects (Chapter 5). 
There was no association between parental negative interpretation biases 
pertaining to the subject of the health threat (self-relevant or child-relevant). In 
contrast, I found no association between parental negative interpretation biases 
pertaining to the source of the health threat and re-vaccination intention or uptake 
in my prospective cohort study, while finding some evidence for an association 
between parental bias and recall of side-effects one month after vaccination 
(Chapter 6). Due to the mixed nature of results, interpretation is difficult. Further 
research, powered to detect small effects, is needed to substantiate whether 
parental interpretation bias is associated with vaccination behaviour. Some 
tentative suggestions might be made from my results, however. For example, my 
results suggest that attempts should be made to remove ambiguity and uncertainty 
from communications, to avoid negative interpretations from those with negative 
biases. However, it is difficult to remove all ambiguity surrounding the child 
influenza vaccine, as parents will likely receive conflicting information from 
different sources such as their friends and family, the media, social media and 
official communications (487).  
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If substantiated by further research, investigating potential associations between 
parental interpretation biases and vaccination behaviour is the first step in 
designing an appropriate intervention to modify underlying biases. Although 
current cognitive bias modification techniques are inappropriate for widespread 
vaccine communications, the notion that interpretation biases may play a causal 
and maintaining role in maladaptive behaviours (192) and worry (449) makes the 
notion of modifying such biases an interesting prospect. In cognitive bias 
modification studies, behaviour and information processing biases are measured, 
after which participants complete cognitive bias modification tasks. Biases are 
then measured again, to ascertain whether biases were successfully modified. 
Behaviour is also measured again, to see whether bias modification has had any 
influence. Studies which employ cognitive bias modification techniques often do 
so in an attempt to prove the causal influence of cognitive biases on behaviour. 
While cognitive bias modification has been successful for some outcomes, such 
as ameliorating the symptoms of anxiety (201, 506) and eating disorders (507), 
few studies have investigated the role of cognitive bias modification on public 
health behaviours. Where studies have investigated the effect of cognitive bias 
modification on public health behaviours, they yield mixed results. A recent 
meta-analysis investigating cognitive bias modification in relation to smoking and 
alcohol problems found that while there was a moderate effect on cognitive bias, 
modification had no effect on addiction behaviour (508). This caused authors to 
call into question the ‘clinical utility of cognitive bias modification as an 
intervention for addiction problems’ (508) (p. 2/19). However, when studies 
investigating bias modification in alcohol disorders were re-analysed taking into 
account differences in study methods and populations, researchers found that 
modification influenced drinking behaviour in the short-term but not long-term 
(e.g. three months, but not six months) (509). Of the studies reviewed, only one 
attempted to modify interpretation bias; all other studies investigated attention 
bias, approach bias and response inhibition. This study found that while 
interpretation bias modification was successful in changing alcohol-related biases 
in a group of male students with hazardous drinking behaviour, there was no 
effect on alcohol consumption (510). 
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Other studies have investigated the effect of cognitive bias modification on 
different public health behaviours, also yielding mixed results. For example, one 
study found that interpretation bias modification in undergraduate students was 
associated with increased spending on sun cream in a virtual task, but was not 
associated with intention to adopt sun protective behaviours (511). Results of this 
study should be taken with caution as, to the best of my knowledge, no research 
exists investigating whether there is an underlying association between 
interpretation bias and sun protective behaviours, nor was adoption of sun 
protective behaviours measured before the bias modification task. Attention bias 
modification has been found to promote healthy eating (455). 
How evidence for cognitive bias modification in behaviours such as smoking, 
drinking alcohol and eating unhealthy foods might translate to vaccination 
decisions is unknown. So far, cognitive bias modification has been used in 
attempts to stop detrimental habitual behaviours, but in the case of vaccine 
uptake, cognitive bias modification would aim to promote a one-off beneficial 
behaviour. Initiating and stopping behaviours are thought to be conceptually 
different (512), so results found in bias modification studies investigating 
smoking, drinking and eating unhealthy foods may not carry over to vaccination. 
In addition, most research investigating cognitive bias modification in public 
health behaviours has looked at the effect of modifying attention bias, not 
interpretation bias. Despite mixed evidence for the use of interpretation bias 
modification for uptake of public health behaviours, interpretation bias 
modification is thought to have a more consistent effect on target bias than 
attention bias modification (400) and may therefore be more likely to bring about 
changes in behaviour. 
While interpretation bias modification may theoretically affect vaccination, the 
practicality of a widescale interpretation bias modification intervention is an 
important consideration. When completing interpretation bias modification 
training, participants are presented with many trials (often up to 100), which are 
consistently disambiguated in a negative or positive manner (negative or positive 
training condition respectively). When later presented with ambiguous task trials, 
participants tend to interpret ambiguity in the direction of training. There are 
many variables which may impact how successful interpretation bias 
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modification training is. First, the effect of multiple training sessions is unclear, 
with a recent review of meta-analyses indicating that two meta-analyses found an 
increased effect of multiple training sessions, while another found that a single 
session was most effective; three found no association (400). Second, the duration 
of cognitive bias modification training is typically short-lived, although studies 
indicate that training effects persist the day after training (513, 514). Third, the 
location of the bias modification training should be considered as cognitive bias 
modification is most effective when delivered in a laboratory setting (400). 
Outside of a research context, could cognitive bias modification be used in 
practice to promote vaccine uptake? Possibly. Although a small number of trials, 
conducted outside of a laboratory might only have a very small, short-lived effect, 
given that any public health intervention would be applied across the population, 
even a small effect that increases vaccine uptake by one or two percentage points 
might still be worthwhile.  
While outside the scope of this thesis, investigating whether other information 
processing biases, such as attention bias and recall bias, may influence parental 
vaccination behaviour may also be valuable. For example, negatively biased 
parents may be more likely to attend to and recall negative information about the 
vaccine, such as previous side-effects that their child has experienced from 
vaccination. This in turn may negatively influence parents’ decision to re-
vaccinate their child. 
7.5.8 Personal and clinical characteristics 
Unlike psychological factors which can help inform the content of 
communications and interventions, personal and clinical characteristics associated 
with vaccine refusal may help identify target groups for more specific or intensive 
communications (95). In the case of child influenza, I identified very few 
associations between vaccine uptake and personal and clinical characteristics. 
Only parent age was associated with re-vaccination intention and actual re-
vaccination in the prospective cohort study (Chapter 6); I found no evidence for 
associations between vaccine uptake and personal or clinical characteristics in the 
cross-sectional study (Chapter 5). Two other studies have investigated the impact 
of population-level factors on child influenza vaccine uptake in the UK. Vaccine 
refusal was associated with living in: more deprived areas (62, 458); urban areas 
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(62); areas with increasing proportions of black-ethnic and Jewish populations 
(62); and areas with a higher number of children living in each household (458). 
Studies did not investigate parent personal or clinical characteristics. More 
research investigating how personal and clinical characteristics impact child 
influenza vaccination is needed to ensure that the relative importance of 
psychological factors on behaviour is not overestimated. 
 Strengths and limitations of the thesis 
The specific strengths and limitations of each component of this thesis are 
described in the appropriate chapters. However, some overarching factors should 
also be considered.  
One of the main strengths of this thesis is the timeliness of the research after the 
introduction of the child influenza vaccine to the vaccine schedule in the UK. My 
thesis includes the first set of studies to investigate what parents thought about the 
child influenza vaccine as well as being the first to assess psychological factors 
associated with vaccination. To the best of my knowledge it is also the first study 
to provide data on re-vaccination rates for the child influenza vaccine; contact 
with Public Health England and NHS England has failed to uncover any official 
data. 
Another strength is that my prospective cohort study was the first to investigate 
the effect of expectation on parental perception of side-effects from vaccination. 
Given the central role of expectation in the nocebo effect (219, 220), this is 
surprising. Studies have so far focused on how psychological factors may impact 
child symptom experience, but my thesis identifies and highlights factors which 
are likely to impact parental perception of symptoms. This is important in its own 
right due to the influence that parental perception of symptoms has on vaccination 
decisions and more broadly, on help-seeking behaviour and medication 
adherence. Parental perception of side-effects may also influence other factors, 
such as how sensitive to medicines parents believe their child to be (e.g. Chapter 
6). 
Other strengths of the thesis include the use of multiple methods, including two 
systematic reviews, a cross-sectional study and a prospective cohort study. Being 
systematic, my reviews not only covered the entirety of the literature as far as 
 221 
 
possible, but also reduced the risk of bias associated with publication bias or 
‘cherry-picking.’ My cross-sectional study had a large, nationally-representative 
sample, increasing confidence that my results would hold true in the wider 
population. My cohort study was conducted prospectively, lending credence to 
the notion that psychological factors are causally associated with parental 
perception of side-effects from vaccination and re-vaccination behaviour. In 
addition, my research was interdisciplinary, exploring vaccination, a public health 
behaviour, using an experimental psychology approach. 
One of the primary aims of this thesis was to investigate factors associated with 
parental perception of side-effects. One overarching limitation of my studies is 
that just taking part, especially in the prospective cohort study, might have 
increased parents’ expectations that their child would experience side-effects and 
reporting of side-effects. The medical setting in which parents were recruited for 
the prospective cohort study may have also affected side-effect perception. 
However, as parents were asked whether their child had experienced side-effects 
from vaccination in follow-up tasks which were not completed at the primary care 
practice, this is unlikely. Being asked about potential side-effects may have 
heightened parents’ attention to signs of side-effects in their child and caused 
parents to interpret any symptoms displayed by the child as arising from the child 
influenza vaccine. I was unable to mitigate this in my study, which through 
necessity relied on self-report. These problems affect all studies in which 
subjective side-effects are investigated, including clinical trials (77). 
Another limitation of the studies in this thesis comes from the use of self-report 
measures, which are open to problems such as recall errors (515). With regard to 
child influenza vaccine uptake, research indicates that parent-report of a child’s 
influenza vaccine status is a robust measure (516). With regard to perception of 
side-effects, as I was interested in parental perception of side-effects from 
vaccination, I necessarily had to use a self-report measure. 
In my cross-sectional and prospective cohort study, I investigated only parent-
reported symptoms; whether children actually did experience symptoms is 
unknown. However, the investigation of factors associated with parental 
perception of vaccine side-effects is important in its own right. The consequences 
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of perceiving side-effects, such as avoiding other vaccinations or medications in 
the future, will occur based on parental perception of side-effects, regardless of 
the child’s subjective experience.  
Other limitations of the thesis relate to the space available for task materials in 
my questionnaires. Restrictions on the length of study materials meant that I was 
not able to investigate all potentially relevant factors in both studies. Factors with 
no theoretical basis for their influence on parental side-effect perception, such as 
child temperament, were not investigated. In addition, I was also only able to 
investigate interpretation bias; other biases of information processing such as 
attention and recall bias may also be important in parental vaccination decision-
making. The retrospective nature of the cross-sectional study meant that 
measuring parental pre-vaccination expectations of side-effects would have been 
confusing for participants, so I did not investigate this factor. Similarly, I did not 
ask if the child had been experiencing other symptoms at the time of vaccination.  
Although my studies were generally well powered to identify factors associated 
with child influenza vaccine uptake and parental perception of side-effects, when 
looking in more detail at some of the predictors, the sample size included in 
analyses decreased. This meant that some analyses relied on small cell counts and 
therefore should be interpreted with caution. In addition, I was only powered to 
identify medium effect sizes in my interpretation bias analyses. Only 
approximately one-third of participants completed interpretation bias tasks 
satisfactorily for inclusion in the analyses. This smaller sample size means that 
factors which could have exerted small, but still important, effects may have been 
missed.  
Finally, data are correlational, and caution should be taken when interpreting 
results and recommendations for implementation as findings do not necessarily 
indicate causal influence.  
 Conclusions 
Vaccination is one of the most successful interventions in modern medicine 
(517). However, uptake of the child influenza vaccine in England has been 
consistently low (15, 56-59). My research shows that this may be associated with 
the perception that the vaccine causes side-effects. However, not all side-effects 
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perceived from vaccination can be attributed to the pharmacological actions of 
the vaccine. While efforts have been made to increase vaccine uptake, they have 
not focused on decreasing the perception that the vaccine causes side-effects. The 
studies reported in this thesis reliably demonstrate that psychological factors such 
as parental pre-vaccination expectations, anxiety, uncertainty-related beliefs and 
interpretation biases play a role in side-effect perception. Current 
communications about vaccines are associated with considerable overestimation 
of the incidence of side-effects from vaccination. My results suggest that bringing 
parental expectations in line with more accurate estimates of the incidence of 
side-effects, might decrease side-effect perception and increase vaccine uptake. 
Decreasing parental worry about potential side-effects from vaccination might 
also increase vaccine uptake. This is a novel target for vaccine communications 
and interventions, and one which could be highly impactful. In the UK alone, 
sixteen children died from influenza in the 2017/18 season (59). Implementing 
the changes suggested in this thesis could help increase uptake of the child 
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Appendix 1. Methods of articles included in systematic review of factors affecting vaccine 
uptake in young children 




Inclusion criteria Age of child Location (time of 
data collection) 











118  Cases (n=50) – Parents of all children 
born in Child Health Centres in 
Gothenburg in 1995 and 1996 who had 
not received MMR vaccine according 
to charts. 
Controls (n=68) – Parents of vaccinated 
children listed prior to unvaccinated 
children in birth register in 1996 cohort 
3-5 years old Gothenburg, Sweden 
(November 1999) 
MMR (Child Health 
Centre chart review)  
Vaccinated with the MMR  9 





7810 Parents of children aged 19-35 months 
in selected urban areas of USA 





DTP, MCV, Hib, hep B 
(verified by child’s 
immunisation provider) 
≥4 DTP, ≥3 poliovirus, ≥1 
any MCV, ≥3 Hib, ≥3 hep B  
17 





688 Latino families with children aged 12-
36 months residing in selected counties 
in Los Angeles 
12-36 
months 
Los Angeles, USA 
(August-December 
1992) 
DTP, OPV (vaccine 
record) 





Cohort (interview) 4779 Members of B-cohort Longitudinal 
Study of Australian Children who had 
given consent for their child’s data to 
be linked 








12 months – 3 DTP, 3 IPV, 2 
Hib, 2 hep B 
24 months – 3 DTP, 3 IPV, 3 
Hib, 3 hep B, 1 MMR 








648 Parents/legal guardians of kindergarten-
enrolled children who resided in Butte 
County for at least 1 year and attended 
a public or private school in the county 
4-5 year olds USA (February-April 
2000) 
Hep A (Vaccination 
registry) 
1 hep A  15 
Bardenheier et 




2315 Parents of US children aged 19-35 
participating in 2000-2001 NIS. 
Cases (n=1016) – parents of children 






DTP/DTaP; Hep B 
(physician-verified 
vaccination status) 
≥4 DTP/DTaP, ≥3 polio, ≥1 
MMR, ≥3 Hib, ≥3 hep B, ≥1 
varicella  
14 
                                                 
2 Numbers refer to number of doses, if specified 
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Control (n=1299) – parents of children 
UTD with all vaccines 




300 Parents of healthy full-term new-borns 
delivered at a large municipal teaching 
hospital 
9-12 months USA (Infants born 
April-September 
1992; follow-up 9-12 
months later) 
DTP, polio (vaccination 
records) 
3 months – 1 DTP and 1 polio 
by 90 days after birth 
7 months - 3 DTP and 2 polio 







‘Over 3000’ Parent of child aged 2 in selected health 
authorities 
2 year olds England and Wales 
(Not reported) 
Measles and pertussis 
(not reported) 









228 Parents of children in Mid-Glamorgan 
aged between 2-2.5 identified by Welsh 
Health Common Services Authority 
childcare database as being fully 
vaccinated (n=85); partially vaccinated 
(n=70); not vaccinated (n=73) 
2-2.5 year 
olds 




Completed all pertussis 
vaccinations 
12 





487 Parents of children born between 1 






Hep B (self-report. 
Verified by information 
in Public Health 
Information System or 
immunisation provider) 
1 Hep B  16 





1779 Parents of children attending council-
run family day care or centre-based care 
for at least one day a week in 
metropolitan Melbourne 
0-3 years Melbourne, Australia 
(May-September 
1997) 
DTP, Hib, OPV, MMR 
(self-report. Verified by 
service provider where 
incomplete information 
given by parents) 
First milestone: 3 DTP, 3 Hib, 
3 OPV.  
Second milestone: 3 DTP, 3 
Hib, 3 OPV, 1 MMR.  
Third milestone: 4 DTP, 4 
Hib, 3 OPV, 1 MMR 
16 
Brenner et al 
2001 (173) 
Cohort (interviews) 370 Mothers of singleton births from 3 
hospitals in the District of Columbia 





DTP, polio, Hib 
(vaccination records) 
3 months - 1 DTP, 1 polio, 1 
Hib before 92 days 
5 months - 2 DTP, 2 polio, 2 
Hib before 152 days 
7 months - 3 DTP, 2 polio, 2 
Hib vaccines before 213 days 
16 







Parents of healthy children aged 6 
months-5 years who did (n=1227) and 











vaccination at clinic; 
decliners recruited in 
line with national 
register) 
2 H1N1  13 





996 Parents of children registered with 
Primary Care Trust born between 1 
October 2000 and 30 September 2002 
1-3 years old Lancashire, UK (May 
2004) 
MMR and single 
antigens (parent self-
report) 
Received MMR  15 
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whose address could be determined 
using Child Health Information System 





452 Parents of children aged 15-24 months 
in Brighton and Hove primary care trust 
who are vaccinated for MMR 
(n=258)/not vaccinated (n=53) 
15-24 
months 
Brighton and Hove, 
UK (March 2004) 
MMR (Child Health 
Dataset) 
Non-vaccinators – parents of 
children for whom no 
vaccinations were recorded on 
the Child Health Database. 
Compliant – reported 
choosing to have MMR 
before 15 months 
Non-compliant – those who 
delayed MMR vaccination, 
who did not vaccinate with 
MMR, who obtained single 







53 Parents of families in a large urban 
practice in Leicester with children born 
in 1975 who had not completed primary 
immunisation course 
3-4 years old Leicester, UK (April-
September 1978) 
Diphtheria, tetanus, 
whooping cough, polio 
(Immunisation history 
recorded on computer) 
Completed primary 
immunisation course of triple 
antigen (diphtheria, tetanus, 
whooping cough) and polio 
by 15 months 
9 
Cuninghame et 




93 Parents of Jewish orthodox children 
from three pre-specified practices aged 
under 2.5 years 
0-2.5 years 
old 
London, UK (June 
1991-March 1992) 
Diphtheria, pertussis, 
MMR (family doctor 
immunisation records) 
6 months – 3 diphtheria, 3 
pertussis  
24 months – MMR 
10 





199 Parents of children registered at Child 
Health Centres on 31st December 2002 
in Östergötland who were born in 1998-









MMR vaccination 9 




191 Parents of infants born in March 1999 
in Vancouver/Richmond Health Board 
8 months Canada (November 
1999) 
Diphtheria, tetanus, 
pertussis, polio, Hib, hep 
B (Health Passport 
records held by parents 
or child's physician) 
3 DPTP-Hib, 3 hep B 
 
11 





178 Parents of children born between 30 
April and 31 July 1999 identified from 
regional immunisation registry living in 
Quebec City area 
14-17 
months 




Vaccinated for varicella 11 








Future new parents expecting a child or 
parents of a healthy new-born aged 0-6 
weeks in three Canadian cities 
(Vancouver, Quebec City, Halifax) 
0-7 months British Columbia, 




Received ≥1 rotavirus  12 
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511 Parents of children born between 1 
November 1997 and 31 January 1998 in 
Brighton and Hove area 
2 years old Brighton and Hove, 
UK (Not reported) 
MMR (child health 
records) 
MMR vaccination by age 2 14 




110 Parents of children attending day-care 








MMR vaccination 12 





9354 Parents of children aged 19-35 months 
participating in 2011 NIS 
19-35 
months 
USA (Not reported) MMR, varicella, 
seasonal influenza, 
tetanus-containing 
vaccine, polio, MCV, 
hep B, PCV (medical 
records) 
36 months – ≥1 varicella, ≥1 
seasonal influenza vaccine, ≥4 
tetanus-containing vaccine, 
≥1 MCV, ≥3 polio, ≥1 
varicella, ≥3 Hep B, ≥4 PCV 
14 





316 Mothers in 18 rural counties who had 
children between the age group of 20-
26 months as of May 31, 1994 
20-26 
months 
West Virginia, USA 
(Not reported) 
DTP, Hib, polio, MMR 
(parent self-report, 
where possible using 
immunisation records) 
4 DTP, 4 Hib, 3 polio, 1 
MMR 
17 





1477 Parents/guardians of NIS participating 
children with adequate provider-
reported immunisation data 
Case (n=463) – under-immunised 
(missing ≥2 high-profile vaccines) 






DTP/DTaP, hep B, 
MCV (child vaccination 
records from vaccine 
provider) 
≥2 DTP/DTaP, ≥2 hep B, ≥1 
MCV 
18 











December 2003 and 
April-December 
2004) 
DTP, polio, MMR, Hib, 
Hep B, varicella, PCV, 
influenza (parent self-
report) 
Vaccinated on time 13 





466 Parents of children who made at least 




Maryland, USA (Not 
reported) 
DTP, MMR, OPV, Hib, 
hep B (medical record) 
(1) Age-appropriate 1 DTP 
(2) Age-appropriate 3 DTP 
(3) Age-appropriate MMR,  
(4) 24 months – 4 DTP, 3 
OPV, 1 MMR, 4 Hib 







423 Parents of children born in Dundee in 
1999 and 2000 
3-4 years Dundee, UK (2003) MMR (parent self-
report) 
1 MMR vaccine 12 
Kim 2004 (129)  Cross-sectional 
(face-to-face 
interview) 
116 Korean immigrant mothers of children 
aged 2-5 years residing in inner-city 
area of Chicago 
2-5 years Chicago, USA 
(February-October 
1998) 
Hep B (Immunisation 
card/record, parent self-
report) 
3 hep B immunisation 14 
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717 Parents of children aged 24-35 months 





DTP, polio, MMR 
(vaccine record) 
4 DTP, 3 polio, 1 MMR 
within 30 days of the 
recommended age 
17 





401 Chinese parent of children aged 6-23 
months who used one of 10 randomly 
selected Maternal and Child Health 
Centres 




2 influenza 14 





506 Parents of children born between 1 
October and 31 December 1995 who 
were registered on ACIR on 4 May 
2001 
5 years old Australia (July 2001) MMR (Immunisation 
record or parental self-
report) 
2 MMR 12 




2029 Parents of children born in Utah in June 
1985 
1 year old Utah, USA (not 
reported) 
Pertussis, DTP (parent 
self-report) 
Vaccinated for pertussis 10 
Maayan-




204 Mothers of healthy term singleton 
babies who gave birth at a large tertiary 
hospital in Israel 
Cases (n=51) – unvaccinated for Hep B 
Controls (n=153) – vaccinated for Hep 
B 
New born Israel (January-
September 2003) 
Hep B (vaccine records) Vaccinated for Hep B 12 
MacDonald et 




461 Parents/primary care givers of children 
who turned 2 between May 2008 and 
April 2009  
Cases (n=130) – partially immunised 
Controls (n=331) – completely 
immunised 
2 years old Alberta, Canada (Not 
reported) 
DTP, polio, Hib, MMR, 
varicella, men C, PCV. 
(Parent self-report) 
4 DTP, 4 polio, 4 Hib, 1 
MMR, 1 varicella, 3 men C, 4 
PCV 
17 





5047 Parents of children who had an 18-
month or a 36-month check-up at 
specified health centres 






Vaccinated for measles 11 




643 Parents of children who lived in 
selected counties in Colorado 
Cases (n=322) – had not received MMR 
by 2 years of age 
Controls (n=321) – had received MMR 
by 2 years of age 




Vaccinated for MMR between 
12-18 months 
13 
Morgan et al 
1987 (132) 
Cohort (interviews) 174 Parents of children who would reach 13 
months during time allocated for 
interviewing parents in South East 
Thames Regional Health Authority 
13-20 
months 




Measles vaccination at 20 
months 
9 




270 Parent of children aged 2-5 belonging 
to ultraorthodox Jewish communities in 
Bnei Brak and Jerusalem 
2-5 years 
Jerusalem; 2-
Israel (Not reported) MMR, hep B, diptheria, 
tetanus, polio, pertussis, 
Hib (medical records, 
1 MMR, 2 hep A, 3 hep B, 4 




Cases (Bnei Brak=31; Jerusalem=28) – 
not adequately vaccinated for age 
Controls (Bnei Brak=77; Jerusalem=83) 
– adequately vaccinated for age 
2.5 years 
Bnei Brak 
immunisation card or 
parent self-report) 
Cases received ≤20 doses (of 
22 recommended doses) 
Controls received 21–22 
doses 
Niederhauser et 
al 2001 (134) 
Cross-sectional 
(telephone survey) 
262 Parents of children who had a 24-month 
physical examination at Kaiser 
Permanente clinics in the state of 
Hawaii in 1998 




Varicella vaccination 12 
Offutt-Powell et 




124 English-speaking parents or primary 
caregivers of children aged between 6 
months and 5 years in selected day-care 
centres 
6 months – 5 
years 




Received influenza vaccine 14 





437 English-speaking parents of children 
aged 2 months who 
were born from 10th July-10th December 
2010 and part of Group Health 
Cooperative Seattle 




poliovirus; MMR; Hib; 




Received all 16 doses by 19 
months of age (does not 
report how many doses of 
each vaccine) 
15 
Pearce et al 
2008 (96) 




Parents of children born in UK between 
September 2000 and January 2002 for 
whom information was available on 







MMR (Personal child 
health record) 
 
Vaccinated with MMR 18 
Pearce et al 
2013 (518) 
751 Same as above, and who were 
unimmunised for MMR at age 3 
5 years Unimmunised = received no 
MMR  
Partially caught-up = 1 MMR 
Fully caught-up = 2 MMR 





3394 Parents of children born between 1 June 
1985 and 31 December 1985 




Vaccinated with measles and 
pertussis 
12 





206 Parents of children born between 1 
October and 31 December 1993, 
resident in North Wales on day of data 
extraction 
Case (n=54) – child had received all 
vaccines except second dose of MMR 
Control (n=152) – child had received all 
vaccines including second dose of 
MMR 
4 years old Wales 
(Questionnaires 
posted on 14-15 May 
1998) 
MMR second dose 
(Data provided by 
Health Solutions Wales) 
Case = 1 MMR 




Prislin et al 
1998 (145, 154) 
Cross-sectional (in-
person interviews) 
4832 Parents of children in a household with 
a child aged 2-24 months in selected 
counties 
2-24 months Texas, USA (Not 
reported) 
DTP, OPV, MMR 
(Vaccine records, 
parent-self report) 
3 to 4 months – 1 DTP, 1 
OPV 
5 to 6 months – 2 DTP, 2 
OPV 
7 to 15 months – 3 DTP, 3 
OPV 
16 to 24 months – 4 DTP, 3 
OPV, 1 MMR 
15 
2368 Hispanic parents of children aged 3-24 
months in selected counties 
3-24 months 
Qutaiba B Al-




528 Parents of children younger than 2 
years of age (born between 1 January 
2003 and 31 June 2008) 
0-2 years Iraq (Not reported) BCG vaccine, OPV, 
DTP, hep B virus, MMR 
vaccine, and the measles 
vaccine (Not reported) 
24 months – 1 BCG, 5 OPV, 







191 Parents of children born in June and 
July 1994 in Brisbane North Regional 
Health Authority 
Group 1 (n=72) – fully vaccinated 
Group 2 (n=119) – not fully vaccinated 
8 months Brisbane, Australia 
(March 1995) 
DTP, Hib, OPV 
(Parental report from 
vaccination record book, 
validated by database 
check) 
3 DTP, 3 Hib, 3 OPV 11 
Samad 2006 
(162) 
Cohort (face to face 
interviews)  
18,488 Parents of children born in UK between 
September 2000 and January 2002 





polio, pertussis, Hib, 
men C (Mother's self-
report and personal child 
health record) 
3 diphtheria, 3 tetanus, 3 
polio, 3 pertussis, 3 Hib, 3 
men C 
11 
Schempf et al 
2007 (146, 147) 
Cohort (phone 
questionnaire) 
4756 Families enrolled in Healthy Steps 
between September 1996 and 
November 1998 
0-24 months USA (September 
1996-November 
1998) 
DTP, polio, MMR 
(vaccine records) 








68 Parents of children resident in London 
Borough of Hackney born between 1 
January 1999 and 15 February 1999 
who had not completed the 
recommended course of immunisation 
18 months London, UK (not 
reported) 
BCG, DT, pertussis, 
polio, Hib, men C, 
MMR (identified 
through population 
database, verified by 
parent self-report) 
Completed recommended 
course of vaccines (includes 
universal BCG) 
10 





12,259 Parents of children aged 19-35 months 
in 2010-2013 NIS 
19-35 
months 
USA (2011-2013) MCV (medical records) ≥1 MCV 12 





3000 Mothers of children aged 0-35 months 0-35 months France (September-
November 2011) 
Men C (parent self-
report) 
Vaccinated for men C 11 




392 Parents of children aged 2-36 months 
members of groups at selected 
community-based organisations 
2-36 months New York, USA 
(May 2007 - June 
2008) 
DTP/DTaP, polio 
vaccine, MCV, hep B, 
varicella (vaccine 
record) 
4 DTP/DT/DTaP, 3 polio, 1 
MCV, 3 hep B, 1 varicella 









557 Parents of a birth cohort of children 
born between August 1988 and March 
1989 to mothers who resided in 1 of 57 
census tracts in Baltimore 
0-24 months Baltimore, USA (not 
reported) 
DTP, OPV, MMR 
(vaccine records) 
4 DTP, 3 OPV, 1 MMR by 24 
months 
15 




13,516 Parents of children aged 8-35 months 
enrolled at selected practitioners 
8-35 months USA (March 1998-
January 2000) 
DTaP, polio, Hib, hep B, 
MMR (medical records) 
8 months – 3 DTP/DT/DTaP, 
2 IPV/OPV,  ≥2 Hib, ≥2 hep 
B 
19 months – 4 
DTP/DT/DTaP, 3 
IPV/OPV, ≥3 Hib, 3 hep B, 1 
MMR 
15 





308 Parents of children whose birthday was 
in July-September 2001 
Cases (n=66) – Child received all 
routine immunisations except MMR by 
second birthday  
Controls (n=242) – Fully immunised 
2.5-3 years South Wales, UK 
(March-May 2002) 
DTP, polio, Hib, MMR, 
men C (Parent self-
report) 
Received full primary course 
for DTP; polio; hib; ≥1 dose 
of MMR and men C 
17 
White & Lines 
1996 (140, 159) 
Cohort (postal 
questionnaire) 
90 Parents of children aged 7 months in 
Adelaide 
7 months Adelaide, Australia 
(December 1991-
September 1992) 
Hep B (Parent self-
report) 
7 months – completion of the 
course of Hep B 
6 





72 Parents of children aged 24-60 months 











96 Somali (n=27) and non-Somali (n=69) 
parents of children aged ≤5 at a Clinic 
in Minneapolis 
0-5 years Minneapolis, USA 
(August 2012-
February 2013) 




Vaccinated for MMR, hep B, 
varicella, DTaP, rotavirus, 
influenza 
12 





540 Parents of Chinese children aged 24-59 







Ever received influenza 
vaccination 
13 





596 Parents of children born between 1 July 
1992 and 30 June 1993 
Case (n=70) – under-immunised 
Control (n=526) – fully immunised 
2-3 years Minneapolis, USA 
(not reported) 
DTP, OPV/IPV, MMR 
(medical records) 
20 months – 4 DTP, 3 







16, 919 Parents of children aged 19-35 months 
who had adequate provider data 
19-35 
months 
USA (not reported) DTaP (not reported) 18 months – 4 DTaP (dose 1 
at 2 months; dose 2 at 4 
months; dose 3 at 6 months) 
9 
 
ACIR – Australian Childhood Immunisation Register; aP – acellular pertussis; BCG – Bacille Calmette-Guérin; CDC – Centers for Disease Control; DPTP-Hib – vaccine for diphtheria, tetanus, pertussis, polio and 
haemophilus influenza B; DT – diphtheria and tetanus vaccine; DTP – whole-cell diphtheria and tetanus toxoids and pertussis vaccine; DTaP – diphtheria and tetanus toxoids with acellular pertussis vaccine; Hep A – 
hepatitis A; Hep B – hepatitis B; Hib – haemophilus influenza B; IPV – inactivated polio vaccine; MCV – measles containing vaccine; men C – meningitis C; MMR – measles, mumps and rubella vaccine; NIS – 
National Immunization Survey; OPV – oral poliovirus vaccine; PCV – pneumococcal conjugate vaccine; USA – United States of America; UK – United Kingdom;  UTD – up-to-date vaccination status. 
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Appendix 2. Full table of results of factors affecting vaccine uptake in young children 
Citation Rate of uptake of vaccine Psychological predictors of child vaccination considered, significant results in 
bold 
Self-reported reasons for and for not vaccinating child  




No knowledge about vaccination before appointment. Parents' experiences 
from the vaccination procedure (dissatisfied with information provided by 
staff).  
Reasons for not vaccinating: Vaccines are harmful; to strengthen child's 
immune system; measles, mumps and rubella are beneficial for child's 
development; parents have undergone diseases without harm; vaccination is 
unnecessary, other methods are better; measles, mumps and rubella are 
harmless 
Reasons for vaccinating: To protect child from measles, mumps and rubella; to 
prevent complications of measles, mumps, rubella; to strengthen child's 
immune system; parents have been vaccinated without complication; to protect 
the child when travelling abroad; the child has a chronic disease 




Vaccinations are safe. Accept multiple vaccines at same time. Children who 
stay at home need same immunisations as those at school/day-care. Children 
can be vaccinated if they have a common cold. Acceptance of new vaccines. 
Child will get so ill from vaccination that they must see a doctor 
 
Anderson et al 
1997 (142) 





12 months – 93.5% (95% 
CI [92.7-94.3]) 
24 months – 95.4% (95% 
CI [94.7-96.0]) 
60 months – 81.4% (95% 
CI [80.1-82.6]) 
12 months. Agreeing with vaccination. Maternal psychological distress 
(moderate, symptomatic). Perceived time pressure. Fewer stressful life events 
(1 event; 2 events; 3+ events). Hostile parenting (medium; high). Parental 
warmth (medium; high). 
24 months. Agreeing with vaccination. Maternal psychological distress 
(moderate, symptomatic). Perceived time pressure. Fewer stressful life events 
(1 event; 2 events; 3+ events). Hostile parenting (medium; high). Parental 
warmth (medium; high). 
60 months. Agreeing with vaccination. Maternal psychological distress 
(moderate, symptomatic). Perceived time pressure. Fewer stressful life events 
(1 event; 2 events; 3+ events). Hostile parenting (medium; high). Parental 
warmth (medium, high). 
 
Bardenheier et al 
2003 (109) 
61.8% (398/648, 95%CI 
[56.9-66.8]) 
Having heard of vaccine for hep A. Thinking that hep A is major problem in 
Butte County. Thinking it is serious if child gets hep A. Thinking child is 
likely to get hep A. Thinking vaccine is safe. Thinking kindergartners 
should be required to get hep A vaccine before school entry.  
 




MCV/MMR. Concern about safety. Refusal of any vaccine for child for 
reason other than illness. Refused vaccine for child. Previous side-effect to an 
immunisation. Shots did not want for child but which were required by law. If 
had a new baby, would want to get all immunisations. Heard that vaccine 
causes side-effects. Causes autism. Believing it causes autism. Causes fever. 
Reasons for not vaccinating: 
MCV/MMR. Concerned about side-effects. Believed child received too 
many shots. Unlikely that child would get disease. Believed disease was not 
serious. Wanted to postpone shot.  
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Believing it causes fever. Causes high fever. Believing it causes high fever. 
Causes brain damage.  
DTP/DTaP. Concern about safety. Refusal of any vaccine for child for 
reason other than illness. Refused vaccine for child. Previous side-effect to 
an immunisation. Shots did not want for child but which were required by 
law. If had a new baby, would want to get all immunisations. Heard that 
vaccine causes side-effects. Causes autism. Believing it causes autism. Causes 
fever. Believing it causes fever. Causes high fever. Believing it causes high 
fever. Causes brain damage.  
Hep B. Concern about safety. Refusal of any vaccine for child for reason 
other than illness. Refused vaccine for child. Previous side-effect to an 
immunisation. Shots did not want for child but which were required by law. 
If had a new baby, would want to get all immunisations. Heard that vaccine 
causes side-effects. Causes autism. Causes fever. Believing it causes fever. 
Causes high fever. Believing it causes high fever. Causes brain damage. 
Believing it causes brain damage. Causes liver problems. Believing it causes 
liver problems. 
DTP/DTaP. Concerned about side-effects. Believed child received too many 
shots. Unlikely child would get disease. Believed disease was not serious. 
Wanted to postpone shot. 
Hep B. Concerned about side-effects. Believed child received too many 
shots. Unlikely child would get disease. Believed disease was not serious. 
Wanted to postpone the shot.  
Bates et al 1994 
(150) 
3 months. 67% (309/465). 
7 months. 29% (135/464) 
7 months. Perceived logistical barriers. Perceived susceptibility to 




Not reported Perception of severity and infectivity of the disease. Perception of safety 
and efficacy of vaccines 
Reasons for not vaccinating: 
Measles (n=449). 21% advised by doctor/health visitor; 16% child unwell (no 
fever); 15% no appointment received; 10% had the illness; 6% did not attend, 
no further appointment received; 5% child had fever; 4% inconvenient 
time/place; 4% did not want it; 4% fear of vaccine; 16% other 
Pertussis (n=526). 43% advised by doctor/health visitor; 31% fear of the 
vaccine; 4% had the illness; 2% child had fever; 20% other 




Pertussis vaccine. Anxiety regarding permanent health problems as a result 
of vaccine. Likelihood of child developing illness if vaccinated. Likelihood 
of child developing illness if not vaccinated. Perceived severity if contracted 
(without vaccination). Perceived importance of vaccination. 
MMR. Anxiety regarding permanent health problems as a result of 
vaccine. 
Measles. Anxiety regarding permanent health problems as a result of 
vaccine. Likelihood of child developing illness if vaccinated. Likelihood of 
child developing illness if not vaccinated. Perceived severity if contracted 
(without vaccination). Perceived importance of disease vaccination.  
Polio. Anxiety regarding permanent health problems as a result of vaccine. 
Likelihood of child developing illness if vaccinated. Likelihood of child 
developing illness if not vaccinated. Perceived severity if contracted (without 
vaccination). Perceived importance of vaccination. 
Diphtheria. Anxiety regarding permanent health problems as a result of 




child developing illness if not vaccinated. Perceived severity if contracted 
(without vaccination). Perceived importance of vaccination.  
Bigham et al 
2006 (110) 
88.9% (433/487; 95% CI 
[85.8%-91.4%]) 1 hep B 
Cues to action. Perceived benefits. Perceived barriers. Perceived illness 
severity. 
Reasons for not vaccinating (n=50): 24% concern about side-effects, 22% 
parental deferral to older age, 10% parental perception that their child was not 
at risk, 6% parent unaware of program, 38% other. 
Bond et al 1999 
(111) 
84% (1494/1779; 95% CI 
[82%-86%]) completely 
immunised.  
15% (272/1779; 95%CI 
[13%-17%] incompletely 
immunised 
1% (13/1779; 95% CI 
[0.3%-1.1%] no 
immunisation 
Complete immunisation. Perceived vaccine safety. Perceived vaccine efficacy 
First milestone.  Perceived vaccine efficacy. Perceived vaccine safety. 
Pertussis (serious; susceptible). Meningitis (serious; susceptible). 
MMR booster uptake.  Perceived vaccine efficacy. Perceived vaccine safety. 
Measles (serious; susceptible).  
DTP/Hib booster uptake.  Perceived vaccine efficacy. Perceived vaccine 
safety. Pertussis (serious; susceptible). Meningitis (serious; susceptible). 
 
Brenner et al 
2001 (173) 
3 months, 75%. 
5 months, 54%. 
7 months, 41% 
3 months. Self-efficacy. Perceived social norms. Fewer perceived barriers. 
Previous experience. Social support. Internal locus of control. Perceived benefit 
of immunisation. 
7 months. Self-efficacy. Perceived social norms. Perceived barriers. Previous 
experience. Social support. Internal locus of control. Perceived benefit of 
immunisation. 
 
Bults et al 2011 
(79) 
N/A Negative feelings after vaccination decision. No feelings of doubt about the 
vaccination decision. Social influence on vaccination decision. Less 
information seeking behaviour. Less advice sought from social network. 
  
Parental reasons for not vaccinating (n=1900): 50.6% fear of side-
effects/harmful consequences; 45.8% just have a bad feeling about it; 38.7% 
vaccine was not thoroughly tested; 35.1% no trust in effectiveness of vaccine; 
34.1% contradictory messages in media; 15.5% no trust in government; 14.5% 
my child is never sick; 10.2% principal convictions/belief in alternative 
medicine; 9.1% child was sick/had fever; 4.5% child has had Mexican 
influenza ; 3.9% other parents didn't vaccinate their child either; 3.3% 
underlying allergic symptoms; 2.8% practical barriers 
Parental reasons for vaccinating (n=1227): 43.4% don't want child to become 
sick; 9.9% Mexican influenza can be severe (hospitalisations/death); 5.5% the 
government advises it, so I do it; 5.5% if I don't do it, I will regret it; 2.7% 
pregnant woman/baby/vulnerable person in household; 2.1% child is very 
susceptible for infections like influenza ; 1.5% GP advises vaccine; 1.5% social 
environment (friends/family) accepted vaccine, so I do too; 1.4% trust in 
effectiveness of vaccine; 1.4% if it doesn't benefit, it won't harm either; 1.3% 
child has underlying disease; 1.1% child receives vaccines according to 
National Immunisation Program. 
Casiday et al 
2005 (112) 
889 (89.3%) received 
MMR vaccine.  
72 (7.2%) started a course 
of single-antigen vaccines, 
Perceived vaccine safety (scientific evidence shows no link between MMR 
and autism; cannot be proved with 100% certainty that MMR is safe; 
more time is needed to fully investigate effects of MMR vaccine; possible 
complications of MMR can be very serious for children), less 




but only 19 of these (26.4) 
had all 3 immunisations.  
31 (3.1%) received neither 
MMR nor single antigens 
vaccines are safe for children; children receiving separate vaccines are at 
risk from time lag between vaccines; if separate vaccines were offered by 
NHS many people wouldn’t show up for all three jabs), importance of 
immunisation (I have responsibility to have my child vaccinated for the 
protection of all children; people who don’t vaccinate their kids put others 
at risk; my child is likely to get measles if s/he isn’t vaccinated), trust in 
doctors and the government (doctors are too dismissive of what parents 
claim about the vaccine side-effects; if I have any concerns about MMR 
they are taken seriously by my doctor; parents should make health 
decisions for their own children rather than leaving it up to professionals,; 
government is too defensive about MMR; NHS does not recognise good 
intentions of parents who opt for single vaccines for child; government 
would stop MMR vaccine if there was evidence of serious risk; 
government does a good job of protecting us from risks to health) 
Cassell et al 
2006 (121) 
N/A Later time when MMR became a concern. Less concern about family 
health in relation to MMR. Higher severity of measles. Higher perception 
of approval by others (health visitor; GP). Less feeling that reasons for 
choice are different from most people you know. Certainty that made 
correct vaccination decision. Wanting to know more about MMR to help 
you make decision. Avoidance of talking to friends about MMR. Not 
believing there is a chance of serious side effects from MMR if there is a 
weakness in that child. Each child's immune system is not different. Single 
vaccines are a larger concern than MMR. MMR is not too much in one go. 
It is not better to get immunity naturally. Inability to forgive oneself if 
child ever got measles. Ability to forgive oneself if child ever got autism or 
other side-effects. Not believing that most important thing is that parents 
have the choice. Believing it to be easier if you were just told, and it wasn’t 
your decision. Considering possible benefits to other children when deciding 
about MMR. Right for health professionals to advise parents to have their 
child vaccinated for the benefit of other children. Government’s 
responsibility to decide whether children should be vaccinated. Trusting 
the government over science. Fewer being suspicious of the influence of the 




63% (116/182)  Reasons for not vaccinating (n=40): 65% adverse publicity; 25% advice from 
general practitioner/health visitor; 10% other reasons 
Cuninghame et al 
1994 (122) 
3 Diphtheria, 86% (n=93).  
3 Pertussis, 82% (n=93).  
MMR 79% (n=42) 
 Reasons for not vaccinating: 
Third diphtheria (n=4); 75% intend to have (delay), 25% minor acute illness. 
Third pertussis (n=8); 50% intend to have (delay), 25% minor acute illness, 
25% side-effects concerns.  
MMR (n=9), 56% intend to have (delay), 22% minor acute illness, 11% side-
effects concerns, 11% difficult access 
 284 
 
Dannetun et al 
2005 (123) 
13.1% (26/199)  Reasons for not vaccinating: (n=70). 64% fear of side-effects; 50% better with 
natural immunity; 16% adjuvant; 9% small risk of disease 
Dawar et al 2002 
(124) 
3 hep B, 73.8%; 2 hep B, 
12.5%; 1 hep B, 0.5%; no 
hep B, 13.1%.  
3 DPTP-Hib, 89.0%; 2 
DPTP-Hib, 7.9%; 1 
DPTP-Hib, 1.0%; no 
DPTP-Hib, 2.1%. 
 Reasons for not vaccinating (n=21): 52% lack of hep B program awareness on 
the part of the physician, 29% physicians or parents felt that the infants were 
not at risk of acquiring the hep B infection, 14% parents did not support the 
program either due to concern regarding possible adverse effects of vaccine, 
5% due to adverse media publicity, 5% parent deferred the vaccination to the 
grade six program 




Vaccine safety. Vaccinator's recommendation. Reasons for not vaccinating (n not reported): 39% complications of disease not 
frequent enough; 32% complications of disease not serious enough; 39% 
vaccine too expensive; 35% weak vaccinator's recommendation 
Dubé et al 2012 
(113) 
42% (165/394) Parental intention. Personal normative belief (parents' perceptions of 
moral correctness of having their child vaccinated). Having a doctor/nurse 
recommend the vaccine. Vaccine administered orally rather than by injection. 
Difficulty in getting an appointment. Cost of vaccine. Having vaccine given 
in fewer than three doses. Having vaccine given in more than two doses. 
Having vaccine given at same time as other vaccines. Difficulty accessing 
doctor’s office/public health immunisation clinics. Less fear of side-effects. 
Smaller problem that vaccine will not protect against all diarrhoea. 
Vaccine given as part of universal immunisation program (free).
3
 
Reasons for not vaccinating (parents with vaccination intention, n=106): 51% 
child receiving enough vaccines; 48% vaccine not useful; 40% vaccine not 
included in free public vaccination program 
Flynn & Ogden 
2004 (126) 
77.7% (397/511) Encouragement from others, perceived risk of illness, guilt about 
consequences, prior experience of issues, faith in the media, faith in the 
medical profession, belief that vaccination is unhealthy 
 
Gellatly et al 
2005 (127) 
72.7% (80/110) Influence of current research findings as important. Finding information 
contained in leaflets and packs useful. Perceived importance of eradication 
of rubella. Perceived importance of risk of adverse reactions. Government 
advice. Government pressure. Health professionals’ advice. Health 
professional’s opinion. Lack of information on single vaccines. Nature of long-
term effects. Other allergic reactions. Perceived protection from illness in one 
dose. 
 
Gilkey et al 
(156) 
85% completed all 
vaccines 
Vaccine confidence. Vaccine benefits. Vaccine harm. Trust in healthcare 
provider. 
 
Gore et al 1999 
(114) 
65.2% fully immunised 
(206/316) 
 
Perceived clinical support. Positive attitude towards immunisation. 
Immunisation-related beliefs. Fewer general problems during 
immunisation. 
 
                                                 
3 At the time of the study, the vaccine was recommended for all children in Canada, but was not included in the publicly funded vaccination programme, meaning that parents 
had to pay for the vaccine (approximately 150-220 US$) 
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Gust et al 2004 
(116) 
N/A Believing vaccines to be unsafe. Believing vaccines to cause minor side-
effects. 
Reasons for not vaccinating 
Under vaccinated children. 57.2% side-effects; 33.7% too many shots 
Fully vaccinated children. 45.5%; 27.1% low perceived severity of illness  
Gust et al 2008 
(115) 
Not reported Vaccine is not effective. Vaccine is not safe or may cause serious side-effects Reasons for not vaccinating (n=234) 
DTaP – 67.4% safety/side effect; 22.6% child was ill; 1.1% effectiveness; 0.5% 
do not know/refused; 8.4% other.  
Polio – 82.4% safety/side effect; 14.4% child was ill; 1.5% effectiveness; 1.7% 
other.  
MMR – 93.9% safety/side effect; 3.9% child was ill; 1.7% effectiveness; 0.5% 
other.  
Hib – 76.5% safety/side effect; 9.3% child was ill; 3.2% effectiveness; 11% 
other.  
Hep B – 62.2% safety/side effect; 26.9% effectiveness; 5.3% child was ill; 
5.6% other. 
Varicella – 49.6% safety/side effect; 45.8% effectiveness; 2.4% child was ill; 
0.9% cost; 1.3% other. 
PCV – 65.5% safety/side effect; 25.1% effectiveness; 8.0% child was ill; 0.9% 
missed/could not get appointment; 0.5% other.  
Influenza –53.3% effectiveness; 34.5% safety/side effect; 1.4% do not 
know/refused; 10.5% other. 
Hughart et al 
1999 (128) 
(1) AA DTP1, 94.1%. 
(2) AA DTP3, 73.0%. 
(3) AA MMR, 67.6%. 
(4) UTD 4DTP, 3OPV, 
1MMR, 4Hib, 70.6%.  
(5) AA 3 Hep B, 49.8% 
Parental knowledge. Parental attitudes.  
Kaur 2011 (143) 94.3% MMR1. Fear (measles; mumps; rubella). Perceived severity of disease 
(measles; mumps; rubella). Vulnerability if not immunised (measles; 
mumps; rubella). Vulnerability if immunised (autism; IBD). Response 
efficacy (More dangerous to have MMR immunisation than to have 
measles; MMR immunisation weakens child’s immune system; strong 
evidence of a link between MMR immunisation and autism; no strong 
evidence that MMR causes IBD). Internal self-efficacy (Child’s distress; 
own anxiety). Subjective norm: wanted to vaccinate (Partner; child’s 
grandparents; friend; GP; health visitor). Followed advice (partner; child’s 
grandparents; friend; GP; health visitor). 
MMR2. Fear. Severity of diseases. Disease vulnerability if not immunised. 
Autism/IBD vulnerability if immunised. Response efficacy: immunisation 
efficacy and attitudes. Response efficacy: safety evidence. Subjective 
norms. 
 
Kim 2004 (129)  56% (n=65) Difficulty remembering immunisation schedule. Perceived severity of illness. 




Kim & Lee 2011 
(171) 
50.3% fully up-to-date.  
Age-appropriate 
immunization:  
4 DTP, 51.7%; 3 polio, 
88.0%; MMR, 87.9%. 
Perceived susceptibility. Perceived benefit. Perceived severity. Perceived 
barrier. Knowing when next shot will be. 
 
Lau et al 2013 
(130) 
6.0% Perceived susceptibility. Perceived severity. Perceived benefits of vaccination. 
Perception of side-effects. Cue to action (recommendation from healthcare 
professional. Awareness of government’s recommendation for vaccination. 
 
Reasons for not vaccinating (first dose; n not reported): 23.2% not necessary, 
11.4% do not know/had not thought about it, 10.0% the baby is too young, 
8.8% had not been recommended by healthcare professionals, 8.1% worry 
about side effects of influenza vaccine, 4.3% out of stock, 3.6% afraid of 
clashing with other injections, 3.1% vaccine not efficacious, 2.6% seldom go 
out, 2.4% did not know where to get influenza vaccine, 1.9% sick, 1.2% not 
living in HK, 0.9% busy, 0.7% did not want to take influenza vaccine, 0.7% 
vaccine taken more than 6 months previously was still efficacious, 0.7% cannot 
afford it, 0.7% allergic to influenza vaccine, 0.7% inadequate knowledge about 
influenza vaccine; 3% other. 
Reasons for not vaccinating (second dose; n not reported): 33.3% did not 
realise a follow-up dose was required, 16.7% out of stock, 16.7% child was 
sick, 33.3% other reasons  





 Reasons for not vaccinating: (n=160): 28.8% knowledge of when second dose 
of MMR due, 18.1% illness/medical reasons, 16.3% forgot, 8.1% family 
logistical issues, 8.1% disagree with immunisation, 5.6% concerned about 
immunisation, 5.0% should have been given (at school) but no record or recall, 
3.8% doctor did not offer MMR vaccination, 3.1% other, 3.1% unsure of reason 
Lewis et al 1988 
(151) 
69% (n=1410) adequately 
immunised 
26% (n=540) partially 
immunised 
4% (n=79) not immunised 
Worry about vaccine. Reasons for vaccinating (adequately immunised; n=1410): 84.6% vaccine 
important, 10.6% physician recommended, 4.2% required by law, 0.6% 
required by day care. 
Reasons for vaccinating (partially immunised; n=530): 81.7% vaccine 
important, 10.3% physician recommended, 5.2% required by law, 0.7% 
required by day care. 
Maayan-Metzger 
et al 2005 (144) 
N/A 
 
Multinomial logistic regression. Vaccinations given to babies in hospital are 
effective. Vaccinations given to babies in the hospital are against 
dangerous diseases. Vaccinations approved by the Ministry of Health are 
not dangerous. Injections are very traumatic to the baby. If one had a 
choice, then home delivery is the best way to give birth. Parents have the 
right to determine the treatment given to their child. Natural medicine is the 
best. 
Reasons for not vaccinating (n not reported): 54.9% child is too young to be 
vaccinated, 19.6% doctors vaccinate without differentiation, 17.6% vaccines 
are dangerous, 13.7% it causes trauma to the baby, 9.8% mother was 
vaccinated. 
Reasons for vaccinating (n not reported): I trust the doctors, vaccines protect 
the baby. 




Concern about vaccine safety. Lack of belief in disease susceptibility and 
severity, and vaccine effectiveness. Distrust in medical professionals. Distrust 
in government.  Bad immunisation experience with older child. Experience 
with side effect(s). Knew someone with vaccine-preventable disease. Positive 
experience with immunisation provider. Received adequate information on 




Delayed immunisations in the past because too many needles at once. 
Considered not getting immunisation because of needle pain. Getting 
immunisations was a hassle/difficult (slightly difficult, somewhat difficult, 
quite/very difficult. 
Matsumura et al 
2005 (152) 
18 months, 73.2% 
36 months, 88.9% 
18-month olds. High knowledge, low concern (reference). Low knowledge, 
low concern. High knowledge, high concern. Low knowledge, high concern. 
 
36-month olds. High knowledge, low concern (reference). Low knowledge, 
low concern. High knowledge, high concern. Low knowledge, high 
concern. 
Reasons for not vaccinating.  
18-month olds (n=698). 76.2% has not received it yet but will in near future, 
32.5% had a cold at time of vaccination, 23.5% had to receive other 
vaccinations first, 22.2% wanted to receive it but missed the chance, 6.9% 
wasn’t aware of/forgot about the vaccination schedule, 4.9% was sick at time of 
vaccination, 4.9% has already been infected with measles, 2.9% concern about 
adverse events of measles vaccination, 2.4%  naturally acquired immunity 
seems more effective, 2.4% vaccination is no longer mandatory, 0.7% 
vaccination does not seem to be sufficiently effective, 5.4% other. 
36-month olds (n=211). 46.9% has not received it yet but will in near future, 
34.1% wanted to receive it but missed the chance,24.2% had a cold at time of 
vaccination, 11.8% has already been infected with measles,11.4% had to 
receive other vaccinations first, 9.5% wasn’t aware of/forgot about the 
vaccination schedule, 9.5% concern about adverse events of measles 
vaccination, 6.6% vaccination is no longer mandatory, 4.7% naturally acquired 
immunity seems more effective,1.9% was sick at time of vaccination, 1.4% 
vaccination does not seem to be sufficiently effective, 3.3% other. 
Miller et al 1994 
(153) 
N/A Seriousness of illness. Susceptibility to illness. Efficacy of vaccine. Vaccine 
likely to be harmful. Worry about fever after vaccination. Believe that multiple 
vaccinations were unsafe. Correct knowledge of age for MMR 
immunisation. 
 
Morgan et al 
1987 (132) 
74% (129/174)  Reasons for not vaccinating (n=20): 35% decided against the immunization, 
with the main reasons being problems of fits in the family, the child's medical 
problems (generally an egg allergy or eczema) or because the child had already 
had measles, 65% 'delay' due to child having an illness and other worries, such 
as the harmful effects of the vaccine. 
Muhsen et al 
2012 (133) 
N/A Religious belief against vaccines (Bnei Brak, Jerusalem. Low perceived 
risk of vaccine preventable diseases (Bnei Brak, Jerusalem). No trust in 
Ministry of Health vaccines (Bnei Brak). 
 
Niederhauser et 
al 2001 (134) 
71% vaccinated (187/262) Awareness (knowledge, cues to action). Assessment (perceptions, barriers, 
benefits). Decision-making (necessity of vaccine for child, thought about 
risks and benefits and decided vaccine was good, confident in vaccine 
preventing disease in child, importance of immunising child on time, sure 
my child needs the shot as the doctors and nurses told me it was 
important, not worried about how long the vaccine will protect my child 





al 2014 (169) 
65%  Physician recommendation. Perceived threat of illness (high, moderate). 
Perceived risk of vaccine-related adverse events (high, moderate). 
 
Opel et al 2013 
(135) 
66.1% fully vaccinated Lower score on PACV questionnaire  
Pearce et al 2008 




 Reasons for not vaccinating (n=1508). 74.4% conscious decision (of these 
24.1% too scared/think the vaccine too dangerous, 18.6% do not want child to 
receive MMR, 14.1% fear over possible links with autism, 9.5% negative 
media attention), 12% medical issues, 3% practical issues, 10% other. 
23.6% (n=184) fully 
caught-up  




Reason for not having had MMR at age 3 (practical – reference), (medical, 
other). Conscious decision.  
 




Parents’ attitude score: measles, pertussis. Reasons for not vaccinating 
Measles (n=449). 21% doctor/health visitor advised against vaccine; 16% child 
'unwell' (no fever); 15% no appointment received; 10% had the disease; 6% did 
not attend (no further appointment received); 5% child had fever; 4% 
time/place inconvenient; 4% did not want it; 3% fear of vaccine; 16% other. 
Pertussis (n=526). 43% doctor/health visitor advised against vaccine; 31% fear 
of vaccine; 4% had the disease; 2% fever; 20% other  
Petrovic et al 
2003 (137) 
N/A Influence from newspapers/television.  Perceived seriousness of illness. 
Worry about MMR vaccine. 
Reasons for not vaccinating (n=33): 75.8% one dose of vaccine is enough, 
63.6% worried about side-effects, 9.7% negative influence of a health visitor 
Prislin et al 1998 
(145, 154) 
Not reported ‘Attitudes and perceived control significantly influenced up-to-date 
immunization: The more positive the attitudes and the stronger the sense 
of personal control, the better the immunization status’ 
 
54% Less acculturation. 
Qutaiba B Al-
lela et al 2014 
(118) 




N/A  Reasons for not vaccinating (n=16): 75% intended to finish the 
schedule/assumed they had completed it, 13% decided against vaccination after 
receiving one or more doses, 6% GP was seemingly unaware of the need for a 
third dose, 6% child had been judged too seriously ill for vaccination. 
Samad 2006 
(162) 
95.6% (n=17,544) fully 
immunised 
3.3% (n=712) partially 
immunised 
 Reasons for not vaccinating 
Partially immunised infants (n=697): 31.4% child unwell, 14.1% next 
appointment in near future, 5.4% parent unable to keep appointment, 5.3% 





whooping cough vaccine excluded, 3.8% parental choice, 3.2% child unwell 
after last vaccination/allergic reaction, 2.9% did not want child to have all 
vaccines at once, 2.6% medical problems related to reaction to vaccination in 
family, 1.0% lack of supplies/ran out of vaccine, 0.1% staffing problems. 
Unimmunised infants (n=228): 9.9% associated health risks/concerns, 6.9% 
prefer to use homeopathic alternative/other method, 6.6% medical problems 
related to reaction to vaccination in family, 6.4% child is too young and prefer 
to wait until older, 3.2% administrative error/difficulties, 3.2% parents have not 
got round to it yet, 2.6% parental choice, 2.2% parent unable to keep 
appointment, 1.5% benefits do not outweigh the risks, 1.1% staffing problems, 
0.5% parent dislikes needles/injections, 0.5% lack of supplies/ran out of 
vaccine. 
Schempf et al 
2007 (146, 147) 
72.4% Satisfaction with care.  
Smailbegovic et 
al 2003 (163) 
57% (39/68) omitted 
MMR 
49% (33/68) omitted men 
C 
18% (12/68) omitted 
pertussis 
15% (10/68) omitted BCG 
6% received no vaccines 
 Reasons for not vaccinating (n=68): 68% vaccine safety; 27% time constraint; 
19% lack of information 
Smith et al 2015 
(157) 
Not reported Perceived necessity of vaccines to protect the health of children. Worry 
less about child’s health after vaccinating. Perceived severity of measles as 
an illness that can hurt child. If don’t vaccinate child, may catch illness 
and cause others to have illness too. Vaccines are effective. Children do not 
receive too many vaccines. Influence of healthcare worker on vaccination 
decision. Less influence of practitioner of complementary or alternative 
medicine on vaccination decision. Higher perceived encouragement from 
healthcare provider to vaccinate). Perception of enough time to discuss 
issues surrounding vaccination with doctor at appointments. Satisfaction 
with information about vaccination. Good relationship with child’s 
healthcare provider. Perception that medical professionals in charge of 
vaccinations have child’s best interest at heart. Influence of school or day-
care requirements on vaccination decision. Vaccines are safe. Vaccines do not 
cause autism. Vaccines do not cause serious side-effects. Too many 
vaccines cannot overwhelm child’s immune system. Vaccination should 
not be delayed if child has minor illness. 
 
Stahl et al 2013 
(164) 
12-23 months, 32.3% 
24-35 months, 57.3% 
Consider vaccination useful. Physician advice to vaccinate.  
Stockwell et al 
2011 (166) 





Strobino et al 
1996 (172) 
283 (54%) UTD. 
71% (374) age appropriate 
DTP1, 35% (186) age 
appropriate DTP3, 53% 
(276) age appropriate 
MMR 
DTP1 age-appropriate immunisation. Not important if child misses a shot. Less 
than sure can complete steps to get child immunized. Bringing other children to 
clinic is a hassle. It is safe to get more than one shot at a time. Keeping shots 
up-to-date is not the norm. Total time at last visit was long (≥90 min). Shots are 
effective. 
DTP3 age-appropriate immunisation. Not important if child misses a shot. 
Less than sure can complete steps to get child immunized. Bringing other 
children to clinic is a hassle. It is safe to get more than one shot at a time. 
Keeping shots up-to-date is not the norm. Total time at last visit was long (≥90 
min). Shots are effective. 
MMR age-appropriate immunisation. Not important if child misses a shot. 
Less than sure can complete steps to get child immunized. Bringing other 
children to clinic is a hassle. It is safe to get more than one shot at a time. 
Keeping shots up-to-date is not the norm. Total time at last visit was long (≥90 
min). Shots are effective. 
UTD. Not important if child misses a shot. Less than sure can complete steps 
to get child immunized. Bringing other children to clinic is a hassle. It is safe to 
get more than one shot at a time. Keeping shots up-to-date is not the norm. 
Total time at last visit was long (≥90 min). Shots are effective. 
 
Taylor et al 2002 
(139) 
79.0% (10,684/13,520)  
 
19+ months, 66.3% 
8 months. Confusing vaccination schedule. Expense of vaccines. 
Inconvenience of vaccination process. Child often too ill to receive 
vaccinations. Religious objections. Any significant barrier. 
 




Influence (newspapers, television, internet, vaccine pressure groups). More 
influenced by a health visitor. Measles is a mild disease. MMR is ineffective. 
Vaccines are protective. MMR does not cause serious diseases. Side-effects 
of MMR are seriously researched. There is not a conspiracy. Infectious 
diseases would disappear without vaccines. Infections are not good for the 
immune system. The second dose is essential. Three-in-one is not harmful. 
MMR has been thoroughly researched. 
 
White & Lines 
1996 (140, 159) 
70.1% Knowledge. Number of barriers.  
Whiting et al 
1990 (141) 
51% (37/72)  Reasons for not vaccinating (n=35): 80% other (lack of prior knowledge, 
physician advice, lack of time), 29% physician advice, 25% lack of prior 
knowledge, 20% possible side effects, 14% lack of scientific data, 11% ill 




22.2% Somali parents 
refused vaccine.  
5.8% non-Somali parents 
refused vaccine. 
 Reasons for not vaccinating (n not reported): 57.1% heard problems with the 
vaccine, 42.9% personally knowing someone who had suffered adverse effects 
to the vaccine.  
Reasons for vaccinating (n not reported). Trust healthcare provider’s 
judgement, concern over child becoming ill, disease spreading in community. 
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Wu et al 2015 
(148) 
58.9%  
42.4% had two or more 
doses 
Perceived susceptibility. Number of items responses reflecting perceived 
benefits (1-3 items; 4+ items). Number of items responses reflecting 
perceived barriers (1-3 items; 4+ items). Number of items responses 
reflecting cues to action (1-3 items; 4-5 items). Subjective norm). Fear 
during H1N1 pandemic. 
 




Problems with transport. Child had been ill. Did not know when next 
vaccine needed. Hard to remember appointment. Afraid child would have 
reaction to injection. Do not like the HCW. Doctor advised child not to have 
the injection. Clinic location not convenient. Injection too expensive. Did not 
want to put child through pain of injection. Did not want child to have more 
than one injection at a time. 
 
Zhao 2015 (149) 85.3% Confidence in value of vaccines. Confidence in efficacy of vaccines. 
Confidence in safety of vaccines. Parents have good relationship with 
providers. 
 
BCG – Bacille Calmette-Guérin; DTP – whole-cell diphtheria and tetanus toxoids and pertussis vaccine; DTaP – diphtheria and tetanus toxoids with acellular pertussis vaccine; GP – general practitioner; Hep A – 
hepatitis A; Hep B – hepatitis B; Hib – haemophilus influenza B; HK – Hong Kong; IBD – irritable bowel disease; MCV – measles containing vaccine; men C – meningitis C; MMR – measles, mumps and rubella 





Appendix 3. Methods of articles included in systematic review of factors affecting parental 
perception of symptoms in one’s child 
 Study design (method) Number of participants 
(child age) 
Inclusion criteria Risk 
of 
bias 
Akbarzadeh et al 2018 (359) Cross-sectional (questionnaire and 
interview) 
212 (7-16 years. Mean age 
9.83 years) 
Parents of children with a diagnosis of chronic or recurrent 
headache in Tehran, Iran 
12 
Aromaa et al 1998 (355) Case-control, as part of wider 
prospective cohort study 
(questionnaire) 
968 (6 years) Parents of children in Finnish Family Competence Study 
with (n=144) and without headache (n=764) in preceding 6 
months 
9 
Baldin et al 2012 (360) Cross-sectional (questionnaire) 9679 (7-15 years. Mean 
10.83 years) 
Parents of school children in all public and private schools 
in Reykjavik, Iceland school district 
8 
Borge & Nordhagen 1995 
(356) 
Prospective cohort (interview) 139 (10 years) Parents of children in a rural birth cohort in Norway 7 
Cerutti et al 2017 (345) Cross-sectional (paper 
questionnaire, delivered to parents 
by children) 
356 (8-15 years) Parents of children aged 8-15 who were not undergoing 
pharmacological or psychological therapy, or had an 
existing diagnosed infection/other medical illness, in Italy 
9 




75 (3-5 years) Mothers of preschool children who were registered in the 
Family Health Program in South-East Brazil 
11 




807 (3-6 years) Parents of children attending pre-school public and private 
nurseries in Spain 
8 
Fabbri et al 2012 (343) Prospective cohort (questionnaire) 1674 (7-11 years) Parents of children born in two areas of Brazil 12 
Fearon & Hotopf 2001 (362) Prospective cohort (interview) 9841 (7-11 years) Parents of children born in Great Britain from 3-9 March 
1958 
10 
Fryer et al 2017 (374) Cross-sectional (questionnaire) 8463 (11 years) Parents of children in the fifth wave of the UK Millennium 
Cohort Study 
13 
Gassmann et al 2012 (363) Prospective cohort (questionnaire) 3984 (7-15 years. Mean 
age 11.3) 
Parents of children in the Children, Adolescents & 
Headache Study (‘KiJuKo’) in Germany 
8 
Giacobo et al 2012 (346) Cross-sectional (paper 
questionnaire) 





Gibb 2014 (347) Cross-sectional (questionnaire and 
interview) 
1368 (7-11 years) Parents of children at selected schools in England 10 
Giray et al 2018 (364) Cross-sectional (questionnaire) 85 (4-12 years. Mean age 
7.1±2.5 years) 
Mothers of children with cerebral palsy attending an 
outpatient clinic between February and April 2016, in 
Turkey 
12 
Grunau et al 1994a (348) Case-control (paper questionnaire at 
18-month visit) 
195 (18 months) Case 1, extremely low birth weight: parents of children who 
weighed less than 801g (n=49).  
Case 2, extremely low birth weight: parents of children who 
weighed 801-1000g (n=75). 
Control: parents of pre-term children who weighed 1500-
2499g (n=42). 
Control: parents of full-birth-weight children, >2499g 
(n=29) 
6 
Grunau et al 1994b (349) Prospective case-control (paper 
questionnaire at multiple visits, 
observation of mother-child 
interaction at 3 year visit) 
72 (4.5 years) Case: extremely low birth weight: parents of children who 
weighed 1000g or less 
Control: parents of full-term children with birthweight 
>2500g 
5 
Henriksen & Thuen 2015 
(365) 
Prospective cohort (questionnaire) 8788 (6-11 months) Mothers of children enrolled in the Norwegian Mother and 
Child Cohort Study 
9 




600 (0-48 months) Parents of children attending an antenatal or postnatal clinic 
in two Dublin, Ireland hospitals; or attending some 
immunisation clinics 
7 
Kohler et al 2017 (366) Cross-sectional (postal 
questionnaire) 
6728 (4 years) Parents of children in Skåne (Scania), Sweden 13 
Link & Fortier 2016 (367) Cross-sectional (questionnaire, 
either at home or at scheduled 
appointment) 
353 (0-18 years. Mean age 
10.6 years) 
Parents of English and Spanish speaking children 
undergoing treatment and attending routine visit at Hyundai 
Cancer Institute at Children’s Hospital of Orange County, 
USA between November 2009 and October 2011 
12 
Litcher et al 2001 (350) Cross-sectional (home interviews) 600 (10-12 years) Parents of children in Kyiv, Ukraine 10 
Morris 2006 (344) Cross-sectional (postal 
questionnaire) 
5474 (7-14 years. Mean 
age 10.3 years) 
Parents of children in the Children, Adolescents & 
Headache Study in Germany 
13 
Pitrou et al 2010 (368) Cross-sectional (questionnaire) 1308 (6-11 years) Parents of children in selected primary schools in France 12 
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Poder et al 2010 (369) Prospective cohort (telephone 
questionnaire) 
214 (0-18 years) Parents of children recently diagnosed with cancer who 
were scheduled for chemotherapy or radiotherapy in certain 
paediatric oncology centres in Sweden 
11 
Ramchandani et al 2005 
(371); Ramchandani et al 
2006 (372); Ramchandani et 
al 2007 (370) 
Prospective cohort (questionnaire) 30 months, n=10,205. 42 




Mothers of children resident in Avon, England, with an 
expected date of delivery between April 1st 1991, 
and December 31st 1992 
14 
Rocha et al 2003 (351) Cross-sectional (postal 
questionnaire, and inoculation 
appointment) 
163 (56-68 months. Mean 
age 62 months) 
Mothers of kindergarten children in Canada 6 
Soltis & Shelestak 2011 (352) Prospective cohort (paper 
questionnaire) 
44 (1 month – 9 years. 
Median age 27 months) 
Parents of children scheduled for voiding 
Cystourethrogram in Ohio, USA 
7 
Srivastava et al 2001 (353) Prospective cohort (paper 
questionnaire) 
25 (1 week – 6.5 years. 
Median age 0.62) 
Parents of children referred for a micturating 
cystourethrogram procedure 
6 
Stevenson et al 1988 (354) Cross-sectional (face-to-face 
interview) 
189 (2.5-3.5 years) Parents of children aged 2.5 to 3.5 years in the UK 3 
Strine et al 2006 (342) Cross-sectional (interview) 9399 (4-17 years) Parents of children in the 2003 National Health Interview 
Survey Sample Child Core in the USA 
16 
Wolff et al 2010 (373) Prospective cohort (postal 
questionnaire) 
5171 (Questionnaires sent 
at age 18 months. Mean 
age 18.4 months) 
Parents of children in Generation R Study in Rotterdam, 
Netherlands 
14 
Zuckerman et al 1987 (358) Prospective cohort (face-to-face 
interviews) 
308 (0-3 years, T1 at 8 
months, T2 at 3 years) 





Appendix 4. Full table of results of factors associated with parental report of symptoms. Unless 
stated, predictors are reported by the same person reporting symptoms and relate to child factors. 
 Symptoms perceived Measure of symptoms Predictors of symptom perception 
Akbarzadeh et al 
2018 (359) 
Pain severity of headache Numeric pain rating scale Mothers’ ratings of child pain: mother catastrophising about 
pain, anxiety, depression 
Fathers’ ratings of child pain: father catastrophising about 
pain, anxiety, depression 
Aromaa et al 1998 
(355) 
Disturbing headache ‘Has your child had headache 
disturbing his/her daily activities 
during the last 6 months? Has your 
child had headache disturbing his/her 
daily activities at some time in his/her 
life (before the last 6 months)?’ 
Answered yes to both questions to be 
case 
Maternal perception of child poor health (9 months), high 
sociability (5 years), behavioural problems (5 years) 
Baldin et al 2012 
(360) 
Recurrent symptoms ‘Has the child had any of the following 
symptoms?’ 
Has the child ‘ever complained of 
recurrent abdominal pain?’  
Migraine: fearful or anxious 
Recurrent abdominal pain: being fearful or anxious 
Recurrent body pain: being fearful or anxious 
Recurrent stomach bugs with vomiting: being fearful or 
anxious 
Recurrent vomiting without cause: being fearful or anxious 
Recurrent nosebleeds: being fearful or anxious 
Recurrent dizzy spells: being fearful or anxious 
Recurrent concussions from minor head injuries: being fearful 
or anxious 
Recurrent fainting spells: being fearful or anxious 
Recurrent visual disturbances: being fearful or anxious  
Recurrent spells rapid/irregular heartbeat: being fearful or 
anxious 
Recurrent chest pains: being fearful or anxious 
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Recurrent episodes of unexplained fever (>38): being fearful 
or anxious 
Recurrent episodes of diarrhoea: being fearful or anxious 
Recurrent wry neck (torticollis): being fearful or anxious 
Moving sickness: being fearful or anxious 
Tender hair: being fearful or anxious 
Other recurrent symptoms: being fearful or anxious 
Borge & Nordhagen 
1995 (356) 
Headache, stomach ache ‘Occurrence versus non-occurrence,’ 
frequency of complaint 
Headache and stomach ache co-occurrence: emotional 
problems (10 years), maternal emotional support, behaviour 
problems (4 years), emotional problems (4 years) 
Cerutti et al 2017 
(345) 
Somatic symptoms Short version of the Children’s 
Somatization Inventory – Parent 
version 
Difficulty in physical and psychological functioning. 
Alexithymia (difficulty identifying feelings (child-reported), 
difficulty describing feelings (child-reported), externally-
oriented thinking (child-reported)) 
Correia & Linhares 
2013 (361) 
Headache ‘Duration and characteristics of 
[headache] episodes over the last six 
months’ 
Adverse life events, extraversion (activity level, high-intensity 
pleasure, impulsivity, shyness), negative affect 
(anger/frustration, discomfort, fear, sadness, soothability), 
effortful control (attention focusing, inhibitory control, low-
intensity pleasure, perceptual sensitivity), approach/positive 
anticipation, smiling/laughter, maternal stress 
Domenech-Llaberia 
et al 2004 (246) 
Presence and frequency of physical 
symptoms (stomach aches, headaches, 
leg pains, tiredness, dizziness) 
‘Questionnaire… inquired about the 
presence and frequency once, two or 
three times, 
over three times) of four somatic 
complaints in the 2 weeks prior to 
assessment’ 
Frequently complaining children (4 or more complaints vs no 
complaints): ADHD inattentive, generalised anxiety 
disorder, adjustment disorder, number of stressful life 
events, maternal mental distress 
Fabbri et al 2012 
(343) 
Headache ≥2 episodes of headache in the past 
two weeks, without any associated 
organic symptoms 
Ribeirão Preto: strengths and difficulties  
São Luís: strengths and difficulties 
 
Fearon & Hotopf 
(362) 
Headache ‘Does your child suffer from 
frequent headache or migraine?’ 
Headache: moderate or severe depression (age 7), mental 
illness in family member (age 7) 
Recurrent headache: moderate or severe depression (age 7), 
mental illness in family member (age 7) 
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Fryer et al 2017 
(374) 
Frequent complaints of pain Parents asked whether child ‘often 
complains of headaches, stomach-
aches or sickness’ 
Maternal distressed mental health (at child 3 years), child 
strengths and difficulties at 5 years 
Gassmann et al 2012 
(363) 
Recurrent headache Headache frequency Boys: reaction to failure, dysfunctional stress coping, anger 
out, anxiousness/depressiveness, aggressive behaviour 
Girls: age, reaction to failure, dysfunctional stress coping, 
anger out, anxiousness/depressiveness, hyperactivity 
Giacobo et al 2012 
(346) 
Presence and frequency of physical 
symptoms (stomach ache, 
headache, fatigue, dizziness, and other 
complaints) 
Qüestionari Pels Pares (Questionnaire 
for Parents) 
Frequent somatisation: any anxiety symptoms, separation 
anxiety, social phobia, psychiatric symptoms (ADHD, 
generalised anxiety, specific phobia, depression, dysthymia, 
conduct disorder, oppositional defiant disorder), 
aggressiveness towards peers, severe mood dysregulation 
Stomach ache: any anxiety symptoms, separation anxiety, 
social phobia 
Leg pain: any anxiety symptoms, separation anxiety, social 
phobia 
Head ache: any anxiety symptoms, separation anxiety, social 
phobia 
Fatigue: any anxiety symptoms, separation anxiety, social 
phobia 
Gibb 2014 (347) Somatic symptoms Children’s Somatization Inventory – 
Parent version 
 
Anxiety, frequency of stressors (child-reported), 
communication scale (child-reported: total communication, 
communication with primary caregiver, open communication, 
inhibited confiding*, confiding of distress, caregiver 
responsiveness*, sharing of news, confiding in friends) 
* When control for child-reported anxiety, but not parent-
reported anxiety, association becomes non-significant  
Giray et al 2018 
(364) 
Pain Non-communicating children’s pain 
checklist-revised 
Quality of life, parental depression 
Grunau et al 1994a 
(348) 
Pain sensitivity ‘Child is very sensitive to pain of 
bumps or cuts or other common hurts.’ 
Likert scale of 1 to 5 from ‘not 
characteristic’ to ‘very characteristic.’  
Differences between groups: Temperament (not in children 




Grunau et al 1994b 
(349) 
Somatisation (at 4.5 year visit) 30 items which include questions about 
occurrence of stomach aches, 
headaches, leg pains among others 
Somatisation in extremely low birth weight group 
(correlations): mother interaction (gratification, sensitivity, 
affect), child interaction (gratification, responsiveness, affect), 
parenting style (acceptance, involvement, responsivity), 
child’s temperament (shyness, emotionality, sociability, 
activity), avoidance of touch, family conflict 
Somatisation in full-term group (correlations): mother 
interaction (gratification, sensitivity, affect), child interaction 
(gratification, responsiveness, affect), parenting style 
(acceptance, involvement, responsivity), child’s temperament 
(shyness, emotionality, sociability, activity), avoidance of 
touch, family conflict 
Somatisation (stepwise multiple regression): family conflict 
Henriksen & Thuen 
2015 (365) 




influenza , ear infection, pseudocroup, 
urinary tract infection, conjunctivitis 
Mothers marked a checklist which 
asked ‘whether their children had or 
had not experienced a disease’ 
<6 months old, common cold: maternal stressful life events, 
maternal relationship dissatisfaction 
<6 months old, throat infection: maternal stressful life 
events, maternal relationship dissatisfaction 
<6 months old, pneumonia/respiratory syncytial 
virus/bronchitis: maternal stressful life events, maternal 
relationship dissatisfaction 
<6 months old, diarrhoea/gastric influenza: maternal stressful 
life events, maternal relationship dissatisfaction 
<6 months old, ear infection: maternal stressful life events, 
maternal relationship dissatisfaction 
<6 months old, pseudocroup: maternal stressful life events, 
maternal relationship dissatisfaction 
<6 months old, urinary tract infection: maternal stressful life 
events, maternal relationship dissatisfaction 
<6 months old, conjunctivitis: maternal stressful life events, 
maternal relationship dissatisfaction 
6-11 months old, common cold: maternal stressful life 
events, maternal relationship dissatisfaction 
6-11 months old, throat infection: maternal stressful life 
events, maternal relationship dissatisfaction 
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6-11 months old, pneumonia/respiratory syncytial 
virus/bronchitis: maternal stressful life events, maternal 
relationship dissatisfaction 
6-11 months old, diarrhoea/gastric influenza: maternal 
stressful life events, maternal relationship dissatisfaction 
6-11 months old, ear infection: maternal stressful life events, 
maternal relationship dissatisfaction 
6-11 months old, pseudocroup: maternal stressful life events, 
maternal relationship dissatisfaction 
6-11 months old, urinary tract infection: maternal stressful life 
events, maternal relationship dissatisfaction 
6-11 months old, conjunctivitis: maternal stressful life 
events, maternal relationship dissatisfaction 
Kilgallen & Gibney 
1996 (357) 
Food allergy ‘presence or absence of perceived food 
allergy’ 
Maternal perception that general prevalence of food 
allergy is common 
Kohler et al 2017 
(366) 
Recurrent abdominal pain ‘How often has the child had 
abdominal pain during the past 6 
months?’  
 
Outcome dichotomised: ‘Yes’ if 
answer ‘practically every day’ or ‘more 
than once a week.’ ‘No’ if more rarely 
than once a week 
Child factors: violence in the family, serious life event 
Maternal factors: worries about economy, low emotional 
support, everyday stress 
Paternal factors: worries about economy, low emotional 
support, everyday stress 
Link & Fortier 2016 
(367) 
Pain severity. Frequency of chronic 
pain 
Pain severity: 0-10 numeric rating 
scale. Frequency of chronic pain in 
past 3 months: six-point Likert scale, 
‘every day’ to ‘less than once per 
month’ 
Pain severity: Parent trait anxiety 
Pain frequency: Parent trait anxiety 
Litcher et al 2001 
(350) 
Somatic symptoms Children’s Somatization Inventory – 
Parent version, amended 
 
Child behaviour somatisation, child behaviour 
depression/anxiety, depression (child-reported), anxiety 




Morris 2006 (344) Weekly headache versus good health Experienced headache in last six 
months. Frequency ‘at least once a 
week.’ Specify absolute number of 
headaches in certain time span 
Anger-out mode of expression, anxiety/depression, sleep 
disturbance, index of life events 
Pitrou et al 2010 
(368) 
Frequent headaches ‘Since his/her birth, did your child 
have frequent headaches, including 
migraines?’ 
Parenting style (punitive behaviours, inverse association; 
caring behaviours, overprotective behaviours), emotional 
problems, conduct disorder, peer relationship difficulties, 
hyperactivity-inattention, abnormal total difficulties on 
Strengths and Difficulties questionnaire, general anxiety 
disorder (child-reported), separation anxiety disorder (child-
reported), specific phobia (child-reported), major depressive 
disorder (child-reported), ADHD (child-reported), 
oppositional defiant disorder (child-reported), conduct 
disorder (child-reported) 
Poder et al 2010 
(369) 
Symptom presence, frequency, 
intensity and distress 
Modified version of the Memorial 
Symptom Assessment Scale 10-18 
(Physical symptom scale) 
Parental PTSD 
Ramchandani et al 
2005 (371); 
Ramchandani et al 
2006 (372); 
Ramchandani et al 
2007 (370) 
Abdominal pain ‘Have there been times when he/she 
seems to have had a pain in his 
stomach in the past 12 months?’ 
Yes/No. ‘How many separate times has 
this happened in the past 12 months?’ 
If ≥5 a year, in recurrent abdominal 
pain group 
30 months: maternal anxiety, maternal depression, partner 
anxiety, partner depression 
42 months: behavioural and emotional problems 
(hyperactivity, emotional, conduct, prosocial, total 
difficulties) 
81 months: strengths and difficulties (hyperactivity, 
emotional, conduct, peer problems, prosocial, total 
difficulties, adjusted emotional), activity (temperament), 
rhythmicity of eating and sleeping (temperament), 
maternal anxiety (mother-reported), paternal anxiety 
(father-reported) 
7 years: hyperactivity score, emotional score, peer problems, 
maternal anxiety, paternal anxiety 
Rocha et al 2003 
(351) 
Somatic symptoms Children’s Somatization Inventory – 
Parent version 
Behavioural style (adjustment, sensitivity,  
activity/persistence), illness behaviour encouragement, child’s 
facial responses to pain reactivity (trained coder rating), 
maternal response to child’s inoculation (trained coder rating) 
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Soltis & Shelestak 
2011 (352) 
Pain Visual analogue scale – 10cm long 
with 100 points, ‘perception of pain’ 
Parental anticipatory anxiety, parental high experienced 
anxiety 
Srivastava et al 2001 
(353) 
Pain Visual analogue scale – 10cm long 
with 100 points, ‘perception of pain’ 
Parental anticipatory anxiety, parental high experienced 
anxiety 
Stevenson et al 1988 
(354) 
Recurring stomach aches Child experiencing a stomach ache 
during the preceding 4 weeks and 
during any time prior to this 
Behaviour (temper tantrums, dependency, fears), maternal 
perception of inadequate social support, maternal depression, 
maternal irritability with child 
Strine et al 2006 
(342) 
Frequent or severe headaches ‘During the past 12 months, has 
[child’s name] had frequent or severe 
headaches, including migraines?’ 
Emotional symptoms (worried, unhappy, nervous, scared, 
total emotional domain), conduct problem (loses temper, 
less well behaved, fights/bullies, lies/cheats, steals, total 
conduct problem domain), hyperactivity-inattention 
(restless, fidgety, poor concentration, less reflective, less 
attentive, total hyperactivity-inattention domain), peer 
problems (plays alone, has good friend, popular, bullied, 
relates better to adults than peers, total peer problems 
domain), total high difficulties prevalence 
Wolff et al 2010 
(373) 
Presence and frequency of somatic 
complaints 
Child Behaviour Checklist Temperament (activity level, distress to limitations, fear, 
duration of orienting, falling reactivity, sadness), maternal 
prenatal symptoms (depression, anxiety), maternal symptoms 
at 2 months (depression, anxiety), parenting stress 
Zuckerman et al 
1987 (358) 
Recurring headaches and stomach 
aches 
At 3-year interview, if parent stated 
that child had experienced a headache 
or stomach ache in the last 4 weeks and 
at any time before this 
Headache: Behaviour problems (dependent, fears), maternal 
concerns about child’s appetite, maternal depression, 
maternal perceived inadequate support 
Stomach ache: Behaviour problems (dependent, fears), 
maternal concerns about child appetite, maternal depression, 
maternal perceived inadequate support 
Abbreviations: ADHD = attention-deficit hyperactivity disorder, PTSD = post-traumatic stress disorder
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Appendix 5. Cross-sectional survey  
• Survey data have been weighted by age, gender, region and working status 
to reflect the profile of parents/guardians of 2-7 year-old children in 
England4. 
• Results are based on all respondents (n=1,001) unless otherwise stated. 
Bases specified are unweighted. 
• Where percentages do not sum to 100, this may be due to respondents being 
able to select multiple responses, computer rounding or the exclusion of 
‘don’t know’/ not stated. 
• An asterisk (*) represents a value of less than half or one percent, but greater 
than zero. 













Q3. In which of the following regions do you live? 
    % 
North East 5 
North West 12 
Yorkshire and Humberside 12 
West Midlands 11 
East Midlands 9 
East of England 10 
South West 11 
South East 17 
London 14 
 
                                                 
4 Please note that because data on parents of children aged 2-7 specifically was not available, data from the 





Q4. Which of the following best describes your employment status?                                                                                                                    
    % 
Working – full time (30 or more hours a week) 51 
Working – part-time (less than 30 hours a week) 18 
Self-employed 5 
Unemployed – looking for a job 3 




Pupil/Student/In full-time education 1 
NET: Working 74 
NET: Not working 26 
 













Q7. Have you or [Specified Child] ever been diagnosed by a medical doctor 
as having any long-lasting illness, disability or infirmity?                                        




 % % 
Breathing complaint (e.g. asthma, bronchitis, 
pulmonary disease, emphysema) 
14 11 
Cancer 1 1 
Diabetes 3 1 
Heart disease (e.g. heart failure, high blood 
pressure) 
2 1 
Kidney disease (e.g. renal failure, kidney 
transplant) 
1 1 
Liver disease (e.g. hepatitis, cirrhosis) 1 1 
Mental health (e.g. depression, anxiety, stress) 16 1 
Neurological condition (i.e. caused by damage 
to the brain, spinal cord or other parts of the 
nervous system) 
2 1 
Stroke (or transient ischaemic attack; TIA) * * 
Substance misuse (i.e. alcohol, drugs) 1 N/A 
Other (please specify) 3 3 
None 67 82 
Don’t know 1 1 
 
Q8. To what extent, if at all, do you agree or disagree with the following 
statement.  





Someone in [Specified 
Child]’s household 
 % % % 
Strongly agree 33 20 22 
Tend to agree 28 28 28 
Neither agree nor disagree 18 22 21 
Tend to disagree 12 17 14 
Strongly disagree 6 9 8 
Don’t know/not sure 4 4 7 
 
The next questions are all about [Specified Child] and the flu vaccine. Please 




Q9. Has [Specified Child] had a flu vaccination at any time before 31st 




Don’t know 5 
 
Q10. As far as you know, was [Specified Child] eligible to have a free flu 




Don’t know 18 
 




Don’t know 3 
 
If ‘Yes’ go to question 12. If ‘No’ go to question 13. 
Q12. Why did you decide to vaccinate [Specified Child] against flu? Please 
give us your main reason(s). 
 % 
I wanted to protect [Specified Child] from flu 61 
I had an invitation/letter from [Specified Child]’s GP/school 57 
I believe/am aware that [Specified Child] is in an at-risk group/more 
vulnerable 
25 
[Specified Child] always has it 23 
The GP says [Specified Child] needs it 19 
Other (Please specify)1 3 
Don’t know 0 
Base: All those whose child had the child flu vaccination this Winter (n=526) 




Q13. Why did you decide not to vaccinate [Specified Child] against flu? 
Please give us your main reason(s). 
 % 
[Specified Child] is generally healthy and I am not overly concerned 
about him/her catching flu 
43 
Side effects/it makes you ill/it causes flu or a bad reaction 22 
I don't know enough about the vaccine 21 
I am concerned over how safe the vaccine is/it hasn't been tested enough 20 
Other (please specify)1 20 
[Specified Child] doesn’t need it 17 
I don't like [Specified Child] having vaccinations 12 
Don’t know 4 
Base: All those whose child did not have the child flu vaccination this Winter 
(n=402) 
Go to question 17. 
Q14. Did [Specified Child] experience any of the following side-effects 
because of the child flu vaccine?   
 % 
No, none 59 
Runny or stuffy nose 16 
Feeling tired, or having low energy 9 
Fever 8 
Generally unwell or not themselves 7 
Headache 6 
Flu 6 
Reduced appetite 4 
Weakness 4 
Muscle aches 4 
Pain in arms, legs or other joints 4 
Nosebleed 3 
Stomach pain 3 
Nausea (feeling sick), gas or indigestion 3 
Trouble sleeping 3 
Dizziness 2 
Rash 2 
Chest pain 2 
Shortness of breath 2 
Back pain 1 
Fainting spells 1 
Feeling of heart pounding or racing 1 
Constipation, loose bowels or diarrhoea 1 
Allergic reactions 1 
Other (please specify) 1 
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One or more side-effects 41 
Base: All those whose child had the child flu vaccination this Winter (526) 
If ‘No, none’ go to question 17. 
Q15. Overall, how severe were the side-effects that [Specified Child] 
experienced?  
 % 




Don’t know 1 
Base: All those whose child had the child flu vaccination this Winter and 
experienced one or more side-effects (216) 
Q16. Overall how worried were you, if at all, about the side-effects?  
  
 % 
Very worried 10 
Fairly worried 31 
Not very worried 38 
Not at all worried 22 
Don’t know 0 
Base: All those whose child had the child flu vaccination this Winter and 
experienced one or more side-effects (216) 
Q17. How much input did you have in the vaccination decision for [Specified 
Child]? 
 % 
I had sole responsibility 37 
I had joint responsibility, along with someone else 61 
I had no responsibility 2 
Other (please specify) 1 
Don’t know 0 
Base: All those whose child had the child flu vaccination this Winter (526) 
Think about next flu season (September 2016 – March 2017). During this 
time, you may be invited to vaccinate [Specified Child] against flu. For the 
following questions, please think about the next flu season. 
 308 
 
For each of the following statements, please tell us to what extent, if at all, 
you agree or disagree: 
Q18. I want [Specified Child] to be vaccinated for flu next year  
      
 % 
Strongly agree 37 
Tend to agree 30 
Neither agree nor disagree 14 
Tend to disagree 8 
Strongly disagree 8 
Don’t know/not sure 4 
 
Q19. I intend [Specified Child] to be vaccinated for flu next year 
 % 
Strongly agree 37 
Tend to agree 27 
Neither agree nor disagree 14 
Tend to disagree 9 
Strongly disagree 9 
Don’t know/not sure 4 
  
Q20. If I don’t vaccinate [Specified Child], then [Specified Child] is likely to 
catch flu 
    % 
Strongly agree 10 
Tend to agree 22 
Neither agree nor disagree 35 
Tend to disagree 20 
Strongly disagree 7 





Q21. Below are some things that other people have said about the child flu 
vaccine. To what extent, if at all, do you agree or disagree with the following 
statements?  





The child flu 
vaccine has not 
been tested 
enough for me 
to feel it is safe 
The child flu 
vaccine can cause 
unpleasant short-
term side-effects 




 % % % % 
Strongly 
agree 
12 10 11 7 
Tend to 
agree 




27 23 26 23 
Tend to 
disagree 
22 24 14 23 
Strongly 
disagree 









Q22. Below are some more things that people have said about the child flu vaccine. To what extent, if at all, do you agree or disagree 
with the following statements? 
 The child flu 
vaccine does not 




campaign is just 
about making money 
for the 
manufacturers 
Having the child flu 
vaccine is an 
effective way of 
preventing 
[Specified Child] 
from catching flu 





A health professional 
has recommended 
that [Specified Child] 
should be vaccinated 
A health professional 
has recommended 
that [Specified Child] 
shouldn’t be 
vaccinated 
 % % % % % % 
Strongly 
agree 
5 8 21 7 14 6 
Tend to 
agree 




16 26 22 26 25 15 
Tend to 
disagreed 
11 23 7 22 14 17 
Strongly 
disagreed 








Q23. Below are some more things that people have said about the child flu vaccine. To what extent, if at all, do you agree or disagree 
with the following statements?  
 The flu vaccine would 
interact with other 
medications that [Specified 
Child] is currently taking 
Vaccinating [Specified 
Child] against flu each 
year will overload his/her 
immune system 
Vaccinating [Specified 
Child] against flu each year 
is too much of an ongoing 
time commitment 
A friend/relative has 
recommended that 
[Specified Child] 
shouldn’t be vaccinated 
Another child I 
know had side-
effects from the 
vaccine 
 % % % % % 
Strongly 
agree 
4 6 6 5 6 
Tend to 
agree 




15 22 19 17 17 
Tend to 
disagree 
15 18 18 16 14 
Strongly 
disagree 








The following question is about your understanding of the effectiveness of 
vaccines. Please select the answer you think is most accurate. Please answer 
even if you are unsure.  
 
Q24. If the child flu vaccine is 50% effective (this is just a made up number 




50% of children who have the vaccine will be immune to 
flu 
29 
A vaccinated child will have a 50% chance of catching 
flu 
27 
If a child had a 50% chance of catching flu before being 
vaccinated, they now have half that chance (i.e. 25%) 
19 
Can’t tell the difference between the options above 10 
Don’t know 15 
 
The next four questions will ask you about some of the possible side-effects of 
the child flu vaccine. Please read the questions carefully, as many of them 
may seem very similar. If you are unsure, please give your best estimate. We 




Q25. The child flu vaccine has severe allergic reaction as a listed side effect. 
The patient information leaflet mentions that: 
Severe allergic reaction is a very rare side effect.  
Imagine 10,000 children are vaccinated with the child flu vaccine. Out of 
these children, how many do you think will get a severe allergic reaction? 
Please type a number in the box below.  If you are unsure, please provide 
your best estimate. 
 % 
0 * 
1 - 100 73 
101 - 500 10 
501 - 1,000 8 
1,001 - 2,500 3 
2,501 - 5,000 4 
5,001 – 8,000 1 
8,001 – 10,000 1 
Mean 516.8 
 
Q26. The child flu vaccine has runny or stuffy nose as a listed side effect. The 
patient information leaflet mentions that: 
Runny or stuffy nose is a very common side effect  
Imagine 10,000 children are vaccinated with the child flu vaccine. Out of 
these children, how many do you think will get a runny or stuffy nose? 
Please type a number in the box below. If you are unsure, please provide 
your best estimate. 
 % 
0 0 
1 - 100 16 
101 - 500 6 
501 - 1,000 14 
1,001 - 2,500 6 
2,501 - 5,000 20 
5,001 – 7,500 11 





Q27. The child flu vaccine has fever as a listed side effect. The patient 
information leaflet mentions that: 
Fever is a common side effect  
Imagine 10,000 children are vaccinated with the child flu vaccine. Out of 
these children, how many do you think will get a fever? Please type a 




1 - 100 22 
101 - 500 8 
501 - 1,000 16 
1,001 - 2,500 8 
2,501 - 5,000 23 
5,001 – 7,500 10 
7,501 – 10,000 14 
Mean 3359.5 
     
 
Q28. The child flu vaccine has rash as a listed side effect. The patient 
information leaflet mentions that: 
Rash is an uncommon side effect  
Imagine 10,000 children are vaccinated with the child flu vaccine. Out of 
these children, how many do you think will get a rash? Please type a number 
in the box below. If you are unsure, please provide your best estimate.  
 % 
0 1 
1 - 100 49 
101 - 500 17 
501 - 1,000 18 
1,001 - 2,500 7 
2,501 - 5,000 7 
5,001 – 7,500 1 





Q29. In which of the following categories would you place your total 
household income from all sources before tax and any other deductions? 
 
 % 
Under £10,000 5 
£10,000 - £19,999 12 
£20,000 - £29,999 19 
£30,000 - £39,999 20 
£40,000 - £49,999 16 
£50,000 - £75,000 14 
£75,000 or over 9 
Don’t know/Prefer not to say 6 
 
Q30. Please tell us which, if any, is the highest educational or professional 




Vocational qualifications (=NVQ1 
or 2) 
9 
A-level or equivalent (=NVQ3) 23 
Bachelor degree or equivalent 
(=NVQ4) 
33 
Masters degree or equivalent 16 
PhD or equivalent 4 
Other 1 
No formal qualifications 1 
Still studying * 






Q31. Which one of these ethnic groups would you describe yourself as 
belonging to?  
 % 
White – English/Welsh/Scottish/Northern 
Irish/British 
75 
White – Irish 1 
White – Gypsy or Irish Traveller * 
White – Any other background 9 
Mixed or multiple ethnic groups – White and Black 
Caribbean 
1 
Mixed or multiple ethnic groups – White and Black 
African 
1 
Mixed or multiple ethnic groups – White and Asian 1 
Mixed or multiple ethnic groups – Any other 
mixed/multiple ethnic background 
1 
Asian or Asian British – Indian 4 
Asian or Asian British – Pakistani 2 
Asian or Asian British – Bangladeshi 1 
Asian or Asian British – Chinese 1 
Asian or Asian British – Any other Asian 
background 
1 
Black, African, Caribbean or Black British – 
African 
1 
Black, African, Caribbean or Black British – 
Caribbean 
* 
Black, African, Caribbean or Black British – Any 
other Black/African/Caribbean background 
* 
Other ethnic group – Arab * 
Other ethnic group – Any other ethnic group * 
Prefer not to say 2 
NET: White  84 





Appendix 6. Scrambled sentence task  
Instructions 
In this section, you will be asked to complete a word sorting task. You will be 
asked to unscramble sentences to form statements.  Each scrambled sentence 
contains six words.  Unscramble five words in each sentence by dragging them 
into the boxes in the correct order. There are no right or wrong answers. 









Thank you. You have completed the practise, and you will now be taken to the 
main task. Unscramble the sentences to form statements, not questions. 
Unscramble the sentences to form whatever statement comes to mind first.  Work 
as quickly as you can, because your time will be limited to 2 minutes. If you 
make a mistake, simply move on to the next item. 
Remembering the number 
Before we start the word-sorting task, you will need to memorise a 6-digit 
number. You will be shown it for a few seconds then it will be hidden. After this 
you will be asked to input the number. When you have done that correctly a 
couple of times, we’ll start the sentences. You will be given up to five attempts in 
total, before moving on to the word sorting exercise. When you click the ‘next’ 
button below, the number will be shown.   
child green has the eyes blue 
the windy yesterday weather snowy was 
the child has eyes blue 
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[Possible numbers: 720185, 615239] 
Please keep the number in your mind. 
Please input the number in the box below: 
__ __ __ __ __ __ 
Word sorting task instructions 
You will now complete the word sorting task. Please keep the number in your 
mind while you unscramble the sentences, as you will be asked to recall it later. 
Please do not use any memory aides to help you to remember the number - it's 
important that you only use your own memory. Remember to work as quickly as 
you can because your time will be limited. Once you have dragged a word into 
a box you will not be able to move it. 
 
Source of health threat 
Man-made health threat items 
1. very   vaccines   don’t   prevent   illnesses   well (vaccines) 
Negative disambiguation: Vaccines don’t prevent illnesses well 
Positive disambiguation: Vaccines prevent illnesses very well 
2. can   protect   people   harm   new   inventions (new inventions)† 
Negative disambiguation: New inventions can harm people 
Positive disambiguation: New inventions can protect people 
3. react   badly   medicines   to   I   well (medicines) 
Negative disambiguation: I react badly to medicines 
Positive disambiguation: I react well to medicines 
4. medicines   me   give   side-effects   often   rarely (side-effects) 
Negative disambiguation: Medicines often give me side-effects 
Positive disambiguation: Medicines rarely give me side-effects 
5. release   phones   harmless   waves   mobile   dangerous (mobile phone 
waves)‡ 
Negative disambiguation: Mobile phones release dangerous waves 




† Item not used in prospective cohort study. In the prospective cohort study, this 
item was replaced by: 
products     prevent     illnesses     cause     household     cleaning 
(household cleaning products) 
Negative disambiguation: Household cleaning products cause illnesses 
Positive disambiguation: Household cleaning products prevent illnesses 
 
‡ Item not used in prospective cohort study. In the prospective cohort study, this 
item was replaced by: 
signals    phone   harmless   dangerous   mobile   are (mobile phone 
waves) 
Negative disambiguation: Mobile phones signals are dangerous 
Positive disambiguation: Mobile phones signals are harmless 
 
Naturally-occurring health threat items 
1. illness a   flu   serious   is   minor (influenza) 
Negative disambiguation: Flu is a serious illness 
Positive disambiguation: Flu is a minor illness 
2. about   regularly   illnesses   I   seldom   worry (illness) 
Negative disambiguation: I regularly worry about illness 
Positive disambiguation: I seldom worry about illness 
3. harmful   bacteria   contained   be   cannot   can (bacteria)§ 
Negative disambiguation: Harmful bacteria cannot be contained 
Positive disambiguation: Harmful bacteria can be contained 
4. people   frequently   make   germs   ill   occasionally (germs)‖ 
Negative disambiguation: Germs frequently make people ill 
Positive disambiguation: Germs occasionally make people ill 
5. suntan   getting   a   is   enjoyable   damaging (sun exposure) 
Negative disambiguation: Getting a suntan is damaging 




§ Item not used in prospective cohort study. In the prospective cohort study, this 
item was replaced by: 
bacteria   are   harmful   quite   usually   helpful (bacteria) 
Negative disambiguation: Bacteria are usually quite harmful 
Positive disambiguation: Bacteria are usually quite helpful 
 
‖ Item not used in prospective cohort study. In the prospective cohort study, this 
item was replaced by: 
contain   nutrients   plats   most   poisons   wild (wild plants) 
Negative disambiguation: Most wild plants contain poisons 
Positive disambiguation: Most wild plants contain nutrients 
 
Subject of health threat 
Self-relevant health threat items 
1. physical   my   health   bad   is   good (physical health) 
Negative disambiguation: My physical health is bad 
Positive disambiguation: My physical health is good 
2. feel   usually   healthy   very   I   tired (energy level) 
Negative disambiguation: I usually feel very tired 
Positive disambiguation: I usually feel very healthy 
3. mostly   my   health   poor   fine   is (general health) 
Negative disambiguation: My health is mostly poor 
Positive disambiguation: My health is mostly fine 
4. abnormal   aches   are   harmless   usually   most (aches) 
Negative disambiguation: Most aches are usually abnormal 
Positive disambiguation: Most aches are usually harmless 
5. experiencing   physical   worrying   is   normal   pain (pains) 
Negative disambiguation: Experiencing physical pain is worrying 




Child-relevant health threat items 
1. is   child   normally   my   tired   energetic (energy level) 
Negative disambiguation: My child is normally tired 
Positive disambiguation: My child is normally energetic 
2. good health   child’s   my   is   worrying (general health) 
Negative disambiguation: My child’s health is worrying 
Positive disambiguation: My child’s health is good 
3. my   strong   is   weak   child   physically (physical strength) 
Negative disambiguation: My child is physically weak 
Positive disambiguation: My child is physically strong 
4. damaging   children   in   common   is   illness (illness) 
Negative disambiguation: Illness is damaging in children 
Positive disambiguation: Illness is common in children 
5. is   development   delayed   healthy   my   child’s (development) 
Negative disambiguation: My child’s development is delayed 




Appendix 7. Table of reasons given by participants for 
vaccinating the child 
Reasons for vaccinating child Reasons for not vaccinating child 








I wanted to protect 
[child] from flu 
322 (61.2) [Child] is generally 
healthy and I am not 
overly concerned about 
him/her catching flu 
189 (43.2) 
I had an 
invitation/letter from 
[child]’s GP/school 
301 (57.2) Side-effects/it makes 
you ill/it causes flu or a 
bad reaction 
95 (21.7) 
I believe/am aware that 
[child] is in an at-risk 
group/more vulnerable 
132 (25.1) I don’t know enough 
about the vaccine 
93 (21.2) 
[Child] always has it 123 (23.4) I am concerned over 
how safe the vaccine 
is/it hasn’t been tested 
enough 
90 (20.5) 
The GP says [child] 
needs it 
101 (19.2) [Child] doesn’t need it 74 (16.9) 
Other 9 (1.7) I don’t like [child] 
having vaccinations 
53 (12.1) 
Don’t know 0 (0.0) Other 86 (19.6) 
  Don’t know 19 (4.3) 
Abbreviations: GP – general practice 
  
                                                 
5 Three participants indicated that they had answered the vaccination question incorrectly and that they had indeed 
vaccinated their child; these participants’ results were recoded. However, due to scripting of the questionnaire, only 
participants who indicated that their child had been vaccinated were asked why they had chosen to vaccinate their child. 
Therefore, data about reasons for vaccinating the child is for 526 participants. 
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Appendix 8. Table showing side-effects perceived by 
parents as a result of the influenza vaccine 
Side-effect perceived Number of parents (%) 
None 310 (59.0) 
Runny or stuffy nose 84 (16.0) 
Feeling tired, or having low energy 49 (9.3) 
Fever 42 (8.0) 
Generally unwell or not themselves 37 (7.0) 
Flu 33 (6.3) 
Headache 30 (5.7) 
Reduced appetite 23 (4.4) 
Muscle aches 23 (4.4) 
Weakness 19 (3.6) 
Pain in arms, legs or other joints 19 (3.6) 
Nausea (feeling sick), gas or indigestion 18 (3.4) 
Trouble sleeping 16 (3.0) 
Nosebleed 15 (2.9) 
Stomach pain 14 (2.7) 
Rash 11 (2.1) 
Shortness of breath 11 (2.1) 
Chest pain 10 (1.9) 
Dizziness 8 (1.5) 
Back pain 8 (1.5) 
Feeling of heart pounding or racing 8 (1.5) 
Constipation, loose bowels or diarrhoea 7 (1.3) 
Fainting spells 6 (1.1) 
Allergic reactions 6 (1.1) 
Other 1 (0.2) 





Appendix 9. Personal and clinical characteristics of those assigned to receive items pertaining to 
source and subject of the health threat; and those who were and were not included in the 
interpretation bias analyses in the cross-sectional study 
  Assigned to source or subject of health 
threat items 
Source of health threat Subject of health threat 

































Parent gender Female 288 (50.3) 285 (49.7) .82 90 (31.3) 198 (68.8) .84 95 (33.3) 190 (66.7) .66 
Male 212 (49.5) 216 (50.5)  68 (32.1) 144 (67.9)  68 (31.5) 148 (68.5)  
Parent age 35+ 294 (49.7) 298 (50.3) .83 89 (30.3) 205 (69.7) .45 94 (31.5) 204 (68.5) .57 
18-34 206 (50.4) 203 (49.6)  69 (33.5) 137 (66.5)  69 (34.0) 134 (66.0)  
Region North East 26 (51.0) 25 (49.0) .99 7 (26.9) 19 (73.1) .49 9 (36.0) 16 (64.0) .57 
North West 63 (49.6) 64 (50.4)  19 (30.2) 44 (69.8)  23 (35.9) 41 (64.1)  
Yorkshire and 
Humberside 54 (46.2) 63 (53.8) 
 14 (25.9) 40 (74.1)  27 (42.9) 36 (57.1)  
West Midlands 57 (53.8) 49 (46.2)  16 (28.1) 41 (71.9)  17 (34.7) 32 (65.3)  
East Midlands 47 (49.0) 49 (51.0)  12 (25.5) 35 (74.5)  17 (34.7) 32 (65.3)  
East of England 39 (50.6) 38 (49.4)  10 (25.6) 29 (74.4)  11 (28.9) 27 (71.1)  
South West 56 (50.5) 55 (49.5)  19 (33.9) 37 (66.1)  14 (25.5) 41 (74.5)  
South East 84 (49.4) 86 (50.6)  35 (41.7) 49 (58.3)  26 (30.2) 60 (69.8)  
London 74 (50.7) 72 (49.3)  26 (35.1) 48 (64.9)  19 (26.4) 53 (73.6)  
Parent 
employment 
Working 375 (49.3) 386 (50.7) .45 116 (30.9) 259 (69.1) .58 131 (33.9) 255 (66.1) .22 
Not working 125 (52.1) 115 (47.9)  42 (33.6) 83 (66.4)  32 (27.8) 83 (72.2)  
Total 
household 
≥£30,000 297 (50.4) 292 (49.6) .87 104 (35.0) 193 (65.0) .05* 90 (30.8) 202 (69.2) .60 










Degree or higher 
(Bachelors, Masters, 
PhD) 




219 (49.5) 223 (50.5)  67 (30.6) 152 (69.4)  76 (34.1) 147 (65.9)  
Parent 
ethnicity 
Black and Minority 77 (55.0) 63 (45.0) .21 12 (15.6) 65 (84.4) .001* 13 (20.6) 50 (79.4) .03* 
White 414 (49.2) 427 (50.8)  144 (34.8) 270 (65.2)  147 (34.4) 280 (65.6)  
Parent chronic 
illness 
Present 167 (52.0) 154 (48.0) .39 57 (34.1) 110 (65.9) .41 46 (29.9) 108 (70.1) .39 
None 331 (49.1) 343 (50.9)  101 (30.5) 230 (69.5)  116 (33.8) 227 (66.2)  
Child gender Female 261 (51.1) 250 (48.9) .47 86 (33.0) 175 (67.0) .50 75 (30.0) 175 (70.0) .23 
Male 239 (48.8) 251 (51.2)  72 (30.1) 167 (69.9)  88 (35.1) 163 (64.9)  
First-born 
child 
Yes  270 (50.2) 268 (49.8) .87 81 (30.0) 189 (70.0) .40 89 (33.2) 179 (66.8) .73 
No 230 (49.7) 233 (50.3)  77 (33.5) 153 (66.5)  74 (31.8) 159 (68.2)  





















Present 82 (50.6) 80 (49.4) .83 28 (34.1) 54 (68.2) .62 28 (35.0) 52 (65.0) .63 




Appendix 10. T1 questionnaire 
• Results are based on all respondents (n=270) unless otherwise stated. 
• Where percentages do not sum to 100, this may be due to respondents 
being able to select multiple responses, computer rounding or the 
exclusion of ‘don’t know.’ 
• An asterisk (*) represents a value of less than half or one percent, but 
greater than zero. 
Please state: 
Q1. Child's name 
 




















Q5. How likely do you think it is that [Specified child] will get short term 
side-effects from the flu vaccine? 
 % 
Very likely 6 
Likely 32 
Neither likely nor unlikely 34 
Unlikely 25 
Very unlikely 3 
Base: n=268 
Q6. These questions relate to your child's sensitivity to medicines. To what 









































 % % % % % 
Strongly 
agree 
* * 1 2 1 
Agree 7 2 2 5 * 
Neutral 36 25 18 9 13 
Disagree 41 49 52 46 49 
Strongly 
disagree 
16 24 27 39 37 
 
Q7. The healthcare worker vaccinating your child is a possible source of 
information about the child flu vaccine. Considering what you know, please 
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select the number between the pair of words that best describes your feelings 
about information from the healthcare worker vaccinating your child. 
 1 2 3 4 5  
 % % % % %  
Can't be 
trusted 
1 0 8 35 56 Can be 
trusted 
Is inaccurate 1 0 12 35 53 Is 
accurate 




* 2 16 37 46 Tells the 
whole 
story 
Is biased 1 4 18 33 44 Is 
unbiased 
Base: Can be trusted, n=269; is accurate, n=267; is fair, n=266; tells the whole 




Q8. To what extent do you agree or disagree that you trust the following as a source of information about the flu vaccine 
 Friends/family/relatives 









 % % % % 
Strongly 
disagree 
2 2 3 2 
Tend to 
disagree 




37 13 47 10 
Tend to 
agree 
37 41 25 29 
Strongly 
agree 






5 5 7 5 
Base: NHS influenza vaccination leaflet, n=269. 
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Q9. We are interested in what you think each of the following said about the likelihood of the flu vaccine causing side-effects. Please tick 
one box for each source of information. 
 Friends/family/relatives 



























8 14 7 15 





35 30 45 26 





Q10.  Not including [Specified child], do you know any children who have 
experienced side-effects from the flu vaccine? 
 % 
Yes, several other children I know had side-effects from the 
flu vaccine 
86 
Yes, one other child I know had side-effects from the flu vaccine 7 





If ‘Yes’ go to question 11. If ‘No’ go to question 12. 
 
Q11. Overall, how severe were the side-effects that the child or children you 
know experienced after the flu vaccine? 
 % 




Very severe 0 
Base: All those who indicated they knew another child who had experienced side-
effects from the influenza vaccine, n=37 
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Q12. Below are some things that other people have said about the child flu 
vaccine. To what extent, if at all, do you agree or disagree with the following 
statements? Please select one answer option for each statement. 





me to feel it 
is safe 











The child flu 
vaccine does not 
suit my religious 
or cultural 
beliefs/values 
 % % % % 
Strongly 
agree 
2 2 1 2.2 
Tend to 
agree 




30 43 27 19 
Tend to 
disagree 
33 29 29 10 
Strongly 
disagree 




Q13. Below are some things that other people have said about the child flu 
vaccine. To what extent, if at all, do you agree or disagree with the following 
statements? Please select one answer option for each statement. 













campaign is just 
about making 
money for the 
manufacturers 








 % % % % 
Strongly 
agree 
1 4 2 0 
Tend to 
agree 




17 32 23 26 
Tend to 
disagree 
27 32 34 27 
Strongly 
disagree 
52 15 39 46 
Base: The vaccination campaign is just about making money for the 
manufacturers, n=269; the flu vaccine would interact with other medications that 





Q14. Below are some things that other people have said about the child flu 
vaccine. To what extent, if at all, do you agree or disagree with the following 












flu each year is 


















 % % % % 
Strongly 
agree 
2 1 29 3 
Tend to 
agree 





20 14 12 45 
Tend to 
disagree 
42 27 6 24 
Strongly 
disagree 
33 56 3 7 
Base: If I don't vaccinate [Specified child], then [Specified child] will get flu, 
n=269 
 





Don’t know 4 
 




Q16. Children sometimes experience side-effects after a vaccine (for 
example, a runny nose, headache or temperature). Has [Specified child] ever 
had side-effects from the flu vaccine before? 
 % 
Yes 21 
No     59 
Don’t know 20 
Base: All those who indicated their child had previously been vaccinated for 
influenza, n=131 
 
If ‘Yes’ go to question 17. If ‘No’ or ‘Don’t know’ go to question 19. 
 
Q17. Overall, how severe were the side-effects that [Specified child] 
experienced as a result of the flu vaccine? 
 % 




Very severe 0 
Base: All those who indicated their child had previously experienced side-effects 
from the child influenza vaccine, n=28 
Q18. Overall, how worried were you about the side-effects that [Specified 
child] got after previous flu vaccinations? 
 % 
Not at all worried 50 
Not very worried 29 
Fairly worried 18 
Very worried 4 
Base: All those who indicated their child had previously experienced side-effects 




Q19. Has [Specified child] ever had side-effects from any other routine 
vaccine (i.e. NOT the child flu vaccine)? 
 % 
Yes 41 
No     49 
Don’t know 9 
Base: n=269 
 
If ‘Yes’ go to question 20. If ‘No’ or ‘Don’t know go to question 21.  
 
Q20. Overall, how worried were you about the side-effects that [Specified 
child] got? 
 % 
Not at all worried 32 
Not very worried 53 
Fairly worried 14 
Very worried 1 
Base: All those who indicated their child had previously experienced side-effects 




Q21. Has [Specified child] shown signs of any of the following symptoms in 
the last 24 hours? 
 % 
No, none 63 
Runny or stuffy nose 22 
Feeling tired, or having low energy 4 
Fever 4 
Generally unwell or not themselves 3 
Headache 1 
Flu 1 
Reduced appetite 2 
Weakness * 
Muscle aches 1 
Pain in arms, legs or other joints 1 
Nosebleed * 
Stomach pain 2 
Nausea (feeling sick), gas or indigestion * 
Trouble sleeping 3 
Dizziness * 
Rash 1 
Chest pain 0 
Shortness of breath 0 
Back pain 0 
Fainting spells 0 
Feeling of heart pounding or racing 0 
Constipation, loose bowels or diarrhoea 2 
Allergic reactions 0 
Other (please specify) 6 





Appendix 11. T2 questionnaire 
• Results are based on all respondents (n=233) unless otherwise stated. 
• Where percentages do not sum to 100, this may be due to respondents 
being able to select multiple responses, computer rounding or the 
exclusion of ‘don’t know.’ 
• An asterisk (*) represents a value of less than half or one percent, but 
greater than zero. 
Q1. Do you think that [Specified child] experienced any of the following side-
effects because of their latest child flu vaccine? Tick all that apply. 
 % 
No, none 57 
Runny or stuffy nose 23 
Feeling tired, or having low energy 15 
Fever 8 
Generally unwell or not themselves 6 
Headache 2 
Flu 2 
Reduced appetite 6 
Weakness 1 
Muscle aches 1 
Pain in arms, legs or other joints 0 
Nosebleed 1 
Stomach pain 2 
Nausea (feeling sick), gas or indigestion 1 
Trouble sleeping 4 
Dizziness * 
Rash 1 
Chest pain 0 
Shortness of breath * 
Back pain 0 
Fainting spells 0 
Feeling of heart pounding or racing * 
Constipation, loose bowels or diarrhoea 3 
Allergic reactions 0 
Other (please specify) 3 
One or more side-effects 43 
Base: n=221 
 




Q2. Overall, how severe were the side-effects that [Specified child] 
experienced from their latest flu vaccine? 
 % 




Very severe 1 
Base: All those who perceived their child to experience side-effects from the 
child influenza vaccine, n=100 
Q3. How worried were you about the overall side-effects that [Specified 
child] experienced from their latest flu vaccine? 
 % 
Not at all worried 50 
Not very worried 38 
Fairly worried 10 
Very worried 2 
Base: All those who perceived their child to experience side-effects from the 
child influenza vaccine, n=100 
 
Think about next flu season (September 2017 to March 2018). You will be 
asked to vaccinate [Specified child] against flu again. The following questions 
relate to the 2017/18 flu season. 
Q4. I want [Specified child] to be vaccinated for flu next year 
 % 
Strongly agree 47 
Agree 41 
Neither agree nor disagree 8 
Disagree 0 
Strongly disagree 4 
Base: n=228 
Q5. I intend [Specified child] to be vaccinated for flu next year 
 % 
Strongly agree 49 
Agree 40 
Neither agree nor disagree 8 
Disagree * 




These questions relate to [Specified child]’s recent flu vaccination 
appointment. To what extent, if at all, do you agree or disagree with the 
following statement? 
 
Q6. The healthcare worker who vaccinated [Specified child] can be trusted 
as a source of information about the flu vaccine 
 % 
Strongly agree 37 
Agree 51 
Neither agree nor disagree 8 
Disagree 1 
Strongly disagree 2 
Base: n=216 
Q7. In your flu vaccine appointment, did the healthcare worker suggest that 
the flu vaccine might cause side-effects? 
 % 
Yes, they said side-effects were very likely 2 
Yes, they said side-effects were likely 33 
No, they didn't mention side-effects 39 
No, they said that side-effects were unlikely 20 
No, they said that side-effects were very unlikely 6 
Base: n=216 
Q8. In addition to children, the flu vaccine is recommended to certain 'at 
risk' groups. Aside from any children born between September 1st 2011 and 
August 31st 2014, is there anyone currently living in your household who is 
eligible for the flu vaccine in order to protect their health? 
 % 
Yes 38 
No     53 
Don’t know 10 
Base: n=216 
Q9. Is [Specified child] your first child? 
 % 
Yes 38 




Q10. Have you ever been diagnosed by a medical doctor as having any long-
lasting illness, disability or infirmity? 
 % 
Breathing complaint (e.g. asthma, 




Heart disease (e.g. heart failure, high blood 
pressure) 
1 
Kidney disease (e.g. renal failure, kidney 
transplant) 
0 
Liver disease (e.g. hepatitis, cirrhosis) 0 
Mental health (i.e. depression, anxiety, 
stress) 
9 
Neurological condition (i.e. caused by 
disease or damage to the brain, spinal cord 
or other parts of the nervous system) 
0 
Stroke (or transient ischaemic attack; TIA) 0 
Substance misuse (i.e. alcohol, drugs) 0 
Other, please specify 4 
No 77 
Don’t know 1 




Q11. Has [Specified child] ever been diagnosed by a medical doctor as 
having any long-lasting illness, disability or infirmity? 
 % 
Breathing complaint (e.g. asthma, 




Heart disease (e.g. heart failure, high blood 
pressure) 
1 
Kidney disease (e.g. renal failure, kidney 
transplant) 
0 
Liver disease (e.g. hepatitis, cirrhosis) 0 
Mental health (i.e. depression, anxiety, 
stress) 
0 
Neurological condition (i.e. caused by 
disease or damage to the brain, spinal cord 
or other parts of the nervous system) 
0 
Stroke (or transient ischaemic attack; TIA) 0 
Other, please specify 3 
No 92 
Don’t know 0 
Child presence of chronic illness 8 
Base: n=216 
Q12. To what extent, if at all, do you agree or disagree with the following 
statement. Flu would be a serious illness for: 




 % % % 
Strongly agree 20 15 21 
Tend to agree 45 33 37 
Neither agree nor disagree 20 26 21 
Tend to disagree 13 20 14 
Strongly disagree 3 7 7 
Base: n=215  
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Q13. If [Specified child] were to catch flu, how much, if at all, would it 
impact your daily life? 
 % 
Not at all 2 
Very little 2 
Somewhat 50 
A great extent 47 
Base: n=215 
Q14. To the best of your knowledge, is [Specified child] up-to-date with other 
routine vaccines? 
 % 
Yes, [Specified child] has completed all routine vaccines 95 
[Specified child] is partially up-to-date 5 
[Specified child] has not had any routine vaccines 0 
Don't know 0 
Base: n=214 
Q15. How much input did you have in the vaccination decision for [Specified 
child]? 
 % 
I had sole responsibility 24 
I had joint responsibility, along with someone else 77 




Q16. We would like to ask you about your personal views about medicines in general. These are statements other people have made 
about medicines in general. Please indicate the extent to which you agree or disagree with them by ticking the appropriate box. There 
are no right or wrong answers; we are interested in your personal views. 
 Doctors use 
too many 
medicines 
People who take 
medicines should 
stop their 
treatment for a 





















If doctors had 




 % % % % % % % % 
Strongly 
agree 
2 1 18 1 1 1 1 6 




36 40 32 36 25 15 29 34 
Disagree 34 33 8 33 49 39 46 21 
Strongly 
disagree 




Q17. A number of statements which people have used to describe themselves 
are given below. Read each statement and then choose the most appropriate 
statement to indicate how you generally feel. There are no right or wrong 
answers. Do not spend too much time on any one statement but give the 
answer which seems to describe your feelings best. 












 % % % % % % 
Almost 
never 
1 9 25 3 2 10 
Sometimes 35 72 71 40 24 70 
Often 53 18 4 50 48 17 
Almost 
always 
11 1 0 7 26 3 
Base: n=213 
Q18.  Please answer each question by selecting either the 'Yes' or the 'No' 
following the question. There are no right or wrong answers, and no trick 
questions. Work quickly and do not think too long about the exact meaning 





























 % % % % % % 
Yes 43 33 16 53 12 9 




Q19. This scale consists of a number of words that describe different feelings and emotions. Read each item and then list the number 
from the scale below next to each word. Indicate the extent you have felt this way over the past week. 
 Distressed Excited Upset Scared Enthusiastic Alert Inspired Nervous Determined Afraid 
 % % % % % % % % % % 
Very 
slightly or 
not at all 
59 14 42 79 8 6 8 51 8 77 
A little 25 24 40 14 19 9 21 36 14 17 
Moderately 12 40 14 7 39 41 36 9 30 5 
Quite a bit 4 20 4 0 32 36 34 4 35 1 




Q20. These days many people worry about the effects of different aspects of modern life on health. Please rate the following items for 
how much you are concerned about their effect on your personal health. Tick one box for each item. 
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 Cell phones Radio or cell phone 
towers 
High tension power 
lines 
Nuclear radiation Air pollution Noise pollution Depletion of the 
ozone layer 
 % % % % % % % 
No concern 34 47 55 35 5 32 14 
A little 
concern 
41 32 28 26 24 26 29 
Moderate 
concern 
17 18 13 18 33 24 26 
High 
concern 
7 3 4 14 32 15 24 
Extreme 
concern 
0 0 0 6 7 3 7 
 Traffic fumes Other 
environmental 
pollution 






Pesticides in food 
 % % % % % % % 
No concern 4 9 18 29 29 11 10 
A little 
concern 
20 26 33 26 29 28 30 
Moderate 
concern 
32 36 26 27 22 31 29 
High 
concern 
35 25 17 15 16 22 22 
Extreme 
concern 
9 5 6 2 5 7 10 








 % % % % % % % 
No concern 18 16 39 37 49 62 14 
A little 
concern 
22 23 24 22 26 24 25 
Moderate 
concern 





30 26 14 14 11 3 24 
Extreme 
concern 
10 12 7 10 3 1 9 















 % % % % % % % 
No concern 16 47 41 13 55 54 35 
A little 
concern 
34 26 31 22 23 33 26 
Moderate 
concern 
30 15 18 27 17 13 24 
High 
concern 
16 9 9 24 4 1 10 
Extreme 
concern 




Q21. Please be as honest and accurate as you can throughout. Try not to let your response to one statement influence your responses to 
other statements. There are no "correct" or "incorrect" answers. Answer according to your own feelings, rather than how you think 
"most people" would answer 













































to happen to 
me than bad 
 % % % % % % % % % % 
Strongly 
agree 
3 3 12 5 25 13 1 5 1 11 




38 35 36 31 12 21 31 35 33 24 
Disagree 18 22 6 12 4 7 47 28 45 7 
Strongly 
disagree 




Q22. Your age (in years) on your last birthday: 
 




Base: n=270  
 352 
 
Appendix 12. T3 questionnaire 
• Results are based on all respondents (n=200) unless otherwise stated. 
• Where percentages do not sum to 100, this may be due to respondents 
being able to select multiple responses, computer rounding or the 
exclusion of ‘don’t know.’ 
• An asterisk (*) represents a value of less than half or one percent, but 
greater than zero. 
Q1. Do you think that [Specified child] experienced any of the following side-
effects because of their latest child flu vaccine? Tick all that apply 
 
 % 
No, none 64 
Runny or stuffy nose 22 
Feeling tired, or having low energy 8 
Fever 10 
Generally unwell or not themselves 6 
Headache 1 
Flu 3 
Reduced appetite 6 
Weakness 1 
Muscle aches 0 
Pain in arms, legs or other joints 1 
Nosebleed 1 
Stomach pain 1 
Nausea (feeling sick), gas or indigestion 1 
Trouble sleeping 3 
Dizziness 0 
Rash 1 
Chest pain 0 
Shortness of breath 0 
Back pain 0 
Fainting spells 0 
Feeling of heart pounding or racing 0 
Constipation, loose bowels or diarrhoea 2 
Allergic reactions 0 
Other (please specify) 1 




If ‘No’ go to question 4. 
 
Q2. Overall, how severe were the side-effects that [Specified child] 
experienced from their latest flu vaccine? 
 % 




Very severe 0 
Base: All those who perceived their child to experience side-effects from the 
child influenza vaccine, n=66 
 
Q3. How worried were you about the overall side-effects that [Specified 
child] experienced from their latest flu vaccine? 
 
 % 
Not at all worried 50 
Not very worried 37 
Fairly worried 11 
Very worried 1 
Base: All those who perceived their child to experience side-effects from the 
child influenza vaccine, n=70 
 
Think about next flu season (September 2017 - March 2018). You will be 
asked to vaccinate [Specified child] against flu again. The following questions 
relate to the 2017/18 flu season. 
Q4. I want [Specified child] to be vaccinated for flu next year 
 % 
Strongly agree 59 
Agree 34 
Neither agree nor disagree 5 
Disagree 1 




Q5. I intend [Specified child] to be vaccinated for flu next year 
 % 
Strongly agree 57 
Agree 36 
Neither agree nor disagree 6 
Disagree 1 
Strongly disagree 2 
 
Q6. The healthcare worker vaccinating your child is a possible source of 
information about the child flu vaccine. Considering what you know, please 
select the number between the pair of words that best describes your feelings 
about information from the healthcare worker vaccinating your child. 
 1 2 3 4 5  
 % % % % %  
Can't be 
trusted 
2 1 9 25 64 Can be 
trusted 
Is inaccurate 2 1 10 33 54 Is 
accurate 




4 3 19 34 42 Tells the 
whole 
story 
Is biased 3 3 26 28 40 Is 
unbiased 
Base: Can be trusted, n=194; is accurate, n=192; is fair, n=192; tells the whole 




Q7. These questions relate to your child's sensitivity to medicines. To what 









































 % % % % % 
Strongly 
agree 
2 1 0 1 0 
Agree 6 1 2 5 1 
Neutral 30 17 25 9 9 
Disagree 36 49 46 46 49 
Strongly 
disagree 
26 34 36 40 41 
Base: [Specified child]'s body is very sensitive to medicines, n=195; [Specified 
child]'s body overreacts to medicines, n=194; [Specified child] usually has a 
stronger reaction to medicines than most other children I know, n=195; [Specified 
child] has had a bad reaction to medicines in the past, n=195; Even small amounts 
of medicine can upset [Specified child]'s body, n=195  
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Appendix 13. Similarity ratings task 
Man-made health threat items 
1) Your travel vaccination 
You went to the health centre to get a vaccination before travelling. The nurse 
used a needle to inject the vaccine into your arm. Surrounding the injection site, 
your arm turned red and was slightly swollen (sw-ll-n) 
 
Did the doctor give you the travel vaccine? [no] 
 
You had a normal reaction to the travel vaccine (T+) 
You had an allergic reaction to the travel vaccine (T-) 
You didn’t have to wait at all for your travel vaccination (F+) 
You had a long wait for your travel vaccination (F-) 
2) Washing up liquid 
You went to the supermarket to buy some washing up liquid, but the brand you 
usually buy was out of stock. You bought a different brand and went home, 
washed your dishes and prepared a large meal. When you finished eating you 
began to feel a pain in your stomach (st-m-ch) 
 
Did you go to the corner shop to buy washing up liquid? [no] 
 
You ate too much and are uncomfortably full (T+) 
The new brand of washing up liquid has contaminated your plates making you 
feel ill (T-) 
You enjoy keeping things clean (F+) 
You dislike washing the dishes (F-) 
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3) Minor surgery 
You were advised to have some minor surgery to correct a painful in-grown 
toenail. You were given an injection to help you relax and drift off to sleep. When 
you woke up, a doctor came over to tell you the outcome of your procedure (pr-c-
d-r-) 
 
Have you had minor surgery on your toe? [yes] 
 
The surgery went well and you no longer have any pain (T+) 
The surgery went badly and you still have considerable pain (T-) 
You don’t mind going to hospitals  (F+) 
You dislike going to hospitals (F-) 
4) New Tablets 
When you meet your friend for a drink they tell you that they have been feeling a 
bit under the weather. They explain that they went to the doctor and were given 
some new tablets that they have not taken before. After leaving your friend you 
think about whether the new tablets will help them feel better (b-tt-r) 
 
Did you meet your friend for lunch? [no] 
 
You expected the new tablets to soon make your friend feel better (T+) 
You expected the new tablets might not work or could have unpleasant side 
effects (T-)  
You get on well with your friend (F+) 
You and your friend have a difficult relationship (F-) 
5) Headache at work 
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You have an important meeting at work that needs to go well. About an hour 
before the meeting starts you find you have a splitting headache. You decide to 
take some pain killers (p—n    k-ll-rs) 
 
Did you have an important meeting at work? [yes] 
 
The pain killers helped the meeting run smoothly  (T+) 
The pain killers were not effective and the meeting was difficult (T-) 
You have an easy journey to work  (F+) 
You have a long and difficult journey to work  (F-) 
6) A new mobile phone 
You recently bought a new mobile phone, which is equipped with lots of features, 
such as GPS, wi-fi and data roaming. While you sleep you put the phone next to 
your head on your bedside table. In the morning, you wake up with a headache 
(h--d-ch-) 
 
Did you buy a new mobile phone recently? [yes] 
 
You must have slept badly and after a while your headache disappears (T+) 
Sleeping with your new mobile phone close to your head gave you a headache (T-
) 
You like the design of your new mobile phone (F+) 
You dislike the design of your new mobile phone (F-) 
7) Mobile phone towers 
A new mobile phone tower has recently been constructed not far from your 
house. For the past few days you have been working in a new job and think it is 
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very demanding. On the way home from work you notice that you feel very 
anxious (-nx---s)  
 
Have you been in your job for a long time? [no] 
 
You have had a long day at work and when you relax at home you feel less 
anxious (T+) 
The new mobile phone tower is making you feel anxious (T-) 
The mobile phone tower blends in to the landscape (F+) 
The mobile phone tower is ugly in the landscape (F-)  
8) Moving to the city 
You used to live in the countryside but were offered a job in a big city. After 
moving to the city you started taking the bus to work. Recently you have noticed 
that you become short of breath when taking the stairs (st--rs) 
 
Do you live in a big city? [yes] 
 
You get short of breath on the stairs now because you don’t get as much exercise 
(T+) 
You get short of breath on the stairs now because of the poorer air quality in the 
city (T-) 
You like city living (F+) 
You dislike city living (F-) 
9) Hosting a dinner party 
You hosted a dinner party for your friends and bought the ingredients from local 
farmers. When you bought the vegetables, the farmer told you he has been using a 
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new kind of pesticide. Your friends seemed to enjoy the meal but afterwards your 
tummy started hurting (h-rt-ng) 
 
Did your colleagues come to the dinner party you were hosting? [no] 
 
After the dinner party you relax and realise that you are just full (T+) 
After the dinner party you think you feel sick because of the new pesticide that 
the farmer used on the vegetables (T-) 
You like to try out new recipes at dinner parties (F+) 
You do not usually try new recipes out at dinner parties (F-) 
10) The factory 
You have recently moved to a new flat on the top floor of a building that has no 
lift. There is a factory a few roads away which releases lots of fumes into the air. 
When you get home in the evenings after work you feel tired and out of breath 
(br--th) 
 
Did you move house recently? [yes] 
 
You are tired and out of breath from walking up the stairs to your new flat (T+) 
The fumes from the factory are making you feel tired and out of breath (T-) 
There is lots to do in your new area (F+) 
There is not much to do in your new area (F-) 
Naturally-occurring health threat items 
1) Journey home 
On your way home from work, you get on a crowded bus and have to stand very 
close to other people. The lady standing next to you starts to sneeze and cough. 




Were you sitting down on the bus?  [no] 
 
The feeling in your throat will go away once you’ve had a glass of water (T+) 
The feeling in your throat is an indicator that you will develop an illness (T-) 
You don’t mind taking the bus even when it is very busy (F+) 
You dislike taking the bus when it is very busy (F-) 
2) Routine health check 
You went to the clinic for your routine check. Your doctor asked you about your 
health in general and took your blood pressure. She looked at the pressure 
reading, and you saw her write down your results (r-s-lts) 
 
Did the doctor take your temperature? [no] 
 
Your blood pressure results were normal (T+) 
Your blood pressure results were abnormal (T-) 
You always go for your routine health check (F+) 
You sometimes miss your routine health check (F-) 
3) Headaches 
You have had a few headaches recently. When you went to see your GP for a 
routine check, you decided to ask about them. The doctor examined you carefully 
and then told you his findings (f-nd-ngs) 
 




The doctor did not find anything unusual and thinks the headaches will go away 
(T+) 
The doctor found something unusual related to the headaches that you have been 
getting (T-) 
You ask the doctor lots of questions at your routine check up (F+) 
You don’t ask many questions at your routine check up (F-) 
4) Hearing 
For the last few weeks you have noticed that your hearing seems worse than it 
was. You decided that you should have your ears examined. After a thorough 
check, the doctor explained to you your condition (c-nd-t--n) 
 
Have you noticed that your hearing has got better over the few weeks? [no] 
 
The doctor explains that your hearing will rapidly recover (T+) 
The doctor explains that your hearing will rapidly deteriorate (T-) 
You did not have to wait long to see the doctor (F+) 
You had to wait a long time to see the doctor (F-) 
5) Winter approaching 
It is approaching winter and the days are getting colder and darker. You know it 
is the beginning of the flu season and have seen more people sneezing at work. 
Walking home from work, you felt a gust of cold wind and started to sneeze. (sn--
z-) 
 
It is the beginning of the flu season? [yes] 
 
The rush of cold air made you sneeze (T+) 
You have caught the flu (T-) 
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You don’t mind the cold weather in the winter (F+) 
You dislike the cold weather in the winter (F-) 
6) Your partner’s flu 
You live with your partner who has the flu. After work one day, you came home 
and threw their tissues away and cleaned the surfaces. Later on that evening you 
started to feel dizzy (d-zzy) 
 
Is your partner feeling well? [no] 
 
You are tired from the day and will feel better in the morning (T+) 
You have caught the flu from your partner  (T-) 
Flu can be stopped from spreading through good hygeine (F+) 
Flu spreads very quickly (F-) 
7) Meeting a friend  
You arranged to meet a friend after dinner, but have come home late from work. 
You grab some food in a rush, but after eating it you realized that the worktop 
was still dirty from last night’s meal. Later, when you are with your friend you 
develop a stomach ache (-ch-) 
 
Did you go to meet your friend after dinner? [yes] 
 
You had a stomach ache because you ate in a rush and by the end of the evening 
it has disappeared (T+) 
There must have been bacteria from the leftover food on the worktop which has 
made you ill (T-) 
You enjoyed your dinner (F+) 
You did not enjoy your dinner (F-) 
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8) Visiting a new restaurant 
Last night you went to a new restaurant in town with your friend. You ordered 
chicken for your main course and noticed that it was a little bit pink. The meal 
was very large and on your way home you started to feel a bit sick (s-ck) 
 
Did you go to a restaurant that you had been to before? [no] 
 
You had a big meal and were just feeling very full (T+) 
The chicken was undercooked and made you feel ill (T-) 
You liked the atmosphere in the new restaurant (F+) 
You didn’t like the atmosphere in the new restaurant (F-) 
9) Beach holiday 
You went on a beach holiday in the summer. It is was very hot and the sun was 
strong. You noticed that a large number of people there were sunbathing (s-nb-th-
ng) 
 
Did you go on a summer holiday this year? [yes] 
 
You reflected on how a lot of people find sun bathing pleasant and perhaps 
beneficial (T+) 
You reflected on how harmful sunbathing can be (T-) 
The beach was very clean (F+) 
The beach was not as clean as you’d hoped (F-) 
10) The tummy bug 
Recently, lots of people at your work have been off sick because of a tummy bug 
that was going round. So far you have not been affected. One day, after lunch you 




Have other people at your work had a tummy bug? [yes] 
 
You ate too much at lunch and felt a bit full (T+) 
You caught the tummy bug that is going around the office (T-) 
You talk to lots of people at work and have many friends there (F+) 
You don’t talk to many people at work and have few friends there (F-)  
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Similarity ratings task 
Similarity ratings task items were developed for this study. Items were adapted 
from Hoppitt et al. (519) or developed from scratch (see Appendix 13 for full 
item list). 
Participants completed twenty items, ten related to man-made health threats and 
ten related to naturally-occurring health threats. Man-made health threats 
included vaccines, household cleaning products, having an operation, 
medications, mobile phones, mobile phone towers, pesticides and fumes and air 
pollution. Naturally-occurring health threats included illness (including 
headaches, stomach ache, hearing ability, blood pressure), influenza, bacteria and 
getting a sun-tan. 
First, participants read twenty short passages presented in a fixed-random order; 
each passage was presented under a separate heading. Passages had ambiguous 
outcomes and the last word of each passage was incomplete. Participants filled in 
the first of the missing letters from the incomplete word and then answered a 
binary comprehension question (yes, no) about the passage.  
An example follows: 
Minor surgery 
 
You were advised to have some minor surgery to correct a painful in-
grown toenail. You were given an injection to help you relax and drift off 
to sleep. When you woke up, a doctor came over to tell you the outcome 
of your pr-c-d-r- (procedure) 
Have you had minor surgery on your toe? [yes] 
After having read all the passages, participants began the similarity ratings aspect 
of the task. Participants were shown the heading of each passage and four 
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statements which related to the passage in question. Two statements were the 
positive and negative interpretations of the ambiguous passage (target items). The 
other two statements did not relate directly to the passage, but were positive and 
negative interpretations of the situations in the passage (foil outcomes); these 
items control for response bias. Participants rated how similar the statements were 
to the passage on a four-point Likert scale from “very different” to “very similar.” 
The statements for the example passage follow: 
The surgery went well and you no longer have any pain (T+) 
The surgery went badly and you still have considerable pain (T-) 
You don’t mind going to hospitals (F+) 
You dislike going to hospitals (F-) 
Bias scores were calculated for target and foil sentences separately by subtracting 
similarity ratings scores for negative statements (negative targets, T- and negative 
foils, F- respectively) from positive statements (positive targets, T+ and positive 
foils, F+ respectively). A positive score indicates a positive bias, while a negative 
score indicates negative bias. 
Procedure 
After having completed T2 materials, participants were asked if they wanted to 
complete an optional additional task: the similarity ratings task. Participants were 
also asked at the end of T3 if they wanted to complete the similarity ratings task. 
Only participants who completed T2 and T3 materials online were asked to 
complete the similarity ratings task. 
Data analysis 
To investigate whether there was an association between interpretation bias and 
vaccine behaviours, I conducted a series of mixed model, repeated measures 
ANOVAs. Between participant factors were side-effect perception at T2 and T3 
(side-effect perception, no side-effect perception), re-vaccination intention 
(intend to vaccinate, do not definitely intend to vaccinate) and actual re-
vaccination (vaccinated, not vaccinated). Within-participant factors were the 
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83 parents initiated similarity ratings task items. To be included in the analyses, 
participants must have completed at least six natural and six man-made items. 
Thus, similarity ratings task analyses are presented for 45 parents. Participant 




Table 26. Parent and child personal and clinical characteristics for those included in similarity ratings task analyses and associations with 
perception of side-effects from vaccination, re-vaccination intention for 2017/18 and re-vaccination in 2017/18 
Participant 
characteristics 
 Side-effects reported at T2 Side-effects reported at T3 Re-vaccination intention for 
2017/18 season 









































Parent gender Female 14 (40.0) 21 (60.0) 1.00 10 (34.5) 19 (65.5) 1.00 2 (5.3) 36 (94.7) .41 6 (17.1) 29 (82.9) 1.00 
Male 3 (42.9) 4 (57.1) 2 (28.6) 5 (71.4) 1 (14.3) 6 (85.7) 1 (14.3) 6 (85.7) 
Parent age 35+ 14 (42.4) 19 (57.6) 1.00 8 (30.8) 18 (69.2) .39 3 (9.1) 30 (90.9) 1.00 4 (12.9) 27 (87.1) 1.00 
18-34 3 (37.5) 5 (62.5) 3 (50.0) 3 (50.0) 0 (0.0) 8 (100.0) 1 (12.5) 7 (87.5) 
Parent chronic 
illness 
Present 4 (40.0) 6 (60.0) 1.00 3 (37.5) 5 (62.5) 1.00 1 (10.0) 9 (90.0) 1.00 2 (22.2) 7 (77.8) .31 
None 13 (40.6) 19 (59.4) 8 (32.0) 17 (68.0) 2 (6.3) 30 (93.8) 3 (9.7) 28 (90.3) 
Other ‘at risk’ 
people in child’s 
household 
Yes 10 (50.0) 10 (50.0) .34 6 (37.5) 10 (62.5) 1.00 1 (5.0) 19 (95.0) 1.00 1 (5.3) 18 (94.7) .60 
No 7 (35.0) 13 (65.0) 5 (33.3) 10 (66.7) 1 (5.0) 19 (95.0) 3 (15.8) 16 (84.2) 
Child gender Female 10 (40.0) 15 (60.0) .94 6 (31.6) 13 (68.4) .81 2 (7.7) 24 (92.3) 1.00 4 (16.7) 20 (83.3) 1.00 
Male 7 (41.2) 10 (58.8) 6 (35.3) 11 (64.7) 1 (5.3) 18 (94.7) 3 (16.7) 15 (83.3) 
First-born child Yes 12 (52.2) 11 (47.8) .12 8 (38.1) 13 (61.9) .70 3 (13.0) 20 (87.0) .24 2 (8.7) 21 (91.3) .63 
No 5 (26.3) 14 (73.7) 3 (25.0) 9 (75.0) 0 (0.0) 19 (100.0) 3 (17.6) 14 (82.4) 



























Present 2 (66.7) 1 (33.3) .56 1 (33.3) 2 (66.7) 1.00 0 (0.0) 3 (100.0) 1.00 0 (0.0) 3 (100.0) 1.00 




Not fully UTD 0 (0.0) 1 (100.0) 1.00 0 (0.0) 0 (0.0) † 0 (0.0) 1 (100.0) 1.00 0 (0.0) 0 (0.0) † 
UTD 17 (41.5) 24 (58.5) 11 (33.3) 22 (66.7) 3 (7.3) 38 (92.7) 5 (12.5) 35 (87.5) 
* p≤.05 
Abbreviations: UTD = up-to-date 
† Unable to run due to lack of numbers
 370 
 
Side-effect perception at T2 
Of participants included in similarity ratings task analyses, seventeen reported 
side-effects three days after vaccination while twenty-five did not. No personal or 
clinical characteristics were found to differ by side-effect perception at T2. Table 
27 shows mean bias scores by outcome. 
There was a main effect of source of health threat (F(1,40)= 7.49, p=.01, p²=.16; 
see Table 28) on bias with more negative bias for naturally-occurring health 
threats (M=-0.17, 95% CI [-0.24 to -0.09]) than man-made health threats (M=-
0.05, 95% CI [-0.14 to 0.03]). There was also a main effect of item type (F(1,40)= 
39.67, p<.001, p²=.50), with more negative bias for target items (M=-0.34, 95% 
CI [-0.46 to -0.21]) compared to foil items (M=0.12, 95% CI [0.05 to 0.19). There 
was an interaction seen between source of health threat and item type (F(1,40)= 
6.46, p=.02, p²=.14), with a difference between bias for man-made and 
naturally-occurring health threats only in the target item condition (target items: 
t(41)=3.03, p=.004; foil items t(41)=0.18, p=.86; see Figure 11). There was no 
main effect of side-effect perception at T2 on negative interpretation bias 
(F(1,40)= 0.46, p=.83, p²=.001), nor were there any other interaction effects. 
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Table 27. Mean interpretation bias scores (95% CI) by perception of side-effects from vaccination, re-vaccination intention for 2017/18 and re-
vaccination in 2017/18 
 Perception of side-effects at T2 Perception of side-effects at T3 Re-vaccination intention in 
2017/18 season 

























threat target items 
-0.25 (-0.45 to -
0.05) 
-0.22 (-0.44 to 
0.004) 
-0.06 (-0.36 to 
0.25) 
-0.27 (-0.48 to -
0.05) 
0.04 (-1.58 to 
1.65) 
-0.24 (-0.38 to 
-0.09) 
-0.33 (-0.74 to 
0.07) 
-0.20 (-0.37 to 
-0.03) 
Man-made health 
threat foil items 
0.16 (-0.02 to 
0.29) 
0.09 (-0.004 to 
0.19) 
0.15 (0.003 to 
0.29) 
0.13 (-0.01 to 
0.26) 
-0.04 (-0.20 to 
0.122) 
0.15 (0.06 to 
0.25) 
0.03 (-0.07 to 
0.13) 
0.12 (0.04 to 
0.21) 
Naturally-occurring 
health threat target 
items 
-.05 (-0.73 to -
0.27) 
-0.39 (-0.55 to -
0.23) 
-0.36 (-0.64 to -
0.08) 
-0.41 (-0.59 to -
0.24) 
-0.47 (-1.83 to 
0.89) 
-0.41 (-0.54 to 
-0.28) 
-0.40 (-0.87 to 
0.07) 
-0.42 (-0.56 to 
-0.28) 
Naturally-occurring 
health threat foil 
items 
0.12 (0.03 to 
0.22) 
0.10 (-0.02 to 
0.23) 
0.17 (0.01 to 
0.32) 
0.15 (-0.004 to 
0.30) 
-0.03 (-0.18 to 
0.11) 
0.15 (0.05 to 
0.24) 
-0.01 (-0.23 to 
0.20) 




Table 28. Results of three-way ANOVAs between interpretation bias and 
perception of side-effects from vaccination, re-vaccination intention for 2017/18, 
re-vaccination in 2017/18  






Source of health threat (man-made, 
naturally-occurring) 
7.4 (1,40) .01* .16 
Side-effect perception (side-effect 
perceived, no side-effects perceived) 
0.05 (1,40) .83 .001 
Item type (target, foil) 39.67 (1,40) <.001* .50 
Source of health threat*side-effect 
perception 
0.59 (1,40) .45 .02 
Item type*side-effect perception 0.60 (1,40) .44 .02 
Source of health threat*item type 6.46 (1,40) .02* .14 
Source of health threat*side-effect 
perception*item type 




Source of health threat (man-made, 
naturally-occurring) 
5.21 (1,34) .03* .13 
Side-effect perception (side-effect 
perceived, no side-effects perceived) 
0.71 (1,34) .40 .02 
Item type (target, foil) 24.59 (1,34) <.001* .42 
Source of health threat*side-effect 
perception 
0.87 (1,34) .36 .03 
Item type*side-effect perception 0.45 (1,34) .51 .01 
Source of health threat*item type 7.23 (1,34) .01* .18 
Source of health threat*side-effect 
perception*item type 





Source of health threat (man-made, 
naturally-occurring) 
5.12 (1,43) .03* .11 
Re-vaccination intention (intend to re-
vaccinate, do not intend to re-vaccinate) 
0.07 (1,43) .79 .002 
Item type (target, foil) 5.68 (1,43) .02* .12 
Source of health threat*intend to re-
vaccinate 
1.18 (1,43) .28 .03 
Item type* intend to re-vaccinate 1.13 (1,43) .29 .03 
Source of health threat*item type 5.60 (1,43) .02* .12 
Source of health threat* intend to re-
vaccinate *item type 




Source of health threat (man-made, 
naturally-occurring) 
2.29 (1,40) .14 .05 
Vaccinated (re-vaccinated, not re-
vaccinated) 
0.94 (1,40) .34 .02 
Item type (target, foil) 17.91 (1,40) <.001* .31 
Source of health threat*re-vaccinated 0.23 (1,40) .64 .01 
Item type*re-vaccinated 0.11 (1,40) .74 .003 
Source of health threat*item type 1.55 (1,40) .22 .04 
Source of health threat*re-
vaccinated*item type 





Figure 11. Mean negative interpretation bias by source of health threat, item type 
and side-effect perception at T2 
 
 
Side-effect perception at T3 
Of participants included in similarity ratings task analyses, twelve reported side-
effects one month after vaccination while twenty-four did not. No personal or 
clinical characteristics were found to differ by side-effect perception at T3. 
There was a main effect of source of health threat (F(1,34)= 5.21, p=.03, p²=.13; 
see Table 28) on bias with more negative bias for naturally-occurring health 
threats (M=-0.11, 95% CI [-0.21 to -0.01]) than man-made health threats (M=-
0.01, 95% CI [-0.12 to 0.09]). There was also a main effect of item type (F(1,34)= 
24.59, p<.001, p²=.42), with more negative bias for target items (M=-0.27, 95% 
CI [-0.42 to -0.13]) compared to foil items (M=0.15, 95% CI [0.04 to 0.25). There 
was an interaction seen between source of health threat and item type (F(1,40)= 
6.46, p=.02, p²=.14), with a difference between means for man-made and natural 
health sources only in the target item condition (target items: t(35)=2.64, p=.01; 
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foil items t(35)=-0.58, p=.57; see Figure 12). There was no main effect of side-
effect perception at T3 (F(1,34)= 0.71, p=.40, p²=.02) on negative interpretation 
bias, nor were there any other interaction effects. 
Figure 12. Mean negative interpretation bias by source of health threat, item type 
and side-effect perception at T3 
 
 
Re-vaccination intention for 2017/18 
Of participants included in similarity ratings task analyses, 42 intended to re-
vaccinate their child in 2017/18 while three did not definitely intend to re-
vaccinate their child. No personal or clinical characteristics were found to differ 
by re-vaccination intention. 
There was a main effect of source of health threat (F(1,43)= 5.12, p=.03, p²=.11; 
see Table 28) on bias with more negative bias for naturally-occurring health 
threats (M=-0.19, 95% CI [-0.35 to -0.03]) than man-made health threats (M=-
0.02, 95% CI [-0.19 to 0.15]). There was also a main effect of item type (F(1,43)= 
5.68, p=.02, p²=.12), with more negative bias for target items (M=-0.27, 95% CI 
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[-0.51 to -0.03]) compared to foil items (M=0.06, 95% CI [-0.10 to 0.22). There 
was an interaction seen between source of health threat and item type (F(1,40)= 
6.46, p=.02, p²=.14), with a difference between means for man-made and natural 
health sources only in the target item condition (target items: t(44)=3.05, p=.004; 
foil items t(44)=0.14, p=.89; see Figure 13). There was no main effect of 
intention on negative interpretation bias (F(1,43)= 0.07, p=.79, p²=.002), nor 
were there any other interaction effects. 
Figure 13. Mean negative interpretation bias by source of health threat, item type 
and re-vaccination intention for 2017/18 
 
 
Re-vaccination in 2017/18 
Of participants included in similarity ratings task analyses, thirty-five re-
vaccinated their child in the 2017/18 influenza season while seven did not. No 




There was a main effect of item type (F(1,40)= 17.91, p<.001, p²=.31), with 
more negative bias for target items (M=-0.34, 95% CI [-0.51 to -0.17]) compared 
to foil items (M=0.068, 95% CI [-0.02 to 0.16). There was no main effect of re-
vaccination or source of health threat on negative interpretation bias (F(1,40)= 
0.94, p=.34, p²=.02), nor were there any interaction effects.
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Appendix 15. Personal and clinical characteristics of 
those who were and were not included in 
interpretation bias analyses in the prospective cohort 
study 
 Level Included in analyses 
(n=75), n (%) 
Not included in analyses 




Female 58 (35.2) 107 (64.8) .04* 
Male 17 (54.8) 14 (45.2) 
Parent age 35+ 48 (40.7) 70 (59.3) .25 




Present 20 (40.8) 29 (59.2) .70 





Yes 29 (40.3) 43 (59.7) .67 
No 39 (37.1) 66 (62.9) 
Child 
gender 
Female 40 (39.2) 62 (60.8) .70 
Male 34 (36.6) 59 (63.4) 
First-born 
child 
Yes 48 (39.7) 73 (60.3) .61 
No 27 (36.0) 48 (64.0) 
Child age 2-4 
years 




Present 6 (33.3) 12 (66.7) .65 
None 69 (38.8) 109 (61.2) 
*p≤.05 
